Document:

EX-4.1

 Exhibit 4.1 

 
  
  

 
  
  

 
  
  

 
 INDENTURE 

Dated as of April 9, 2014 
 Among

 KINDRED HEALTHCARE, INC., 

THE GUARANTORS NAMED ON THE SIGNATURE PAGES HERETO 

and 
 WELLS FARGO BANK, NATIONAL
ASSOCIATION, 
 as Trustee 

6.375% SENIOR NOTES DUE 2022 

 CROSS-REFERENCE TABLE* 
  

			
	Trust Indenture Act Section	  	Indenture Section
	 310(a)(1)
	  	7.10
	       (a)(2)
	  	7.10
	       (a)(3)
	  	N.A.
	       (a)(4)
	  	N.A.
	       (a)(5)
	  	7.10
	       (b)
	  	7.10
	       (c)
	  	N.A.
	 311(a)
	  	7.11
	       (b)
	  	7.11
	       (c)
	  	N.A.
	 312(a)
	  	2.05
	       (b)
	  	12.03
	       (c)
	  	12.03
	 313(a)
	  	7.06
	       (b)(1)
	  	N.A.
	       (b)(2)
	  	7.06;7.07
	       (c)
	  	7.06;12.02
	       (d)
	  	7.06
	 314(a)
	  	4.03; 4.04;12.05
	       (b)
	  	N.A.
	       (c)(1)
	  	12.04
	       (c)(2)
	  	12.04
	       (c)(3)
	  	N.A.
	       (d)
	  	N.A.
	       (e)
	  	12.05
	       (f)
	  	N.A.
	 315(a)
	  	7.01
	       (b)
	  	7.05
	       (c)
	  	7.01
	       (d)
	  	7.01
	       (e)
	  	6.14
	 316(a)(last sentence)
	  	2.11
	       (a)(1)(A)
	  	6.05
	       (a)(1)(B)
	  	6.04
	       (a)(2)
	  	N.A.
	       (b)
	  	6.07
	       (c)
	  	1.05, 2.14
	 317(a)(1)
	  	6.08
	       (a)(2)
	  	6.12
	       (b)
	  	2.04
	 318(a)
	  	12.01
	       (b)
	  	N.A.
	       (c)
	  	12.01

 N.A. means not applicable. 
  

	*	This Cross-Reference Table is not part of this Indenture. 

 TABLE OF CONTENTS 
  

 

							
	 	 	 	  	Page	 
	 ARTICLE 1
	   

	
	 DEFINITIONS AND INCORPORATION BY REFERENCE
	   

			
	 Section 1.01
	 	Definitions	  	 	1	  
	 Section 1.02
	 	Other Definitions	  	 	27	  
	 Section 1.03
	 	Incorporation by Reference of Trust Indenture Act	  	 	28	  
	 Section 1.04
	 	Rules of Construction	  	 	29	  
	 Section 1.05
	 	Acts of Holders	  	 	29	  
	
	 ARTICLE 2
	   

	
	 THE NOTES
	   

			
	 Section 2.01
	 	Form and Dating; Terms	  	 	30	  
	 Section 2.02
	 	Execution and Authentication	  	 	36	  
	 Section 2.03
	 	Registrar and Paying Agent	  	 	37	  
	 Section 2.04
	 	Paying Agent to Hold Money in Trust	  	 	37	  
	 Section 2.05
	 	Holder Lists	  	 	38	  
	 Section 2.06
	 	Transfer and Exchange	  	 	38	  
	 Section 2.07
	 	[Reserved.]	  	 	41	  
	 Section 2.08
	 	Form of Certificate to be Delivered in Connection with Transfers Pursuant to Regulation S	  	 	41	  
	 Section 2.09
	 	Replacement Notes	  	 	42	  
	 Section 2.10
	 	Outstanding Notes	  	 	42	  
	 Section 2.11
	 	Treasury Notes	  	 	43	  
	 Section 2.12
	 	Temporary Notes	  	 	43	  
	 Section 2.13
	 	Cancellation	  	 	43	  
	 Section 2.14
	 	Defaulted Interest	  	 	43	  
	 Section 2.15
	 	CUSIP Numbers	  	 	44	  
	
	 ARTICLE 3
	  

	
	 REDEMPTION
	  

			
	 Section 3.01
	 	Notices to Trustee	  	 	44	  
	 Section 3.02
	 	Selection of Notes to Be Redeemed or Purchased	  	 	44	  
	 Section 3.03
	 	Notice of Redemption	  	 	44	  
	 Section 3.04
	 	Effect of Notice of Redemption	  	 	45	  
	 Section 3.05
	 	Deposit of Redemption or Purchase Price	  	 	46	  
	 Section 3.06
	 	Notes Redeemed or Purchased in Part	  	 	46	  
	 Section 3.07
	 	Optional Redemption	  	 	46	  
	 Section 3.08
	 	Mandatory Redemption	  	 	47	  
	 Section 3.09
	 	Offers to Repurchase by Application of Excess Proceeds	  	 	47	  
		
	 ARTICLE 4
	  			
		
	 COVENANTS
	  			
			
	 Section 4.01
	 	Payment of Notes	  	 	48	  
	 Section 4.02
	 	Maintenance of Office or Agency	  	 	48	  

  
 -i- 

							
	 	 	 	  	Page	 
	 Section 4.03
	 	Reports and Other Information	  	 	49	  
	 Section 4.04
	 	Compliance Certificate	  	 	50	  
	 Section 4.05
	 	Taxes	  	 	50	  
	 Section 4.06
	 	Stay, Extension and Usury Laws	  	 	50	  
	 Section 4.07
	 	Limitation on Restricted Payments	  	 	51	  
	 Section 4.08
	 	Limitation on Restrictions on Distributions from Restricted Subsidiaries	  	 	55	  
	 Section 4.09
	 	Limitation on Indebtedness	  	 	56	  
	 Section 4.10
	 	Sales of Assets and Subsidiary Stock	  	 	60	  
	 Section 4.11
	 	Transactions with Affiliates	  	 	63	  
	 Section 4.12
	 	Limitation on Liens	  	 	64	  
	 Section 4.13
	 	Corporate Existence	  	 	65	  
	 Section 4.14
	 	Offer to Repurchase Upon Change of Control	  	 	65	  
	 Section 4.15
	 	Future Subsidiary Guarantors	  	 	66	  
	 Section 4.16
	 	[Reserved]	  	 	67	  
	 Section 4.17
	 	Suspension of Covenants	  	 	67	  
		
	 ARTICLE 5
	  			
		
	 SUCCESSORS
	  			
	 Section 5.01
	 	Merger and Consolidation	  	 	68	  
	 Section 5.02
	 	Successor Entity Substituted	  	 	69	  
	
	 ARTICLE 6
	   

	
	 DEFAULTS AND REMEDIES
	   

			
	 Section 6.01
	 	Events of Default	  	 	70	  
	 Section 6.02
	 	Acceleration	  	 	72	  
	 Section 6.03
	 	Other Remedies	  	 	72	  
	 Section 6.04
	 	Waiver of Past Defaults	  	 	73	  
	 Section 6.05
	 	Control by Majority	  	 	73	  
	 Section 6.06
	 	Limitation on Suits	  	 	73	  
	 Section 6.07
	 	Rights of Holders of Notes to Receive Payment	  	 	74	  
	 Section 6.08
	 	Collection Suit by Trustee	  	 	74	  
	 Section 6.09
	 	Restoration of Rights and Remedies	  	 	74	  
	 Section 6.10
	 	Rights and Remedies Cumulative	  	 	74	  
	 Section 6.11
	 	Delay or Omission Not Waiver	  	 	74	  
	 Section 6.12
	 	Trustee May File Proofs of Claim	  	 	74	  
	 Section 6.13
	 	Priorities	  	 	75	  
	 Section 6.14
	 	Undertaking for Costs	  	 	75	  
	
	 ARTICLE 7
	   

	
	 TRUSTEE
	   

			
	 Section 7.01
	 	Duties of Trustee	  	 	75	  
	 Section 7.02
	 	Rights of Trustee	  	 	76	  
	 Section 7.03
	 	Individual Rights of Trustee	  	 	78	  
	 Section 7.04
	 	Trustee’s Disclaimer	  	 	78	  
	 Section 7.05
	 	Notice of Defaults	  	 	78	  
	 Section 7.06
	 	Reports by Trustee to Holders of the Notes	  	 	78	  
	 Section 7.07
	 	Compensation and Indemnity	  	 	78	  
	 Section 7.08
	 	Replacement of Trustee	  	 	79	  
	 Section 7.09
	 	Successor Trustee by Merger, Etc.	  	 	80	  

  
 -ii- 

							
	 	 	 	  	Page	 
	 Section 7.10
	 	Eligibility; Disqualification	  	 	80	  
	 Section 7.11
	 	Preferential Collection of Claims Against the Company	  	 	80	  
	
	 ARTICLE 8
	   

	
	 LEGAL DEFEASANCE AND COVENANT DEFEASANCE
	   

			
	 Section 8.01
	 	Option to Effect Legal Defeasance or Covenant Defeasance	  	 	80	  
	 Section 8.02
	 	Legal Defeasance and Discharge	  	 	80	  
	 Section 8.03
	 	Covenant Defeasance	  	 	81	  
	 Section 8.04
	 	Conditions to Legal or Covenant Defeasance	  	 	82	  
	 Section 8.05
	 	Deposited Money and U.S. Government Obligations to Be Held in Trust; Other Miscellaneous Provisions	  	 	82	  
	 Section 8.06
	 	Repayment to the Company	  	 	83	  
	 Section 8.07
	 	Reinstatement	  	 	83	  
	
	 ARTICLE 9
	   

	
	 AMENDMENT, SUPPLEMENT AND WAIVER
	   

			
	 Section 9.01
	 	Without Consent of Holders of Notes	  	 	83	  
	 Section 9.02
	 	With Consent of Holders of Notes	  	 	85	  
	 Section 9.03
	 	Compliance with Trust Indenture Act	  	 	86	  
	 Section 9.04
	 	Revocation and Effect of Consents	  	 	86	  
	 Section 9.05
	 	Notation on or Exchange of Notes	  	 	86	  
	 Section 9.06
	 	Trustee to Sign Amendments, Etc.	  	 	86	  
	
	 ARTICLE 10
	   

	
	 SUBSIDIARY GUARANTEES
	   

			
	 Section 10.01
	 	Subsidiary Guarantee	  	 	86	  
	 Section 10.02
	 	Limitation on Subsidiary Guarantor Liability	  	 	88	  
	 Section 10.03
	 	Execution and Delivery	  	 	88	  
	 Section 10.04
	 	Subrogation	  	 	88	  
	 Section 10.05
	 	Benefits Acknowledged	  	 	88	  
	 Section 10.06
	 	Release of Subsidiary Guarantees	  	 	89	  
	
	 ARTICLE 11
	   

	
	 SATISFACTION AND DISCHARGE
	   

			
	 Section 11.01
	 	Satisfaction and Discharge	  	 	89	  
	 Section 11.02
	 	Application of Trust Money	  	 	90	  
	
	 ARTICLE 12
	   

	
	 MISCELLANEOUS
	   

			
	 Section 12.01
	 	Trust Indenture Act Controls	  	 	91	  
	 Section 12.02
	 	Notices	  	 	91	  
	 Section 12.03
	 	Communication by Holders of Notes with Other Holders of Notes	  	 	92	  
	 Section 12.04
	 	Certificate and Opinion as to Conditions Precedent	  	 	92	  
	 Section 12.05
	 	Statements Required in Certificate or Opinion	  	 	92	  
	 Section 12.06
	 	Rules by Trustee and Agents	  	 	92	  

  
 -iii- 

							
	 	 	 	  	Page	 
	 Section 12.07
	 	No Personal Liability of Directors, Officers, Employees and Stockholders	  	 	93	  
	 Section 12.08
	 	Governing Law	  	 	93	  
	 Section 12.09
	 	Waiver of Jury Trial	  	 	93	  
	 Section 12.10
	 	Force Majeure	  	 	93	  
	 Section 12.11
	 	No Adverse Interpretation of Other Agreements	  	 	93	  
	 Section 12.12
	 	Successors	  	 	93	  
	 Section 12.13
	 	Severability	  	 	93	  
	 Section 12.14
	 	Counterpart Originals	  	 	93	  
	 Section 12.15
	 	Table of Contents, Headings, etc.	  	 	94	  
	 Section 12.16
	 	Qualification of Indenture	  	 	94	  
	 Section 12.17
	 	U.S.A. Patriot Act	  	 	94	  

  

					
	 Exhibit A
	 	Form of Initial Note	  	
	 Exhibit B
	 	Form of Exchange Note	  	
	 Exhibit C
	 	Form of Supplemental Indenture to Be Delivered by Subsequent Subsidiary Guarantors	  	

  
 -iv- 

 INDENTURE, dated as of April 9, 2014, among Kindred Healthcare, Inc., a Delaware corporation
(the “Company”), the Subsidiary Guarantors (as defined herein) listed on the signature pages hereto and Wells Fargo Bank, National Association, as Trustee. 

W I T N E S S E T H 
 WHEREAS,
the aggregate principal amount of the Notes that may be authenticated and delivered under this Indenture is unlimited; 
 WHEREAS, the
Company has duly authorized the issuance of $500,000,000 aggregate principal amount of 6.375% Senior Notes due 2022 (the “Initial Notes”); and 

WHEREAS, the Company and each of the Subsidiary Guarantors have duly authorized the execution and delivery of this Indenture. 

NOW, THEREFORE, the Company, the Subsidiary Guarantors and the Trustee agree as follows for the benefit of each other and for the equal and
ratable benefit of the Holders of the Notes. 
 ARTICLE 1 

DEFINITIONS AND INCORPORATION BY REFERENCE 

Section 1.01 Definitions. 

“ABL Facility” means the credit facility provided under the ABL Credit Agreement dated as of June 1, 2011 among the
Company, the lenders party thereto from time to time in their capacities as lenders thereunder, and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent, including any notes, mortgages, guarantees, collateral documents,
instruments and agreements executed in connection therewith, and any amendments, supplements, modifications, extensions, amendment and restatements, replacements, renewals, restatements, refundings or refinancings thereof and any one or more
indentures or credit facilities or commercial paper facilities with banks or other institutional lenders or investors that extend, replace, refund, refinance, renew or defease any part of the loans, notes, other credit facilities or commitments
thereunder, including any such replacement, refunding or refinancing facility or indenture that increases the amount borrowable thereunder (provided that such increase in borrowing is permitted under Section 4.09) or alters the maturity
thereof or adds Restricted Subsidiaries as additional borrowers or guarantors thereunder and whether by the same or any other agent, lender or group of lenders. 

“Acquired Indebtedness” means, with respect to any specified Person, 

(a) Indebtedness of any Person or any of its Subsidiaries existing at the time such Person becomes a Restricted Subsidiary or
merges with or into the Company or a Restricted Subsidiary; or 
 (b) assumed in connection with the acquisition of property
or assets from such Person, in each case whether or not Incurred by such Person in connection with, or in anticipation or contemplation of, such Person becoming a Restricted Subsidiary or such merger or acquisition, and Indebtedness secured by a
Lien encumbering any property or asset acquired by such specified Person. 
 Acquired Indebtedness shall be deemed to have been Incurred,
with respect to clause (a) of the preceding sentence, on the date such Person becomes a Restricted Subsidiary or merges with or into the Company or a Restricted Subsidiary and, with respect to clause (b) of the preceding sentence, on the
date of consummation of such acquisition of property or assets. The term “Acquired Indebtedness” does not include Indebtedness of a Person that is redeemed, defeased, retired or otherwise repaid at the time of or immediately upon
consummation of the transactions by which such Person becomes a Restricted Subsidiary or merges with or into the Company or a Restricted Subsidiary or such property or assets are acquired, which Indebtedness of such Person will not be deemed to be
Indebtedness of the Company or any Restricted Subsidiary. 

 “Additional Assets” means: 

(1) any property, plant, equipment or other asset (excluding any asset classified as a current asset under GAAP), including
improvements thereto through capital expenditures or otherwise, to be used, or that is useful, in a Similar Business; 
 (2)
all or substantially all of the assets of a Similar Business; 
 (3) the Capital Stock of a Person that becomes a Restricted
Subsidiary as a result of the acquisition of such Capital Stock by the Company or a Restricted Subsidiary; or 
 (4) Capital
Stock in any Person that at such time is a Restricted Subsidiary; 
 provided, however, that, in the case of clauses (3) and (4), such
Restricted Subsidiary is primarily engaged in a Similar Business. 
 “Additional Interest” means the additional
interest payable as a consequence of the failure to effectuate in a timely manner the Exchange Offer and/or shelf registration procedures set forth in the Registration Rights Agreement and the additional interest payable pursuant to
Section 6.01(c) of this Indenture. 
 “Additional Notes” means additional Notes (other than the Initial Notes and
other than Exchange Notes for such Initial Notes) issued from time to time under this Indenture in accordance with Sections 2.01 and 4.09. 

“Affiliate” of any specified Person means any other Person, directly or indirectly, controlling or controlled by or under
direct or indirect common control with such specified Person. For the purposes of this definition, “control” (including, with correlative meanings, the terms “controlling,” “controlled by” and
“under common control with”) when used with respect to any Person means possession, directly or indirectly, of the power to direct the management and policies of such Person, directly or indirectly, whether through the ownership of
voting securities, by contract or otherwise; and the terms “controlling” and “controlled” have meanings correlative to the foregoing. 

“Agent” means any Registrar or Paying Agent or Custodian. 

“Applicable Premium” means, with respect to a Note on any date of redemption, the greater of: 

(1) 1.0% of the principal amount of such Note; and 

(2) the excess, if any, of (a) the present value as of such date of redemption of (i) the redemption price of such
Note on April 15, 2017, (each such redemption price being described under Section 3.07) plus (ii) all required interest payments due on such Note through April 15, 2017 (excluding accrued but unpaid interest to the date of
redemption), computed using a discount rate equal to the Treasury Rate as of such date of redemption plus 50 basis points, over (b) the then-outstanding principal of such Note. 

Calculation of the Applicable Premium will be made by the Company or on behalf of the Company by such Person as the Company shall designate;
provided that such calculation or the correctness thereof shall not be a duty or obligation of the Trustee. 
 “Applicable
Procedures” means, with respect to any payment, tender, redemption, transfer or exchange of or for beneficial interests in any Global Note, the rules and procedures of the Depositary, Euroclear and Clearstream that apply to such payment,
tender, redemption, transfer or exchange. 
 “Asset Sale” means any direct or indirect sale, lease (other than an operating
lease entered into in the ordinary course of business), transfer, issuance or other disposition, or a series of related sales, leases, transfers, issuances or dispositions that are part of a common plan, of shares of Capital Stock of a Subsidiary of
the Company 

  
 -2- 

 
(other than directors’ qualifying shares and shares issued to foreign nationals to the extent required by applicable law), property or other assets (each referred to for the purposes of this
definition as a “disposition”) by the Company or any of its Restricted Subsidiaries, including any disposition by means of a merger, consolidation or similar transaction. 

Notwithstanding the preceding, the following items shall not be deemed to be Asset Sales: 

(1) a disposition of Capital Stock, property or other assets by a Restricted Subsidiary to the Company or by the Company or a
Restricted Subsidiary to a Restricted Subsidiary; 
 (2) the disposition of Cash Equivalents in the ordinary course of
business; 
 (3) a disposition of equipment, inventory, receivables or other tangible or intangible assets or property in the
ordinary course of business; 
 (4) a disposition of obsolete, damaged or worn-out property or equipment, or property or
equipment that is no longer useful in the conduct of the business of the Company and its Restricted Subsidiaries; 
 (5) a
disposition pursuant to a Sale/Leaseback Transaction otherwise permitted under this Indenture; 
 (6) the disposition of all
or substantially all of the assets of the Company in a manner permitted pursuant to Article 5 or any disposition that constitutes a Change of Control pursuant to this Indenture; 

(7) an issuance of Capital Stock by a Restricted Subsidiary to the Company or to a Restricted Subsidiary; 

(8) for purposes of Section 4.10 only, the making of a Permitted Investment or a disposition subject to Section 4.07;

 (9) dispositions of property or assets in a single transaction or series of related transactions with a fair market value
of less than $10.0 million; 
 (10) the creation or Incurrence of a Permitted Lien or any other Lien created or Incurred in
compliance with Section 4.12, and dispositions in connection therewith; 
 (11) dispositions of receivables in
connection with the compromise, settlement or collection thereof in the ordinary course of business or in bankruptcy or similar proceedings and exclusive of factoring or similar arrangements; 

(12) the issuance by a Restricted Subsidiary of Preferred Stock or Disqualified Stock that is permitted by Section 4.09;

 (13) a surrender or waiver of contract rights or a settlement, release or surrender of contract, tort or other claims in
the ordinary course of business; 
 (14) foreclosure on assets or property; 

(15) any sale or other disposition of Capital Stock in, or Indebtedness or other securities of, an Unrestricted Subsidiary or a
Minority-Owned Affiliate; 
 (16) with respect to a lease of any property, surrender to or repossession by the lessor of such
property, or the termination or expiration of the lease relating to such property; 

  
 -3- 

 (17) the unwinding of any Hedging Obligations; 

(18) the sale, transfer or other disposition of Investments in joint ventures (including any Minority-Owned Affiliates) to the
extent required by customary buy/sell arrangements between, the joint venture parties set forth in joint venture agreements or similar binding arrangements, provided that any Net Cash Proceeds received therewith are applied in accordance with
Section 4.10; and 
 (19) an Asset Swap. 

“Asset Swap” means any concurrent purchase and sale or exchange of any property, plant, equipment or other asset to be used,
or that is useful, in a Similar Business (including Capital Stock of a Person that is a Restricted Subsidiary at the time of, or becomes a Restricted Subsidiary as a result of, the relevant transaction) between the Company or any Restricted
Subsidiary and another Person; provided that, taken as a whole, the fair market value of any such property, plant, equipment or other asset (including any such Capital Stock and cash) received by the Company or any such Restricted Subsidiary
in such purchase or exchange is at least equal to the fair market value of the property, plant, equipment or other asset of the Company or any such Restricted Subsidiary sold or exchanged (in each case, such fair market value to be determined as of
the date of contractually agreeing to such Asset Swap); provided, further, that any cash received must be applied in accordance with Section 4.10 as if the Asset Swap was an Asset Sale. 

“Attributable Indebtedness” in respect of a Sale/Leaseback Transaction means, as at the time of determination, the present
value (discounted at the interest rate implicit in the transaction) of the total obligations of the lessee for rental payments during the remaining term of the lease included in such Sale/Leaseback Transaction (including any period for which such
lease has been extended), determined in accordance with GAAP; provided, however, that if such Sale/Leaseback Transaction results in a Capitalized Lease Obligation, the amount of Indebtedness represented thereby will be determined in
accordance with the definition of “Capitalized Lease Obligations.” 
 “Average Life” means, as of the date of
determination, with respect to any Indebtedness or Preferred Stock, the quotient obtained by dividing (1) the sum of the products of the numbers of years from the date of determination to the dates of each successive scheduled principal payment
of such Indebtedness or redemption or similar payment with respect to such Preferred Stock multiplied by the amount of such payment by (2) the sum of all such payments. 

“Bankruptcy Custodian” means any receiver, trustee, assignee, liquidator, custodian or similar official under any Bankruptcy
Law. 
 “Bankruptcy Law” means Title 11, U.S. Code or any similar federal or state law for the relief of debtors. 

“Board of Directors” means: 

(1) with respect to a corporation, the board of directors of the corporation or a duly authorized committee of the board of
directors; 
 (2) with respect to a partnership, the board of directors of the general partner of the partnership; 

(3) with respect to a limited liability company, the managing member or members or any controlling committee or board of
managers of such company or the Board of Directors of the sole member or the managing member thereof; and 
 (4) with respect
to any other Person, the board or committee of such Person serving a similar function. 

  
 -4- 

 “Borrowing Base” means, as of any date of determination, 85% of the book value
of the receivables of the Company and each of the Restricted Subsidiaries that guarantee or borrow under the ABL Facility or any other revolving credit facility Incurred pursuant to clause (1) of the Section 4.09(b), as determined in
accordance with GAAP as of the end of the most recent calendar month that ended at least 30 days prior to such date of determination or such later date upon which the Company has provided a calculation of the book value of such receivables for
lenders or investors under a Credit Facility, after giving pro forma effect to the occurrence of any event by which any Person became or ceased to be a Restricted Subsidiary or merged with or into the Company or a Restricted Subsidiary since
such end of a calendar month, including any such event that occurs on such date of determination. 
 “Business Day” means
each day that is not a Saturday, Sunday or other day on which banking institutions in New York, New York or the cities in which the corporate trust offices of the Trustee are located (currently in Chicago, Illinois and Minneapolis, Minnesota) are
authorized or required by law to close. 
 “Capital Stock” of any Person means any and all shares, interests, rights to
purchase, participations (including rights to receive a share of profits or losses), equity appreciation rights or other equivalents (however designated) of or in equity of such Person, including any Preferred Stock or any limited liability company,
membership or partnership interests (whether general or limited), together with any and all warrants, options or other rights to purchase or acquire any of the foregoing, but excluding any debt securities convertible into or exchangeable for any of
the foregoing. 
 “Capitalized Lease Obligations” means an obligation that is required to be classified and accounted for
as a capitalized lease for financial reporting purposes in accordance with GAAP, and the amount of Indebtedness represented by such obligation will be the capitalized amount of such obligation at the time any determination thereof is to be made as
determined in accordance with GAAP, and the Stated Maturity thereof will be the date of the last payment of rent or any other amount due under such lease prior to the first date such lease may be terminated without penalty. 

“Cash Equivalents” means: 

(1) U.S. dollars, or in the case of any Foreign Subsidiary, such local currencies held by it from time to time in the ordinary
course of business; 
 (2) securities issued or directly and fully guaranteed or insured by the United States Government or
any agency or instrumentality of the United States (provided that the full faith and credit of the United States is pledged in support thereof), having maturities of not more than one year from the date of acquisition; 

(3) marketable general obligations issued by any state of the United States of America or any political subdivision of any such
state or any public instrumentality thereof maturing within one year from the date of acquisition and, at the time of acquisition, having a credit rating of “A” or better from either Standard & Poor’s Ratings Group, Inc. or
Moody’s Investors Service, Inc.; 
 (4) certificates of deposit, demand deposits, time deposits, eurodollar time
deposits, overnight bank deposits or bankers’ acceptances having maturities of not more than one year from the date of acquisition thereof issued by any commercial bank the long-term debt of which is rated at the time of acquisition thereof at
least “A” or the equivalent thereof by Standard & Poor’s Ratings Group, Inc., or “A” or the equivalent thereof by Moody’s Investors Service, Inc., and having combined capital and surplus in excess of $500.0
million; 
 (5) repurchase obligations with a term of not more than seven days for underlying securities of the types
described in clauses (2), (3) and (4) entered into with any bank meeting the qualifications specified in clause (4) above; 

(6) commercial paper rated at the time of acquisition thereof at least “A-2” or the equivalent thereof by
Standard & Poor’s Ratings Group, Inc. or “P-2” or the equivalent thereof by Moody’s Investors Service, Inc., or carrying an equivalent rating by a nationally recognized Rating Agency, if both of the two

  
 -5- 

 
named Rating Agencies cease publishing ratings of investments, and in any case maturing within one year after the date of acquisition thereof; and 

(7) interests in any investment company or money market fund which invests 95% or more of its assets in instruments of the type
specified in clauses (1) through (6) above. 
 “Change of Control” means: 

(1) the Company becomes aware (by way of a report or another filing pursuant to Section 13(d) of the Exchange Act, proxy,
vote, written notice or otherwise) of the acquisition by any “person” or “group” of related persons (as such terms are used in Sections 13(d) and 14(d) of the Exchange Act) of the beneficial ownership (as defined in Rules 13d-3
and 13d-5 under the Exchange Act), directly or indirectly, of more than 50% of the total voting power of the Voting Stock of the Company (or its successor by merger, consolidation or purchase of all or substantially all of their assets) other than
by virtue of the imposition of a holding company, the beneficial owners of whose Voting Stock would not have caused a Change of Control if such beneficial owners had directly held the Voting Stock of the Company held by such holding company; or 

(2) during any period of 24 consecutive calendar months, individuals who were members of the Board of Directors of the Company
on the first day of such period (together with any new directors whose election or appointment by such members or whose nomination for election by the shareholders of the Company was approved by a vote of a majority of the directors then still in
office who were either directors at the beginning of such period or whose election or nomination for election was previously so approved) shall cease to constitute a majority of the Board of Directors of the Company; or 

(3) the sale, assignment, lease, conveyance, transfer or other disposition (other than by way of merger or consolidation), in
one or a series of related transactions, of all or substantially all of the assets of the Company and its Subsidiaries taken as a whole to any “person” (as such term is used in Sections 13(d) and 14(d) of the Exchange Act); or 

(4) the adoption by the stockholders of the Company of a plan or proposal for the liquidation or dissolution of the Company.

 “Code” means the Internal Revenue Code of 1986, as amended. 

“Commodity Agreement” means any commodity futures contract, commodity swap, commodity option or other similar agreement or
arrangement entered into by the Company or any Restricted Subsidiary designed or intended to protect the Company or any of its Restricted Subsidiaries against fluctuations in the price of commodities actually used in the ordinary course of business
of the Company and its Restricted Subsidiaries. 
 “Common Stock” means with respect to any Person, any and all shares of,
interest or other participations in, and other equivalents (however designated and whether voting or nonvoting) of such Person’s common stock whether or not outstanding on the Issue Date, and includes, without limitation, all series and classes
of such common stock. 
 “Company” means Kindred Healthcare, Inc., a Delaware corporation, and any successor in interest
thereto. 
 “Company Order” means a written request or order signed on behalf of the Company by an Officer of the Company,
who must be the principal executive officer, the principal financial officer, the treasurer or the principal accounting officer of the Company, and delivered to the Trustee. 

  
 -6- 

 “Consolidated Coverage Ratio” means as of any date of determination, with
respect to any Person, the ratio of (x) the aggregate amount of Consolidated EBITDA of such Person for the period of the most recent four consecutive fiscal quarters ending prior to the date of such determination for which financial statements
prepared on a consolidated basis in accordance with GAAP are available to (y) Consolidated Interest Expense for such four fiscal quarters, provided, however, that: 

(1) if the Company or any Consolidated Subsidiary: 

(a) has Incurred any Indebtedness since the beginning of such period that remains outstanding on such date of determination or
if the transaction giving rise to the need to calculate the Consolidated Coverage Ratio includes an Incurrence of Indebtedness, Consolidated EBITDA and Consolidated Interest Expense for such period will be calculated after giving effect on a pro
forma basis to such Indebtedness as if such Indebtedness had been Incurred on the first day of such period (except that in making such computation, the amount of Indebtedness under any revolving Credit Facility (including, without limitation,
the ABL Facility) outstanding on the date of such calculation will be deemed to be (i) the average daily balance of such Indebtedness during such four fiscal quarters or such shorter period for which such facility was outstanding or
(ii) if such facility was created after the end of such four fiscal quarters, the average daily balance of such Indebtedness during the period from the date of creation of such facility to the date of such calculation) and the discharge of any
other Indebtedness repaid, repurchased, defeased or otherwise discharged with the proceeds of such new Indebtedness as if such discharge had occurred on the first day of such period; or 

(b) has repaid, repurchased, redeemed, retired, defeased or otherwise discharged any Indebtedness since the beginning of the
period that is no longer outstanding on such date of determination or if the transaction giving rise to the need to calculate the Consolidated Coverage Ratio includes a discharge of Indebtedness (in each case, other than Indebtedness Incurred under
any revolving Credit Facility (including, without limitation, the ABL Facility) unless such Indebtedness has been permanently repaid and the related commitment terminated), Consolidated EBITDA and Consolidated Interest Expense for such period will
be calculated after giving effect on a pro forma basis to such discharge of such Indebtedness, including with the proceeds of such new Indebtedness, as if such discharge had occurred on the first day of such period; 

(2) if since the beginning of such period the Company or any Consolidated Subsidiary will have made any Asset Sale or disposed
of or discontinued (as defined under GAAP) any company, division, operating unit, segment, business, group of related assets or properties or line of business or if the transaction giving rise to the need to calculate the Consolidated Coverage Ratio
includes such a transaction: 
 (a) the Consolidated EBITDA for such period will be reduced by an amount equal to the
Consolidated EBITDA (if positive) directly attributable to the assets or properties that are the subject of such disposition or discontinuation for such period or increased by an amount equal to the Consolidated EBITDA (if negative) directly
attributable thereto for such period; and 
 (b) Consolidated Interest Expense for such period will be reduced by an amount
equal to the Consolidated Interest Expense directly attributable to any Indebtedness of the Company or any Consolidated Subsidiary repaid, repurchased, redeemed, retired, defeased or otherwise discharged with respect to the Company and its
continuing Consolidated Subsidiaries in connection with such transaction for such period (or, if the Capital Stock of any Consolidated Subsidiary is sold, the Consolidated Interest Expense for such period directly attributable to the Indebtedness of
such Consolidated Subsidiary to the extent the Company and its continuing Consolidated Subsidiaries are no longer liable for such Indebtedness after such sale); 

(3) if since the beginning of such period the Company or any Consolidated Subsidiary (by merger or otherwise) will have made an
Investment in any Consolidated Subsidiary (or any Person that becomes a Consolidated Subsidiary or is merged or consolidated with or into the Company or a Consolidated Subsidiary) or an acquisition of assets or property, including any acquisition of
assets or property occurring in connection with a transaction causing a calculation to be made hereunder, which constitutes all or substantially all of a company, division, operating unit, segment, business, group of related assets or properties or
line of business, Consolidated EBITDA and Consolidated Interest Expense 

  
 -7- 

 
for such period will be calculated after giving pro forma effect thereto (including the Incurrence of any Indebtedness) as if such Investment or acquisition occurred on the first day of
such period; and 
 (4) if since the beginning of such period any Person (that subsequently became a Consolidated Subsidiary
or was merged or consolidated with or into the Company or any Consolidated Subsidiary since the beginning of such period) will have Incurred any Indebtedness or discharged any Indebtedness, made any disposition or any Investment or acquisition of
assets or property that would have required an adjustment pursuant to clause (1), (2) or (3) above if made by the Company or a Consolidated Subsidiary during such period, Consolidated EBITDA and Consolidated Interest Expense for such
period will be calculated after giving pro forma effect thereto as if such transaction occurred on the first day of such period. 

For purposes of this definition, whenever pro forma effect is to be given to any calculation under this definition, the pro
forma calculations will be determined in good faith by a responsible financial or accounting Officer of the Company to reflect adjustments (i) required or permitted under Regulation S-X and (ii) at the option of the Company, to reflect
expected improvements to Consolidated EBITDA resulting from cost savings and synergies in connection with any acquisition or disposition based upon specifically identified actions that have been taken or are expected to be taken within 12 months of
the date of the relevant acquisition or disposition so long as such improvement is expected to be reflected in the Company’s Consolidated EBITDA within four fiscal quarters following the date such actions are taken. If any Indebtedness bears a
floating rate of interest and is being given pro forma effect, the interest expense on such Indebtedness will be calculated as if the rate in effect on the date of determination had been the applicable rate for the entire period (taking into
account any Interest Rate Agreement applicable to such Indebtedness if such Interest Rate Agreement has a remaining term in excess of 12 months). If any Indebtedness that is being given pro forma effect bears an interest rate at the option of
the Company, the interest rate shall be calculated by applying such optional rate chosen by the Company. 
 “Consolidated
EBITDA” means, with respect to any Person for any period, the Consolidated Net Income of such Person for such period: 

(1) increased (without duplication) by the following items to the extent deducted in calculating such Consolidated Net Income:

 (a) Consolidated Interest Expense; plus 

(b) Consolidated Income Taxes; plus 

(c) consolidated depreciation expense; plus 

(d) consolidated amortization expense or impairment charges; plus 

(e) other non-cash charges (including non-cash Restructuring Charges) reducing Consolidated Net Income, including any
write-offs or write-downs (excluding any such non-cash charge to the extent it represents an accrual of or reserve for cash charges in any future period or amortization of a prepaid cash expense that was paid in a prior period not included in the
calculation); plus 
 (f) the amount of any Restructuring Charges (other than those added back pursuant to clause
(e) above) and expenses or charges related to any proposed or consummated Equity Offering, Investment, acquisition, disposition, Incurrence of Indebtedness or recapitalization (including the Transactions); provided that any amounts added
to Consolidated Net Income for Restructuring Charges pursuant to this clause will not exceed, in any four-fiscal-quarter period, the greater of (i) $20.0 million and (ii) 5% of Consolidated EBITDA of such Person as otherwise determined in
accordance with this definition for such four-fiscal-quarter period with such pro forma adjustments as are consistent with the definition of Consolidated Coverage Ratio; plus 

  
 -8- 

 (g) the amount of “run-rate” cost savings projected by the Company in
good faith and certified by the chief financial officer of the Company to result from actions either taken or initiated prior to or during such period (which cost savings shall be calculated on a pro forma basis as though such cost savings
had been realized on the first day of such period), net of the amount of actual benefits realized prior to or during such period from such actions; provided that (A) (x) such cost savings are reasonably quantifiable and reasonably
anticipated to result from such actions and (y) such actions have been taken or initiated and the benefits resulting therefrom are anticipated by the Company to be realized within 12 months, (B) no cost savings shall be added pursuant to
this clause (g) to the extent duplicative of any expenses or charges relating to such cost savings that are included in clause (f) above with respect to such period and (C) the aggregate amount of cost savings added pursuant to this
clause (g) shall not exceed 10% of Consolidated EBITDA for any period of four consecutive fiscal quarters prior to giving effect to amounts added back pursuant to this clause (g) or such clause (f), 

(2) decreased (without duplication) by non-cash items increasing Consolidated Net Income of such Person for such period
(excluding any items which represent the reversal of any accrual of, or reserve for, anticipated cash charges that reduced Consolidated EBITDA in any prior period), and 

(3) increased or decreased by (without duplication) the following items reflected in Consolidated Net Income: 

(a) any net gain or loss resulting in such period from Hedging Obligations and the application of Accounting Standards
Codification 450; 
 (b) any net gain or loss resulting in such period from currency translation gains or losses related to
currency remeasurements of Indebtedness (including any net loss or gain resulting from Hedging Obligations for currency exchange risk); and 

(c) effects of adjustments (including the effects of such adjustments pushed down to the Company and its Restricted
Subsidiaries) in any line item in such Person’s consolidated financial statements pursuant to GAAP resulting from the application of purchase accounting in relation to any completed acquisition. 

“Consolidated Income Taxes” means, with respect to any Person for any period, taxes imposed upon such Person or other
payments required to be made by such Person by any governmental authority which taxes or other payments are calculated by reference to the income or profits or capital of such Person or such Person and its Consolidated Subsidiaries (to the extent
such income or profits were included in computing Consolidated Net Income for such period), including, without limitation, state, franchise and similar taxes and foreign withholding taxes regardless of whether such taxes or payments are required to
be remitted to any governmental authority. 
 “Consolidated Interest Expense” means, for any period, the total interest
expense of the Company and its Consolidated Subsidiaries, whether paid or accrued, plus, to the extent not included in such interest expense (without duplication): 

(1) interest expense attributable to Capitalized Lease Obligations and the interest portion of rent expense associated with
Attributable Indebtedness in respect of the relevant lease giving rise thereto, determined as if such lease were a capitalized lease in accordance with GAAP and the interest component of any deferred payment obligations; 

(2) amortization of debt discount (including the amortization of original issue discount resulting from the issuance of
Indebtedness at less than par), but excluding amortization or write-off of debt issuance costs and non-recurring bridge, commitment and other financing fees; provided, however, that any amortization of bond premium will be credited to
reduce Consolidated Interest Expense unless, pursuant to GAAP, such amortization of bond premium has otherwise reduced Consolidated Interest Expense; 

  
 -9- 

 (3) non-cash interest expense, but excluding any non-cash interest expense
attributable to the movement in the mark to market valuation of Hedging Obligations or other derivative instruments pursuant to GAAP; 

(4) commissions, discounts and other fees and charges owed with respect to letters of credit and bankers’ acceptance
financing; 
 (5) interest actually paid by the Company or any such Consolidated Subsidiary under any Guarantee of
Indebtedness or other obligation of any other Person; 
 (6) costs associated with Hedging Obligations (including
amortization of fees); provided, however, that if Hedging Obligations result in net benefits rather than costs, such benefits shall be credited to reduce Consolidated Interest Expense unless, pursuant to GAAP, such net benefits are
otherwise reflected in Consolidated Net Income; 
 (7) the product of (a) all dividends paid or payable, in cash, Cash
Equivalents or Indebtedness, or accrued during such period, on any series of Disqualified Stock of such Person or on Preferred Stock of its Consolidated Subsidiaries payable to a party other than the Company or a Consolidated Subsidiary, times
(b) a fraction, the numerator of which is one and the denominator of which is one minus the then-current combined federal, state, provincial and local statutory tax rate of such Person, expressed as a decimal, in each case, on a consolidated
basis and in accordance with GAAP; 
 (8) Receivables Fees; and 

(9) the cash contributions to any employee stock ownership plan or similar trust to the extent such contributions are used by
such plan or trust to pay interest or fees to any Person (other than the Company and its Consolidated Subsidiaries) in connection with Indebtedness Incurred by such plan or trust. 

For the purpose of calculating the Consolidated Coverage Ratio, the calculation of Consolidated Interest Expense shall include all interest
expense (including any amounts described in clauses (1) through (9) above) relating to any Indebtedness of the Company or any Consolidated Subsidiary described in the final paragraph of the definition of “Indebtedness.” 

For purposes of the foregoing, total interest expense will be determined (i) after giving effect to any net payments made or received by
the Company and its Consolidated Subsidiaries with respect to Interest Rate Agreements and (ii) exclusive of amounts classified as other comprehensive income in the balance sheet of the Company. Notwithstanding anything to the contrary
contained herein, without duplication of clause (8) above, commissions, discounts, yield and other fees and charges Incurred in connection with any transaction pursuant to which the Company or its Consolidated Subsidiaries may sell, convey or
otherwise transfer or grant a security interest in any accounts receivable or related assets shall be included in Consolidated Interest Expense. 

“Consolidated Net Income” means, for any period, the net income (loss) of the Company and its Consolidated Subsidiaries
determined on a consolidated basis in accordance with GAAP; provided, however, that there will not be included in such Consolidated Net Income on an after-tax basis (without duplication): 

(1) any net income (loss) of any Person if such Person is not a Consolidated Subsidiary or that is accounted for by the equity
method of accounting, except that: 
 (a) subject to the limitations contained in clauses (3) through (6) below,
the Company’s equity in the net income of any such Person for such period will be included in such Consolidated Net Income up to the aggregate amount of cash actually distributed by such Person during such period to the Company or a
Consolidated Subsidiary as a dividend or other distribution (subject, in the case of a dividend or other distribution to a Consolidated Subsidiary, to the limitations contained in clause (2) below); and 

  
 -10- 

 (b) the Company’s equity in a net loss of any such Person (other than a
Consolidated Subsidiary) for such period will be included in determining such Consolidated Net Income to the extent such loss has been funded with cash from the Company or a Consolidated Subsidiary; 

(2) solely for the purpose of determining the amount available for Restricted Payments under clause (c)(i) of
Section 4.07(a), any net income (but not loss) of any Non-Guarantor Restricted Subsidiary if such Subsidiary is subject to prior government approval or other restrictions due to the operation of its charter or any agreement, instrument,
judgment, decree, order, statute, rule or government regulation (which have not been waived), directly or indirectly, on the payment of dividends or the making of distributions by such Subsidiary, directly or indirectly, to the Company, except that:

 (a) subject to the limitations contained in clauses (3) through (6) below, the Company’s equity in the net
income of any such Subsidiary for such period will be included in such Consolidated Net Income up to the aggregate amount of cash that could have been distributed by such Subsidiary during such period to the Company or another Restricted Subsidiary
as a dividend (subject, in the case of a dividend to another Restricted Subsidiary, to the limitation contained in this clause); and 

(b) the Company’s equity in a net loss of any such Subsidiary for such period will be included in determining such
Consolidated Net Income; 
 (3) (x) gains or losses from Asset Sales, (y) any effect of income (loss) from disposed or
discontinued operations and any net gains or losses on disposal of disposed, abandoned or discontinued operations pursuant to Financial Accounting Standards Board Accounting Standards Codification 205-20 and (z) any non-cash impairment charge
or asset-write off effected after the Issue Date in connection with the Transactions or any acquisition or Investment pursuant to Financial Accounting Standards Board Accounting Standards Codification 350, 360 or 805, as applicable; 

(4) any after-tax effect of income (loss) from the early extinguishment of Indebtedness or Hedging Obligations or other
derivative instruments; 
 (5) any net after-tax extraordinary gain or loss; 

(6) the cumulative effect of a change in accounting principles; 

(7) any non-cash compensation charges; and 

(8) any increase in amortization or depreciation resulting from purchase accounting adjustments in connection with any
acquisition consummated following the Issue Date. 
 “Consolidated Subsidiary” means, as to any Person at any date, any
Subsidiary or other entity the accounts of which would be consolidated with those of such Person in its consolidated financial statements if such statements were prepared as of such date. 

“Cornerstone” means Cornerstone Insurance Company, a Cayman Islands corporation. 

“Corporate Trust Office of the Trustee” shall be the address of the Trustee specified in Section 12.02, and for purposes
of Section 2.03 and Section 4.02 such office shall also mean the office or agency of the Trustee located at 608 Second Avenue South, N9303-121, Minneapolis, MN 55479, Attn: Corporate Trust Operations, or such other address as to which the
Trustee may give notice to the Holders and the Company. 
 “Credit Facility” means, with respect to the Company or any
Subsidiary Guarantor, one or more debt facilities (including, without limitation, the Senior Credit Facilities) or commercial paper facilities or indentures with banks or other institutional lenders or trustees providing for revolving credit loans,
term loans, receivables 

  
 -11- 

 
financing (including through the sale of receivables to such lenders or to special purpose entities formed to borrow from such lenders against such receivables) or letters of credit or issuances
of notes or other debt securities, in each case, as amended, restated, modified, renewed, refunded, replaced or refinanced (including by means of sales of debt securities) in whole or in part from time to time (and whether or not with the original
administrative agent and lenders or another administrative agent or agents or other lenders). 
 “Currency Agreement” means
in respect of a Person any foreign exchange contract, currency swap agreement, futures contract or option contract with respect to foreign exchange rates or currency values, or other similar agreement as to which such Person is a party or a
beneficiary. 
 “Custodian” means the Trustee, as custodian with respect to the Notes in global form, or any successor
entity thereto. 
 “Default” means any event that is, or after notice or passage of time or both would be, an Event of
Default. 
 “Definitive Note” means a certificated Initial Note, Additional Note or Exchange Note (bearing the Restricted
Notes Legend if the transfer of such Note is restricted by applicable law) that does not bear the Global Notes Legend and does not have the “Schedule of Exchanges of Interests in the Global Note” attached thereto. 

“Depositary” means, with respect to the Notes issuable or issued in whole or in part in global form, the Person specified in
Section 2.03 as the Depositary with respect to the Notes, and any and all successors thereto appointed as Depositary hereunder and having become such pursuant to the applicable provision of this Indenture. 

“Designated Noncash Consideration” means the fair market value of noncash consideration received by the Company or one of its
Restricted Subsidiaries in connection with an Asset Sale that is so designated as Designated Noncash Consideration pursuant to an Officers’ Certificate setting forth the basis of such valuation, less the amount of cash or Cash Equivalents
received in connection with a subsequent sale or other disposition, redemption or payment of, on or with respect to such Designated Noncash Consideration. 

“Disqualified Stock” means, with respect to any Person, any Capital Stock of such Person that by its terms (or by the terms
of any security into which it is convertible or for which it is exchangeable, in each case at the option of the holder thereof) or upon the happening of any event: 

(1) matures or is mandatorily redeemable pursuant to a sinking fund obligation or otherwise; 

(2) is convertible into or exchangeable for Indebtedness or Disqualified Stock (excluding Capital Stock which is convertible or
exchangeable solely at the option of the Company or a Restricted Subsidiary (it being understood that upon such conversion or exchange it shall be an Incurrence of such Indebtedness or Disqualified Stock)); or 

(3) is redeemable at the option of the holder of the Capital Stock in whole or in part, 

in each case on or prior to the date 91 days after the earlier of the final maturity date of the Notes or the date the Notes are no longer outstanding;
provided, however, that only the portion of Capital Stock that so matures or is mandatorily redeemable, is so convertible or exchangeable or is so redeemable at the option of the holder thereof prior to such date will be deemed to be
Disqualified Stock; provided further that any Capital Stock that would constitute Disqualified Stock solely because the holders thereof have the right to require the Company to repurchase such Capital Stock upon the occurrence of a change of
control or asset sale shall not constitute Disqualified Stock if the terms of such Capital Stock (and all such securities into which it is convertible or for which it is ratable or exchangeable) provide that the Company may not repurchase or redeem
any such Capital Stock pursuant to such provision prior to compliance by the Company with the provisions of this Indenture described under Sections 4.10 and 4.14 unless such repurchase or redemption complies with Section 4.07. 

“Domestic Wholly Owned Subsidiary” means any Wholly Owned Subsidiary that is organized under the laws of any State of the
United States or the District of Columbia. 

  
 -12- 

 “Equity Offering” means a public offering or private placement for cash by the
Company of Capital Stock (other than Disqualified Stock), other than (x) public offerings with respect to the Company’s Capital Stock, registered on Form S-4 or S-8, (y) an issuance to any Subsidiary of the Company or (z) any
offering of the Company’s Common Stock issued in connection with a transaction that constitutes a Change of Control. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the SEC promulgated
thereunder. 
 “Exchange Notes” means the Exchange Notes issued in exchange for the Notes pursuant to the Registration
Rights Agreement. 
 “Exchange Offer” has the meaning set forth in the Registration Rights Agreement. 

“Excluded Contribution” means net cash proceeds, marketable securities or Qualified Proceeds received by the Company from
(a) contributions to its common equity capital (other than through an issuance of Disqualified Stock) and (b) the sale (other than to a Restricted Subsidiary or an employee stock ownership plan or trust established by the Company or any
Subsidiary of the Company for the benefit of their employees to the extent funded by the Company or any Restricted Subsidiary) of Capital Stock (other than Disqualified Stock), in each case of the Company and after the Issue Date, in each case
designated as Excluded Contributions pursuant to an Officers’ Certificate on the date such capital contributions are made or the date such equity interests are sold, as the case may be. 

“Excluded Partnerships” means Fox Hill Village Partnership, Northridge Surgery Center, Ltd., Northridge Surgery Center
Development, Ltd., Starr Farm Partnership and Triumph Medical Plaza, L.P.; provided that any such partnership or limited liability company shall cease to be an Excluded Partnership at such time as such Person becomes a “Restricted
Subsidiary,” as defined under the Senior Credit Facilities. 
 “Existing Indenture” means the indenture dated as of
June 1, 2011 among the Company, the Subsidiary Guarantors and the Trustee, pursuant to which the Existing Notes have been issued, as the same may be amended and supplemented from time to time. 

“Existing Notes” means the $550,000,000 aggregate principal amount of 8.25% Senior Notes due 2019 issued by the Company
pursuant to the Existing Indenture. 
 “Foreign Subsidiary” means any Subsidiary that is not organized or existing under
the laws of any State of the United States or the District of Columbia. 
 “GAAP” means generally accepted
accounting principles in the United States of America as in effect from time to time; provided that, (x) all leases of the Company and its Restricted Subsidiaries that are treated as operating leases for purposes of GAAP on the Issue
Date shall continue to be accounted for as operating leases for all purposes of this Indenture regardless of any change to GAAP following the Issue Date which would otherwise require such leases to be treated as Capitalized Lease Obligations.
Notwithstanding any other provision contained herein, all terms of an accounting or financial nature used herein shall be construed, and all computations of amounts and ratios referred to herein shall be made, without giving effect to any election
under Financial Accounting Standards Board Accounting Standards Codification 820 (or any other Financial Accounting Standard having a similar result or effect) to value any Indebtedness or other liabilities of the Company or any Subsidiary at
“fair value,” as defined therein. 
 “Global Notes Legend” means the legend set forth in
Section 2.01(d)(2). 
 “Guarantee” means any obligation, contingent or otherwise, of any Person directly or indirectly
guaranteeing any Indebtedness of any other Person and any obligation, direct or indirect, contingent or otherwise, of such Person: 

  
 -13- 

 (1) to purchase or pay (or advance or supply funds for the purchase or payment
of) such Indebtedness of such other Person (whether arising by virtue of partnership arrangements, or by agreement to keep-well, to purchase assets, properties, goods, securities or services, to take-or-pay, or to maintain financial statement
conditions or otherwise); or 
 (2) entered into for purposes of assuring in any other manner the obligee of such
Indebtedness of the payment thereof or to protect such obligee against loss in respect thereof (in whole or in part); provided, however, that the term “Guarantee” will not include endorsements for collection or deposit in the
ordinary course of business. The term “Guarantee” used as a verb has a corresponding meaning. 
 “Guarantor Pari Passu
Indebtedness” means Indebtedness that ranks equally in right of payment to its Subsidiary Guarantee. 
 “Guarantor
Subordinated Obligation” means, with respect to a Subsidiary Guarantor, any Indebtedness of such Subsidiary Guarantor (whether outstanding on the Issue Date or thereafter Incurred) that is expressly subordinated in right of payment to the
obligations of such Subsidiary Guarantor under its Subsidiary Guarantee pursuant to a written agreement. 
 “Healthcare
Facility” means (i) a hospital, outpatient clinic, nursing center, assisted or independent living community, long-term care facility or any other facility that is used or useful in the provision of healthcare or custodial care
services, (ii) any healthcare business affiliated or associated with a Healthcare Facility (as defined in clause (i)) or (iii) any business related or ancillary to the provision of healthcare services or the operation of a Healthcare
Facility (as defined in clause (i)) including, but not limited to, pharmacy supply and services, contract therapy services, as well as hospice and home care services. 

“Hedging Obligations” of any Person means the obligations of such Person pursuant to any Interest Rate Agreement, Currency
Agreement or Commodity Agreement. 
 “Holder” means a Person in whose name a Note is registered on the Registrar’s
books. 
 “Incur” means issue, create, assume, Guarantee, incur or otherwise become liable for; provided,
however, that any Indebtedness or Capital Stock of a Person existing at the time such Person becomes a Restricted Subsidiary (whether by merger, consolidation, acquisition or otherwise) will be deemed to be Incurred by such Restricted Subsidiary
at the time it becomes a Restricted Subsidiary; and the terms “Incurred” and “Incurrence” have meanings correlative to the foregoing. 

“Indebtedness” means, with respect to any Person on any date of determination (without duplication): 

(1) the principal of and premium (if any) in respect of indebtedness of such Person for borrowed money; 

(2) the principal of and premium (if any) in respect of obligations of such Person evidenced by bonds, debentures, notes or
other similar instruments; 
 (3) the principal component of all obligations of such Person in respect of letters of credit,
bankers’ acceptances or other similar instruments (including reimbursement obligations with respect thereto except to the extent such reimbursement obligation relates to a trade payable and such obligation is satisfied within 30 days of
Incurrence); 
 (4) the principal component of all obligations of such Person to pay the deferred and unpaid purchase price
of property, which purchase price is due more than 364 days after the date of placing such property in service or taking delivery and title thereto, other than (i) any such balance that constitutes a trade payable or similar obligation to a
trade creditor, in each case accrued in the ordinary course of 

  
 -14- 

 
business or (ii) any earn-out obligation until the amount of such obligation becomes a liability on the balance sheet of such Person in accordance with GAAP; 

(5) Capitalized Lease Obligations and all Attributable Indebtedness of such Person (whether or not such items would appear on
the balance sheet of the guarantor or obligor); 
 (6) the principal component or liquidation preference of all obligations
of such Person with respect to the redemption, repayment or other repurchase of any Disqualified Stock or, with respect to any Non-Guarantor Restricted Subsidiary, any Preferred Stock (but excluding, in each case, any accrued dividends); 

(7) the principal component of all Indebtedness of other Persons secured by a Lien on any asset or property of such Person,
whether or not such Indebtedness is assumed by such Person; provided, however, that the amount of such Indebtedness will be the lesser of (a) the fair market value of such asset or property at such date of determination and (b) the amount
of such Indebtedness of such other Persons; 
 (8) the principal component of Indebtedness of other Persons to the extent
Guaranteed by such Person (whether or not such items would appear on the balance sheet of the guarantor or obligor); 
 (9)
to the extent not otherwise included in this definition, net obligations of such Person under Hedging Obligations (the amount of any such obligations to be equal at any time to the termination value of such agreement or arrangement giving rise to
such Obligation that would be payable by such Person at such time); and 
 (10) to the extent not otherwise included in this
definition, the amount of obligations outstanding under the legal documents entered into as part of a securitization transaction or series of securitization transactions that would be characterized as principal if such transaction were structured as
a secured lending transaction rather than as a purchase outstanding relating to a securitization transaction or series of securitization transactions. 

Notwithstanding anything to the contrary contained herein, neither (a) trade accounts payable nor (b) amounts owed to patients or
residents arising in the ordinary course of business nor (c) obligations arising in respect of insurance policies or performance or surety bonds which are not themselves Guarantees of Indebtedness (nor drafts, acceptances or similar instruments
evidencing the same nor obligations in respect of letters of credit supporting the payment of the same) nor (d) guarantees of any obligation of the Company or a Restricted Subsidiary pursuant to an operating lease shall constitute Indebtedness.

 The amount of Indebtedness of any Person at any date will be the outstanding balance at such date of all unconditional obligations as
described above and the maximum liability, upon the occurrence of the contingency giving rise to the obligation, of any contingent obligations at such date. 

“Indenture” means this Indenture, as amended or supplemented from time to time including the Exhibits hereto. 

“Independent Financial Advisor” means an accounting, appraisal, investment banking firm or consultant to Persons engaged in
Similar Businesses of nationally recognized standing that is, in the good faith judgment of the Company, qualified to perform the task for which it has been engaged. 

“Initial Notes” has the meaning set forth in the recitals hereto. 

“Interest Payment Date” means April 15 and October 15 of each year to the Stated Maturity of the Notes, commencing
October 15, 2014. 
 “Interest Rate Agreement” means, with respect to any Person, any interest rate protection
agreement, interest rate future agreement, interest rate option agreement, interest rate swap agreement, interest rate cap 

  
 -15- 

 
agreement, interest rate collar agreement, interest rate hedge agreement or other similar agreement or arrangement as to which such Person is party or a beneficiary. 

“Investment” means, with respect to any Person, all investments by such Person in other Persons (including Affiliates) in the
form of any direct or indirect advance, loan (other than advances or extensions of credit to customers in the ordinary course of business) or other extensions of credit (including by way of Guarantee or similar arrangement, but excluding any debt or
extension of credit represented by a bank deposit other than a time deposit) or capital contribution to (by means of any transfer of cash or other property to others or any payment for property or services for the account or use of others), or any
purchase or acquisition of Capital Stock, Indebtedness or other similar instruments issued by, such Person and all other investments in another Person that are or would be classified as investments on a balance sheet prepared in accordance with
GAAP; provided that none of the following will be deemed to be an Investment: 
 (1) Hedging Obligations entered into
in the ordinary course of business and in compliance with this Indenture; 
 (2) endorsements of negotiable instruments and
documents in the ordinary course of business; and 
 (3) an acquisition of property, assets, Capital Stock or other
securities by the Company or a Subsidiary for consideration to the extent such consideration consists of Common Stock of the Company. 
 For
purposes of Section 4.07, 
 (1) “Investment” will include the portion (proportionate to the Company’s
equity interest in a Restricted Subsidiary to be designated as an Unrestricted Subsidiary) of the fair market value of the net assets of such Restricted Subsidiary at the time that such Restricted Subsidiary is designated an Unrestricted Subsidiary;
provided, however, that upon a redesignation of such Subsidiary as a Restricted Subsidiary, the Company will be deemed to continue to have a permanent “Investment” in an Unrestricted Subsidiary in an amount (if positive)
equal to (a) the Company’s aggregate “Investment” in such Subsidiary as of the time of such redesignation less (b) the portion (proportionate to the Company’s equity interest in such Subsidiary) of the fair market value
of the net assets (as determined in good faith by an Officer of the Company (as evidenced by an Officers’ Certificate)) of such Subsidiary at the time that such Subsidiary is so re-designated a Restricted Subsidiary; and 

(2) any property transferred to or from an Unrestricted Subsidiary will be valued at its fair market value at the time of such
transfer (in each case, as determined in good faith by an Officer of the Company). 
 “Investment Grade Rating” means a
rating equal to or higher than Baa3 (or the equivalent) by Moody’s Investors Service, Inc. and BBB- (or the equivalent) by Standard & Poor’s Ratings Group, Inc., in each case, with a stable or better outlook (or the equivalent
rating from any replacement Rating Agency). 
 “Issue Date” means the date of the initial issuance of the Notes under this
Indenture. 
 “Lien” means, with respect to any asset or property, any mortgage, lien (statutory or otherwise),
pledge, hypothecation, charge, security interest, preference, priority or encumbrance of any kind in respect of such asset or property, whether or not filed, recorded or otherwise perfected under applicable law, including any conditional sale or
other title retention agreement, any lease in the nature thereof, any option or other agreement to sell or give a security interest in any asset or property and any filing of or agreement to give any financing statement under the Uniform Commercial
Code (or equivalent statutes) of any jurisdiction; provided that in no event shall an operating lease be deemed to constitute a Lien. 

  
 -16- 

 “Master Lease Agreements” means the Master Lease Agreements and any other lease
agreement pursuant to which the Company and/or one or more of its Restricted Subsidiaries lease real property, in each case with any Ventas Company in effect on the Issue Date, as amended from time to time in accordance with the terms thereof. 

“Minority-Owned Affiliate” means any Person in which the Company or any of its Restricted Subsidiaries owns any class of
Capital Stock but is not otherwise a Consolidated Subsidiary of the Company. 
 “Net Available Cash” from an Asset Sale
means the aggregate cash payments received (including any cash payments received by way of deferred payment of principal pursuant to a note or installment receivable or otherwise and net proceeds from the sale or other disposition of any securities
or other assets or property received as consideration, but only as and when received, but excluding any other consideration received in the form of assumption, by the acquiring Person, of Indebtedness or other obligations relating to the properties
or assets that are the subject of such Asset Sale or received in any other non-cash form) therefrom, in each case net of: 

(1) all legal, accounting, brokerage and investment banking fees and expenses, title and recording tax expenses, commissions
and other fees, expenses and direct costs (including, without limitation, employee severance and relocation costs and expenses) Incurred, and all federal, state, provincial, foreign and local taxes required to be paid or accrued as a liability under
GAAP (after taking into account any available tax credits or deductions and any tax sharing agreements), as a consequence of such Asset Sale; 

(2) all payments made on any Indebtedness that is secured by any assets or property subject to such Asset Sale, in accordance
with the terms of any Lien upon such assets or property, or which must by its terms, or in order to obtain a necessary consent to such Asset Sale, or by applicable law, be repaid out of the proceeds from such Asset Sale; 

(3) all distributions and other payments required to be made to minority interest holders in Subsidiaries or joint ventures as
a result of such Asset Sale; 
 (4) the deduction of appropriate amounts to be provided by the seller as a reserve, in
accordance with GAAP, against any liabilities associated with the assets or property disposed of in such Asset Sale and retained by the Company or any Restricted Subsidiary after such Asset Sale; and 

(5) until received by the selling person, any portion of the purchase price from an Asset Sale placed in escrow or withheld by
the purchaser, whether as a reserve for adjustment of the purchase price, for satisfaction of indemnities in respect of such Asset Sale or otherwise in connection with such Asset Sale. 

“Net Cash Proceeds,” with respect to any issuance or sale of Capital Stock, means the cash proceeds of such issuance or sale
net of attorneys’ fees, accountants’ fees, underwriters’ or placement agents’ fees, listing fees, discounts or commissions and brokerage, consultant and other fees and charges actually Incurred in connection with such issuance or
sale (other than those payable to the Borrower or any of its Restricted Subsidiaries or any Affiliate of the Borrower or any of its Restricted Subsidiaries except for those payable on terms and conditions as favorable to the Borrower or the
applicable Restricted Subsidiary of the Borrower as would be obtainable by it in a comparable arm’s length transaction with an independent, unrelated third party). 

“Non-Guarantor Restricted Subsidiary” means any Restricted Subsidiary that is not a Subsidiary Guarantor. 

“Note Purchase Agreement” means the purchase agreement, dated March 26, 2014, among the Company, the Subsidiary
Guarantors and J.P. Morgan Securities LLC, as representative of the several initial purchasers listed in Schedule I thereto. 

“Notes” means the Initial Notes, the Exchange Notes and more particularly means any Note authenticated and delivered under
this Indenture. For all purposes of this Indenture, the term “Notes” shall also include any Additional Notes that may be issued. For purposes of this Indenture, all references to Notes to be issued or

  
 -17- 

 
authenticated upon transfer, replacement or exchange shall be deemed to refer to Notes of the applicable series. The Notes and the Additional Notes, if any, shall be treated as a single class for
all purposes under this Indenture. 
 “Obligations” means any principal, interest (including any interest accruing
subsequent to the filing of a petition in bankruptcy, reorganization or similar proceeding at the rate provided for in the documentation with respect thereto, whether or not such interest is an allowed claim under applicable state, federal or
foreign law), other monetary obligations, penalties, fees, indemnifications, reimbursements (including reimbursement obligations with respect to letters of credit and banker’s acceptances), damages and other liabilities, and Guarantees of
payment of such principal, interest, penalties, fees, indemnifications, reimbursements, damages and other liabilities, payable under the documentation governing any Indebtedness. 

“Offering Memorandum” means the offering memorandum, dated March 26, 2014, relating to the sale of the Initial Notes.

 “Officer” means the Chairman of the Board, the Chief Executive Officer, the President, the Chief Operating Officer,
Chief Financial Officer, any Executive Vice President, Senior Vice President or Vice President, the Controller, the Treasurer or the Secretary of the Company. “Officer” of any Subsidiary Guarantor has a correlative meaning. 

“Officers’ Certificate” means a certificate signed by two Officers or by an Officer and either an Assistant Treasurer or
an Assistant Secretary of the Company. 
 “Opinion of Counsel” means a written opinion from legal counsel who may be an
employee of or counsel to the Company, or other counsel who is reasonably acceptable to the Trustee. 
 “Pari Passu
Indebtedness” means Indebtedness that ranks equally in right of payment to the Notes. 
 “Permitted Investment”
means an Investment by the Company or any Restricted Subsidiary in: 
 (1) the Company or a Restricted Subsidiary; 

(2) any Investment by the Company or any of its Restricted Subsidiaries in a Person that is engaged in a Similar Business if as
a result of such Investment: 
 (a) such Person becomes a Restricted Subsidiary; or 

(b) such Person, in one transaction or a series of related transactions, is merged or consolidated with or into, or transfers
or conveys all or substantially all of its assets to, or is liquidated into, the Company or a Restricted Subsidiary, and, in each case, any Investment held by such Person; provided that such Investment was not acquired by such Person in
contemplation of such acquisition, merger, consolidation or transfer; 
 (3) cash and Cash Equivalents; 

(4) receivables owing to the Company or any Restricted Subsidiary created or acquired in the ordinary course of business and
payable or dischargeable in accordance with customary trade terms; provided, however, that such trade terms may include such concessionary trade terms as the Company or any such Restricted Subsidiary deems reasonable under the
circumstances; 
 (5) commission, payroll, travel and similar advances to cover matters that are expected at the time of such
advances ultimately to be treated as expenses for accounting purposes and that are made in the ordinary course of business; 

  
 -18- 

 (6) loans or advances to employees, officers or directors of the Company or any
Restricted Subsidiary in the ordinary course of business consistent with past practices in an aggregate amount not in excess of $5.0 million at any one time outstanding; 

(7) any Investment acquired by the Company or any of its Restricted Subsidiaries: 

(a) in exchange for any other Investment or accounts receivable held by the Company or any such Restricted Subsidiary in
connection with or as a result of a bankruptcy, workout, reorganization or recapitalization of the issuer of such other Investment or accounts receivable; 

(b) in satisfaction of judgments or in compromise, settlement or resolution of any litigation, arbitration or other dispute; or

 (c) as a result of a foreclosure by the Company or any of its Restricted Subsidiaries with respect to any secured
Investment or other transfer of title with respect to any secured Investment in default; 
 (8) Investments made as a result
of the receipt of noncash consideration from an Asset Sale that was made pursuant to and in compliance with Section 4.10 or any other disposition of assets or property not constituting an Asset Sale; 

(9) Investments (x) in existence on the Issue Date and (y) with respect to any such Investment in a Minority-Owned
Affiliate in existence on the Issue Date, Investments made with net cash proceeds from any Asset Sale in respect of any such Investment in a Minority-Owned Affiliate in an amount not to exceed the book value as of the Issue Date of such sold
Investment; 
 (10) Currency Agreements, Interest Rate Agreements, Commodity Agreements and related Hedging Obligations,
which transactions or obligations are Incurred in compliance with Section 4.09; 
 (11) Guarantees of Indebtedness
issued in accordance with Section 4.09; 
 (12) Investments made in connection with the funding of contributions under
any non-qualified retirement plan or similar employee compensation plan in an amount not to exceed the amount of compensation expense recognized by the Company and its Restricted Subsidiaries in connection with such plans; 

(13) Investments by the Company or any of its Restricted Subsidiaries, when taken together with all other Investments made
pursuant to this clause (13) since the Issue Date that are at that time outstanding, having an aggregate fair market value (with the fair market value of each Investment being measured at the time made and without giving effect to subsequent
changes in value) at the time of such Investment not to exceed the greater of (x) $100.0 million and (y) 2.50% of Total Assets; 

(14) Investments to the extent made in exchange for the issuance of Capital Stock (other than Disqualified Stock) of the
Company; 
 (15) working capital loans to, and other Investments in, Minority-Owned Affiliates and any other Investment in
any Person engaged in any business related to or ancillary to the provision of healthcare services or the operation of a Healthcare Facility, so long as the aggregate amount of all Investments made after the Issue Date pursuant to this clause
(15) outstanding at any time shall not exceed the greater of (x) $250.0 million and (y) 6.50% of Total Assets determined as of the date of the most recent Investment in reliance on this clause (15); 

(16) the licensing or contribution of intellectual property pursuant to joint marketing arrangements with other Persons, in
each case in the ordinary course of business; 

  
 -19- 

 (17) Investments made to repurchase or retire Capital Stock of the Company owned
by any employee stock ownership plan or key employee stock ownership plan of the Company in an aggregate amount not to exceed $7.5 million in any fiscal year; 

(18) Investments in Cornerstone of required amounts notified to the Company in writing from time to time by (i) the
insurance regulatory authorities in the Cayman Islands or (ii) the Internal Revenue Service pursuant to applicable treasury rules or regulations or interpretations thereof; and 

(19) Investments in and acquisitions of Healthcare Facilities and any business related to the owning, operating or managing of
Healthcare Facilities (including any businesses related thereto) and any business that is a natural outgrowth or reasonable extension of any such business or is similar, reasonably related, incidental, complementary or ancillary to any of the
foregoing or any business that in the Company’s good faith business judgment constitutes a reasonable diversification of business conducted by the Company and its Subsidiaries, so long as the aggregate amount of all such Investments made after
the Issue Date pursuant to this clause (19) in Persons that will not upon the applicable Investment become Restricted Subsidiaries or in assets that will not upon the applicable Investment be held by the Company or the Restricted Subsidiaries
shall not (measured at the time of each Investment pursuant to this clause (19)) exceed the greater of (x) $250.0 million and (y) 6.50% of Total Assets. 

“Permitted Liens” means, with respect to any Person: 

(1) Liens securing Indebtedness and other obligations of the Company and its Restricted Subsidiaries (i) under a Credit
Facility permitted to be Incurred under clause (1) of Section 4.09(b); provided that the amount of Indebtedness permitted to be secured under this clause (i) will not be deemed to be exceeded solely as a result of changes in
the Borrowing Base subsequent to the incurrence of Indebtedness secured under this clause (i), and (ii) in respect of Indebtedness in excess of the maximum amount of Indebtedness permitted to be secured by Liens pursuant to the foregoing
subclause (i), so long as, in the case of this subclause (ii), immediately after giving effect to the Incurrence of such Indebtedness on the date such Indebtedness is Incurred on a pro forma basis the Secured Leverage Ratio would not exceed
3.50 to 1.00 (and Refinancing Indebtedness in respect thereof); 
 (2) Liens by such Person under workers’ compensation
laws, unemployment insurance laws or similar legislation, in connection with good faith pledges or deposits in connection with bids, tenders, contracts (other than for the payment of Indebtedness) or leases, or Liens to secure public or statutory
obligations of such Person or deposits of cash or United States government bonds to secure surety or appeal bonds, or deposits as security for contested taxes or import or customs duties or for the payment of rent, in each case Incurred in the
ordinary course of business; 
 (3) Liens imposed by law, including carriers’, warehousemen’s, mechanics’,
suppliers’, vendors’, materialmen’s and repairmen’s Liens or similar Liens, Incurred in the ordinary course of business; 

(4) Liens for taxes, assessments or other governmental charges not yet subject to penalties for non-payment or that are being
contested in good faith provided appropriate reserves to the extent required pursuant to GAAP have been made in respect thereof; 

(5) Liens to secure surety, stay, appeal, indemnification, performance or similar bonds or letters of credit or bankers’
acceptances or similar obligations; provided, however, that such letters of credit do not constitute Indebtedness, or Liens with respect to insurance premium financing; 

(6) survey exceptions, encumbrances, ground leases, easements or reservations of, or rights of others for, licenses, rights of
way, sewers, electric lines, telegraph and telephone lines and other similar purposes, or zoning, building codes or other restrictions (including, without limitation, minor defects or irregularities in title and similar encumbrances) as to the use
of real properties or Liens incidental to the conduct of the business of such Person or to the ownership of its properties that do not in the aggregate 

  
 -20- 

 
materially adversely affect the value of said properties or materially impair their use in the operation of the business of such Person; 

(7) Liens securing Hedging Obligations so long as any related Indebtedness is permitted to be Incurred under this Indenture;

 (8) leases, licenses, subleases and sublicenses of assets or property (including, without limitation, real property and
intellectual property rights) that do not materially interfere with the ordinary conduct of the business of the Company or any of its Restricted Subsidiaries; 

(9) judgment and attachment Liens and Liens arising by reason of a court order or decree and notices of lis pendens and
associated rights related to litigation being contested in good faith, in each case not giving rise to an Event of Default; 

(10) Liens securing Indebtedness (including Capitalized Lease Obligations, Attributable Indebtedness, mortgage financings and
purchase money obligations) permitted under clause (8) of Section 4.09(b), which Liens cover only assets or property acquired, financed, designed, leased, constructed, repaired, maintained, installed or improved with or by such
Indebtedness (including any proceeds thereof, accessions thereto and any upgrades or improvements thereto); provided that the aggregate principal amount of Indebtedness secured by such Liens is otherwise permitted to be Incurred under this
Indenture and does not exceed the cost of the assets or property so financed, designed, leased, constructed, repaired, maintained, installed or improved; 

(11) Liens arising solely by virtue of any statutory or common law provisions relating to banker’s liens, rights of
set-off, revocation, refund or chargeback or similar rights and remedies as to deposit or securities accounts or other funds or instruments maintained with a depositary institution; provided that: (a) such deposit or securities account
is not a dedicated cash collateral account and is not subject to restrictions against access by the Company in excess of those set forth by regulations promulgated by the Federal Reserve Board; and (b) such deposit or securities account is not
intended by the Company or any Restricted Subsidiary to provide collateral to the depository institution; 
 (12) Liens
arising from Uniform Commercial Code financing statement filings regarding operating leases entered into by the Company and its Restricted Subsidiaries in the ordinary course of business; 

(13) Liens existing on the Issue Date (other than Liens permitted under clause (1)); 

(14) Liens on property or Capital Stock of a Person at the time such Person becomes a Restricted Subsidiary or is merged or
consolidated with or into the Company or a Restricted Subsidiary; provided, however, that such Liens were in existence prior to such Person became a Restricted Subsidiary or merged or consolidated with or into the Company or a
Restricted Subsidiary and were not Incurred in connection with, or in contemplation of, such event; provided further, however, that any such Lien may not extend to any other property owned by the Company or any Restricted Subsidiary;

 (15) Liens on property (including Capital Stock) at the time the Company or a Restricted Subsidiary acquired the
property, including any acquisition by means of a merger or consolidation with or into the Company or any Restricted Subsidiary; provided, however, that such Liens were in existence prior to such acquisition and were not Incurred in
connection with, or in contemplation of, such acquisition; provided further, however, that such Liens do not extend to any other property owned by the Company or any Restricted Subsidiary; 

(16) Liens securing Indebtedness or other obligations of the Company owing to a Restricted Subsidiary, or of a Restricted
Subsidiary owing to the Company or another Restricted Subsidiary (other than a receivables entity); 

  
 -21- 

 (17) Liens securing the Notes and Subsidiary Guarantees; 

(18) Liens securing Refinancing Indebtedness Incurred to refinance, refund, replace, defease, amend, extend or modify, as a
whole or in part, Indebtedness that was previously so secured pursuant to clauses (10), (13), (14), (15), (17) and this clause (18) of this definition; provided that any such Lien is limited to all or part of the same property or
assets (plus improvements, accessions, proceeds or dividends or distributions in respect thereof) that secured (or, under the written arrangements under which the original Lien arose, could secure) the Indebtedness being refinanced or is in respect
of property that is the security for a Permitted Lien hereunder; 
 (19) any interest or title of a lessor under any
Capitalized Lease Obligation or operating lease; 
 (20) Liens in favor of the Company or any Restricted Subsidiary; 

(21) Liens securing Indebtedness and other obligations (other than Subordinated Obligations and Guarantor Subordinated
Obligations) in an aggregate principal amount outstanding at any one time not to exceed the greater of (x) $50.0 million and (y) 1.25% of Total Assets; 

(22) other non-consensual Liens Incurred in the ordinary course of business that do not materially interfere with the ordinary
conduct of the business of the Company and its Restricted Subsidiaries; 
 (23) Liens that may be deemed to exist by virtue
of contractual provisions that restrict the ability of the Company or any of its Restricted Subsidiaries from incurring or creating Liens on their assets or property; and 

(24) Liens securing cash management obligations (that do not constitute Indebtedness) Incurred in the ordinary course of
business. 
 “Person” means any individual, corporation, limited liability company, partnership, joint venture,
association, joint-stock company, trust, unincorporated organization, government or any agency or political subdivision hereof or any other entity. 

“Preferred Stock,” as applied to the Capital Stock of any corporation, means Capital Stock of any class or classes (however
designated) that is preferred as to the payment of dividends upon liquidation, dissolution or winding up. 
 “QIB” means
any “qualified institutional buyer” as such term is defined in Rule 144A. 
 “Qualified Proceeds” means assets
that are used or useful in, or Capital Stock of any Person engaged in, a Similar Business; provided that the fair market value of any such assets or Capital Stock shall be determined by the Company in good faith. 

“Rating Agencies” means Standard & Poor’s Ratings Group, Inc. and Moody’s Investors Service, Inc. or if
Standard & Poor’s Ratings Group, Inc. or Moody’s Investors Service, Inc. or both shall not make a rating on the Notes publicly available, a nationally recognized statistical Rating Agency or agencies, as the case may be, selected
by the Company (as certified by resolution of the Board of Directors) which shall be substituted for Standard & Poor’s Ratings Group, Inc. or Moody’s Investors Service, Inc. or both, as the case may be. 

“Receivable” means a right to receive payment arising from a sale or lease of goods or the performance of services by a
Person pursuant to an arrangement with another Person pursuant to which such other Person is obligated to pay for goods or services under terms that permit the purchase of such goods and services on credit and shall include, in any event, any items
of property that would be classified as an “account,” “chattel paper,” “payment intangible” or “instrument” under the Uniform Commercial Code as in effect in the State of New York and any “supporting
obligations” as so defined. 

  
 -22- 

 “Receivables Fees” means any fees or interest paid to purchasers or lenders
providing the financing in connection with a factoring agreement or other similar agreement, including any such amounts paid by discounting the face amount of Receivables or participations therein transferred in connection with a factoring agreement
or other similar arrangement, regardless of whether any such transaction is structured as on-balance sheet or off- balance sheet or through a Restricted Subsidiary or an Unrestricted Subsidiary. 

“Record Date” for the interest or Additional Interest, if any, payable on any applicable Interest Payment Date means the
April 1 or October 1 (whether or not a Business Day) preceding such Interest Payment Date. 
 “Redemption Price,”
when used with respect to any Note to be redeemed, means the price at which it is to be redeemed pursuant to this Indenture. 

“Refinancing Indebtedness” means Indebtedness that is Incurred to refund, refinance, replace, exchange, renew, repay or
extend (including pursuant to any defeasance or discharge mechanism) (collectively, “refinance,” “refinances” and “refinanced” shall each have a correlative meaning) any Indebtedness existing on the Issue Date or
Incurred in compliance with this Indenture (including Indebtedness of the Company that refinances Indebtedness of any Restricted Subsidiary, Indebtedness of any Restricted Subsidiary that refinances Indebtedness of another Restricted Subsidiary or
Indebtedness of any Subsidiary Guarantor that refinances Indebtedness of the Company or any Subsidiary Guarantor) including Indebtedness that refinances Refinancing Indebtedness, provided, however, that: 

(1) (a) if the Stated Maturity of the Indebtedness being refinanced is earlier than the Stated Maturity of the Notes, the
Refinancing Indebtedness has a Stated Maturity no earlier than the Stated Maturity of the Indebtedness being refinanced or (b) if the Stated Maturity of the Indebtedness being refinanced is later than the Stated Maturity of the Notes, the
Refinancing Indebtedness has a Stated Maturity at least 91 days later than the Stated Maturity of the Notes; 
 (2) the
Refinancing Indebtedness has an Average Life at the time such Refinancing Indebtedness is Incurred that is equal to or greater than the Average Life of the Indebtedness being refinanced; 

(3) such Refinancing Indebtedness is Incurred in an aggregate principal amount (or if issued with original issue discount, an
aggregate issue price) that is equal to or less than the sum of the aggregate principal amount (or if issued with original issue discount, the aggregate accreted value) then outstanding of the Indebtedness being refinanced (plus, without
duplication, any additional Indebtedness Incurred to pay interest or premiums (including reasonable, as determined by the Company, tender premiums), defeasance costs and fees and expenses Incurred in connection therewith); 

(4) if the Indebtedness being refinanced is subordinated in right of payment to the Notes or the Subsidiary Guarantees, such
Refinancing Indebtedness is subordinated in right of payment to the Notes or the Subsidiary Guarantees on terms not materially less favorable, when taken as a whole, to the holders as those contained in the documentation governing the Indebtedness
being refinanced; and 
 (5) Refinancing Indebtedness shall not include Indebtedness of a Non-Guarantor Restricted Subsidiary
that refinances Indebtedness of the Company or a Subsidiary Guarantor. 
 “Registration Rights Agreement” means the
Registration Rights Agreement in respect of the Notes, dated as of the Issue Date, among the Company, the Subsidiary Guarantors and J.P. Morgan Securities LLC, as representative of the several initial purchasers listed in Schedule I to the Note
Purchase Agreement, and, with respect to any Additional Notes, if applicable, one or more registration rights agreements among the Company and the other parties thereto, as such agreements may be amended from time to time. 

“Regulation S” means Regulation S under the Securities Act. 

“Restricted Investment” means any Investment other than a Permitted Investment. 

  
 -23- 

 “Restricted Notes Legend” means the legend set forth in Section 2.01(d)(1).

 “Restricted Subsidiary” means any Subsidiary of the Company other than an Unrestricted Subsidiary. 

“Restructuring Charges” means all charges and expenses caused by or attributable to any restructuring, severance, relocation,
consolidation, closing, integration, business optimization or transition, signing, retention or completion bonus or curtailments or modifications to pension and post-retirement employee benefit plans. 

“Rule 144A” means Rule 144A under the Securities Act. 

“Sale/Leaseback Transaction” means an arrangement relating to property now owned or hereafter acquired whereby the Company or
a Restricted Subsidiary transfers such property to a Person (other than the Company or any of its Subsidiaries) and the Company or a Restricted Subsidiary leases it from such Person. 

“SEC” means the United States Securities and Exchange Commission. 

“Secured Indebtedness” means any Indebtedness for borrowed money of the Company or any of its Restricted Subsidiaries secured
by a Lien on any assets of the Company or any of its Restricted Subsidiaries (other than (i) Hedging Obligations permitted to be Incurred pursuant to clause (7) of Section 4.09(b) and (ii) the Notes, to the extent secured by any
such Lien). 
 “Secured Leverage Ratio,” as of any date of determination, means the ratio of: 

(1) (a) the outstanding principal amount of Secured Indebtedness of the Company and its Consolidated Subsidiaries as of
such date on a consolidated basis in accordance with GAAP less (b) the aggregate amount of any unrestricted cash and Cash Equivalents, in each case that is held by the Company and its Restricted Subsidiaries as of such date; provided that such
amount in this clause (b) shall not exceed $100.0 million in the aggregate; to 
 (2) Consolidated EBITDA of the Company
and its Consolidated Subsidiaries for the period of the most recent four consecutive fiscal quarters ending prior to such date for which financial statements prepared on a consolidated basis in accordance with GAAP are available; provided, however,
that Consolidated EBITDA shall be determined for purposes of this definition with such pro forma adjustment consistent with the definition of Consolidated Coverage Ratio; 

provided, further, that Cornerstone shall be disregarded for purposes of determining the Secured Leverage Ratio. 

“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations of the SEC promulgated
thereunder. 
 “Senior Credit Facilities” means the ABL Facility and the Term Loan Facility. 

“Shelf Registration Statement” means the Shelf Registration Statement as defined in the Registration Rights Agreement. 

“Significant Subsidiary” means any Restricted Subsidiary that would be a “Significant Subsidiary” of the Company
within the meaning of Rule 1-02 under Regulation S-X promulgated by the SEC, as in effect on the Issue Date. 
 “Similar
Business” means any business conducted or proposed to be conducted by the Company and its Restricted Subsidiaries on the Issue Date or any business that is similar, reasonably related, incidental, complementary or ancillary thereto, or that
constitutes a reasonable extension or expansion thereof. 

  
 -24- 

 “Specified Joint Ventures” means CTRH, L.L.C., Central Texas Specialty Hospital,
L.L.C., Dallas LTACH, L.L.C., Greater Peoria Specialty Hospital, L.L.C., Rhode Island Specialty Hospital, L.L.C., St. Luke’s Rehabilitation Hospital, L.L.C. and The Specialty Hospital, L.L.C. 

“Stated Maturity” means, with respect to any security, the date specified in the agreement governing or certificate relating
to such Indebtedness as the fixed date on which the final payment of principal of such security is due and payable, including pursuant to any mandatory redemption provision, but shall not include any contingent obligations to repay, redeem or
repurchase any such principal prior to the date originally scheduled for the payment thereof. 
 “Subordinated Obligation”
means any Indebtedness of the Company (whether outstanding on the Issue Date or thereafter Incurred) that is subordinated or junior in right of payment to the Notes pursuant to a written agreement. 

“Subsidiary” of any Person means (a) any corporation, association or other business entity (other than a partnership,
joint venture, limited liability company or similar entity) of which more than 50% of the total ordinary voting power of shares of Capital Stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors,
managers or trustees thereof (or Persons performing similar functions) or (b) any partnership, joint venture limited liability company or similar entity of which more than 50% of the capital accounts, distribution rights, total equity and
voting interests or general or limited partnership interests, as applicable, is, in the case of clauses (a) and (b), at the time owned or controlled, directly or indirectly, by (1) such Person, (2) such Person and one or more
Subsidiaries of such Person or (3) one or more Subsidiaries of such Person. Unless otherwise specified herein, each reference to a Subsidiary will refer to a Subsidiary of the Company. 

“Subsidiary Guarantee” means, individually, any Guarantee of payment of the Notes and Exchange Notes issued in a registered
Exchange Offer pursuant to the Registration Rights Agreement by a Subsidiary Guarantor pursuant to the terms of this Indenture and any supplemental indenture thereto, and, collectively, all such Guarantees. Each such Subsidiary Guarantee will be in
the form prescribed by this Indenture. 
 “Subsidiary Guarantor” means each Restricted Subsidiary in existence on the Issue
Date that provides a Subsidiary Guarantee on the Issue Date (and any other Restricted Subsidiary that provides a Subsidiary Guarantee in accordance with this Indenture); provided that upon release or discharge of such Restricted Subsidiary
from its Subsidiary Guarantee in accordance with this Indenture, such Restricted Subsidiary shall cease to be a Subsidiary Guarantor. 

“Term Loan Facility” means the credit facility provided under the Term Loan Credit Agreement dated as of June 1, 2011
among the Company, the lenders party thereto from time to time in their capacities as lenders thereunder, and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent, or other financing arrangements (including, without limitation,
commercial paper facilities or indentures) providing for revolving credit loans, term loans, letters of credit or other long-term indebtedness, including any notes, mortgages, guarantees, collateral documents, instruments and agreements executed in
connection therewith, and any amendments, supplements, modifications, extensions, amendment and restatements, replacements, renewals, restatements, refundings or refinancings thereof and any one or more indentures or credit facilities or commercial
paper facilities with banks or other institutional lenders or investors that extend, replace, refund, refinance, renew or defease any part of the loans, notes, other credit facilities or commitments thereunder, including any such replacement,
refunding or refinancing facility or indenture that increases the amount borrowable thereunder (provided that such increase in borrowing is permitted under Section 4.09) or alters the maturity thereof or adds Restricted Subsidiaries as
additional borrowers or guarantors thereunder and whether by the same or any other agent, lender or group of lenders. 
 “Total
Assets” means, at any date, the total consolidated assets of the Company and its Consolidated Subsidiaries (but excluding Cornerstone), as shown on the most recent balance sheet of the Company available on such date. 

  
 -25- 

 “Transactions” means, collectively, the offering of the Notes, the entering into
of and the initial borrowings under the Senior Credit Facilities, the redemption of all the Existing Notes and the satisfaction and discharge thereof. 

“Transfer Restricted Notes” means Definitive Notes and any other Notes that bear or are required to bear the Restricted Notes
Legend. 
 “Treasury Rate” means the yield to maturity at the time of computation of United States Treasury securities with
a constant maturity (as compiled and published in the most recent Federal Reserve Statistical Release H.15 (519) that has become publicly available at least two Business Days prior to the redemption date (or, if such Statistical Release is no
longer published, any publicly available source or similar market data)) most nearly equal to the period from the redemption date to April 15, 2017; provided, however, that if the period from the redemption date to April 15,
2017 is not equal to the constant maturity of a United States Treasury security for which a weekly average yield is given, the Treasury Rate shall be obtained by linear interpolation (calculated to the nearest one-twelfth of a year) from the weekly
average yields of United States Treasury securities for which such yields are given, except that if the period from the redemption date to April 15, 2017 is less than one year, the weekly average yield on actually traded United States Treasury
securities adjusted to a constant maturity of one year will be used. 
 “Trust Indenture Act” means the Trust Indenture Act
of 1939, as amended (15 U.S.C. §§ 77aaa-777bbbb). 
 “Trust Officer” means, when used with respect to the
Trustee, any officer within the corporate trust department of the Trustee having direct responsibility for the administration of this Indenture, or any other officer to whom any corporate trust matter is referred because of such officer’s
knowledge of and familiarity with the particular subject. 
 “Trustee” means Wells Fargo Bank, National Association, not in
its individual capacity but solely as trustee, until a successor replaces it in accordance with the applicable provisions of this Indenture and thereafter means the successor serving hereunder. 

“Unrestricted Subsidiary” means: 

(1) Cornerstone, each Excluded Partnership that is a Subsidiary and each Specified Joint Venture; 

(2) any Subsidiary of the Company that at the time of determination shall be designated an Unrestricted Subsidiary by the
Company in the manner provided below; and 
 (3) any Subsidiary of an Unrestricted Subsidiary. The Company may designate any
Subsidiary of the Company (including any newly acquired or newly formed Subsidiary or a Person becoming a Subsidiary through merger or consolidation or Investment therein) to be an Unrestricted Subsidiary only if: 

(1) such Subsidiary or any of its Subsidiaries has not Guaranteed any Capital Stock or Indebtedness of or have any Investment
in, the Company or any Restricted Subsidiary and does not hold any Liens on any property or assets of the Company or any Restricted Subsidiary; 

(2) (a) the aggregate fair market value of all outstanding Investments of the Company and its Restricted Subsidiaries in such
Subsidiary complies with Section 4.07 or constitutes a Permitted Investment and (b) the sum of (i) the total assets of such Subsidiary (or, if any such Subsidiary itself has Subsidiaries, the consolidated total assets of such
Subsidiary and its Consolidated Subsidiaries) and the total assets of every other Unrestricted Subsidiary (other than Cornerstone, the Specified Joint Ventures and Excluded Partnerships that are Subsidiaries), in each case determined as of the date
of the most recent designation of a Person as an Unrestricted Subsidiary and (ii) the amount of any Investments made in the Specified Joint Ventures after the Issue Date (determined as of the date of such designation in accordance with the
definition of 

  
 -26- 

 
“Investment”), does not exceed 5% of the Total Assets of the Company and its Consolidated Subsidiaries; 

(3) such Subsidiary is a Person with respect to which neither the Company nor any of its Restricted Subsidiaries has any direct
or indirect obligation to maintain or preserve such Person’s financial condition or to cause such Person to achieve any specified levels of operating results; and 

(4) except as permitted by the covenant above under Section 4.11, on the date such Subsidiary is designated an
Unrestricted Subsidiary, such Subsidiary is not a party to any agreement, contract, arrangement or understanding with the Company or any Restricted Subsidiary with terms substantially less favorable to the Company or such Restricted Subsidiary, when
taken as a whole, than those that would have been obtained from Persons who are not Affiliates of the Company. 
 Any such
designation by the Company after the Issue Date shall be evidenced to the Trustee by filing with the Trustee an Officers’ Certificate certifying that such designation complies with the foregoing conditions. If, at any time, any Unrestricted
Subsidiary would fail to meet the foregoing requirements as an Unrestricted Subsidiary, it shall thereafter cease to be an Unrestricted Subsidiary for purposes of this Indenture and any Indebtedness of such Subsidiary shall be deemed to be Incurred
as of such date. The Company may designate any Unrestricted Subsidiary to be a Restricted Subsidiary; provided that immediately after giving effect to such designation, no Event of Default shall have occurred and be continuing or would occur
as a consequence thereof and the Indebtedness of such Restricted Subsidiary would be permitted under Section 4.09 on a pro forma basis taking into account such designation assuming such Indebtedness was Incurred on the date of such
designation. 
 “U.S. Government Obligations” means securities that are: 

(a) direct obligations of the United States of America for the timely payment of which its full faith and credit is pledged; or

 (b) obligations of a Person controlled or supervised by and acting as an agency or instrumentality of the United States of
America the timely payment of that is unconditionally guaranteed as a full faith and credit obligation of the United States of America, which, in either case, are not callable or redeemable at the option of the issuer thereof. 

“Ventas Company” means Ventas, Inc., a Delaware corporation, or any of its Subsidiaries. 

“Voting Stock” of a Person means all classes of Capital Stock of such Person then outstanding and normally entitled to vote
in the election of directors, managers or trustees, as applicable, of such Person. 
 “Wholly Owned Subsidiary” means a
Restricted Subsidiary, all of the Capital Stock of which (other than directors’ qualifying shares) is owned by the Company or another Wholly Owned Subsidiary. 

Section 1.02 Other Definitions. 
  

					
	 Term
	  	Defined in
Section	 
	 “Acceptable Commitment”
	  	 	4.10	(a) 
	 “Additional Restricted Notes”
	  	 	2.01	(b) 
	 “Affiliate Transaction”
	  	 	4.11	(a) 
	 “Agent Members”
	  	 	2.01	(e)(iii) 
	 “Asset Sale Offer”
	  	 	4.10	(c) 
	 “Asset Sale Offer Amount”
	  	 	4.10	(c) 
	 “Asset Sale Offer Period”
	  	 	4.10	(c) 
	 “Asset Sale Proceeds Application Period”
	  	 	4.10	(a) 

  
 -27- 

					
	 Term
	  	Defined in
Section	 
	 “Asset Sale Purchase Date”
	  	 	4.10	(c) 
	 “Authenticating Agent”
	  	 	2.02	  
	 “Authentication Order”
	  	 	2.02	  
	 “Automatic Exchange”
	  	 	2.06	(e) 
	 “Automatic Exchange Date”
	  	 	2.06	(e) 
	 “Automatic Exchange Notice”
	  	 	2.06	(e) 
	 “Automatic Exchange Notice Date”
	  	 	2.06	(e) 
	 “Change of Control Offer”
	  	 	4.14	(b) 
	 “Change of Control Payment”
	  	 	4.14	(b)(1) 
	 “Change of Control Payment Date”
	  	 	4.14	(b)(2) 
	 “Clearstream”
	  	 	2.01	(b) 
	 “Covenant Defeasance”
	  	 	8.03	  
	 “DTC”
	  	 	2.03	  
	 “Euroclear”
	  	 	2.01	(b) 
	 “Event of Default”
	  	 	6.01	  
	 “Excess Proceeds”
	  	 	4.10	(b) 
	 “Exchange Global Note”
	  	 	2.01	(b) 
	 “Global Notes”
	  	 	2.01	(b) 
	 “Legal Defeasance”
	  	 	8.02	  
	 “Note Register”
	  	 	2.03	  
	 “Paying Agent”
	  	 	2.03	  
	 “Registrar”
	  	 	2.03	  
	 “Regulation S Global Note”
	  	 	2.01	(b) 
	 “Regulation S Notes”
	  	 	2.01	(b) 
	 “Resale Restriction Termination Date”
	  	 	2.06	(b) 
	 “Restricted Global Note”
	  	 	2.06	(e) 
	 “Restricted Payment”
	  	 	4.07	(a) 
	 “Restricted Period”
	  	 	2.01	(b) 
	 “Rule 144A Global Note”
	  	 	2.01	(b) 
	 “Rule 144A Notes”
	  	 	2.01	(b) 
	 “Successor Company”
	  	 	5.01	(a)(1) 
	 “Successor Guarantor”
	  	 	5.01	(b)(1) 
	 “Unrestricted Global Note”
	  	 	2.06	(e) 

 Section 1.03 Incorporation by Reference of Trust Indenture Act. 

Whenever this Indenture refers to a provision of the Trust Indenture Act, the provision is incorporated by reference in and made a part of this
Indenture. 
 The following Trust Indenture Act terms used in this Indenture have the following meanings: 

(a) “Commission” means the SEC; 

(b) “indenture securities” means the Notes and the Subsidiary Guarantees; 

(c) “indenture security Holder” means a Holder of a Note; 

(d) “indenture to be qualified” means this Indenture; 

(e) “indenture trustee” or “institutional trustee” means the Trustee; and 

  
 -28- 

 (f) “obligor” on the Notes and the Subsidiary Guarantees means the
Company and the Subsidiary Guarantors, respectively, and any successor obligor upon the Notes and the Subsidiary Guarantees, respectively. 

All other terms used in this Indenture that are defined by the Trust Indenture Act, defined by Trust Indenture Act reference to another
statute or defined by SEC rules under the Trust Indenture Act have the meanings so assigned to them. 
 Section 1.04
Rules of Construction. 
 Unless the context otherwise requires: 

(a) a term has the meaning assigned to it; 

(b) an accounting term not otherwise defined has the meaning assigned to it in accordance with GAAP; 

(c) “or” is not exclusive; 

(d) words in the singular include the plural, and in the plural include the singular; 

(e) “will” shall be interpreted to express a command; 

(f) provisions apply to successive events and transactions; 

(g) references to sections of, or rules under, the Securities Act shall be deemed to include substitute, replacement or
successor sections or rules adopted by the SEC from time to time; 
 (h) unless the context otherwise requires, any reference
to an “Article,” “Section” or “clause” refers to an Article, Section or clause, as the case may be, of this Indenture; and 

(i) the words “herein,” “hereof” and “hereunder” and other words of similar import refer to this
Indenture as a whole and not any particular Article, Section, clause or other subdivision. 
 Section 1.05 Acts of
Holders. 
 (a) Any request, demand, authorization, direction, notice, consent, waiver or other action provided by this Indenture to be
given or taken by Holders may be embodied in and evidenced by one or more instruments of substantially similar tenor signed by such Holders in person or by an agent duly appointed in writing. Except as herein otherwise expressly provided, such
action shall become effective when such instrument or instruments or record or both are delivered to the Trustee and, where it is hereby expressly required, to the Company. Proof of execution of any such instrument or of a writing appointing any
such agent, or the holding by any Person of a Note, shall be sufficient for any purpose of this Indenture and (subject to Section 7.01) conclusive in favor of the Trustee and the Company, if made in the manner provided in this
Section 1.05. 
 (b) The fact and date of the execution by any Person of any such instrument or writing may be proved by the affidavit
of a witness of such execution or by the certificate of any notary public or other officer authorized by law to take acknowledgments of deeds, certifying that the individual signing such instrument or writing acknowledged to him the execution
thereof. Where such execution is by or on behalf of any legal entity other than an individual, such certificate or affidavit shall also constitute proof of the authority of the Person executing the same. The fact and date of the execution of any
such instrument or writing, or the authority of the Person executing the same, may also be proved in any other manner that the Trustee deems sufficient. 

(c) The ownership of Notes shall be proved by the Note Register. 

  
 -29- 

 (d) Any request, demand, authorization, direction, notice, consent, waiver or
other action by the Holder of any Note shall bind every future Holder of the same Note and the Holder of every Note issued upon the registration of transfer thereof or in exchange therefor or in lieu thereof, in respect of any action taken, suffered
or omitted by the Trustee or the Company in reliance thereon, whether or not notation of such action is made upon such Note. 

(e) The Company may, set a record date which need not be the date specified in Section 316(c) of the Trust Indenture Act,
for purposes of determining the identity of Holders entitled to give any request, demand, authorization, direction, notice, consent, waiver or take any other act, or to vote on or consent to any action by vote or consent authorized or permitted to
be given or taken by Holders. If a record date is fixed, then only those Persons who were Holders at such record date (or their duly designated proxies), and only such Persons, shall be entitled to give any such request, demand, authorization,
direction, notice, consent, waiver or take any such other act or vote on or consent to any such action by vote or consent, whether or not such Holders remain Holders after such record date. Unless otherwise specified by the Company, if not set by
the Company prior to the first solicitation of a Holder made by any Person in respect of any such action, or in the case of any such vote, prior to such vote, any such record date shall be the later of 30 days prior to the first solicitation of such
consent or the date of the most recent list of Holders furnished to the Trustee prior to such solicitation. 
 (f) Without
limiting the foregoing, a Holder entitled to take any action hereunder with regard to any particular Note may do so with regard to all or any part of the principal amount of such Note or by one or more duly appointed agents, each of which may do so
pursuant to such appointment with regard to all or any part of such principal amount. Any notice given or action taken by a Holder or its agents with regard to different parts of such principal amount pursuant to this Section 1.05(f) shall have
the same effect as if given or taken by separate Holders of each such different part. 
 (g) Without limiting the generality
of the foregoing, a Holder, including DTC that is the Holder of a Global Note, may make, give or take, by a proxy or proxies duly appointed in writing, any request, demand, authorization, direction, notice, consent, waiver or other action provided
in this Indenture to be made, given or taken by Holders, and DTC that is the Holder of a Global Note may provide its proxy or proxies to the beneficial owners of interests in any such Global Note through such depositary’s standing instructions
and customary practices. 
 (h) The Company may fix a record date for the purpose of determining the Persons who are
beneficial owners of interests in any Global Note held by DTC entitled under the procedures of such depositary to make, give or take, by a proxy or proxies duly appointed in writing, any request, demand, authorization, direction, notice, consent,
waiver or other action provided in this Indenture to be made, given or taken by Holders. If such a record date is fixed, the Holders on such record date or their duly appointed proxy or proxies, and only such Persons, shall be entitled to make, give
or take such request, demand, authorization, direction, notice, consent, waiver or other action, whether or not such Holders remain Holders after such record date. No such request, demand, authorization, direction, notice, consent, waiver or other
action shall be valid or effective if made, given or taken more than 120 days after such record date. 
 ARTICLE 2 

THE NOTES 

Section 2.01 Form and Dating; Terms. 

(a) The aggregate principal amount of Notes that may be authenticated and delivered under this Indenture is unlimited. The Initial Notes issued
on the date hereof will be in an aggregate principal amount of $500,000,000. In addition, after the Issue Date, the Company may issue, from time to time in accordance with the provisions of this Indenture, Additional Notes (as provided herein) and
Exchange Notes. Furthermore, Notes may be authenticated and delivered upon registration of transfer, exchange or in lieu of, other Notes pursuant to Section 2.02, 2.06, 2.10, 3.06 or 9.05, in connection with an Asset Sale Offer pursuant to
Section 4.10 or in connection with a Change of Control Offer pursuant to Section 4.14. 

  
 -30- 

 Notwithstanding anything to the contrary contained herein, the Company may not issue any
Additional Notes, unless at the time of such issuance, the Company would be in compliance with Section 4.09. 
 The Notes shall be
known and designated as “6.375% Senior Notes due 2022” of the Company. 
 With respect to any Additional Notes, the Company
shall set forth in (x) a Board Resolution and (y) (i) an Officers’ Certificate or (ii) one or more indentures supplemental hereto, the following information: 

(1) the aggregate principal amount of such Additional Notes to be authenticated and delivered pursuant to this Indenture; and

 (2) the issue price and the issue date of such Additional Notes, including the date from which interest shall accrue. 

In authenticating and delivering Additional Notes, the Trustee shall be entitled to receive and shall be fully protected in relying upon, in
addition to the Opinion of Counsel and Officers’ Certificate required by Section 12.04, an Opinion of Counsel as to the due authorization, execution, delivery, validity and enforceability of such Additional Notes. 

The Initial Notes, the Additional Notes and the Exchange Notes shall be considered collectively as a single class for all purposes of this
Indenture. Holders of the Initial Notes, the Additional Notes and the Exchange Notes will vote and consent together on all matters to which such Holders are entitled to vote or consent as one class, and none of the Holders of the Initial Notes, the
Additional Notes or the Exchange Notes shall have the right to vote or consent as a separate class on any matter to which such Holders are entitled to vote or consent. Additional Notes may have different issue prices, first interest payment dates
and amounts, provisions with respect to transferability under securities laws, registration rights and tax treatment and CUSIP numbers from Initial Notes, Exchange Notes and other Additional Notes. 

A copy of the Board Resolutions of the Company establishing the terms of any Additional Notes, certified by the Secretary or any Assistant
Secretary of the Company, shall be delivered to the Trustee at or prior to the delivery of the Officers’ Certificate or the indenture supplemental hereto setting forth the terms of the Additional Notes. 

(b) The Initial Notes are being offered and sold by the Company pursuant to the Note Purchase Agreement. The Initial Notes and any Additional
Notes (if issued as Transfer Restricted Notes) (the “Additional Restricted Notes”) will be resold initially only to (A) QIBs in reliance on Rule 144A and (B) Non-U.S. Persons in reliance on Regulation S. Such Initial Notes
and Additional Restricted Notes may thereafter be transferred to, among others, QIBs and purchasers in reliance on Regulation S, in each case, in accordance with the procedure described herein. Additional Notes offered after the date hereof may be
offered and sold by the Company from time to time pursuant to one or more purchase agreements in accordance with applicable law. 
 Initial
Notes and Additional Restricted Notes offered and sold to QIBs in the United States of America in reliance on Rule 144A (the “Rule 144A Notes”) shall be issued in the form of a permanent global Note substantially in the form of
Exhibit A, which is hereby incorporated by reference and made a part of this Indenture, including appropriate legends as set forth in Section 2.01(d) (the “Rule 144A Global Note”), deposited with the Trustee, as
custodian for DTC, duly executed by the Company and authenticated by the Trustee as hereinafter provided. The Rule 144A Global Note may be represented by more than one certificate, if so required by DTC’s rules regarding the maximum principal
amount to be represented by a single certificate. The aggregate principal amount of the Rule 144A Global Note may from time to time be increased or decreased by adjustments made on the records of the Trustee, as custodian for DTC or its nominee, as
hereinafter provided. 
 Initial Notes and any Additional Restricted Notes offered and sold outside the United States of America (the
“Regulation S Notes”) in reliance on Regulation S shall be issued in the form of a permanent global Note, without interest coupons, substantially in the form of Exhibit A including appropriate legends as set forth in
Section 2.01(d) (the “Regulation S Global Note”). Each Regulation S Global Note will be deposited upon issuance with, or 

  
 -31- 

 
on behalf of, the Trustee as custodian for DTC in the manner described in this Article 2 for credit to the respective accounts of the purchasers (or to such other accounts as they may direct),
including, but not limited to, accounts at Euroclear Bank S.A./N.V. (“Euroclear”) or Clearstream Banking, société anonyme (“Clearstream”). Prior to the 40th day after the later of the commencement of
the offering of the Initial Notes and the Issue Date (such period through and including such 40th day, the “Restricted Period”), interests in the Regulation S Global Note may only be transferred to non-U.S. persons pursuant to
Regulation S, unless exchanged for interests in a Global Note in accordance with the transfer and certification requirements described herein. 

Investors may hold their interests in the Regulation S Global Note through organizations other than Euroclear or Clearstream that are
participants in DTC’s system or directly through Euroclear or Clearstream, if they are participants in such systems, or indirectly through organizations which are participants in such systems. If such interests are held through Euroclear or
Clearstream, Euroclear and Clearstream will hold such interests in the applicable Regulation S Global Note on behalf of their participants through customers’ securities accounts in their respective names on the books of their respective
depositaries. Such depositaries, in turn, will hold such interests in the applicable Regulation S Global Note in customers’ securities accounts in the depositaries’ names on the books of DTC. 

The Regulation S Global Note may be represented by more than one certificate, if so required by DTC’s rules regarding the maximum
principal amount to be represented by a single certificate. The aggregate principal amount of the Regulation S Global Note may from time to time be increased or decreased by adjustments made on the records of the Trustee, as custodian for DTC or its
nominee, as hereinafter provided. 
 Exchange Notes exchanged for interests in the Rule 144A Notes and the Regulation S Notes will be issued
in the form of a permanent global Note, substantially in the form of Exhibit B, which is hereby incorporated by reference and made a part of this Indenture, deposited with the Trustee as hereinafter provided, including the appropriate legend
set forth in Section 2.01(d) (the “Exchange Global Note”). The Exchange Global Note will be deposited upon issuance with, or on behalf of, the Trustee as custodian for DTC or its nominee, duly executed by the Company and
authenticated by the Trustee as hereinafter provided. The Exchange Global Note may be represented by more than one certificate, if so required by DTC’s rules regarding the maximum principal amount to be represented by a single certificate. 

The Rule 144A Global Note, the Regulation S Global Note and the Exchange Global Note are sometimes collectively herein referred to as the
“Global Notes.” 
 The principal of (and premium, if any) and interest on the Notes shall be payable at the office
or agency of the Company maintained for such purpose or at such other office or agency of the Company as may be maintained for such purpose pursuant to Section 2.03; provided, however, that, at the option of the Company, each
installment of interest may be paid by (i) check mailed to addresses of the Persons entitled thereto as such addresses shall appear on the Note Register or (ii) wire transfer to an account located in the United States maintained by the
payee, subject to the last sentence of this paragraph. Payments in respect of Notes represented by a Global Note (including principal, premium, if any, and interest) will be made by wire transfer of immediately available funds to the accounts
specified by DTC. Payments in respect of Notes represented by Definitive Notes (including principal, premium, if any, and interest) held by a Holder of at least $1,000,000 aggregate principal amount of Notes represented by Definitive Notes will be
made by wire transfer to a U.S. dollar account maintained by the payee with a bank in the United States if such Holder elects payment by wire transfer by giving written notice to the Trustee or the Paying Agent to such effect designating such
account no later than 15 days immediately preceding the relevant due date for payment (or such other date as the Trustee may accept in its discretion). 

The Notes may have notations, legends or endorsements required by law, stock exchange rule or usage, in addition to those set forth on
Exhibit A and Exhibit B and in Section 2.01(d). The Company shall approve any notation, endorsement or legend on the Notes. Each Note shall be dated the date of its authentication. The terms of the Notes set forth in Exhibit
A and Exhibit B are part of the terms of this Indenture and, to the extent applicable, the Company, the Subsidiary Guarantors and the Trustee, by their execution and delivery or assumption of this Indenture, as applicable, expressly agree
to be bound by such terms. 

  
 -32- 

 (c) Denominations. The Notes shall be issuable only in fully registered form, without
coupons, and only in denominations of $2,000 and any integral multiple of $1,000 in excess thereof. 
 (d) Restrictive Legends. Unless
and until (i) an Initial Note or an Additional Note issued as a Transfer Restricted Note is sold under an effective registration statement, (ii) an Initial Note or an Additional Note issued as a Transfer Restricted Note is exchanged for an
Exchange Note in connection with an effective registration statement, in each case pursuant to the Registration Rights Agreement or a similar agreement or (iii) an Initial Note or Additional Note is exchanged for a Note that does not bear the
Restricted Notes Legend in accordance with Section 2.06(e): 
 (1) the Rule 144A Global Note and the Regulation S Global
Note shall bear the following legend on the face thereof the “Restricted Notes Legend”: 
 THIS NOTE HAS NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION. NEITHER THIS NOTE NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE OFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED,
ENCUMBERED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR UNLESS SUCH TRANSACTION IS EXEMPT FROM, OR NOT SUBJECT TO, SUCH REGISTRATION. THE HOLDER OF THIS NOTE, BY ITS ACCEPTANCE HEREOF, AGREES ON ITS OWN BEHALF AND ON BEHALF OF ANY
INVESTOR ACCOUNT FOR WHICH IT HAS PURCHASED SECURITIES TO OFFER, SELL OR OTHERWISE TRANSFER SUCH SECURITY, PRIOR TO THE DATE (THE “RESALE RESTRICTION TERMINATION DATE”) THAT IS ONE YEAR, IN THE CASE OF RULE 144A NOTES, AND 40 DAYS, IN THE
CASE OF REGULATION S NOTES, AFTER THE LATER OF THE ORIGINAL ISSUE DATE HEREOF, THE ORIGINAL ISSUE DATE OF THE ISSUANCE OF ANY ADDITIONAL NOTES AND THE LAST DATE ON WHICH THE ISSUER OR ANY AFFILIATE OF THE ISSUER WAS THE OWNER OF THIS SECURITY (OR
ANY PREDECESSOR OF SUCH SECURITY), ONLY (A) TO THE ISSUER, (B) PURSUANT TO A REGISTRATION STATEMENT THAT HAS BEEN DECLARED EFFECTIVE UNDER THE SECURITIES ACT, (C) FOR SO LONG AS THE SECURITIES ARE ELIGIBLE FOR RESALE PURSUANT TO RULE
144A UNDER THE SECURITIES ACT (“RULE 144A”), TO A PERSON IT REASONABLY BELIEVES IS A “QUALIFIED INSTITUTIONAL BUYER” AS DEFINED IN RULE 144A THAT PURCHASES FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF A QUALIFIED INSTITUTIONAL BUYER
TO WHOM NOTICE IS GIVEN THAT THE TRANSFER IS BEING MADE IN RELIANCE ON RULE 144A, (D) PURSUANT TO OFFERS AND SALES TO NON-U.S. PERSONS THAT OCCUR OUTSIDE THE UNITED STATES WITHIN THE MEANING OF REGULATION S UNDER THE SECURITIES ACT, (E) TO
AN INSTITUTIONAL “ACCREDITED INVESTOR” WITHIN THE MEANING OF RULE 501(a)(1), (2), (3) OR (7) UNDER THE SECURITIES ACT THAT IS AN INSTITUTIONAL ACCREDITED INVESTOR ACQUIRING THE SECURITY FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF
SUCH AN INSTITUTIONAL ACCREDITED INVESTOR, IN EACH CASE IN A MINIMUM PRINCIPAL AMOUNT OF THE SECURITIES OF $250,000, FOR INVESTMENT PURPOSES AND NOT WITH A VIEW TO OR FOR OFFER OR SALE IN CONNECTION WITH ANY DISTRIBUTION IN VIOLATION OF THE
SECURITIES ACT, OR (F) PURSUANT TO ANOTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT, SUBJECT TO THE ISSUER’S AND THE TRUSTEE’S RIGHT PRIOR TO ANY SUCH OFFER, SALE OR TRANSFER (1) PURSUANT TO
CLAUSES (D), (E) OR (F) TO REQUIRE THE DELIVERY OF AN OPINION OF COUNSEL, CERTIFICATION AND/ OR OTHER INFORMATION SATISFACTORY TO EACH OF THEM, AND (2) IN EACH OF THE FOREGOING CASES, TO REQUIRE THAT A CERTIFICATE OF TRANSFER IN THE
FORM APPEARING ON THIS NOTE IS COMPLETED AND 

  
 -33- 

 
DELIVERED BY THE TRANSFEROR TO THE TRUSTEE. THIS LEGEND WILL BE REMOVED UPON THE REQUEST OF THE HOLDER AFTER THE RESALE RESTRICTION TERMINATION DATE. [IN THE CASE OF REGULATION S NOTES: BY ITS
ACQUISITION HEREOF, THE HOLDER HEREOF REPRESENTS THAT IT IS NOT A U.S. PERSON NOR IS IT PURCHASING FOR THE ACCOUNT OF A U.S. PERSON AND IS ACQUIRING THIS SECURITY IN AN OFFSHORE TRANSACTION IN ACCORDANCE WITH REGULATION S UNDER THE SECURITIES ACT.]

 (2) Each Global Note, whether or not an Initial Note, shall bear the following legend on the face thereof: 

UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION
(“DTC”), NEW YORK, NEW YORK, TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN
AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS
WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 
 TRANSFERS OF THIS GLOBAL SECURITY SHALL BE
LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO DTC, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE
RESTRICTIONS SET FORTH IN THE INDENTURE REFERRED TO ON THE REVERSE HEREOF. 
 (e) Book-Entry Provisions. 

(i) This Section 2.01(e) shall apply only to Global Notes deposited with the Trustee, as custodian for DTC. 

(ii) Each Global Note initially shall (x) be registered in the name of DTC or the nominee of DTC, (y) be delivered to the Trustee as
custodian for DTC and (z) bear legends as set forth in Section 2.01(d). Transfers of a Global Note (but not a beneficial interest therein) will be limited to transfers thereof in whole, but not in part, to the Depositary, its successors or
their respective nominees, except as set forth in Sections 2.01(e)(v) and 2.01(f). If a beneficial interest in a Global Note is transferred or exchanged for a beneficial interest in another Global Note, the Trustee will (x) record a decrease in
the principal amount of the Global Note being transferred or exchanged equal to the principal amount of such transfer or exchange and (y) record a like increase in the principal amount of the other Global Note on the Schedule of Exchanges of
Interests with respect to such Global Note. Any beneficial interest in one Global Note that is transferred to a Person who takes delivery in the form of an interest in another Global Note, or exchanged for an interest in another Global Note, will,
upon transfer or exchange, cease to be an interest in such Global Note and become an interest in the other Global Note and, accordingly, will thereafter be subject to all transfer and exchange restrictions, if any, and other procedures applicable to
beneficial interests in such other Global Note for as long as it remains such an interest. 
 (iii) Members of, or participants in, DTC
(“Agent Members”) shall have no rights under this Indenture with respect to any Global Note held on their behalf by DTC or by the Trustee as the custodian of DTC or under such Global Note, and DTC may be treated by the Company, the
Trustee and any agent of the Company or the Trustee as the absolute owner of such Global Note for all purposes whatsoever. Notwithstanding the foregoing, nothing herein shall prevent the Company, the Trustee or any agent of the Company or the
Trustee from giving 

  
 -34- 

 
effect to any written certification, proxy or other authorization furnished by DTC or impair, as between DTC and its Agent Members, the operation of customary practices of DTC governing the
exercise of the rights of a Holder of a beneficial interest in any Global Note. 
 (iv) In connection with any transfer of a portion of the
beneficial interest in a Global Note pursuant to Section 2.01(f) to beneficial owners who are required to hold Definitive Notes, the Custodian shall reflect on its books and records the date and a decrease in the principal amount of such Global
Note in an amount equal to the principal amount of the beneficial interest in the Global Note to be transferred, and the Company shall execute, and the Trustee shall authenticate and make available for delivery, one or more Definitive Notes of like
tenor and amount. 
 (v) In connection with the transfer of an entire Global Note to beneficial owners pursuant to Section 2.01(f), such
Global Note shall be deemed to be surrendered to the Trustee for cancellation, and the Company shall execute, and the Trustee shall authenticate and make available for delivery, to each beneficial owner identified by DTC in exchange for its
beneficial interest in such Global Note, an equal aggregate principal amount of Definitive Notes of authorized denominations. 
 (vi) The
Holder of a Global Note may grant proxies and otherwise authorize any person, including Agent Members and persons that may hold interests through Agent Members, to take any action which a Holder is entitled to take under this Indenture or the Notes.

 (vii) Any Holder of a Global Note shall, by acceptance of such Global Note, agree that transfers of beneficial interests in such Global
Note may be effected only through a book-entry system maintained by (a) the Holder of such Global Note (or its agent) or (b) any holder of a beneficial interest in such Global Note, and that ownership of a beneficial interest in such
Global Note shall be required to be reflected in a book entry. 
 (f) Definitive Notes. 

(i) Except as provided below, owners of beneficial interests in Global Notes will not be entitled to receive Definitive Notes. If required to
do so pursuant to any applicable law or regulation, beneficial owners may obtain Definitive Notes in exchange for their beneficial interests in a Global Note upon written request in accordance with DTC’s and the Registrar’s procedures. In
addition, Definitive Notes shall be transferred to all beneficial owners in exchange for their beneficial interests in a Global Note if (A) DTC notifies the Company that it is unwilling or unable to continue as depositary for such Global Note
or DTC ceases to be a clearing agency registered under the Exchange Act, at a time when DTC is required to be so registered in order to act as depositary, and in each case a successor depositary is not appointed by the Company within 90 days of such
notice or, (B) the Company in its sole discretion executes and delivers to the Trustee and Registrar an Officers’ Certificate stating that such Global Note shall be so exchangeable or (C) an Event of Default has occurred and is
continuing and the Registrar has received a request from DTC. In the event of the occurrence of any of the events specified in the second preceding sentence or in clause (A), (B) or (C) of the preceding sentence, the Company shall promptly
make available to the Trustee a reasonable supply of Definitive Notes. 
 (ii) Any Definitive Note delivered in exchange for an interest in a
Global Note pursuant to Section 2.01(e)(iii) or (iv) shall, except as otherwise provided by Section 2.06(d), bear the Restricted Notes Legend. 

(iii) If a Definitive Note is transferred or exchanged for a beneficial interest in a Global Note, the Trustee will (x) cancel such
Definitive Note, (y) record an increase in the principal amount of such Global Note equal to the principal amount of such transfer or exchange and (z) in the event that such transfer or exchange involves less than the entire principal
amount of the canceled Certificated Note, the Company shall execute, and the Trustee shall authenticate and make available for delivery, to the transferring Holder a new Definitive Note in authorized denominations representing the principal amount
not so transferred. 
 (iv) If a Definitive Note is transferred or exchanged for another Definitive Note, (x) the Trustee will cancel
the Definitive Note being transferred or exchanged, (y) the Company shall execute, and the Trustee shall authenticate and make available for delivery, one or more new Definitive Notes in authorized denominations having

  
 -35- 

 
an aggregate principal amount equal to the principal amount of such transfer or exchange to the transferee (in the case of a transfer) or the Holder of the canceled Definitive Note (in the case
of an exchange), registered in the name of such transferee or Holder, as applicable, and (z) if such transfer or exchange involves less than the entire principal amount of the canceled Definitive Note, the Company shall execute, and the Trustee
shall authenticate and make available for delivery to the Holder thereof, one or more Definitive Notes in authorized denominations having an aggregate principal amount equal to the untransferred or unexchanged portion of the canceled Definitive
Notes, registered in the name of the Holder thereof. 
 Section 2.02 Execution and Authentication. 

On the Issue Date, the Trustee shall, upon receipt of a Company Order (an “Authentication Order”), authenticate and deliver
the Initial Notes. In addition, at any time, from time to time, the Trustee shall upon receipt of an Authentication Order authenticate and deliver any Additional Notes and Exchange Notes for an aggregate principal amount specified in such
Authentication Order for such Additional Notes or Exchange Notes issued hereunder. At least one Officer shall sign the Notes for the Company by manual or facsimile signature. If the Officer whose signature is on a Note no longer holds that office at
the time the Trustee authenticates the Note, the Note shall be valid nevertheless. 
 A Note shall not be valid until an authorized officer
of the Trustee manually authenticates the Note. The signature of the Trustee on a Note shall be conclusive evidence that such Note has been duly and validly authenticated and issued under this Indenture. A Note shall be dated the date of its
authentication. 
 At any time and from time to time after the execution and delivery of this Indenture, the Trustee shall authenticate and
make available for delivery: (1) Initial Notes for original issue on the Issue Date in an aggregate principal amount of $500,000,000, (2) subject to the terms of this Indenture, Additional Notes for original issue in an unlimited principal
amount, (3) Exchange Notes for issue only in an Exchange Offer pursuant to the Registration Rights Agreement or upon resale under an effective Shelf Registration Statement, and only in exchange for Initial Notes or Additional Notes of an equal
principal amount and (4) under the circumstances set forth in Section 2.06(e), Initial Notes or Additional Notes in the form of an Unrestricted Global Note, in each case upon a Company Order. Such Company Order shall specify whether the
Notes will be in the form of Definitive Notes or Global Notes, the amount of the Notes to be authenticated and the date on which the original issue of Notes is to be authenticated and whether the Notes are to be Initial Notes, Additional Notes or
Exchange Notes. Notwithstanding anything herein to the contrary, prior to authenticating any Note hereunder, the Trustee (or Authenticating Agent) shall receive an Authentication Order from the Company. 

The Trustee may appoint an agent (the “Authenticating Agent”) reasonably acceptable to the Company to authenticate the Notes.
Any such instrument shall be evidenced by an instrument signed by a Trust Officer, a copy of which shall be furnished to the Company. Unless limited by the terms of such appointment, any such Authenticating Agent may authenticate Notes whenever the
Trustee may do so. Each reference in this Indenture to authentication by the Trustee includes authentication by the Authenticating Agent. An Authenticating Agent has the same rights as any Registrar, Paying Agent or agent for service of notices and
demands. 
 In case the Company, pursuant to Article 5, shall be consolidated or merged with or into or wind up into any other Person or
shall sell, assign, convey, transfer or otherwise dispose of all or substantially all of the properties and assets of the Company and its Restricted Subsidiaries, taken as a whole, and the successor Person resulting from such consolidation, or
surviving such merger, or into which the Company shall have been merged or wound up into, or the Person which shall have received a sale, assignment, conveyance, transfer, or other disposition as aforesaid, shall have executed an indenture
supplemental hereto with the Trustee pursuant to Article 5, any of the Notes authenticated or delivered prior to such consolidation, merger, sale, assignment, conveyance, transfer, lease or other disposition may, from time to time, at the request of
the successor Person, be exchanged for other Notes executed in the name of the successor Person with such changes in phraseology and form as may be appropriate, but otherwise in substance of like tenor as the Notes surrendered for such exchange and
of like principal amount; and the Trustee, upon Company Order of the successor Person, shall authenticate and make available for delivery Notes as specified in such order for the purpose of such exchange. If Notes shall at any time be authenticated
and delivered in any new name of a successor Person pursuant to this Section 2.02 in exchange or substitution for or upon registration of 

  
 -36- 

 
transfer of any Notes, such successor Person, at the option of the Holders but without expense to them, shall provide for the exchange of all Notes at the time outstanding for Notes authenticated
and delivered in such new name. 
 Section 2.03 Registrar and Paying Agent. 

The Company shall maintain an office or agency where Notes may be presented for registration of transfer or for exchange (the
“Registrar”) and an office or agency where Notes may be presented for payment (the “Paying Agent”). The Registrar shall keep a register of the Notes and of their transfer and exchange (the “Note
Register”). The Company may have one or more co-registrars and one or more additional paying agents. The term “Paying Agent” includes any additional paying agent and the term “Registrar” includes any co-registrar. 

The Company shall enter into an appropriate agency agreement with any Registrar or Paying Agent not a party to this Indenture, which shall
incorporate the terms of the Trust Indenture Act to the extent required thereunder. The agreement shall implement the provisions of this Indenture that relate to such agent. The Company shall notify the Trustee of the name and address of each such
agent. If the Company fails to maintain a Registrar or Paying Agent, the Trustee shall act as such and shall be entitled to appropriate compensation therefor pursuant to Section 7.07. The Company or any of its Restricted Subsidiaries organized
in the United States may act as Paying Agent, Registrar or transfer agent. 
 The Company initially appoints the Trustee as Registrar
and Paying Agent for the Notes and as Custodian. The Company may remove any Registrar or Paying Agent upon written notice to such Registrar or Paying Agent and to the Trustee; provided, however, that no such removal shall become
effective until (i) acceptance of any appointment by a successor as evidenced by an appropriate agreement entered into by the Company and such successor Registrar or Paying Agent, as the case may be, and delivered to the Trustee or
(ii) notification to the Trustee that the Trustee shall serve as Registrar or Paying Agent until the appointment of a successor in accordance with clause (i) above. The Registrar or Paying Agent may resign at any time upon written notice
to the Company and the Trustee. 
 The Company initially appoints The Depository Trust Company (“DTC”) to act as
Depositary with respect to the Global Notes. The Company has entered into a letter of representations with DTC in the form provided by DTC and the Trustee and each Agent are hereby authorized to act in accordance with such letter and Applicable
Procedures. 
 The Company will be responsible for making calculations called for under the Notes, including but not limited to
determination of Redemption Price, premium, if any, and any additional amounts or other amounts payable to the Notes. The Company will make the calculations in good faith and, absent manifest error, its calculations will be final and binding on the
Holders. The Company will provide a schedule of its calculations to the Trustee when requested by the Trustee, and the Trustee is entitled to rely conclusively on the accuracy of the Company’s calculations without independent verification. 

Section 2.04 Paying Agent to Hold Money in Trust. 

The Company shall require each Paying Agent (other than the Trustee) to agree in writing that such Paying Agent shall hold in trust for the
benefit of Holders of the Notes or the Trustee all money held by such Paying Agent for the payment of principal of, premium, if any, or interest on the Notes (whether such assets have been distributed to it by the Company or other obligors on the
Notes), shall notify the Trustee in writing of any default by the Company or any Subsidiary Guarantor in making any such payment and shall during the continuance of any default by the Company (or any other obligor upon the Notes) in the making of
any payment in respect of the Notes, upon the written request of the Trustee, forthwith deliver to the Trustee all sums held in trust by such Paying Agent for payment in respect of the Notes together with a full accounting thereof. If the Company or
a Subsidiary of the Company acts as Paying Agent, it shall segregate the money held by it as Paying Agent and hold it as a separate trust fund. The Company at any time may require a Paying Agent (other than the Trustee) to pay all money held by it
to the Trustee and to account for any funds or assets disbursed by such Paying Agent. Upon payment to the Trustee, the Paying Agent (if other than the Company or a Subsidiary of the Company) shall have no further liability for the money delivered to
the Trustee. Upon any bankruptcy, reorganization or similar proceeding with respect to the Company, the Trustee shall serve as Paying Agent for the Notes. 

  
 -37- 

 Section 2.05 Holder Lists. 

The Trustee shall preserve in as current a form as is reasonably practicable the most recent list available to it of the names and addresses of
Holders of the Notes and shall otherwise comply with Trust Indenture Act Section 312(a). If the Trustee is not the Registrar, or to the extent otherwise required under the Trust Indenture Act, the Company, on its own behalf and on behalf of
each of the Subsidiary Guarantors, shall furnish or cause the Registrar to furnish to the Trustee, in writing at least five Business Days before each Interest Payment Date and at such other times as the Trustee may request in writing, a list in such
form and as of such date as the Trustee may reasonably require of the names and addresses of Holders of the Notes and the Company shall otherwise comply with Trust Indenture Act Section 312(a). 

Section 2.06 Transfer and Exchange. 

(a) General. A Holder may transfer a Note to another Person or exchange a Note for another Note or Notes of any authorized denomination
by presenting to the Trustee a written request therefor stating the name of the proposed transferee or requesting such an exchange, accompanied by any certification, opinion or other document required by this Section 2.06. The Trustee will
promptly register any transfer or exchange that meets the requirements of this Section 2.06 by noting the same in the register maintained by the Trustee for the purpose, and no transfer or exchange will be effective until it is registered in
such register. The transfer or exchange of any Note may only be made in accordance with this Section 2.06 and Section 2.01(e) and 2.01(f), as applicable, and, in the case of a Global Note, the applicable rules and procedures of DTC,
Euroclear and Clearstream. The Trustee shall refuse to register any requested transfer or exchange that does not comply with this Section 2.06(a). 

(b) Transfers of Rule 144A Notes. The following provisions shall apply with respect to any proposed registration of transfer of a Rule
144A Note or a beneficial interest therein prior to the date which is one year after the later of the date of its original issue and the last date on which the Company or any Affiliate of the Company was the owner of such Notes (or any predecessor
thereto) (the “Resale Restriction Termination Date”): 
 (i) a registration of transfer of a Rule 144A Note
or a beneficial interest therein to a QIB shall be made upon the representation of the transferee in the form as set forth on the reverse of the Note that it is purchasing for its own account or an account with respect to which it exercises sole
investment discretion and that it and any such account is a “qualified institutional buyer” within the meaning of Rule 144A, and is aware that the sale to it is being made in reliance on Rule 144A and acknowledges that it has received such
information regarding the Company as the undersigned has requested pursuant to Rule 144A or has determined not to request such information and that it is aware that the transferor is relying upon its foregoing representations in order to claim the
exemption from registration provided by Rule 144A; provided that no such written representation or other written certification shall be required in connection with the transfer of a beneficial interest in the Rule 144A Global Note to a
transferee in the form of a beneficial interest in that Rule 144A Global Note; and 
 (ii) a registration of transfer of a
Rule 144A Note or a beneficial interest therein to a Non-U.S. Person shall be made upon receipt by the Trustee or its agent of a certificate substantially in the form set forth in Section 2.08 from the proposed transferee and, if requested by
the Company, the delivery of an opinion of counsel, certification and/or other information satisfactory to the Company. 
 (c) Transfers
of Regulations S Notes. The following provisions shall apply with respect to any proposed transfer of a Regulation S Note or a beneficial interest therein prior to the expiration of the Restricted Period: 

(i) a transfer of a Regulation S Note or a beneficial interest therein to a QIB shall be made upon the representation of the
transferee, in the form of assignment on the reverse of the certificate, that it is purchasing the Note for its own account or an account with respect to which it exercises sole investment discretion and that it and any such account is a
“qualified institutional buyer” within the meaning of Rule 144A, is aware that the sale to it is being made in reliance on Rule 144A and acknowledges that it has received such information regarding the Company as the undersigned has
requested pursuant to Rule 144A 

  
 -38- 

 
or has determined not to request such information and that it is aware that the transferor is relying upon its foregoing representations in order to claim the exemption from registration provided
by Rule 144A; and 
 (ii) a transfer of a Regulation S Note or a beneficial interest therein to a Non-U.S. Person shall be
made upon receipt by the Trustee or its agent of a certificate substantially in the form set forth in Section 2.08 from the proposed transferee and, if requested by the Company, receipt by the Trustee or its agent of an opinion of counsel,
certification and/or other information satisfactory to the Company provided that no such written representation or other written certification shall be required in connection with the transfer of a beneficial interest in the Regulation S
Global Note to a transferee in the form of a beneficial interest in that Regulation S Note. 
 After the expiration of the Restricted
Period, interests in the Regulation S Note may be transferred in accordance with applicable law without requiring the certification set forth in Section 2.07, Section 2.08 or any additional certification. 

(d) Restricted Notes Legend. Upon the transfer, exchange or replacement of Notes not bearing a Restricted Notes Legend, the Registrar
shall deliver Notes that do not bear a Restricted Notes Legend. Upon the transfer, exchange or replacement of Notes bearing a Restricted Notes Legend, the Registrar shall deliver only Notes that bear a Restricted Notes Legend unless (i) Initial
Notes or Additional Notes are being exchanged for Exchange Notes in an Exchange Offer pursuant to the Registration Rights Agreement, in which case the Exchange Notes shall not bear a Restricted Notes Legend, (ii) an Initial Note or Additional
Note is being transferred pursuant to the Shelf Registration Statement or other effective registration statement, (iii) Initial Notes or Additional Notes are being exchanged for Notes that do not bear the Restricted Notes Legend in accordance
with Section 2.06(e) or (iv) there is delivered to the Registrar an Opinion of Counsel reasonably satisfactory to the Company and the Trustee to the effect that neither such legend nor the related restrictions on transfer are required in
order to maintain compliance with the provisions of the Securities Act. Any Additional Notes sold in a registered offering shall not be required to bear the Restricted Notes Legend. 

(e) Automatic Exchange of Beneficial Interests in a Restricted Global Note for Beneficial Interests in an Unrestricted Global Note. Upon
the Company’s satisfaction that the Restricted Notes Legend shall no longer be required in order to maintain compliance with the Securities Act, beneficial interests in a Global Note bearing the Restricted Notes Legend (a “Restricted
Global Note”) may be automatically exchanged into beneficial interests in a Global Note not bearing the Restricted Notes Legend (an “Unrestricted Global Note”) without any action required by or on behalf of the Holder (the
“Automatic Exchange”) at any time on or after the date that is the 366th calendar day after (A) with respect to the Notes issued on the Issue Date, the Issue Date or (B) with respect to Additional Notes, if any, the issue
date of such Additional Notes, or, in each case, if such day is not a Business Day, on the next succeeding Business Day (the “Automatic Exchange Date”). Upon the Company’s satisfaction that the Restricted Notes Legend shall no
longer be required in order to maintain compliance with the Securities Act, the Company may pursuant to the Applicable Procedures (i) provide written notice to DTC, with a copy to the Trustee, at least fifteen (15) calendar days prior to
the Automatic Exchange Date, instructing DTC to direct the Depositary to exchange all of the outstanding beneficial interests in a particular Restricted Global Note to the Unrestricted Global Note, which the Company shall have previously otherwise
made eligible for exchange with the DTC, (ii) provide prior written notice (the “Automatic Exchange Notice”) to each Holder at such Holder’s address appearing in the register of Holders at least 15 calendar days prior to
the Automatic Exchange Date (the “Automatic Exchange Notice Date”), which notice must include (w) the Automatic Exchange Date, (x) the section of this Indenture pursuant to which the Automatic Exchange shall occur,
(y) the “CUSIP” number of the Restricted Global Note from which such Holder’s beneficial interests will be transferred and the (z) “CUSIP” number of the Unrestricted Global Note into which such Holder’s
beneficial interests will be transferred, and (iii) on or prior to the Automatic Exchange Date, deliver to the Trustee for authentication one or more Unrestricted Global Notes, duly executed by the Company, in an aggregate principal amount
equal to the aggregate principal amount of Restricted Global Notes to be exchanged. At the Company’s request on no less than five (5) Business Days’ notice prior to the date notice to Holders of the Automatic Exchange is required to
be sent (or such shorter time as the Trustee may agree), the Trustee shall deliver, in the Company’s name and at its expense, the Automatic Exchange Notice to each Holder at such Holder’s address appearing in the register of Holders.
Notwithstanding anything to the contrary in this Section 2.06(e), during the fifteen (15) day period prior to the Automatic Exchange Date, no transfers or exchanges other than pursuant to this Section 2.06(e) shall be permitted
without the prior written consent of the Company. As a condition to any 

  
 -39- 

 
Automatic Exchange, the Company shall provide, and the Trustee shall be entitled to rely upon, an Officers’ Certificate in form reasonably acceptable to the Trustee to the effect that the
Automatic Exchange shall be effected in compliance with the Securities Act and that the restrictions on transfer contained herein and in the Restricted Notes Legend shall no longer be required in order to maintain compliance with the Securities Act
and that the aggregate principal amount of the particular Restricted Global Note is to be transferred to the particular Unrestricted Global Note by adjustment made on the records of the Trustee, as custodian for the Depositary to reflect the
Automatic Exchange. Upon such exchange of beneficial interests pursuant to this Section 2.06(e), the aggregate principal amount of the Global Notes shall be increased or decreased by adjustments made on the records of the Trustee, as custodian
for the Depositary, to reflect the relevant increase or decrease in the principal amount of such Global Note resulting from the applicable exchange. The Restricted Global Note from which beneficial interests are transferred pursuant to an Automatic
Exchange shall be canceled following the Automatic Exchange. 
 (f) Retention of Written Communications. The Registrar shall retain
copies of all letters, notices and other written communications received pursuant to Section 2.01 or this Section 2.06. The Company shall have the right to inspect and make copies of all such letters, notices or other written
communications at any reasonable time upon the giving of reasonable prior written notice to the Registrar. 
 (g) Obligations with Respect
to Transfers and Exchanges of Notes. 
 (i) To permit registrations of transfers and exchanges, the Company shall, subject to the other
terms and conditions of this Article II, execute and the Trustee shall authenticate and make available for delivery Definitive Notes and Global Notes at the Registrar’s request. 

(ii) No service charge shall be made to a Holder for any registration of transfer or exchange, but Holders shall be required to pay a sum
sufficient to cover any transfer tax assessments or similar governmental charge payable in connection therewith (other than any such transfer taxes, assessments or similar governmental charges payable upon exchange or transfer pursuant to Sections
2.02, 2.06, 2.10, 3.06, 4.10, 4.14, or 9.05). 
 (iii) The Company (and the Registrar) shall not be required to register the transfer of or
exchange of any Note (A) for a period beginning (1) 15 days before the mailing of a notice of an offer to repurchase or redeem Notes and ending at the close of business on the day of such mailing or (2) 15 days before an Interest
Payment Date and ending on such Interest Payment Date or (B) called for redemption or repurchase, except the unredeemed portion of any Note being redeemed in part. 

(iv) Prior to the due presentation for registration of transfer of any Note, the Company, the Trustee, the Paying Agent or the Registrar may
deem and treat the person in whose name a Note is registered as the owner of such Note for the purpose of receiving payment of principal of, premium, if any, and (subject to paragraph 2 of the forms of Note attached hereto as Exhibit A)
interest on such Note and for all other purposes whatsoever, including without limitation the transfer or exchange of such Note, whether or not such Note is overdue, and none of the Company, the Trustee, the Paying Agent or the Registrar shall be
affected by notice to the contrary. 
 (v) Any Definitive Note delivered in exchange for an interest in a Global Note pursuant to
Section 2.01(f) shall, except as otherwise provided by Section 2.06(d), bear the Restricted Notes Legend. 
 (vi) All Notes issued
upon any transfer or exchange pursuant to the terms of this Indenture shall evidence the same debt and shall be entitled to the same benefits under this Indenture as the Notes surrendered upon such transfer or exchange. 

(h) No Obligation of the Trustee. 

(i) The Trustee shall have no responsibility or obligation under any circumstances to any beneficial owner of a Global Note, a member of, or a
participant in, DTC or other Person, including without limitation, with respect to the accuracy of the records of DTC or its nominee or of any participant or member thereof, with respect to any ownership interest in the Notes or with respect to the
delivery to any participant, member, beneficial owner or other Person (other than DTC) of any notice (including any notice of redemption or purchase) or the payment of any 

  
 -40- 

 
amount or delivery of any Notes (or other security or property) under or with respect to such Notes. All notices and communications to be given to the Holders and all payments to be made to
Holders in respect of the Notes shall be given or made only to or upon the order of the Holders (which shall be DTC or its nominee in the case of a Global Note). The Trustee may rely and shall be fully protected in relying upon information furnished
by DTC with respect to its members, participants and any beneficial owners. 
 (ii) Notwithstanding anything contained herein to the
contrary, neither the Trustee nor the Registrar shall be responsible to monitor, determine, inquire or otherwise ascertain whether any transfer complies with applicable law, including the registration provisions of or exemptions from the Securities
Act, applicable state securities laws, the rules of any Depositary, ERISA, the Code or the Investment Company Act; provided that if a certificate is specifically required by the express terms of this Section 2.06 to be delivered to the
Trustee or the Registrar by a purchaser or transferee of a Note, the Trustee or the Registrar, as the case may be, shall be under a duty to receive and examine the same to determine whether the certificate substantially complies on its face with the
express terms of this Indenture and shall promptly notify the party delivering the same if such transfer does not comply with such terms. 

(iii) Affiliate Holders. By accepting a beneficial interest in a Global Note, any Person that is an Affiliate of the Company agrees to
give notice to the Company, the Trustee and the Registrar of the acquisition and its Affiliate status. 
 Section 2.07 [Reserved.] 

Section 2.08 Form of Certificate to be Delivered in Connection with Transfers Pursuant to Regulation S. 

[Date] 
 Kindred Healthcare, Inc. 

c/o Wells Fargo Bank, National Association 
 608 Second Avenue
South, N9303-121 
 Minneapolis, Minnesota 55479 
 Attention:
Corporate Trust Operations 
 Email: DAPSReorg@wellsfargo.com 
  

	 	Re:	Kindred Healthcare, Inc. (the “Company”) 

	 	    	6.375% Senior Notes due 2022 (the “Notes”) 

 Ladies and Gentlemen: 

In connection with our proposed sale of $[            ] aggregate principal amount
of the Rule 144A Note in exchange for an equivalent beneficial interest in a Regulation S Note, we confirm that such sale has been effected pursuant to and in accordance with Regulation S under the United States Securities Act of 1933, as amended
(the “Securities Act”), and, accordingly, we represent that: 
 (a) the offer of the Notes was not made to a
person in the United States; 
 (b) either (i) at the time the buy order was originated, the transferee was outside the
United States or we and any person acting on our behalf reasonably believed that the transferee was outside the United States or (ii) the transaction was executed in, on or through the facilities of a designated off-shore securities market and
neither we nor any person acting on our behalf knows that the transaction has been pre-arranged with a buyer in the United States; 

(c) no directed selling efforts have been made in the United States in contravention of the requirements of Rule 903(a)(2) or
Rule 904(a)(2) of Regulation S, as applicable; and 

  
 -41- 

 (d) the transaction is not part of a plan or scheme to evade the registration
requirements of the Securities Act. 
 In addition, if the sale is made during a restricted period and the provisions of Rule 903(b)(2),
Rule 903(b)(3) or Rule 904(b)(1) of Regulation S are applicable thereto, we confirm that such sale has been made in accordance with the applicable provisions of Rule 903(b)(2), Rule 903(b)(3) or Rule 904(b)(1), as the case may be. 

We also hereby certify that we [are][are not] an Affiliate of the Company and, to our knowledge, the transferee of the Notes [is][is not] an
Affiliate of the Company. 
 You and the Company are entitled to rely upon this letter and are irrevocably authorized to produce this letter
or a copy hereof to any interested party in any administrative or legal proceedings or official inquiry with respect to the matters covered hereby. Terms used in this certificate have the meanings set forth in Regulation S. 

 

			
	Very truly yours,
	
	[Name of Transferor]
		
	By:	 	  

		 	Authorized Signature

 Section 2.09 Replacement Notes. 

If any mutilated Note is surrendered to the Trustee, the Registrar or the Company and the Trustee receives evidence to its satisfaction of the
ownership and destruction, loss or theft of any Note, the Company shall issue and the Trustee, upon receipt of an Authentication Order, shall authenticate and deliver a replacement Note if the Trustee’s reasonable requirements are met. If
required by the Trustee or the Company, an affidavit of loss and an indemnity bond must be supplied by the Holder that is sufficient in the judgment of the Trustee and the Company to protect the Company, the Trustee, any Agent and any authenticating
agent from any loss that any of them may suffer if a Note is replaced. The Company and the Trustee may charge for their expenses in replacing a Note. 

Every replacement Note is a contractual obligation of the Company and shall be entitled to all of the benefits of this Indenture equally and
proportionately with all other Notes duly issued hereunder. 
 Section 2.10 Outstanding Notes. 

The Notes outstanding at any time are all the Notes authenticated by the Trustee except for those canceled by it, those delivered to it for
cancellation, those reductions in the interest in a Global Note effected by the Trustee in accordance with the provisions hereof, and those described in this Section 2.08 as not outstanding. Except as set forth in Section 2.09, a Note does
not cease to be outstanding because the Company or an Affiliate of the Company holds the Note. 
 If a Note is replaced pursuant to
Section 2.09, it ceases to be outstanding unless the Trustee receives proof satisfactory to it that the replaced Note is held by a protected purchaser. 

If the principal amount of any Note is considered paid under Section 4.01, it ceases to be outstanding and interest on it ceases to
accrue. 
 If the Paying Agent (other than the Company, a Subsidiary or an Affiliate of any thereof) holds, on a redemption date or maturity
date, money sufficient to pay Notes payable on that date, then on and after that date such Notes shall be deemed to be no longer outstanding and shall cease to accrue interest. 

  
 -42- 

 Section 2.11 Treasury Notes. 

In determining whether the Holders of the required principal amount of Notes have concurred in any direction, waiver or consent, Notes owned by
the Company, or by any Affiliate of the Company, shall be considered as though not outstanding, except that for the purposes of determining whether the Trustee shall be protected in relying on any such direction, waiver or consent, only Notes that a
Trust Officer of the Trustee knows are so owned shall be so disregarded. Notes so owned that have been pledged in good faith shall not be disregarded if the pledgee establishes to the satisfaction of the Trustee the pledgee’s right to deliver
any such direction, waiver or consent with respect to the Notes and that the pledgee is not the Company or any obligor upon the Notes or any Affiliate of the Company or of such other obligor. 

Section 2.12 Temporary Notes. 

Until certificates representing Notes are ready for delivery, the Company may prepare and the Trustee, upon receipt of an Authentication Order,
shall authenticate and make ready for delivery temporary Notes. Temporary Notes shall be substantially in the form of certificated Notes but may have variations that the Company considers appropriate for temporary Notes and as shall be reasonably
acceptable to the Trustee. Without unreasonable delay, the Company shall prepare and the Trustee shall authenticate definitive Notes in exchange for temporary Notes. 

Holders and beneficial holders, as the case may be, of temporary Notes (until exchanged) shall be entitled to all of the benefits accorded to
Holders, or beneficial holders, respectively, of Notes under this Indenture. 
 Section 2.13 Cancellation. 

The Company at any time may deliver Notes to the Trustee for cancellation. The Registrar and Paying Agent shall forward to the Trustee any
Notes surrendered to them for registration of transfer, exchange or payment. The Trustee or, at the direction of the Trustee, the Registrar or the Paying Agent and no one else shall cancel all Notes surrendered for registration of transfer,
exchange, payment, replacement or cancellation and shall dispose of cancelled Notes in accordance with its customary procedures (subject to the record retention requirement of the Exchange Act). Certification of cancellation of all cancelled Notes
shall be delivered to the Company upon request. The Company may not issue new Notes to replace Notes that it has paid or that have been delivered to the Trustee for cancellation other than in connection with a transfer or exchange upon an
Authentication Order. 
 Section 2.14 Defaulted Interest. 

If the Company defaults in a payment of interest on the Notes, it shall pay the defaulted interest in any lawful manner plus, to the
extent lawful, interest payable on the defaulted interest to the Persons who are Holders on a subsequent special record date, in each case at the rate provided in the Notes and in Section 4.01. The Company shall notify the Trustee in writing of
the amount of defaulted interest proposed to be paid on each Note and the date of the proposed payment, and at the same time the Company shall deposit with the Trustee an amount of money equal to the aggregate amount proposed to be paid in respect
of such defaulted interest or shall make arrangements satisfactory to the Trustee for such deposit prior to the date of the proposed payment, such money when deposited to be held in trust for the benefit of the Persons entitled to such defaulted
interest as provided in this Section 2.14. The Company shall fix or cause to be fixed each such special record date and payment date; provided that no such special record date shall be less than 10 days prior to the related payment date
for such defaulted interest. The Company shall promptly notify the Trustee of such special record date. At least 15 days before the special record date, the Company (or, upon the written request of the Company, the Trustee in the name and at the
expense of the Company) shall mail or cause to be mailed, first-class postage prepaid, to each Holder a notice at his or her address as it appears in the Note Register that states the special record date, the related payment date and the amount of
such interest to be paid. 
 Subject to the foregoing provisions of this Section 2.14 and for greater certainty, each Note
delivered under this Indenture upon registration of transfer of or in exchange for or in lieu of any other Note shall carry the rights to interest accrued and unpaid, and to accrue, which were carried by such other Note. 

  
 -43- 

 Section 2.15 CUSIP Numbers. 

The Company in issuing the Notes may use CUSIP numbers (if then generally in use) and, if so, the Trustee may use CUSIP numbers in
notices (including notices of redemption) as a convenience to Holders; provided, that any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Notes or as contained in any notice
or notice of redemption and that reliance may be placed only on the other identification numbers printed on the Notes, and any such notice or redemption shall not be affected by any defect in or omission of such numbers. The Company will as promptly
as practicable notify the Trustee in writing of any change in the CUSIP numbers. 
 ARTICLE 3 

REDEMPTION 
 Section 3.01
Notices to Trustee. 
 If the Company provides notice of redemption in accordance with this Indenture, it shall deliver a copy of such
redemption notice to the Trustee at or promptly following the time it is delivered to Holders. If the Redemption Price is not known at the time the redemption notice is to be given, the actual Redemption Price, calculated as described in the terms
of the Securities, will be set forth in an Officers’ Certificate of the Company delivered to the Trustee no later than two Business Days prior to the redemption date (unless the Trustee agrees to a shorter period). 

Section 3.02 Selection of Notes to Be Redeemed or Purchased. 

If less than all of the Notes are to be redeemed or purchased in an offer to purchase at any time, the Trustee shall select the Notes to be
redeemed or purchased (a) if the Notes are listed on any national securities exchange, in compliance with the requirements of the principal national securities exchange on which the Notes are listed or (b) on a pro rata basis or, to the
extent that selection on a pro rata basis is not practicable, by lot or by such other method the Trustee shall deem fair and appropriate in accordance with and subject to the procedures of DTC. In the event of partial redemption or purchase by lot,
the particular Notes to be redeemed or purchased shall be selected, unless otherwise provided herein, not less than 30 nor more than 60 days prior to the redemption date by the Trustee from the outstanding Notes not previously called for redemption
or purchase. 
 The Trustee shall promptly notify the Company in writing of the Notes selected for redemption or purchase and, in the case
of any Note selected for partial redemption or purchase, the principal amount thereof to be redeemed or purchased. Notes and portions of Notes selected shall be in amounts of $2,000 or whole multiples of $1,000 on excess thereof; no Notes of $2,000
or less can be redeemed in part, except that if all of the Notes of a Holder are to be redeemed or purchased, the entire outstanding amount of Notes held by such Holder, even if not $2,000 or a multiple of $1,000 in excess thereof, shall be redeemed
or purchased. Except as provided in the preceding sentence, provisions of this Indenture that apply to Notes called for redemption or purchase also apply to portions of Notes called for redemption or purchase. 

Section 3.03 Notice of Redemption. 

(a) Subject to Section 3.09, the Company shall mail or cause to be mailed by first-class mail, postage prepaid, notices of redemption at
least 30 days but not more than 60 days before the redemption date to each Holder of Notes to be redeemed at such Holder’s registered address or otherwise in accordance with the procedures of DTC, except that redemption notices may be mailed
more than 60 days prior to a redemption date if the notice is issued in connection with Article 8 or Article 11. Except as set forth in Section 3.07(g) and Section 4.14, (and subject to the Company’s right to send a notice of
redemption applicable to Notes outstanding after completion of the tender offer) notices of redemption may not be conditional. 
 The notice
shall identify the Notes to be redeemed and shall state: 
 (i) the redemption date; 

  
 -44- 

 (ii) the Redemption Price (or manner of calculation if not then known); 

(iii) if any Note is to be redeemed in part only, the portion of the principal amount of that Note that is to be redeemed and
that, after the redemption date upon surrender of such Note, a new Note or Notes in principal amount equal to the unredeemed portion of the original Note representing the same indebtedness to the extent not redeemed will be issued in the name of the
Holder of the Notes upon cancellation of the original Note; 
 (iv) the name and address of the Paying Agent; 

(v) that Notes called for redemption must be surrendered to the Paying Agent to collect the redemption price; 

(vi) that, unless the Company defaults in making such redemption payment, interest on Notes called for redemption ceases to
accrue on and after the redemption date; 
 (vii) the paragraph or subparagraph of the Notes and/or Section of this Indenture
pursuant to which the Notes called for redemption are being redeemed and any conditions precedent to such redemption described in reasonable detail; and 

(viii) that no representation is made as to the correctness or accuracy of the CUSIP number, if any, listed in such notice or
printed on the Notes. 
 (b) At the Company’s request, the Trustee shall give the notice of redemption in the Company’s name
and at the Company’s expense; provided that the Company shall have delivered to the Trustee, at least 5 Business Days before notice of redemption is required to be mailed or caused to be mailed to Holders pursuant to this
Section 3.03 (unless a shorter notice shall be agreed to by the Trustee), an Officers’ Certificate requesting that the Trustee give such notice and setting forth the information to be stated in such notice as provided in Section
3.03(a). 
 (c) If any notice of redemption is conditioned upon the occurrence of one or more conditions precedent, such notice of
redemption shall state that such redemption may not occur and such notice may be rescinded in the event that any such condition precedent shall not have occurred as stated in such notice of redemption. The Company will provide prompt written notice
to the Trustee not later than 5:00 p.m. (New York City time) on the second Business Day prior to the latest date specified as the redemption date (or such shorter time period with the consent of the Trustee) rescinding such redemption in the
event that any such condition precedent shall not have occurred, and such redemption and notice of redemption shall be rescinded and of no force or effect. Upon receipt of such notice from the Company rescinding such redemption, the Trustee will
promptly send a copy such notice to the holders of the Notes to be redeemed in the same manner in which the notice of redemption was given. 

Section 3.04 Effect of Notice of Redemption. 

Once notice of redemption is mailed in accordance with Section 3.03, Notes called for redemption become irrevocably due and payable on the
redemption date at the redemption price (except in connection with a conditional redemption pursuant to Section 3.07(g) or 4.14 and subject to the earlier repurchase of Notes called for redemption that are the subject of a tender offer). The
notice, if mailed in a manner herein provided, shall be conclusively presumed to have been given, whether or not the Holder receives such notice. In any case, failure to give such notice by mail or any defect in the notice to the Holder of any Note
designated for redemption in whole or in part shall not affect the validity of the proceedings for the redemption of any other Note. Subject to Section 3.05, on and after the redemption date, interest ceases to accrue on Notes or portions of
Notes called for redemption. 
 Section 3.05 Deposit of Redemption or Purchase Price. 

(a) Prior to 10:00 a.m. (New York City time) on the redemption or purchase date, the Company shall deposit with the Trustee or with the Paying
Agent money sufficient to pay the redemption or purchase price of and 

  
 -45- 

 
accrued and unpaid interest (including Additional Interest, if any) on all Notes to be redeemed or purchased on that date. The Trustee or the Paying Agent shall promptly return to the Company any
money deposited with the Trustee or the Paying Agent by the Company in excess of the amounts necessary to pay the redemption price of, and accrued and unpaid interest on, all Notes to be redeemed or purchased. 

(b) If the Company complies with the provisions of Section 3.05(a), on and after the redemption or purchase date, interest shall cease to
accrue on the Notes or the portions of Notes called for redemption or purchase. If the optional redemption date is on or after a Record Date and on or before the related Interest Payment Date, the accrued and unpaid interest, if any, shall be paid
to the Person in whose name the Note is registered at the close of business on such Record Date, and no Additional Interest shall be payable to Holders whose Notes shall be subject to redemption by the Company. If any Note called for redemption or
purchase shall not be so paid upon surrender for redemption or purchase because of the failure of the Company to comply with Section 3.05(a), interest shall be paid on the unpaid principal, from the redemption or purchase date until such
principal is paid, and to the extent lawful on any interest accrued to the redemption or purchase date not paid on such unpaid principal, in each case at the rate provided in the Notes and in Section 4.01. 

Section 3.06 Notes Redeemed or Purchased in Part. 

Upon surrender of a Note that is redeemed or purchased in part, the Company shall issue and the Trustee shall authenticate for the
Holder at the expense of the Company a new Note equal in principal amount to the unredeemed or unpurchased portion of the Note surrendered representing the same indebtedness to the extent not redeemed or purchased, subject to Applicable Procedures;
provided that each new Note will be in a principal amount of $2,000 or an integral multiple of $1,000 in excess thereof. It is understood that, notwithstanding anything in this Indenture to the contrary, none of an Authentication Order, an
Opinion of Counsel or an Officers’ Certificate is required for the Trustee to authenticate such new Note. 
 Section 3.07
Optional Redemption. 
 (a) At any time prior to April 15, 2017, upon not less than 30 nor more than 60 days’ prior notice
mailed by first-class mail to each Holder’s registered address (or with respect to Global Notes, to the extent permitted or required by applicable DTC procedures or regulations, send electronically), the Company may redeem all or part of the
Notes at a redemption price equal to 100% of the principal amount thereof plus the Applicable Premium as of, plus accrued and unpaid interest, if any, to, the redemption date (subject to the right of Holders on the relevant Record Date to receive
interest due on the relevant Interest Payment Date). 
 (b) At any time prior to April 15, 2017, the Company may on any one or
more occasions, at its option, redeem up to 35% of the aggregate principal amount of Notes issued by it (calculated after giving effect to any issuance of Additional Notes) with the Net Cash Proceeds of one or more Equity Offerings at a redemption
price of 106.375% of the principal amount thereof, plus accrued and unpaid interest, if any, to the redemption date (subject to the right of Holders on the relevant Record Date to receive interest due on the relevant Interest Payment Date);
provided that: 
 (1) at least 65% of the aggregate original principal amount of Notes issued under this
Indenture (calculated after giving effect to any issuance of Additional Notes) remains outstanding immediately after each such redemption; and 

(2) the redemption occurs within 120 days after the closing of each such Equity Offering. 

(c) Except pursuant to clause (a) or (b) of this Section 3.07, the Notes shall not be redeemable until April 15, 2017. 

(d) On and after April 15, 2017, the Company may, at its option, redeem all or, from time to time, a part of the Notes upon not less than
30 nor more than 60 days’ notice, at the following redemption prices (expressed as a percentage of principal amount of the Notes to be redeemed) plus accrued and unpaid interest and Additional Interest on the Notes, if any, to the applicable
redemption date (subject to the right of Holders on the relevant 

  
 -46- 

 
Record Date to receive interest due on the relevant Interest Payment Date), if redeemed during the twelve-month period beginning on April 15 of the years indicated below: 

 

					
	Year	  	Percentage	 
	 2017
	  	 	104.781	% 
	 2018
	  	 	103.188	% 
	 2019
	  	 	101.594	% 
	 2020 and thereafter
	  	 	100.000	% 

 (e) Any redemption pursuant to this Section 3.07 shall be made pursuant to the provisions of Sections 3.01
through 3.06. 
 (f) If the optional redemption date is on or after a Record Date and on or before the related Interest Payment Date, the
accrued and unpaid interest, if any, will be paid to the Person in whose name the Note is registered at the close of business on such Record Date, and no Additional Interest will be payable to Holders whose Notes will be subject to redemption by the
Company. 
 (g) Notice of any redemption upon any Equity Offering may be given prior to the completion thereof. In addition, any such
redemption or notice may, at the Company’s discretion, be subject to one or more conditions precedent, including, but not limited to, completion of the related Equity Offering, in the case of a redemption upon completion of an Equity Offering.

 Section 3.08 Mandatory Redemption. 

The Company is not required to make any mandatory redemption or sinking fund payments with respect to the Notes. 

Section 3.09 Offers to Repurchase by Application of Excess Proceeds. 

(a) In the event that, pursuant to Section 4.10, the Company shall be required to commence an Asset Sale Offer, they shall follow the
procedures specified below. 
 (b) Upon the commencement of an Asset Sale Offer, the Company shall send, by first-class mail, a notice to
each of the Holders, with a copy to the Trustee. The notice shall contain all instructions and materials necessary to enable such Holders to tender Notes pursuant to the Asset Sale Offer. The Asset Sale Offer shall be made to all Holders and, to the
extent required by the terms of other Pari Passu Indebtedness, holders of Pari Passu Indebtedness. The notice, which shall govern the terms of the Asset Sale Offer, shall state: 

(i) that the Asset Sale Offer is being made pursuant to this Section 3.09 and Section 4.10 and the length of time the
Asset Sale Offer shall remain open; 
 (ii) the Asset Sale Offer Amount, the purchase price and the Asset Sale Purchase Date;

 (iii) that any Note not tendered or accepted for payment shall continue to accrue interest; 

(iv) that, unless the Company defaults in making such payment, any Note accepted for payment pursuant to the Asset Sale Offer
shall cease to accrue interest after the Asset Sale Purchase Date; 
 (v) that Holders electing to have a Note purchased
pursuant to an Asset Sale Offer may elect to have Notes purchased in amounts of $2,000 or in integral multiples of $1,000 in excess thereof only; 

(vi) that Holders electing to have a Note purchased pursuant to any Asset Sale Offer shall be required to surrender the Note,
with the form entitled “Option of Holder to Elect Purchase” attached to the Note completed, or transfer by book-entry transfer, to the Company, the Depositary, if appointed by the 

  
 -47- 

 
Company, or a Paying Agent at the address specified in the notice at least three days before the Asset Sale Purchase Date; 

(vii) that Holders shall be entitled to withdraw their election if the Company, the Depositary or the Paying Agent, as the case
may be, receives, not later than the expiration of the Asset Sale Offer Period, a telegram, facsimile transmission or letter setting forth the name of the Holder, the principal amount of the Note the Holder delivered for purchase and a statement
that such Holder is withdrawing his election to have such Note purchased, subject to Applicable Procedures; 
 (viii) that,
if the aggregate principal amount of Notes and Pari Passu Indebtedness surrendered by the holders or lenders thereof exceeds the Asset Sale Offer Amount, the Trustee shall select the Notes, and the trustee or agent for the Pari Passu Indebtedness
shall select the Pari Passu Indebtedness, to be purchased on a pro rata basis based on the accreted value or principal amount of the Notes or such Pari Passu Indebtedness tendered (with such adjustments as may be deemed appropriate by the
Trustee so that only Notes in denominations of $2,000 or in integral multiples of $1,000 in excess thereof, shall be purchased), subject to Applicable Procedures; and 

(ix) that Holders whose Notes were purchased only in part shall be issued new Notes equal in principal amount to the
unpurchased portion of the Notes surrendered representing the same indebtedness to the extent not repurchased, subject to Applicable Procedures. 

Other than as specifically provided in this Section 3.09 or Section 4.10, any purchase pursuant to this Section 3.09 shall be
made pursuant to the applicable provisions of Sections 3.01 through 3.06. 
 ARTICLE 4 

COVENANTS 
 Section 4.01
Payment of Notes. 
 The Company shall pay or cause to be paid the principal of, premium, if any, Additional Interest, if any, and
interest on the Notes on the dates and in the manner provided in the Notes. Principal, premium, if any, Additional Interest, if any, and interest shall be considered paid on the date due if the Paying Agent, if other than the Company or a
Subsidiary, holds as of noon Eastern Time on the due date money deposited by the Company in immediately available funds and designated for and sufficient to pay all principal, premium, if any, Additional Interest, if any, and interest then due. In
any case where the Stated Maturity of any payment required to be made on the Notes shall not be a Business Day, then each such payment need not be made on such date, but may be made on the next succeeding Business Day with the same force and effect
as if made on the Stated Maturity of such payment and no interest shall accrue for the period from and after such Stated Maturity. 
 The
Company shall pay all Additional Interest, if any, in the same manner on the dates and in the amounts set forth in the Registration Rights Agreement. 

The Company shall pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue principal at the rate
equal to the then applicable interest rate on the Notes to the extent lawful; it shall pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue installments of interest and Additional Interest (without
regard to any applicable grace period) at the same rate to the extent lawful. 
 Section 4.02 Maintenance of Office or Agency.

 The Company shall maintain an office or agency (which may be an office of the Trustee or an affiliate of the Trustee, Registrar or
co-registrar) where Notes may be surrendered for registration of transfer or for exchange and where notices and demands to or upon the Company in respect of the Notes and this Indenture may be served. The Company shall give prompt written notice to
the Trustee of the location, and any change in the location, of such 

  
 -48- 

 
office or agency. If at any time the Company shall fail to maintain any such required office or agency or shall fail to furnish the Trustee with the address thereof, such presentations,
surrenders, notices and demands may be made or served at the Corporate Trust Office of the Trustee. 
 The Company may also from time to
time designate one or more other offices or agencies where the Notes may be presented or surrendered for any or all such purposes and may from time to time rescind such designations. The Company shall give prompt written notice to the Trustee of any
such designation or rescission and of any change in the location of any such other office or agency. 
 The Company hereby designates the
Corporate Trust Office of the Trustee as one such office or agency of the Company in accordance with Section 2.03. 
 Section 4.03
Reports and Other Information. 
 Notwithstanding that the Company is subject to the reporting requirements of Section 13 or
15(d) of the Exchange Act or is otherwise required to report on an annual and quarterly basis on forms provided for such annual and quarterly reporting pursuant to rules and regulations promulgated by the SEC, so long as the Notes are outstanding
(unless defeased in a legal defeasance), the Company shall (a) file with the SEC (unless the SEC will not accept such filing), and (b) make available to the Trustee and, upon written request, a Holder of the Notes, without cost to any
Holder, from and after the Issue Date: 
 (1) within the time periods specified by the Exchange Act (including all applicable
extension periods), an annual report on Form 10-K (or any successor or comparable form) containing the information required to be contained therein (or required in such successor or comparable form); 

(2) within the time periods specified by the Exchange Act (including all applicable extension periods), a quarterly report on
Form 10-Q (or any successor or comparable form); and 
 (3) all current reports that would be required to be filed with the
SEC on Form 8-K (or any successor or comparable form). 
 In the event that the Company is not permitted to file such reports with the SEC
pursuant to the Exchange Act, the Company will nevertheless make available such Exchange Act reports to the Trustee and the Holders of the Notes as if the Company were subject to the reporting requirements of Section 13 or 15(d) of the Exchange
Act (including Regulation S-X, other than the reporting requirements under Rule 3-10 and 3-16 of Regulation S-X) within the time periods specified by the Exchange Act (including all applicable extension periods), which requirement may be satisfied
by posting such reports on its website within the time periods specified by this Section 4.03. Notwithstanding the foregoing, (i) the availability of the reports referred to in paragraphs (1) through (3) above on the SEC’s
Electronic Data Gathering, Analysis and Retrieval (“EDGAR”) system (or any successor system, including the SEC’s Interactive Data Electronic Application system) and the Company’s website within the time periods specified
above will be deemed to satisfy the above delivery obligation and (ii) prior to the filing of a registration statement for the notes pursuant to the Registration Rights Agreement, the Company shall not be required to prepare or file any
financial statements or other information or disclosure required pursuant to Rule 3-10 or 3-16 of Regulation S-X (or any successor provision) under the Exchange Act. 

If the Company has designated any of its Subsidiaries as Unrestricted Subsidiaries, and the Unrestricted Subsidiaries taken together would
constitute a Significant Subsidiary, then the quarterly and annual financial information required by this Section 4.03 shall include a report summarizing the amount of revenues, EBITDA and long-term debt with respect to such Unrestricted
Subsidiaries. 
 In addition, the Company and the Subsidiary Guarantors have agreed that they will make available to the Holders and to
prospective investors, upon the request of such Holders, the information required to be delivered pursuant to Rule 144A(d)(4) under the Securities Act so long as the Notes are not freely transferable under the Securities Act. For purposes of this
Section 4.03, the Company and the Subsidiary Guarantors will be deemed to have furnished the reports to the Trustee and the Holders of Notes as required by this covenant if it has filed such reports with the

  
 -49- 

 
SEC via the EDGAR filing system and such reports are publicly available. 
 Delivery
of such reports, information and documents to the Trustee hereunder is for informational purposes only and the Trustee’s receipt of such shall not constitute constructive notice of any information contained therein or determinable from
information contained therein, including the Company’s compliance with any of its covenants hereunder (as to which the Trustee is entitled to rely exclusively on Officers’ Certificates or certificates delivered pursuant to
Section 4.04). The Trustee shall not be obligated to monitor or confirm, on a continuing basis or otherwise, our compliance with the covenants or with respect to any reports or other documents filed with the SEC or EDGAR or any website under
the Indenture. 
 Section 4.04 Compliance Certificate. 

(a) The Company and each Subsidiary Guarantor (to the extent that such Subsidiary Guarantor is so required under the Trust Indenture Act) shall
deliver to the Trustee, within 120 days after the end of each fiscal year ending after the Issue Date, a certificate from the principal executive officer, principal financial officer or principal accounting officer stating that a review of the
activities of the Company and its Restricted Subsidiaries during the preceding fiscal year has been made under the supervision of the signing Officer with a view to determining whether the Company has kept, observed, performed and fulfilled its
obligations under this Indenture, and further stating, as to such Officer signing such certificate, that to his or her knowledge, the Company has kept, observed, performed and fulfilled each and every condition and covenant contained in this
Indenture and is not in default in the performance or observance of any of the terms, provisions, covenants and conditions of this Indenture (or, if a Default shall have occurred, describing all such Defaults (including all Defaults that had
occurred during the previous year, whether cured or uncured) of which he or she may have knowledge and what action the Company has or is taking or proposes to take with respect thereto). 

(b) If any Default has occurred and is continuing under this Indenture, the Company shall promptly (which shall be no more than five
(5) Business Days upon becoming aware of such Default) deliver to the Trustee by overnight courier guaranteeing next day delivery, or by registered or certified mail or by facsimile transmission an Officers’ Certificate specifying such
event and what action the Company proposes to take with respect thereto. 
 Section 4.05 Taxes. 

The Company shall pay, and shall cause each of its Restricted Subsidiaries to pay, prior to delinquency, all material taxes, assessments and
governmental levies except such as are contested in good faith and by appropriate negotiations or proceedings or where the failure to effect such payment is not adverse in any material respect to the Holders of the Notes. 

Section 4.06 Stay, Extension and Usury Laws. 

The Company and each of the Subsidiary Guarantors covenant (to the extent that they may lawfully do so) that they shall not at any time insist
upon, plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law wherever enacted, now or at any time hereafter in force, that may affect the covenants or the performance of this Indenture; and the
Company and each of the Subsidiary Guarantors (to the extent that they may lawfully do so) hereby expressly waive all benefit or advantage of any such law, and covenant that they shall not, by resort to any such law, hinder, delay or impede the
execution of any power herein granted to the Trustee, but shall suffer and permit the execution of every such power as though no such law has been enacted. 

  
 -50- 

 Section 4.07 Limitation on Restricted Payments. 

(a) The Company shall not, and shall not permit any of its Restricted Subsidiaries, directly or indirectly, to: 

(1) declare or pay any dividend or make any distribution (whether made in cash, securities or other assets or property) on or
in respect of its Capital Stock (including any payment in connection with any merger or consolidation involving the Company or any of its Restricted Subsidiaries) other than: 

(a) dividends or distributions payable solely in Capital Stock of the Company (other than Disqualified Stock); and 

(b) dividends or distributions by a Restricted Subsidiary payable to the Company or another Restricted Subsidiary (and if such
Restricted Subsidiary is not a Wholly Owned Subsidiary, to its other holders of the relevant class of Capital Stock on a pro rata basis subject to any tax-related adjustment as set forth in its charter or similar documents or agreements binding on
such Restricted Subsidiary); 
 (2) purchase, redeem, retire or otherwise acquire for value any Capital Stock of the Company
or any direct or indirect parent of the Company held by Persons other than the Company or a Restricted Subsidiary (other than in exchange for Capital Stock of the Company (other than Disqualified Stock); 

(3) make any principal payment on, or purchase, repurchase, redeem, defease or otherwise acquire or retire for value, prior to
any scheduled maturity, scheduled repayment or scheduled sinking fund payment or any Subordinated Obligations or Guarantor Subordinated Obligations, other than: 

(a) Indebtedness permitted under clause (5) of Section 4.09(b); or 

(b) the purchase, repurchase, redemption, defeasance or other acquisition or retirement of Subordinated Obligations or
Guarantor Subordinated Obligations purchased in anticipation of satisfying a sinking fund obligation, principal installment or final maturity, in each case due within one year of the date of purchase, repurchase, redemption, defeasance or other
acquisition or retirement; or 
 (4) make any Restricted Investment; 

(all such payments and other actions referred to in clauses (1) through (4) (other than any exception thereto) shall be referred to as a
“Restricted Payment”), unless, at the time of and after giving effect to such Restricted Payment: 
 (a) no
Default has occurred and is continuing (or would result therefrom); 
 (b) immediately after giving effect to such Restricted
Payment on a pro forma basis, the Company would be able to Incur $1.00 of additional Indebtedness under the provisions of Section 4.09(a); and 

(c) the aggregate amount of such Restricted Payment and all other Restricted Payments declared or made subsequent to the Issue
Date (excluding Restricted Payments made pursuant to clauses (1), (2), (3), (4), (6), (7), (8), (9), (10), (11), (12), (13) and (14) of Section 4.07(b)) would not exceed the sum of (without duplication): 

(i) 50% of the Company’s Consolidated Net Income for the period (treated as one accounting period) from January 1,
2014 to the end of the Company’s most recent fiscal quarter ending prior to the date of such Restricted Payment for which financial statements prepared on a consolidated basis in accordance with GAAP are available; 

  
 -51- 

 (ii) 100% of the aggregate Net Cash Proceeds and the fair market value, as
determined in good faith by an Officer of the Company (as evidenced by an Officers’ Certificate), of marketable securities or other property received by the Company since the Issue Date from the issue or sale of its Capital Stock (other than
Disqualified Stock) or as a capital contribution, other than: 
 (A) Net Cash Proceeds received from an issuance or sale of
such Capital Stock to a Subsidiary of the Company or to an employee stock ownership plan, option plan or similar trust (to the extent such sale to an employee stock ownership plan or similar trust is financed by loans from or Guaranteed by the
Company or any Restricted Subsidiary unless such loans have been repaid with cash on or prior to the date of determination); 

(B) Net Cash Proceeds received by the Company from the issue and sale of its Capital Stock or capital contributions to the
extent applied to redeem Notes in compliance with the provisions set forth under Section 3.07(b); and 
 (C) Excluded
Contributions; 
 (iii) 100% of any cash dividends or cash distributions received directly or indirectly by the Company or a
Subsidiary Guarantor after the Issue Date from an Unrestricted Subsidiary, to the extent that such dividends or distributions were not otherwise included in Consolidated Net Income and the Investment in such Unrestricted Subsidiary at the time it
was designated as such was included in the calculation of Restricted Payments; 
 (iv) the amount by which Indebtedness
(other than Subordinated Obligations or Guarantor Subordinated Obligations) of the Company or its Restricted Subsidiaries is reduced on the Company’s consolidated balance sheet upon the conversion or exchange subsequent to the Issue Date of any
Indebtedness of the Company or its Restricted Subsidiaries (other than debt owing to and held by a Subsidiary of the Company) convertible or exchangeable for Capital Stock (other than Disqualified Stock) of the Company (less the amount of any cash,
or the fair market value of any other property, distributed by the Company upon such conversion or exchange); and 
 (v) the
amount equal to the net reduction in Restricted Investments made by the Company or any of its Restricted Subsidiaries in any Person resulting from: 

(A) repurchases or redemptions of such Restricted Investments by such Person, proceeds realized upon the sale of such
Restricted Investment to an unaffiliated purchaser, or repayments of loans or advances or other transfers of property or assets (including by way of dividend or distribution) by such Person to the Company or any Restricted Subsidiary (other than for
reimbursement of tax payments); 
 (B) the release of any Guarantee (except to the extent any amounts are paid under such
Guarantee); or 
 (C) the redesignation of Unrestricted Subsidiaries as Restricted Subsidiaries or the merger or
consolidation of an Unrestricted Subsidiary with and into the Company or any of its Restricted Subsidiaries (valued in each case as provided in the definition of “Investment”) not to exceed the amount of Investments previously made by the
Company or any Restricted Subsidiary in such Unrestricted Subsidiary, 
 which amount in each case under this clause (v) was included
in the calculation of the amount of Restricted Payments; provided, however, that no amount shall be included under this clause (v) to the extent it is already included in Consolidated Net Income. 

  
 -52- 

 (b) Section 4.07(a) shall not prohibit: 

(1) a Restricted Payment made with Excluded Contributions; 

(2) any purchase, repurchase, redemption, defeasance or other acquisition or retirement of Subordinated Obligations of the
Company or Guarantor Subordinated Obligations of any Subsidiary Guarantor made within 90 days after and by exchange for, or out of the proceeds of, the sale of, Subordinated Obligations of the Company or any purchase, repurchase, redemption,
defeasance or other acquisition or retirement of Guarantor Subordinated Obligations made within 90 days after and by exchange for, or out of the proceeds of, the sale of Guarantor Subordinated Obligations so long as such refinancing Subordinated
Obligations or Guarantor Subordinated Obligations are permitted to be Incurred pursuant to Section 4.09 and constitute Refinancing Indebtedness; 

(3) any purchase, repurchase, redemption, defeasance or other acquisition or retirement of Disqualified Stock of the Company or
a Restricted Subsidiary made by exchange for, or out of the proceeds of, the sale of Disqualified Stock of the Company or such Restricted Subsidiary, as the case may be, so long as such refinancing Disqualified Stock is permitted to be Incurred
pursuant to Section 4.09 and constitutes Refinancing Indebtedness; 
 (4) the purchase, repurchase, redemption,
defeasance or other acquisition or retirement for value of any Subordinated Obligation (a) at a purchase price not greater than 101% of the principal amount of such Subordinated Obligation in the event of a Change of Control in accordance with
provisions similar to Section 4.14 or (b) at a purchase price not greater than 100% of the principal amount thereof in accordance with provisions similar to Section 4.10; provided that, prior to or simultaneously with such
purchase, repurchase, redemption, defeasance or other acquisition or retirement, the Company has made the Change of Control Offer or Asset Sale Offer, as applicable, as provided in such covenant with respect to the Notes and has completed the
repurchase or redemption of all Notes validly tendered for payment in connection with such Change of Control Offer or Asset Sale Offer; 

(5) the payment of any dividend or distribution, or the consummation of any irrevocable redemption, within 60 days after the
date of declaration of the dividend or distribution or giving of the redemption notice, as the case may be, if at such date of declaration or redemption notice such dividend, distribution or redemption, as the case may be, would have complied with
this provision; 
 (6) the purchase, redemption or other acquisition, cancellation or retirement for value of Capital Stock
of the Company held by any existing or former employees, officers, directors, management or consultants of the Company or any Subsidiary of the Company or their assigns, estates or heirs, in each case in connection with the repurchase provisions
under employee stock option or stock purchase agreements or other agreements to compensate employees, officers, directors, management or consultants entered into in the ordinary course of business or approved by the Board of Directors of the
Company; provided that such Capital Stock was received for services related to, or for the benefit of, the Company and its Restricted Subsidiaries; and provided, further, that such redemptions or repurchases pursuant to this
clause shall not exceed $5.0 million in the aggregate during any fiscal year (with unused amounts in any fiscal year being carried over to succeeding fiscal years), although such amount in any fiscal year may be increased by an amount not to exceed:

 (a) the Net Cash Proceeds from the sale of Capital Stock (other than Disqualified Stock) of the Company and, to the extent
contributed to the Company, Capital Stock of any of the Company’s direct or indirect parent companies, in each case to existing or former employees, officers, directors, management or consultants of the Company or any Subsidiary of the Company
that occurs after the Issue Date, to the extent the cash proceeds from the sale of such Capital Stock have not otherwise been applied to the payment of Restricted Payments (provided that the amount of Net Cash Proceeds from such sales or
contributions that is utilized for redemptions or repurchases pursuant to this clause (6) shall be excluded from clause (c)(ii) of Section 4.07(a)); plus 

  
 -53- 

 (b) the cash proceeds of key man life insurance policies received by the Company
or its Restricted Subsidiaries after the Issue Date; less 
 (c) the amount of any Restricted Payments previously made with
the cash proceeds described in clauses (a) and (b) of this clause (6); 
 (7) the declaration and payment of
dividends or distributions to holders of any class or series of Disqualified Stock of the Company or any of its Restricted Subsidiaries Incurred in accordance with Section 4.09; 

(8) the purchase, redemption or other acquisition, cancellation or retirement of Capital Stock (a) deemed to occur upon
the exercise or exchange of options, warrants, other rights to purchase or acquire Capital Stock or other securities convertible into or exchangeable for Capital Stock if such Capital Stock represents a portion of the exercise or exchange price
thereof, or (b) made in lieu of withholding taxes resulting from the exercise or exchange of options, warrants, other rights to purchase or acquire Capital Stock or other securities convertible into or exchangeable for Capital Stock; 

(9) any payments made in connection with the Transactions as described in the Offering Memorandum; 

(10) the distribution, by dividend or otherwise, of shares of Capital Stock of Unrestricted Subsidiaries to the extent the
Investments in such Unrestricted Subsidiaries were Restricted Investments; 
 (11) other Restricted Payments in an aggregate
amount, which, when taken together with all other Restricted Payments made pursuant to this clause (11) (as reduced by the amount of capital repaid or otherwise returned from any such Restricted Payments that constituted Restricted Investments
in the form of cash and Cash Equivalents (exclusive of items reflected in Consolidated Net Income)) not to exceed the greater of (x) $175.0 million and (y) 4.50% of Total Assets; 

(12) payments in lieu of the issuance of fractional shares in connection with the exercise or exchange of options, warrants,
other rights to purchase or acquire Capital Stock or other securities convertible into or exchangeable for Capital Stock and repurchases of Capital Stock deemed to occur upon the exercise of stock options, warrants, other rights to purchase Capital
Stock or other convertible securities if such Capital Stock represents a portion of the exercise price thereof; 
 (13) the
purchase, redemption, acquisition, cancellation or other retirement of any Capital Stock of the Company or a Restricted Subsidiary to the extent necessary, in the good faith judgment of the Company, to prevent the loss or secure the renewal or
reinstatement of any license, permit or other authorization held by the Company or any of its Subsidiaries issued by any governmental or regulatory authority or to comply with government contracting regulations; and 

(14) the payment of a dividend on common stock of the Company of up $30.0 million in any calendar year (with unused amounts in
any calendar year being carried over to succeeding fiscal years but subject to a maximum of $60.0 million in any calendar year); 
 provided,
however, that at the time of and after giving effect to, any Restricted Payment permitted under clauses (6), (10), (11) and (14), no Default shall have occurred and be continuing or would occur as a consequence thereof. 

(c) The amount of all Restricted Payments (other than cash) shall be the fair market value on the date such Restricted Payment is made of the
assets, securities or other property proposed to be declared, paid, made, purchased, redeemed, retired, defeased or acquired pursuant to such Restricted Payment. The fair market value of any cash Restricted Payment shall be its face amount. With
respect to any non-cash Restricted Payment in excess of $50.0 million such fair market value shall be determined by an Officer of the Company (as evidenced by an Officers’ Certificate). 

  
 -54- 

 As of the Issue Date, all of the Company’s Subsidiaries (other than Cornerstone, the
Specified Joint Ventures and Excluded Partnerships that are Subsidiaries) will be Restricted Subsidiaries. The Company will not permit any Unrestricted Subsidiary to become a Restricted Subsidiary except pursuant to the last sentence of the
definition of “Unrestricted Subsidiary.” For purposes of designating any Restricted Subsidiary as an Unrestricted Subsidiary, all outstanding Investments by the Company and its Restricted Subsidiaries (except to the extent repaid) in the
Subsidiary so designated will be deemed to be Restricted Payments and/or Permitted Investments in an amount determined as set forth in the definition of “Investment.” Such designation will be permitted only if a Restricted Payment and/or
Permitted Investment in such amount would be permitted at such time and if such Subsidiary otherwise meets the definition of an Unrestricted Subsidiary. Unrestricted Subsidiaries will not be subject to any of the restrictive covenants set forth in
this Indenture. 
 Section 4.08 Limitation on Restrictions on Distributions from Restricted Subsidiaries. 

(a) The Company shall not, and shall not permit any Restricted Subsidiary to, directly or indirectly, create or otherwise cause or permit to
exist or become effective any consensual encumbrance or consensual restriction on the ability of any Restricted Subsidiary to: 

(1) pay dividends or make any other distributions on its Capital Stock to the Company or any of its Restricted Subsidiaries, or
with respect to any other interest or participation in, or measured by, its profits, or pay any Indebtedness or other obligations owed to the Company or any Restricted Subsidiary (it being understood that the priority of any Preferred Stock in
receiving dividends or liquidating distributions prior to dividends or liquidating distributions being paid on Common Stock shall not be deemed a restriction on the ability to make distributions on Capital Stock); 

(2) make any loans or advances to the Company or any Restricted Subsidiary (it being understood that the subordination of loans
or advances made to the Company or any Restricted Subsidiary to other Indebtedness Incurred by the Company or any Restricted Subsidiary shall not be deemed a restriction on the ability to make loans or advances); or 

(3) sell, lease or transfer any of its property or assets to the Company or any Restricted Subsidiary (it being understood that
such transfers shall not include any type of transfer described in clause (1) or (2) above). 
 (b) Section 4.08(a) shall not
prohibit encumbrances or restrictions existing under or by reason of: 
 (1) the Senior Credit Facilities, the Master Lease
Agreements, or any other agreement or instrument in effect at or entered into on the Issue Date; 
 (2) this Indenture, the
Notes, the Exchange Notes and the Subsidiary Guarantees; 
 (3) any agreement or other instrument of a Person acquired by or
merged or consolidated with or into the Company or any of its Restricted Subsidiaries in existence at the time of such acquisition, merger or consolidation (but not created in contemplation thereof), which encumbrance or restriction is not
applicable to any Person, or the property or assets of any Person, other than the Person and its Subsidiaries, or the property or assets of the Person and its Subsidiaries, so acquired (including after-acquired property and assets); 

(4) any amendment, restatement, modification, renewal, supplement, extension, refunding, replacement or refinancing of an
agreement referred to in clauses (1), (2), (3) or this clause (4) of this Section 4.08(b); provided, however, that the encumbrances or restrictions contained in such amendment, restatement, modification, renewal,
supplement, extension, refunding, replacement or refinancing is, in the good faith judgment of the Company, not materially more restrictive, when taken as a whole, than the encumbrances and restrictions contained in any of the agreements or
instruments referred to in clauses (1), (2) or (3) of this Section 4.08(b) on the Issue Date or the date such Restricted Subsidiary became a 

  
 -55- 

 
Restricted Subsidiary or was merged or consolidated with or into the Company or a Restricted Subsidiary, whichever is applicable; 

(5) in the case of clause (3) of Section 4.08(a), Permitted Liens or Liens otherwise permitted to be Incurred under
Section 4.12 that limit the right of the debtor to dispose of property or assets subject to such Liens; 
 (6) purchase
money obligations, mortgage financings, Capitalized Lease Obligations and similar obligations or agreements permitted under this Indenture, in each case, that impose encumbrances or restrictions of the nature described in clause (3) of
Section 4.08(a) with respect to the property or assets acquired, financed, designed, leased, constructed, repaired, maintained, installed or improved in connection therewith or thereby (including any proceeds thereof, accessions thereto and any
upgrades or improvements thereto); 
 (7) agreements for the sale, transfer or other disposition of property or assets,
including without limitation customary restrictions with respect to a Subsidiary of the Company pursuant to an agreement that has been entered into for the sale, transfer or other disposition of all or a portion of the Capital Stock, property or
assets of such Subsidiary; 
 (8) restrictions on cash, Cash Equivalents or other deposits or net worth imposed by customers,
suppliers or landlords under contracts entered into in the ordinary course of business or as required by insurance surety or bonding companies; 

(9) any customary provisions in joint venture agreements, partnership agreements, LLC agreements and other similar agreements,
which, as determined in good faith by an Officer of the Company, do not adversely affect the Company’s ability to make payments of principal or interest payments on the Notes when due; 

(10) any customary provisions in leases, subleases, licenses, asset sale agreements, sale/leaseback agreements or stock sale
agreements and other agreements entered into by the Company or any Restricted Subsidiary entered into in the ordinary course of business; 

(11) applicable law or any applicable rule, regulation or order, or any license, permit or other authorization issued by any
governmental or regulatory authority; or 
 (12) (i) Credit Facilities or other debt arrangements Incurred by the Company or
any Restricted Subsidiary, or Preferred Stock issued by any Restricted Subsidiary, in accordance with Section 4.09, that are not materially more restrictive, when taken as a whole, than those applicable in either this Indenture or the Senior
Credit Facilities on the Issue Date or (ii) any encumbrance so long as, in the good faith judgment of the Company, such encumbrance will not impact its ability to pay the obligations of the Company as they come due. 

Section 4.09 Limitation on Indebtedness. 

(a) The Company shall not, and shall not permit any of its Restricted Subsidiaries to, directly or indirectly, Incur any Indebtedness
(including Acquired Indebtedness); provided, however, that the Company and any Restricted Subsidiary may Incur Indebtedness (including Acquired Indebtedness) if on the date of such Incurrence and after giving effect thereto on a pro
forma basis the Consolidated Coverage Ratio for the Company is at least 2.00 to 1.00; provided that the aggregate principal amount of Indebtedness that may be Incurred pursuant to the foregoing by Non-Guarantor Restricted Subsidiaries
(including Indebtedness Incurred by Non-Guarantor Restricted Subsidiaries pursuant to clauses (6)(ii) and (15) of Section 4.09(b) shall not at any time exceed the greater of (x) $150.0 million and (y) 4.00% of Total Assets)
at any one time outstanding. 

  
 -56- 

 (b) Section 4.09(a) shall not prohibit the Incurrence of the following Indebtedness: 

(1) Indebtedness of the Company under one or more Credit Facilities in an aggregate principal amount not to exceed the sum of:
(A) $1,100.0 million and (B) the greater of (i) $750.0 million and (ii) the Borrowing Base; 
 (2)
Indebtedness represented by the Notes (including any Subsidiary Guarantee) (other than any Additional Notes) and any Exchange Notes (including any Subsidiary Guarantee thereof); 

(3) Indebtedness of the Company and its Restricted Subsidiaries in existence on the Issue Date (other than Indebtedness
described in clauses (1), (2), (4), (5), (7), (9) and (11)); 
 (4) Guarantees by the Company or its Restricted
Subsidiaries of Indebtedness permitted to be Incurred by the Company or a Restricted Subsidiary in accordance with the provisions of this Indenture; provided that in the event such Indebtedness that is being Guaranteed is a Subordinated
Obligation or a Guarantor Subordinated Obligation, then the related Guarantee shall be subordinated in right of payment to the Notes or the Subsidiary Guarantee, as the case may be; 

(5) Indebtedness of the Company owing to and held by any Restricted Subsidiary or Indebtedness of a Restricted Subsidiary
owing to and held by the Company or any other Restricted Subsidiary; provided, however, 
 (a) if the Company
is the obligor on Indebtedness owing to a Non-Guarantor Restricted Subsidiary, such Indebtedness is expressly subordinated to the prior payment in full in cash of all obligations with respect to the Notes; 

(b) if a Subsidiary Guarantor is the obligor on Indebtedness owing to a Non-Guarantor Subsidiary, such Indebtedness is
subordinated in right of payment to the Subsidiary Guarantees of such Subsidiary Guarantor; and 
 (c) (i) any subsequent
issuance or transfer of Capital Stock or other event that results in any such Indebtedness being beneficially held by a Person other than the Company or a Restricted Subsidiary of the Company; and 

(ii) any sale or other transfer of any such Indebtedness to a Person other than the Company or a Restricted Subsidiary of the
Company, 
 shall be deemed, in each case, to constitute an Incurrence of such Indebtedness by the Company or such Restricted Subsidiary, as
the case may be, 
 (6) (i) Indebtedness of Persons Incurred and outstanding on the date on which such Person became a
Restricted Subsidiary or was acquired by, or merged into, the Company or any Restricted Subsidiary (other than Indebtedness Incurred by such Person (a) to provide all or any portion of the funds utilized to consummate the transaction or series
of related transactions pursuant to which such Restricted Subsidiary became a Restricted Subsidiary or was otherwise acquired by the Company or (b) otherwise either in connection with, or in contemplation of, such acquisition); and
(ii) Indebtedness Incurred by the Company or any Restricted Subsidiary to finance an acquisition (provided that the aggregate outstanding principal amount of Indebtedness of Non-Guarantor Restricted Subsidiaries permitted by this clause
(6)(ii) (including Indebtedness Incurred by Non-Guarantor Restricted Subsidiaries pursuant to Section 4.09(a) and clause (15) of this Section 4.09(b)) shall not at any time exceed the greater of (x) $150.0 million and
(y) 4.00% of Total Assets); provided, however, that, with respect to subclause (i) above, at the time such Person is acquired or, with respect to subclause (ii) above, after giving pro forma effect to the
acquisition and such Incurrence, at the time such Indebtedness is Incurred, either: 

  
 -57- 

 (a) the Company would have been able to Incur $1.00 of additional Indebtedness
pursuant to Section 4.09(a) after giving pro forma effect to such acquisition and the Incurrence of such Indebtedness pursuant to this clause (6); or 

(b) the Consolidated Coverage Ratio for the Company is at least equal to the Consolidated Coverage Ratio immediately prior to
such acquisition or merger; 
 (7) Indebtedness under Hedging Obligations that are Incurred in the ordinary course of
business (and not for speculative purposes); 
 (8) Indebtedness (including Capitalized Lease Obligations, Attributable
Indebtedness, mortgage financings or purchase money obligations) of the Company or a Restricted Subsidiary Incurred to finance any part of the purchase price for, or the cost of design, lease, construction, repair, maintenance, installation or
improvement of, any property (real or personal), plant or equipment used or to be used in the business of the Company or a Restricted Subsidiary (or the Capital Stock of any Person owning any such property, plant or equipment (but no other material
assets other than cash or cash equivalents)), and any Indebtedness of the Company or a Restricted Subsidiary that serves to refund, refinance, replace, exchange, renew, repay or extend any Indebtedness Incurred pursuant to this clause (8), in
principal amount not to exceed the greater of (x) $125.0 million and (y) 3.25% of Total Assets in the aggregate at any one time outstanding together with all other Indebtedness issued under this clause (8) then outstanding; 

(9) Indebtedness consisting of trade obligations or accrued current liabilities for services rendered to the Company or any
Restricted Subsidiary, in each case, arising in the ordinary course of business; 
 (10) Indebtedness arising from agreements
of the Company or a Restricted Subsidiary providing for indemnification, adjustment of purchase price or similar obligations, in each case, Incurred or assumed in connection with the acquisition of, or other Investments in, and the disposition of,
any business, property or assets of the Company or any business, property, assets or Capital Stock of a Restricted Subsidiary, other than Guarantees of Indebtedness Incurred by any Person acquiring all or any portion of such business, property,
assets or a Subsidiary for the purpose of financing such acquisition; 
 (11) (a) Indebtedness arising from the honoring by a
bank or other financial institution of a check, draft or similar instrument drawn against insufficient funds in the ordinary course of business, provided, however, that such Indebtedness is extinguished, refinanced or otherwise covered
within ten Business Days of Incurrence or (b) Indebtedness owed on a short-term basis of no longer than 30 days to banks or financial institutions Incurred in the ordinary course of business that arise from treasury, depository and cash
management services or in connection with any automated clearinghouse transfers of funds; 
 (12) the Incurrence or issuance
by the Company or any Restricted Subsidiary of Refinancing Indebtedness that serves to refund, refinance, replace, exchange, renew, repay or extend any Indebtedness Incurred as permitted under Section 4.09(a) and clauses (2), (3), (6) and
this clause (12) or any Indebtedness issued to so refund, refinance, replace, exchange, renew, repay or extend such Indebtedness, including additional Indebtedness Incurred to pay premiums (including reasonable, as determined in good faith by
the Company, tender premiums), defeasance costs, accrued interest and fees and expenses in connection therewith prior to its respective maturity; 

(13) shares of Preferred Stock of a Restricted Subsidiary issued to the Company or another Restricted Subsidiary;
provided that any subsequent issuance or transfer of any Capital Stock or any other event that results in any such Restricted Subsidiary ceasing to be a Restricted Subsidiary or any other subsequent transfer of any such shares of Preferred
Stock (except to the Company or another of its Restricted Subsidiaries) shall be deemed in each case to be an issuance of such shares of Preferred Stock not permitted by this clause (13); 

  
 -58- 

 (14) Indebtedness to the extent that the net proceeds thereof are promptly
deposited to defease or to satisfy and discharge the Notes; and 
 (15) in addition to the items referred to in clauses
(1) through (14) above, Indebtedness of the Company and its Restricted Subsidiaries in an aggregate outstanding principal amount that, when taken together with the principal amount of all other Indebtedness Incurred pursuant to this clause
(15) and then outstanding, shall not exceed the greater of (x) $175.0 million and (y) 4.50% of Total Assets; provided that the aggregate outstanding principal amount of Indebtedness of Non-Guarantor Restricted Subsidiaries
permitted by this clause (15) (including Indebtedness Incurred by Non-Guarantor Restricted Subsidiaries pursuant to Section 4.09(a) and clause (6)(ii) of this Section 4.09(b)) shall not at any time exceed the greater of
(x) $150.0 million and (y) 4.00% of Total Assets. 
 (c) For purposes of determining compliance with, and the outstanding principal
amount of any particular Indebtedness Incurred pursuant to and in compliance with, this Section 4.09: 
 (1) in the
event that an item of Indebtedness meets the criteria of more than one of the types of Indebtedness described in clauses (a) and (b) of this Section 4.09, the Company, in its sole discretion, shall divide and classify such item of
Indebtedness on the date of Incurrence and may later divide and reclassify such item of Indebtedness in any manner that complies with this Section 4.09 and only be required to include the amount and type of such Indebtedness in one of such
clauses; 
 (2) Guarantees of, or obligations in respect of letters of credit relating to, Indebtedness that is otherwise
included in the determination of a particular amount of Indebtedness shall not be included; 
 (3) if obligations in respect
of letters of credit are Incurred pursuant to a Credit Facility and are being treated as Incurred pursuant to clause (1) of Section 4.09(b) above and the letters of credit relate to other Indebtedness, then such other Indebtedness shall
not be included; 
 (4) the principal amount of any Disqualified Stock of the Company or a Restricted Subsidiary, or
Preferred Stock of a Non-Guarantor Restricted Subsidiary, shall be deemed to be equal to the greater of the maximum mandatory redemption or repurchase price (not including, in either case, any redemption or repurchase premium) and the liquidation
preference thereof, exclusive of any accrued dividends; 
 (5) Indebtedness permitted by this Section 4.09 need not be
permitted solely by reference to one provision permitting such Indebtedness but may be permitted in part by one such provision and in part by one or more other provisions of this Section 4.09 permitting such Indebtedness; 

(6) the principal amount of any Indebtedness outstanding in connection with a securitization transaction or series of
securitization transactions is the amount of obligations outstanding under the legal documents entered into as part of such transaction that would be characterized as principal if such transaction were structured as a secured lending transaction
rather than as a purchase relating to such transaction; and 
 (7) the amount of Indebtedness issued at a price that is less
than the principal amount thereof shall be equal to the amount of the liability in respect thereof determined in accordance with GAAP. 

Accrual of interest, accrual of dividends, the accretion of accreted value or original issue discount, the amortization of debt discount, the
payment of interest in the form of additional Indebtedness and the payment of dividends in the form of additional shares of Preferred Stock or Disqualified Stock shall not be deemed to be an Incurrence of Indebtedness for purposes of this
Section 4.09. The amount of any Indebtedness outstanding as of any date shall be (i) the accreted value thereof in the case of any Indebtedness issued with original issue discount or the aggregate principal amount outstanding in the case
of Indebtedness issued with interest payable in kind and (ii) the principal amount or liquidation preference thereof in the case of any other Indebtedness. 

  
 -59- 

 If at any time an Unrestricted Subsidiary becomes a Restricted Subsidiary, any Indebtedness of
such Subsidiary shall be deemed to be Incurred by such Restricted Subsidiary as of such date (and, if such Indebtedness is not permitted to be Incurred as of such date under this Section 4.09, the Company shall be in Default of this
Section 4.09). 
 For purposes of determining compliance with any U.S. dollar-denominated restriction on the Incurrence of
Indebtedness, the U.S. dollar-equivalent principal amount of Indebtedness denominated in a foreign currency shall be calculated based upon the relevant currency exchange rate in effect on the date such Indebtedness was Incurred, in the case of term
Indebtedness, or first committed, in the case of revolving credit Indebtedness; provided that if such Indebtedness is Incurred to refinance other Indebtedness denominated in a foreign currency, and such refinancing would cause the applicable
U.S. dollar-denominated restriction to be exceeded if calculated at the relevant currency exchange rate in effect on the date of such refinancing, such U.S. dollar-denominated restriction shall be deemed not to have been exceeded so long as the
principal amount of such Refinancing Indebtedness does not exceed the principal amount of such Indebtedness being refinanced. Notwithstanding any other provision of this Section 4.09, the maximum amount of Indebtedness that the Company may
Incur pursuant to this Section 4.09 shall not be deemed to be exceeded solely as a result of fluctuations in the exchange rate of currencies. The principal amount of any Indebtedness Incurred to refinance other Indebtedness, if Incurred in a
different currency from the Indebtedness being refinanced, shall be calculated based upon the currency exchange rate applicable to the currencies in which such Refinancing Indebtedness is denominated that is in effect on the date of such
refinancing. 
 Section 4.10 Sales of Assets and Subsidiary Stock. 

(a) The Company shall not, and shall not permit any of its Restricted Subsidiaries to, consummate any Asset Sale unless: 

(1) the Company or such Restricted Subsidiary, as the case may be, receives consideration at least equal to the fair market
value (such fair market value to be determined as of the date of contractually agreeing to such Asset Sale) of the Capital Stock, property or assets subject to such Asset Sale; 

(2) such fair market value (including the fair market value of all non-cash consideration) shall be determined in good faith by
the Company or such Restricted Subsidiary (which determination, if the sale price exceeds $25.0 million, is evidenced by a resolution of the Company’s or such Restricted Subsidiary’s Board of Directors) as at the time of such Asset Sale;

 (3) at least 75% of the consideration from such Asset Sale received by the Company or such Restricted Subsidiary, as the
case may be, is in the form of cash or Cash Equivalents; and 
 (4) an amount equal to 100% of the Net Available Cash from
such Asset Sale is applied by the Company or a Restricted Subsidiary within 366 days from the date of receipt of such Net Available Cash (the “Asset Sale Proceeds Application Period”), as follows: 

(a) to repay, prepay, defease, redeem, purchase or otherwise retire (and to permanently reduce commitments with respect thereto
in the case of revolving borrowings): (x) Indebtedness or other obligations under the Senior Credit Facilities; (y) Indebtedness of the Company (other than any Disqualified Stock or Subordinated Obligations) or a Subsidiary Guarantor that
is secured by a Lien (other than Indebtedness owed to an Affiliate of the Company); or (z) Indebtedness of a Non-Guarantor Restricted Subsidiary (other than Disqualified Stock and Indebtedness owed to the Company or an Affiliate of the
Company); 
 (b) to permanently reduce obligations under any other Indebtedness of the Company (other than any Disqualified
Stock or Subordinated Obligations) or Indebtedness of a Restricted Subsidiary (other than any Disqualified Stock or Guarantor Subordinated Obligations) (in each case other than Indebtedness owed to the Company or an Affiliate of the Company);
provided that the Company shall on a pro rata basis reduce (or offer to reduce) obligations, under the Notes as provided under Section 3.07, through open market purchases (to the extent such purchases are at

  
 -60- 

 
or above 100% of the principal amount thereof) or by making an offer (in accordance with the procedures set forth below for an Asset Sale Offer) to all Holders to purchase their Notes at 100% of
the principal amount thereof, plus the amount of accrued but unpaid interest, if any, on the amount of Notes that would otherwise be prepaid; and/or 

(c) to invest in, purchase or otherwise acquire Additional Assets, or to make payments (including without limitation
prepayments and progress payments) in connection with such investment, purchase or other acquisition; 
 provided that in the case of clause (c), a
binding commitment shall be treated as a permitted application of the Net Available Cash from the date of such commitment so long as the Company or such other Restricted Subsidiary enters into such commitment prior to the expiration of the Asset
Proceeds Application Period with the good faith expectation that such Net Available Cash will be applied to satisfy such commitment no later than 180 days after the expiration of the Asset Proceeds Application Period (an “Acceptable
Commitment”), it being understood that if an Acceptable Commitment is later cancelled or terminated for any reason before such Net Available Cash is applied, or such Net Available Cash is not applied within such period, then all such Net
Available Cash not so applied shall constitute Excess Proceeds. 
 (b) For the purposes of clause (3) of Section 4.10(a) and for no
other purpose, the following shall be deemed to be cash: 
 (1) any liabilities (as shown on the Company’s or such
Restricted Subsidiary’s most recent balance sheet) of the Company or any Restricted Subsidiary (other than liabilities that are by their terms subordinated to the Notes or the Subsidiary Guarantees) that are assumed by the transferee of any
such Capital Stock, property or assets and from which the Company and all Restricted Subsidiaries have been validly released from further liability therefor; 

(2) any securities, notes or other obligations received by the Company or any Restricted Subsidiary from the transferee that
are converted by the Company or such Restricted Subsidiary into cash (to the extent of the cash received in such conversion) within 180 days following the closing of such Asset Sale; and 

(3) any Designated Noncash Consideration received by the Company or any of its Restricted Subsidiaries in such Asset Sale
having an aggregate fair market value (as determined in good faith by an Officer of the Company (as evidenced by an Officers’ Certificate)), taken together with all other Designated Noncash Consideration received pursuant to this clause
(3) that is at that time outstanding, not to exceed the greater of (x) $70.0 million and (y) 1.75% of Total Assets at the time of the receipt of such Designated Noncash Consideration (with the fair market value of each item of
Designated Noncash Consideration being measured at the time received without giving effect to subsequent changes in value). 

Notwithstanding the foregoing, the 75% limitation referred to in clause (3) of Section 4.10(a) shall be deemed satisfied with
respect to any Asset Sale in which the cash or Cash Equivalents portion of the consideration received therefrom, determined in accordance with the foregoing provision on an after-tax basis, was less than 75%, if the proceeds before tax would have
complied with the aforementioned 75% limitation. 
 (c) Any Net Available Cash from Asset Sales that is not applied (it being understood that
an offer in respect of the Notes referred to in clause (b) of Section 4.10(a)(4) above shall be deemed an application up to the amount of the offer so long as the Company repurchased any Notes tendered in such offer) or invested as
provided in clause (4) of Section 4.10(a) shall be deemed to constitute “Excess Proceeds.” On the 367th day after the date receipt of such Net Available Cash (or such later date upon which an applicable Acceptable Commitment is
canceled or terminates or the applicable 180-day period with respect to an applicable Acceptable Commitment expires without full application of such Net Available Cash), if the aggregate amount of Excess Proceeds exceeds $25.0 million, the Company
shall be required to make an offer (“Asset Sale Offer”) to all Holders of Notes and to the extent required by the terms of other Pari Passu Indebtedness, to all holders of other Pari Passu Indebtedness outstanding with similar
provisions requiring the Company to make an offer to purchase such Pari Passu Indebtedness with the proceeds from any Asset Sale, to purchase the maximum principal amount of Notes and any 

  
 -61- 

 
such Pari Passu Indebtedness to which the Asset Sale Offer applies that may be purchased out of the Excess Proceeds, at an offer price in cash in an amount equal to 100% of the principal amount
of the Notes and Pari Passu Indebtedness plus accrued and unpaid interest to the date of purchase, in accordance with the procedures set forth in this Indenture or the agreements governing the Pari Passu Indebtedness, as applicable, in each case in
minimum denominations of $2,000 and larger integral multiples of $1,000. To the extent that the aggregate amount of Notes and Pari Passu Indebtedness so properly tendered and not withdrawn pursuant to an Asset Sale Offer is less than the Excess
Proceeds, the Company may use any remaining Excess Proceeds for any purpose not prohibited by this Indenture. If the aggregate principal amount of Notes surrendered by Holders thereof and other Pari Passu Indebtedness surrendered by holders or
lenders, collectively, exceeds the amount of Excess Proceeds, subject to DTC procedures the Trustee shall select the Notes subject to the applicable DTC procedures, and the trustee or agent for the Pari Passu Indebtedness shall select the Pari Passu
Indebtedness, to be purchased on a pro rata basis on the basis of the aggregate principal amount of tendered Notes and Pari Passu Indebtedness. Upon completion of such Asset Sale Offer, the amount of Excess Proceeds shall be reset at zero.
Accordingly, to the extent that the aggregate amount of Notes and other Indebtedness tendered pursuant to an Asset Sale Offer is less than the aggregate amount of unapplied Excess Proceeds, the Company may use any remaining amount for the general
corporate purposes of the Company and its Restricted Subsidiaries. 
 The Asset Sale Offer shall remain open for a period of at least 20
Business Days following its commencement, except to the extent that a longer period is required by applicable law (the “Asset Sale Offer Period”). No later than five Business Days after the termination of the Asset Sale Offer Period
(the “Asset Sale Purchase Date”), the Company shall purchase the principal amount of Notes and Pari Passu Indebtedness required to be purchased pursuant to this Section 4.10 (the “Asset Sale Offer Amount”) or,
if less than the Asset Sale Offer Amount has been so validly tendered, all Notes and Pari Passu Indebtedness validly tendered in response to the Asset Sale Offer. 

If the Asset Sale Purchase Date is on or after a Record Date and on or before the related Interest Payment Date, any accrued and unpaid
interest shall be paid to the Person in whose name a Note is registered at the close of business on such Record Date, and no Additional Interest shall be payable to Holders who tender Notes pursuant to the Asset Sale Offer. 

Pending the final application of any Net Available Cash pursuant to this Section 4.10, the Company and its Restricted Subsidiaries may
temporarily apply such Net Available Cash to reduce Indebtedness or otherwise invest or use such Net Available Cash in any manner not prohibited by this Indenture. 

(d) On or before the Asset Sale Purchase Date, the Company shall, to the extent lawful, accept for payment, on a pro rata basis to the
extent necessary, the Asset Sale Offer Amount of Notes and Pari Passu Indebtedness or portions of Notes and Pari Passu Indebtedness so validly tendered and not properly withdrawn pursuant to the Asset Sale Offer, or if less than the Asset Sale Offer
Amount has been validly tendered and not properly withdrawn, all Notes and Pari Passu Indebtedness so validly tendered and not properly withdrawn, in each case in integral multiples of $1,000. The Company shall deliver to the Trustee an
Officers’ Certificate stating that such Notes or portions thereof were accepted for payment by the Company in accordance with the terms of this Section 4.10 and, in addition, the Company shall deliver all certificates and notes required,
if any, by the agreements governing the Pari Passu Indebtedness. The Company, the Depositary or the Paying Agent, as the case may be, shall promptly (but in any case not later than five Business Days after termination of the Asset Sale Offer Period)
mail or deliver to each tendering Holder of Notes an amount equal to the purchase price of the Notes so validly tendered and not properly withdrawn by such Holder and accepted by the Company for purchase, and the Company shall promptly issue a new
Note, and the Trustee, upon delivery of an Officers’ Certificate from the Company, shall authenticate and mail or deliver by book entry such new Note to such Holder, in a principal amount equal to any unpurchased portion of the Note
surrendered; provided that each such new Note shall be in a principal amount of $2,000 or an integral multiple of $1,000 in excess thereof. In addition, the Company shall take any and all other actions required by the agreements governing the
Pari Passu Indebtedness. Any Note not so accepted shall be promptly mailed or delivered by book entry by the Company to the Holder thereof. The Company shall publicly announce the results of the Asset Sale Offer on the Asset Sale Purchase Date.

 The Company shall comply, to the extent applicable, with the requirements of Rule 14e-1 under the Exchange Act and any other
securities laws or regulations in connection with the repurchase of Notes pursuant to 

  
 -62- 

 
the Asset Sale Offer. To the extent that the provisions of any securities laws or regulations conflict with provisions of this Section 4.10, the Company shall comply with the applicable
securities laws and regulations and shall not be deemed to have breached its obligations under this Indenture by virtue of such compliance. 

Section 4.11 Transactions with Affiliates. 

(a) The Company shall not, and shall not permit any of its Restricted Subsidiaries to, directly or indirectly, enter into or conduct any
transaction (including the purchase, sale, lease or exchange of any property or the rendering of any service) with any Affiliate of the Company (an “Affiliate Transaction”) involving payments or consideration in excess of $5.0
million unless: 
 (1) the terms of such Affiliate Transaction are not materially less favorable to the Company or
such Restricted Subsidiary, as the case may be, when taken as a whole, than those that would have been obtained in a comparable transaction at the time of such transaction on an arm’s-length basis with a Person who is not an Affiliate; and 

(2) in the event such Affiliate Transaction involves an aggregate consideration in excess of $25.0 million, the terms of such
transaction have been approved by a majority of the disinterested members of the Board of Directors of the Company and the Board of the Directors of the Company shall have determined in good faith that such Affiliate Transaction satisfies the
criteria in clause (1) above. 
 (b) Section 4.11(a) shall not apply to: 

(1) any transaction between or among the Company and one or more Restricted Subsidiaries or between or among any Restricted
Subsidiaries and any Guarantees issued by the Company or a Restricted Subsidiary for the benefit of the Company or a Restricted Subsidiary, as the case may be, in accordance with Section 4.09; 

(2) any Restricted Payment permitted to be made pursuant to Section 4.07 or any Permitted Investment; 

(3) any employment, consulting, service or termination agreement, or indemnification arrangement, entered into by the Company
or a Restricted Subsidiary with a current or former director, officer or employee of the Company or a Restricted Subsidiary; the payment of compensation or expense reimbursement to any current or former director, officer or employee of the Company
or a Restricted Subsidiary (including amounts paid pursuant to employee benefit, employee stock option or similar plans); or any issuance of securities, or other payments, awards or grants in cash, securities or otherwise pursuant to, or the funding
of, employment agreements and other compensation arrangements, options to purchase Capital Stock of the Company, restricted stock plans, restricted stock unit plans, long-term incentive plans, stock appreciation rights plans, participation plans or
similar employee benefits plans and/or indemnity provided on behalf of directors, officers and employees of the Company or a Restricted Subsidiary (a) approved by the Board of Directors of the Company or by the shareholders of the Company in
accordance with such voting requirements as may be applicable, (b) immaterial in amount or (c) maintained, entered into or adopted in the ordinary course of business of the Company or any Restricted Subsidiary; 

(4) the payment of reasonable fees and expense reimbursements to current or former directors of the Company or any Restricted
Subsidiary; 
 (5) loans or advances to employees, officers or directors of the Company or any Restricted Subsidiary in the
ordinary course of business consistent with past practices, in an aggregate amount not in excess of $5.0 million outstanding at any time; 

(6) any agreement as in effect as of the Issue Date, as such agreement may be amended, modified, supplemented, extended or
renewed from time to time, so long as any such amendment, 

  
 -63- 

 
modification, supplement, extension or renewal, when taken as a whole, is not materially more disadvantageous to the Holders in the reasonable determination of an Officer of the Company; 

(7) any agreement between any Person and an Affiliate of such Person existing at the time such Person is acquired by or merged or
consolidated with or into the Company or a Restricted Subsidiary, as such agreement may be amended, modified, supplemented, extended or renewed from time to time; provided that such agreement was not entered in contemplation of such
acquisition, merger or consolidation, and so long as any such amendment, modification, supplement, extension or renewal, when taken as a whole, is not materially more disadvantageous to the Holders, in the reasonable determination of an Officer of
the Company, than the applicable agreement as in effect on the date immediately prior to such amendment, modification, supplement, extension or renewal, as applicable; 

(8) transactions with customers, clients, suppliers, joint venture partners or purchasers or sellers of goods or services, in each case
in the ordinary course of the business of the Company and its Restricted Subsidiaries and otherwise in compliance with the terms of this Indenture; provided that in the reasonable determination of an Officer of the Company, such transactions
are on terms that are not materially less favorable, when taken as a whole, to the Company or the relevant Restricted Subsidiary than those that would have been obtained in a comparable transaction by the Company or such Restricted Subsidiary with
an unrelated Person; 
 (9) any issuance or sale of Capital Stock (other than Disqualified Stock) to Affiliates of the Company and the
granting of registration and other customary rights with respect thereto; 
 (10) transactions in which the Company or any Restricted
Subsidiary delivers to the Trustee a letter or opinion from an Independent Financial Advisor stating that such transaction is fair to the Company or such Restricted Subsidiary from a financial point of view or stating that the terms are not
materially less favorable, when taken as a whole, than those that might reasonably have been obtained by the Company or such Restricted Subsidiary in a comparable transaction at such time on an arm’s-length basis from a Person that is not an
Affiliate; 
 (11) the Transactions and the payment of all fees and expenses related to the Transactions, in each case as disclosed in the
Offering Memorandum; 
 (12) transactions with Cornerstone substantially consistent, taken as a whole, with past practice (including without
limitation, the extension of lines of insurance coverage); 
 (13) payments of principal, interest and premium by the Company or any
Restricted Subsidiary on any of its Indebtedness held by an Affiliate if the terms of such Indebtedness are substantially as favorable to the Company or such Restricted Subsidiary as the terms which could have been obtained at the time of the
creation of such Indebtedness from a lender which was not an Affiliate; and 
 (14) any transaction with a Person (other than an Unrestricted
Subsidiary) that is an Affiliate solely because the Company or a Subsidiary of the Company holds an equity interest in or otherwise controls such Person. 

Section 4.12 Limitation on Liens. 

(a) The Company shall not, and shall not permit any of its Restricted Subsidiaries to, directly or indirectly, create or incur any Lien
securing Indebtedness (other than Permitted Liens) upon any of its property or assets (including Capital Stock of Subsidiaries), or income or profits therefrom, or assign or convey any right to receive income therefrom, whether owned on the Issue
Date or acquired after that date, which Lien is securing any Indebtedness, unless contemporaneously with the Incurrence of such Liens: 

  
 -64- 

 (1) in the case of Liens securing Subordinated Obligations or Guarantor
Subordinated Obligations, the Notes and related Subsidiary Guarantees are secured by a Lien on such property, assets or proceeds that is senior to such Liens; or 

(2) in all other cases, the Notes and related Subsidiary Guarantees are equally and ratably secured or are secured by a Lien on
such property, assets or proceeds that is senior in priority to such Liens. 
 (b) Any Lien created for the benefit of Holders of the Notes
on any property or assets pursuant to this Section 4.12 shall be automatically and unconditionally released and discharged upon the release and discharge of each of the Liens on such property or assets described in clauses (1) and
(2) above. 
 Section 4.13 Corporate Existence. 

Subject to Article 5, the Company shall do or cause to be done all things necessary to preserve and keep in full force and effect
(i) its corporate existence, in accordance with its organizational documents (as the same may be amended from time to time) and (ii) the rights (charter and statutory), licenses and franchises of the Company and its Restricted
Subsidiaries; provided that the Company shall not be required to preserve any such right, license or franchise, if the Company in good faith shall determine that the preservation thereof is no longer desirable in the conduct of the business
of the Company and its Restricted Subsidiaries, taken as a whole. 
 Section 4.14 Offer to Repurchase Upon Change of
Control. 
 (a) If a Change of Control occurs, unless the Company has exercised its right to redeem all of the Notes as described under
Section 3.07, each Holder shall have the right to require the Company to repurchase all or any part (equal to $2,000 or larger integral multiples of $1,000) of such Holder’s Notes at a purchase price in cash equal to 101% of the aggregate
principal amount of the Notes repurchased plus accrued and unpaid interest, if any, to, but not including, the date of purchase (subject to the right of Holders on the relevant Record Date to receive interest due on the relevant Interest Payment
Date). 
 (b) Within 30 days following any Change of Control, unless the Company has exercised its right to redeem all of the Notes as
described under Section 3.07, the Company shall mail a notice (the “Change of Control Offer”) to each Holder of the Notes (or with respect to Global Notes, to the extent permitted or required by applicable DTC procedures or
regulations, send electronically), with a copy to the Trustee, stating: 
 (1) that a Change of Control has occurred and that
such Holder has the right to require the Company to purchase such Holder’s Notes at a purchase price in cash equal to 101% of the principal amount of such Notes plus accrued and unpaid interest, if any, to the date of purchase (subject to the
right of Holders on a Record Date to receive interest on the relevant Interest Payment Date) (the “Change of Control Payment”); 

(2) the repurchase date (which shall be no earlier than 30 days nor later than 60 days from the date such notice is sent) (the
“Change of Control Payment Date”); provided that if the Change of Control Offer is conditioned upon the occurrence of a Change of Control, such Change of Control Offer may be extended to the date of the occurrence of such
Change of Control even if later than such 60th day; and 
 (3) the procedures determined by the Company, consistent with this
Indenture, that a Holder must follow in order to have its Notes repurchased. 
 On the Change of Control Payment Date, the Company shall, to
the extent lawful: 
 (1) accept for payment all Notes or portions of Notes (equal to $2,000 or larger integral multiples of
$1,000) properly tendered and not withdrawn pursuant to the Change of Control Offer; 

  
 -65- 

 (2) deposit with the Paying Agent an amount equal to the Change of Control
Payment in respect of all Notes or portions of Notes properly tendered and not withdrawn; and 
 (3) deliver or cause to be
delivered to the Trustee the Notes so accepted together with an Officers’ Certificate stating the aggregate principal amount of Notes or portions of Notes being purchased by the Company. 

The Paying Agent shall promptly mail to each Holder of Notes properly tendered and not withdrawn the Change of Control Payment for such
Notes, and the Trustee shall promptly authenticate and mail (or cause to be transferred by book entry) to each Holder a new Note equal in principal amount to any unpurchased portion of the Notes surrendered, if any; provided that each such
new Note shall be in a principal amount of $2,000 or larger integral multiples of $1,000. 
 The notice, if mailed in a manner herein
provided, shall be conclusively presumed to have been given, whether or not the Holder receives such notice. If (a) the notice is mailed in a manner herein provided and (b) any Holder fails to receive such notice or a Holder receives such
notice but it is defective, such Holder’s failure to receive such notice or such defect shall not affect the validity of the proceedings for the purchase of the Notes as to all other Holders that properly received such notice without defect.

 If the Change of Control Payment Date is on or after an interest record date and on or before the related interest payment date, any
accrued and unpaid interest, if any, will be paid on the relevant interest payment date to the Person in whose name a Note is registered at the close of business on such record date, and no Additional Interest will be payable to holders who tender
pursuant to the Change of Control Offer. 
 (c) The Company shall not be required to make a Change of Control Offer upon a Change of Control
if a third party makes the Change of Control Offer in the manner, at the times and otherwise in compliance with the requirements set forth in this Indenture applicable to a Change of Control Offer made by the Company and purchases all Notes properly
tendered and not withdrawn under such Change of Control Offer. A Change of Control Offer may be made in advance of a Change of Control, conditional upon such Change of Control, if a definitive agreement is in place for the Change of Control at the
time of the making of the Change of Control Offer. 
 (d) The Company shall comply, to the extent applicable, with the requirements of Rule
14e-1 under the Exchange Act and any other securities laws or regulations in connection with the repurchase of Notes pursuant to the Change of Control Offer. To the extent that the provisions of any securities laws or regulations conflict with
provisions of this Indenture, the Company shall comply with the applicable securities laws and regulations and shall not be deemed to have breached its obligations described in this Indenture by virtue of such compliance. 

Section 4.15 Future Subsidiary Guarantors. 

(a) The Company shall cause any Domestic Wholly Owned Subsidiary that borrows under or guarantees the Senior Credit Facilities after the Issue
Date to execute and deliver to the Trustee a supplemental indenture, the form of which is attached as Exhibit C hereto, pursuant to which such Domestic Wholly Owned Subsidiary will unconditionally Guarantee, on a joint and several basis, the
full and prompt payment of the principal of, premium, if any, and interest (including Additional Interest, if any) in respect of the Notes on a senior basis and all other obligations under this Indenture. 

(b) Notwithstanding the foregoing, each Subsidiary Guarantee shall provide by its terms that it shall be automatically and unconditionally
released and discharged under the circumstances described in Section 10.06. 

  
 -66- 

 Section 4.16 [Reserved]. 

Section 4.17 Suspension of Covenants. 

(a) Following the first day (the “Suspension Date”) that: 

(1) the Notes have an Investment Grade Rating from both of the Rating Agencies; and 

(2) no Default has occurred and is continuing under this Indenture; 

the Company and its Restricted Subsidiaries shall not be subject to Sections 4.07, 4.08, 4.09, 4.10, 4.11 and clause (4) of Section 5.01(a)
(collectively, the “Suspended Covenants”). If at any time following a Suspension Date the Notes’ credit rating is downgraded from an Investment Grade Rating by either Rating Agency or if a Default or Event of Default occurs and
is continuing (such date, the “Reinstatement Date”), then the Suspended Covenants shall thereafter be reinstated as if such covenants had never been suspended and be applicable pursuant to the terms of this Indenture (including in
connection with performing any calculation or assessment to determine compliance with the terms of this Indenture), unless and until a subsequent Suspension Date occurs (in which event the Suspended Covenants shall no longer be in effect until a
subsequent Reinstatement Date occurs). 
 (b) Notwithstanding the reinstatement of the Suspended Covenants upon a Reinstatement Date, no
Default, Event of Default or breach of any kind shall be deemed to exist under this Indenture, the Notes or the Subsidiary Guarantees with respect to the Suspended Covenants based upon, and none of the Company or any of its Subsidiaries shall bear
any liability for, any actions taken or events occurring during the Suspension Period (as defined below), or any actions taken at any time pursuant to any contractual obligation arising prior to the Reinstatement Date, regardless of whether such
actions or events would have been permitted if the applicable Suspended Covenants remained in effect during such period. The period of time between Suspension Date and the Reinstatement Date is referred to as the “Suspension
Period.” 
 (c) On each Reinstatement Date, all Indebtedness Incurred during the applicable Suspension Period shall be classified to
have been Incurred pursuant to Section 4.09(a) or one of the clauses set forth in Section 4.09(b) (to the extent such Indebtedness would be permitted to be Incurred thereunder as of such Reinstatement Date and after giving effect to
Indebtedness Incurred prior to the Suspension Period and outstanding on the Reinstatement Date). To the extent such Indebtedness would not be so permitted to be Incurred pursuant Section 4.09(a) or Section 4.09(b), such Indebtedness shall
be deemed to have been outstanding on the Issue Date, so that it is classified as permitted under clause (3) of Section 4.09(b). Calculations made after each Reinstatement Date of the amount available to be made as Restricted Payments
under Section 4.07 shall be made as though Section 4.07 had been in effect since the Issue Date and throughout any and all Suspension Periods. Accordingly, Restricted Payments made during a Suspension Period shall reduce the amount
available to be made as Restricted Payments under Section 4.07(a) to the extent required by Section 4.07. For purposes of determining compliance with Section 4.10, on the Reinstatement Date, the Net Available Cash from all Asset Sales
not applied in accordance with such section shall be deemed reset at zero. The Company shall provide written notice to the Trustee of the occurrence of any Suspension Date or Reinstatement Date. The Trustee shall have no obligation to independently
determine or verify if such events have occurred or notify the holders of the continuance and termination of any Suspension Period. The Trustee may provide a copy of such notice to any holder of Notes upon request. 

(d) During any period when the Suspended Covenants are suspended, the Company shall not designate any of the Company’s Subsidiaries as
Unrestricted Subsidiaries pursuant to this Indenture unless such designation would have been allowed if the Suspended Covenants had been in effect at the time of such designation and throughout such period and applied to all activities of the
Company and its Restricted Subsidiaries throughout such period. 

  
 -67- 

 ARTICLE 5 

SUCCESSORS 
 Section 5.01
Merger and Consolidation. 
 (a) The Company shall not consolidate with or merge with or into or wind up into (whether or not the
Company is the surviving corporation), or sell, assign, convey, transfer or otherwise dispose of all or substantially all of the properties and assets of the Company and its Restricted Subsidiaries, taken as a whole, in one or more related
transactions, to any Person unless: 
 (1) the resulting, surviving or transferee Person (the “Successor
Company”) is the Company or will be a corporation, limited liability company or partnership organized and existing under the laws of the United States of America, any State of the United States, the District of Columbia or any territory of
the United States; provided that if such Person is not a corporation, such Person shall immediately cause a Subsidiary that is a corporation to be added as a co-issuer of the Notes under this Indenture; 

(2) the Successor Company (if other than the Company) assumes all of the obligations of the Company under the Notes and this
Indenture pursuant to a supplemental indenture or other documentation or instruments in forms reasonably satisfactory to the Trustee and assumes by written agreement all of the obligations of the Company, if applicable, under the Registration Rights
Agreement; 
 (3) immediately after giving effect to such transaction, no Default or Event of Default shall have occurred and
be continuing; 
 (4) immediately after giving pro forma effect to such transaction and any related financing
transactions, as if such transactions had occurred at the beginning of the applicable four-fiscal-quarter period, 
 (i) the
Successor Company would be able to Incur at least $1.00 of additional Indebtedness pursuant to Section 4.09(a), or 

(ii) the Consolidated Coverage Ratio for the Successor Company would be equal to or greater than such ratio for the Company
immediately prior to such transaction; 
 (5) each Subsidiary Guarantor (unless it is the other party to the transactions
above, in which case clause (1) shall apply) shall have confirmed in writing to the Trustee that its Subsidiary Guarantee shall apply to such Person’s obligations in respect of this Indenture and the Notes and, if applicable, that its
obligations under the Registration Rights Agreement shall continue to be in effect; and 
 (6) the Successor Company delivers
to the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that such consolidation, merger or transfer and the supplemental indenture or other documentation referenced in clause (2) comply with this Indenture. 

Notwithstanding the preceding clauses (3) and (4), 

(1) any Restricted Subsidiary may consolidate with, merge with or into or transfer all or part of its properties and assets to
the Company or a Subsidiary Guarantor so long as no Capital Stock of the Restricted Subsidiary is distributed to any Person other than the Company or such Subsidiary Guarantor, and 

(2) the Company may merge with an Affiliate of the Company solely for the purpose of reincorporating the Company in another
jurisdiction. 

  
 -68- 

 (b) The Company shall not permit any Subsidiary Guarantor to consolidate with or merge with or
into or wind up into (whether or not the Subsidiary Guarantor is the surviving corporation), or sell, assign, convey, transfer or otherwise dispose of all or substantially all of its properties and assets to any Person (other than to the Company or
another Subsidiary Guarantor) unless: 
 (1) (a) if such entity remains a Subsidiary Guarantor, the resulting,
surviving or transferee Person (the “Successor Guarantor”) will be a corporation, partnership, trust or limited liability company organized and existing under the laws of the United States of America, any State of the United States,
the District of Columbia or any other territory thereof and, if applicable, shall assume by written agreement all the obligations of the Subsidiary Guarantor under the Registration Rights Agreement; (b) the Successor Guarantor, if other than
such Subsidiary Guarantor, expressly assumes all the obligations of such Subsidiary Guarantor under the Notes and this Indenture pursuant to a supplemental indenture or other documents or instruments in form reasonably satisfactory to the Trustee;
(c) immediately after giving effect to such transaction, no Default of Event or Default shall have occurred and be continuing; and (d) the Company shall have delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel,
each stating that such consolidation, merger or transfer and such supplemental indenture (if any) comply with this Indenture; or 

(2) the transaction is made in compliance with Section 4.10 (it being understood that only such portion of the Net
Available Cash as is required to be applied on the date of such transaction in accordance with the terms of this Indenture needs to be applied in accordance therewith at such time), or excluded from the definition of “Asset Sale,” and, if
applicable, this Section 5.01. 
 (c) In addition, the Company shall not, directly or indirectly, lease, or permit any Subsidiary
Guarantor to lease, all or substantially all of the properties of the Company and its Restricted Subsidiaries, taken as a whole, in one or more related transactions, to any Person other than the Company or a Subsidiary Guarantor. 

(d) Notwithstanding the foregoing, (i) any Subsidiary Guarantor may (x) merge with or into or transfer all or part of its properties
and assets to another Subsidiary Guarantor or the Company, or (y) merge with a Restricted Subsidiary of the Company solely for the purpose of reincorporating the Subsidiary Guarantor in a State of the United States or the District of Columbia,
as long as the amount of Indebtedness of such Subsidiary Guarantor and its Restricted Subsidiaries is not increased thereby and (ii) any Subsidiary Guarantor may liquidate or dissolve if the Company determines in good faith that such
liquidation or dissolution is in the best interests of the Company and is not adverse in any material respect to the holders; provided that the proceeds of such liquidation or dissolution shall be retained by the Company or a Subsidiary
Guarantor. 
 (e) For purposes of this Section 5.01, the sale, lease, assignment, conveyance, transfer or other disposition of all or
substantially all of the properties and assets of one or more Restricted Subsidiaries of the Company, which properties and assets, if held by the Company instead of such Restricted Subsidiaries, would constitute all or substantially all of the
properties and assets of the Company on a consolidated basis, shall be deemed to be the transfer of all or substantially all of the properties and assets of the Company. 

(f) Upon any consolidation or merger, or any sale, assignment, transfer, conveyance or other disposition of all or substantially all of the
assets of a Subsidiary Guarantor in accordance with this Section 5.01, such Subsidiary Guarantor shall be released from its obligations under this Indenture and the Subsidiary Guarantee and the Successor Guarantor shall succeed to, and be
substituted for, and may exercise every right and power of, the Subsidiary Guarantor under this Indenture and the Subsidiary Guarantee, but, in the case of a lease of all or substantially all its properties and assets, such Subsidiary Guarantor
shall not be released from its obligations under its Subsidiary Guarantee. 
 Section 5.02 Successor Entity Substituted. 

Upon any consolidation or merger, or any sale, assignment, transfer, conveyance or other disposition of all or substantially all of the assets
of the Company in accordance with Section 5.01, the Company shall be released from its obligations under this Indenture and the Successor Company formed by such consolidation or into or with which the Company is merged or to which such sale,
assignment, transfer, conveyance or other disposition is made 

  
 -69- 

 
shall succeed to, and be substituted for (so that from and after the date of such consolidation, merger, sale, conveyance or other disposition, the provisions of this Indenture referring to the
Company shall refer instead to the Successor Company and not to the Company), and may exercise every right and power of the Company under this Indenture with the same effect as if such Successor Company had been named as the Company herein; provided
that the predecessor Company shall not be relieved from the obligation to pay the principal of and interest and Additional Interest, if any, on the Notes except in the case of a sale, assignment, transfer, conveyance or other disposition of all of
the Company’s assets that meets the requirements of Section 5.01. 
 ARTICLE 6 

DEFAULTS AND REMEDIES 

Section 6.01 Events of Default. 

(a) An “Event of Default” wherever used herein, means any one of the following events (whatever the reason for such Event of
Default and whether it shall be voluntary or involuntary or be effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental body): 

(1) default in any payment of interest or Additional Interest (as required by the Registration Rights Agreement) on any Note
when due, continued for 30 days; 
 (2) default in the payment of principal of or premium, if any, on any Note when due at
its Stated Maturity, upon optional redemption, upon required repurchase, upon declaration of acceleration or otherwise; 

(3) failure by the Company to comply with its obligations under Section 5.01 (other than its obligations under clause
(5) of Section 5.01(a)) or the failure by any Subsidiary Guarantor to comply with its obligations under clauses (1)(b), (1)(c), (1)(d) and (2) of Section 5.01(b), in each case continued for 30 days; 

(4) failure by the Company or any Subsidiary Guarantor to comply for 30 days after notice as provided below with any of its
obligations under Sections 4.10 and 4.14 (in each case, other than (a) a failure to purchase Notes that constitutes an Event of Default under clause (2) above or (b) a failure to comply with Section 5.01 that constitutes an Event
of Default under clause (3) above); 
 (5) failure by the Company or any Subsidiary Guarantor to comply for 60 days
after notice as provided below with its other covenants and agreements contained in this Indenture; 
 (6) default by the
Company or any Restricted Subsidiary under any mortgage, indenture or instrument under which there may be issued or by which there may be secured or evidenced any indebtedness for money borrowed by the Company or any of its Restricted Subsidiaries
(or the payment of which is guaranteed by the Company or any of its Restricted Subsidiaries), other than indebtedness owed to the Company or a Restricted Subsidiary, whether such Indebtedness or Guarantee now exists or is created after the Issue
Date, which default: 
 (i) is caused by a failure, after the expiration of the grace period provided in such Indebtedness,
to pay principal of, or premium, if any, on such Indebtedness (“payment default”); or 
 (ii) results in the
acceleration of such Indebtedness prior to its maturity; 
 and, in each case, the principal amount of any such Indebtedness, together with
the principal amount of any other such Indebtedness under which there has been a payment default or the maturity of which has been so accelerated, aggregates $50.0 million or more; 

  
 -70- 

 (7) the Company or a Significant Subsidiary or group of Restricted Subsidiaries
that, taken together (as of the latest audited consolidated financial statements for the Company and its Restricted Subsidiaries), would constitute a Significant Subsidiary pursuant to or within the meaning of any Bankruptcy Law: 

(i) commences a voluntary case or proceeding with respect to itself; 

(ii) consents to the entry of an order for relief against it in an involuntary case or proceeding; 

(iii) consents to the appointment of a Bankruptcy Custodian of it or for substantially all of its property; or 

(iv) makes a general assignment for the benefit of its creditors, or takes any comparable action under any foreign laws
relating to insolvency; 
 (8) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that:

 (i) is for relief against the Company or any Significant Subsidiary or a group of Restricted Subsidiaries that, taken
together (as of the latest audited financial statements for the Company and its Restricted Subsidiaries), would constitute a Significant Subsidiary, in an involuntary case; 

(ii) appoints a Bankruptcy Custodian of the Company, any Significant Subsidiary or a group of Restricted Subsidiaries that,
taken together (as of the latest audited financial statements for the Company and its Restricted Subsidiaries), would constitute a Significant Subsidiary, for substantially all of its property; or 

(iii) orders the winding up or liquidation of the Company, any Significant Subsidiary or a group of Restricted Subsidiaries
that, taken together (as of the latest audited financial statements for the Company and its Restricted Subsidiaries), would constitute a Significant Subsidiary; 

or any similar relief is granted under any foreign laws and the order, decree or relief remains unstayed and in effect for 60 days; 

(9) failure by the Company or any Restricted Subsidiary or group of Restricted Subsidiaries that, taken together (as of the
latest audited consolidated financial statements for the Company and its Restricted Subsidiaries), would constitute a Significant Subsidiary to pay final judgments aggregating in excess of $50.0 million (net of any amounts that are covered by
insurance provided by a reputable and creditworthy insurance company), which judgments are not paid, discharged or stayed for a period of 60 days; or 

(10) any Subsidiary Guarantee of a Significant Subsidiary or group of Restricted Subsidiaries that taken together as of the
latest audited consolidated financial statements for the Company and its Restricted Subsidiaries would constitute a Significant Subsidiary ceases to be in full force and effect (except as contemplated by the terms of this Indenture) or is declared
null and void in a judicial proceeding or any Subsidiary Guarantor that is a Significant Subsidiary or group of Subsidiary Guarantors that taken together as of the latest audited consolidated financial statements of the Company and its Restricted
Subsidiaries would constitute a Significant Subsidiary denies or disaffirms its obligations under this Indenture or its Subsidiary Guarantee. 

(b) A Default under clauses (4) and (5) above shall not constitute an Event of Default until the Trustee or the Holders of 25% in
aggregate principal amount of the then outstanding Notes (with a copy to the Trustee) 

  
 -71- 

 
provide written notice to the Company of the Default and the Company does not cure such default within the time specified in clauses (4) and (5) above after receipt of such notice. 

(c) Notwithstanding the foregoing, at the election of the Company, the sole remedy for an Event of Default relating to the failure to comply
with Section 4.03 shall, for the first 60 days after the occurrence of such an Event of Default, consist exclusively of the right to receive additional interest on the Notes at an annual rate equal to 0.25% of the principal amount of the Notes.
If the Company so elects, such additional interest shall accrue on all outstanding Notes from and including the date on which the Event of Default relating to the failure to comply with the reporting obligations in this Indenture first occurs to but
not including the earlier of (a) the 60th day thereafter or (b) the date on which such Event of Default is cured or waived by the Holders of a majority in principal amount of the outstanding Notes. On such 60th day (or earlier, if the
Event of Default relating to the reporting obligations under this Indenture is cured or waived by the Holders of a majority in principal amount of the outstanding Notes prior to such 60th day), such additional interest shall cease to accrue and, if
the Event of Default relating to reporting obligations has not been cured or waived prior to such 60th day, the Notes shall be subject to acceleration as provided in Section 6.02. The provisions of this Indenture described in this
Section 6.01(c) shall not affect the rights of Holders of Notes in the event of the occurrence of any other Event of Default. In the event the Company does not elect to pay the additional interest upon an Event of Default in accordance with
this Section 6.01(c), the Notes shall be subject to acceleration as provided in Section 6.02. 
 In order to elect to pay the
additional interest on the Notes as the sole remedy during the first 60 days after the occurrence of an Event of Default relating to the failure to comply with Section 4.03 in accordance with Section 6.01(c), the Company shall notify all
Holders of Notes and the Trustee and Paying Agent of such election on or before the close of business on the date on which such Event of Default first occurs. The Company may make such an election with respect to the Notes. 

Section 6.02 Acceleration. 

(a) If an Event of Default (other than an Event of Default described in Section 6.01(a)(7) or (8) with respect to the Company) occurs
and is continuing, the Trustee by notice in writing specifying the Event of Default and that it is a “notice” to the Company, or the Holders of at least 25% in aggregate principal amount of the then outstanding Notes by notice to the
Company and the Trustee, may declare the principal of, premium, if any, and accrued and unpaid interest, if any, on all the Notes to be due and payable. Upon such a declaration, such principal, premium and accrued and unpaid interest shall be due
and payable immediately. 
 (b) In the event of a declaration of acceleration of the Notes because an Event of Default described in clause
(6) under Section 6.01(a) has occurred and is continuing, the declaration of acceleration of the Notes shall be automatically annulled if the default triggering such Event of Default pursuant to clause (6) of Section 6.01(a)
shall be remedied or cured by the Company or a Restricted Subsidiary or waived by the Holders of the relevant Indebtedness within 20 days after the declaration of acceleration with respect thereto and if (1) the annulment of the acceleration of
the Notes would not conflict with any judgment or decree of a court of competent jurisdiction and (2) all existing Events of Default, except nonpayment of principal, premium or interest on the Notes that became due solely because of the
acceleration of the Notes, have been cured or waived, and all amounts owing to the Trustee have been paid. 
 (c) If an Event of Default
described in Section 6.01(a)(7) or (8) occurs and is continuing with respect to the Company, the principal of, premium, if any, and accrued and unpaid interest on all the Notes shall become and be immediately due and payable without any
declaration or other act on the part of the Trustee or any Holders. 
 Section 6.03 Other Remedies. 

Subject to Section 6.01(c), if an Event of Default occurs and is continuing, the Trustee may pursue any available remedy to collect the
payment of principal, premium, if any, Additional Interest, if any, and interest on the Notes or to enforce the performance of any provision of the Notes or this Indenture. 

  
 -72- 

 The Trustee may maintain a proceeding even if it does not possess any of the Notes or does not
produce any of them in the proceeding. A delay or omission by the Trustee or any Holder of a Note in exercising any right or remedy accruing upon an Event of Default shall not impair the right or remedy or constitute a waiver of or acquiescence in
the Event of Default. All remedies are cumulative to the extent permitted by law. 
 Section 6.04 Waiver of Past Defaults. 

The Holders of a majority in aggregate principal amount of the then outstanding Notes may waive all past defaults (except with respect to a
continuing Default or Event of Default with respect to nonpayment of principal, premium or interest on the Notes) and rescind any such acceleration with respect to the Notes and its consequences if (1) rescission would not conflict with any
judgment or decree of a court of competent jurisdiction and (2) all existing Events of Default, other than the nonpayment of the principal of, premium, if any, and interest on the Notes that have become due solely by such declaration of
acceleration, have been cured or waived and all amounts owing to the Trustee under this Indenture have been paid. 
 Upon any such waiver,
such Default shall cease to exist, and any Event of Default arising therefrom shall be deemed to have been cured for every purpose of this Indenture; but no such waiver shall extend to any subsequent or other Default or impair any right consequent
thereon. 
 Section 6.05 Control by Majority. 

Subject to the express terms of this Indenture, including, without limitation, Sections 7.02(f), 7.02(k) and 7.07, the Holders of a majority in
aggregate principal amount of the then outstanding Notes are given the right to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee or of exercising any trust or power conferred on the Trustee. The
Trustee, however, may refuse to follow any direction that conflicts with law or this Indenture or that the Trustee determines is unduly prejudicial to the rights of any other Holder (it being understood that the Trustee does not have an affirmative
duty to ascertain whether or not any such directions are unduly prejudicial) or that would involve the Trustee in personal liability; provided, however, that the Trustee may take any other action deemed proper by the Trustee which is
not inconsistent with such direction. Prior to taking any action under this Indenture, the Trustee shall be entitled to indemnification from the Holders satisfactory to it in its sole discretion against all losses and expenses caused by taking or
not taking such action. 
 Section 6.06 Limitation on Suits. 

Subject to Section 6.07, no Holder of a Note may pursue any remedy with respect to this Indenture or the Notes unless: 

(1) such Holder has previously given the Trustee written notice that an Event of Default is continuing; 

(2) Holders of at least 25% in aggregate principal amount of the then outstanding Notes have requested the Trustee, by notice
in writing, to pursue the remedy; 
 (3) such Holders have offered the Trustee satisfactory security or indemnity against any
loss, liability or expense; 
 (4) the Trustee has not complied with such request within 60 days after the receipt of the
request and the offer of security or indemnity; and 
 (5) the Holders of a majority in aggregate principal amount of the
then outstanding Notes have not given the Trustee a direction that, in the opinion of the Trustee, is inconsistent with such request within such 60-day period. 

A Holder of a Note may not use this Indenture to prejudice the rights of another Holder of a Note or to obtain a preference or priority over
another Holder of a Note. 

  
 -73- 

 Section 6.07 Rights of Holders of Notes to Receive Payment. 

Notwithstanding any other provision of this Indenture, the right of any Holder of a Note to receive payment of principal of, premium, if any,
and Additional Interest, if any, and interest on the Note, on or after the respective due dates expressed in the Note (including in connection with an Asset Sale Offer or a Change of Control Offer), or to bring suit for the enforcement of any such
payment on or after such respective dates, shall not be impaired or affected without the consent of such Holder. 
 Section 6.08
Collection Suit by Trustee. 
 If an Event of Default specified in Section 6.01(a)(1) or (2) occurs and is continuing, the
Trustee is authorized to recover judgment in its own name and as trustee of an express trust against the Company or the Subsidiary Guarantors for the whole amount of principal of, premium, if any, and Additional Interest, if any, and interest
remaining unpaid on the Notes and interest on overdue principal and, to the extent lawful, interest and such further amount as shall be sufficient to cover the costs and expenses of collection, including the reasonable compensation, expenses,
disbursements and advances of the Trustee, its agents and counsel. 
 Section 6.09 Restoration of Rights and Remedies. 

If the Trustee or any Holder has instituted any proceeding to enforce any right or remedy under this Indenture and such proceeding has been
discontinued or abandoned for any reason, or has been determined adversely to the Trustee or to such Holder, then and in every such case, subject to any determination in such proceedings, the Company, the Trustee and the Holders shall be restored
severally and respectively to their former positions hereunder and thereafter all rights and remedies of the Trustee and the Holders shall continue as though no such proceeding has been instituted. 

Section 6.10 Rights and Remedies Cumulative. 

Except as otherwise provided with respect to the replacement or payment of mutilated, destroyed, lost or stolen Notes in Section 2.07, and
except as set forth in Section 6.01(c), no right or remedy herein conferred upon or reserved to the Trustee or to the Holders is intended to be exclusive of any other right or remedy, and every right and remedy shall, to the extent permitted by
law, be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the
concurrent assertion or employment of any other appropriate right or remedy. 
 Section 6.11 Delay or Omission Not Waiver. 

No delay or omission of the Trustee or of any Holder of any Note to exercise any right or remedy accruing upon any Event of Default shall
impair any such right or remedy or constitute a waiver of any such Event of Default or an acquiescence therein. Every right and remedy given by this Article or by law to the Trustee or to the Holders may be exercised from time to time, and as often
as may be deemed expedient, by the Trustee or by the Holders, as the case may be. 
 Section 6.12 Trustee May File Proofs of
Claim. 
 The Trustee is authorized to file such proofs of claim and other papers or documents as may be necessary or advisable in order
to have the claims of the Trustee (including any claim for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel) and the Holders of the Notes allowed in any judicial proceedings relative to the
Company (or any other obligor upon the Notes including the Subsidiary Guarantors), their creditors or their property and shall be entitled and empowered to vote for the election of a trustee in bankruptcy or similar official and participate as a
member in any official committee of creditors appointed in such matter and to collect, receive and distribute any money or other property payable or deliverable on any such claims and any custodian in any such judicial proceeding is hereby
authorized by each Holder to make such payments to the Trustee, and in the event that the Trustee shall consent to the making of such payments directly to the Holders, to 

  
 -74- 

 
pay to the Trustee any amount due to it for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, and any other amounts due the Trustee under
Section 7.07. To the extent that the payment of any such compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, and any other amounts due the Trustee under Section 7.07 out of the estate in any such
proceeding, shall be denied for any reason, payment of the same shall be secured by a Lien on, and shall be paid out of, any and all distributions, dividends, money, securities and other properties that the Holders may be entitled to receive in such
proceeding whether in liquidation or under any plan of reorganization or arrangement or otherwise. Nothing herein contained shall be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Holder any plan of
reorganization, arrangement, adjustment or composition affecting the Notes or the rights of any Holder, or to authorize the Trustee to vote in respect of the claim of any Holder in any such proceeding. 

Section 6.13 Priorities. 

After an Event of Default any moneys or properties distributable in respect of the Company’s or any Subsidiary Guarantor’s
obligations under this Indenture, or any money or property collected by the Trustee pursuant to this Article 6, shall be paid out or distributed in the following order: 

(i) to the Trustee, its agents and attorneys for amounts due under Section 7.07, including payment of all compensation,
expenses and liabilities incurred, and all advances made, by the Trustee and the costs and expenses of collection; 
 (ii) to
Holders of Notes for amounts due and unpaid on the Notes for principal, premium, if any, and Additional Interest, if any, and interest, ratably, without preference or priority of any kind, according to the amounts due and payable on the Notes for
principal, premium, if any, and Additional Interest, if any, and interest, respectively; and 
 (iii) to the Company or to
such party as a court of competent jurisdiction shall direct, including a Subsidiary Guarantor, if applicable. 
 The Trustee may upon
notice to the Company, fix a record date and payment date for any payment to Holders of Notes pursuant to this Section 6.13. 

Section 6.14 Undertaking for Costs. 

In any suit for the enforcement of any right or remedy under this Indenture or in any suit against the Trustee for any action taken or omitted
by it as a Trustee, a court in its discretion may require the filing by any party litigant in the suit of an undertaking to pay the costs of the suit, and the court in its discretion may assess reasonable costs, including reasonable attorneys’
fees, against any party litigant in the suit, having due regard to the merits and good faith of the claims or defenses made by the party litigant. This Section 6.14 does not apply to a suit by the Trustee, a suit by the Company, a suit by a
Holder of a Note pursuant to Section 6.07, or a suit by Holders of more than 10% in principal amount of the then outstanding Notes. 

ARTICLE 7 
 TRUSTEE 

Section 7.01 Duties of Trustee. 

(a) In the case of an Event of Default known to the Trustee to have occurred and be continuing, the Trustee shall exercise such of the rights
and powers vested in it by this Indenture, and use the same degree of care and skill in its exercise as a prudent person would exercise or use under the circumstances in the conduct of such person’s own affairs. 

  
 -75- 

 (b) Except during the continuance of an Event of Default: 

(1) the duties of the Trustee shall be determined solely by the express provisions of this Indenture and the Trustee need
perform only those duties that are specifically set forth in this Indenture and no others, and no implied covenants or obligations shall be read into this Indenture against the Trustee; and 

(2) in the absence of bad faith on its part, the Trustee may conclusively rely, as to the truth of the statements and the
correctness of the opinions expressed therein, upon certificates or opinions furnished to the Trustee and conforming to the requirements of this Indenture. However, in the case of any such certificates or opinions which by any provision are
specifically required to be furnished to the Trustee, the Trustee shall examine the certificates and opinions to determine whether or not they conform to the requirements of this Indenture (but need not confirm or investigate the accuracy of
mathematical calculations or other facts stated therein). 
 (c) The Trustee may not be relieved from liability for its own negligent action,
its own negligent failure to act, or its own willful misconduct, except that: 
 (i) this Section 7.01(c) does not limit
the effect of Section 7.01(b); 
 (ii) the Trustee shall not be liable for any error of judgment made in good faith by a
Trust Officer, unless it is proved in a court of competent jurisdiction that the Trustee was negligent in ascertaining the pertinent facts; and 

(iii) the Trustee shall not be liable with respect to any action it takes or omits to take in good faith in accordance with a
direction received by it pursuant to Section 6.05. 
 (d) Whether or not therein expressly so provided, every provision of this
Indenture that in any way relates to the Trustee is subject to clauses (a), (b) and (c) of this Section 7.01. 
 (e) No
provision of this Indenture shall require the Trustee to risk its own funds or otherwise incur any financial liability in the performance of any of its duties, or in the exercise of any of its rights or powers, if it shall have reasonable grounds
for believing that repayment of such funds or adequate indemnity against such risk is not reasonably assured to it. The Trustee shall be under no obligation to exercise any of its rights or powers under this Indenture at the request or direction of
any of the Holders of the Notes unless the Holders have offered to the Trustee indemnity or security satisfactory to it against any loss, liability or expense. 

(f) The Trustee shall not be liable for interest on any money received by it except as the Trustee may agree in writing with the Company. Money
and other property held in trust by the Trustee need not be segregated from other funds except to the extent required by law. 

Section 7.02 Rights of Trustee. 

(a) The Trustee may conclusively rely upon any document (whether in its original or facsimile form) believed by it to be genuine and to have
been signed or presented by the proper Person. The Trustee need not investigate any fact or matter stated in the document, but the Trustee, in its discretion, may make such further inquiry or investigation into such facts or matters as it may see
fit, and, if the Trustee shall determine to make such further inquiry or investigation, it shall be entitled, upon reasonable notice to the Company and during normal business hours, to examine the books, records and premises of the Company,
personally or by agent or attorney and shall incur no liability or additional liability of any kind by reason of such inquiry or investigation. Any permissive right or authority granted to the Trustee shall not be construed as a mandatory duty. 

(b) Before the Trustee acts or refrains from acting, it may require an Officers’ Certificate or an Opinion of Counsel or both subject to
the other provisions of this Indenture. The Trustee shall not be liable for any action it takes or omits to take in good faith in reliance on such Officers’ Certificate or Opinion of Counsel. The Trustee may consult with counsel of its
selection and the advice of such counsel or any Opinion of Counsel shall be 

  
 -76- 

 
full and complete authorization and protection from liability in respect of any action taken, suffered or omitted by it hereunder in good faith and in reliance thereon. Whenever in the
administration of this Indenture the Trustee shall deem it desirable that a matter be proved or established prior to taking, suffering or omitting any action hereunder, the Trustee (unless other evidence be herein specifically prescribed) may, in
the absence of bad faith or willful misconduct on its part, conclusively rely upon an Officers’ Certificate. 
 (c) The Trustee may act
through its attorneys and agents and shall not be responsible for the misconduct or negligence of any agent or attorney appointed with due care. 

(d) The Trustee shall not be liable for any action it takes or omits to take in good faith that it believes to be authorized or within the
rights or powers conferred upon it by this Indenture. 
 (e) Unless otherwise specifically provided in this Indenture, any demand, request,
direction or notice from the Company shall be sufficient if signed by an Officer of the Company. The Trustee shall have no duty to inquire as to the performance of, or otherwise monitor compliance with, the Company’s or any Subsidiary
Guarantor’s covenants herein. 
 (f) None of the provisions of this Indenture shall require the Trustee to expend or risk its own funds
or otherwise to incur any liability, financial or otherwise, in the performance of any of its duties hereunder, or in the exercise of any of its rights or powers if it shall have reasonable grounds for believing that repayment of such funds or
indemnity satisfactory to it against such risk or liability is not assured to it. 
 (g) The Trustee shall not be deemed to have notice of
any Default or Event of Default unless a Trust Officer of the Trustee has actual knowledge thereof or unless written notice only from the Company or from the Holders of at least 25% of the aggregate principal amount of the Notes of any event which
is in fact such a Default or Event of Default is received by the Trustee at the Corporate Trust Office of the Trustee, and such notice references the existence of a Default or Event of Default, the Notes and this Indenture. 

(h) In no event shall the Trustee be responsible or liable for punitive, special, indirect, or consequential loss or damage of any kind
whatsoever (including, but not limited to, loss of profit) irrespective of whether the Trustee has been advised of the likelihood of such loss or damage and regardless of the form of action. 

(i) The rights, privileges, protections, immunities and benefits given to the Trustee, including, without limitation, its right to be
compensated, reimbursed and indemnified, are extended to, and shall be enforceable by, the Trustee in each of its capacities hereunder, and each agent, custodian and other Person employed to act hereunder. 

(j) In the event the Company is required to pay Additional Interest, the Company will provide written notice to the Trustee of the
Company’s obligation to pay Additional Interest no later than 15 days prior to the next Interest Payment Date, which notice shall set forth the accrual period and the amount of the Additional Interest to be paid by the Company in reasonable
detail. The Trustee shall not at any time be under any duty or responsibility to any Holders to determine whether the Additional Interest is payable and the amount thereof. The Trustee may provide a copy of such notice received from the Company
relating to Additional Interest to any Holder upon request. 
 (k) The Trustee shall not be required to give any bond or surety in respect of
the performance of its powers or duties. 
 (l) The Trustee may request that the Company deliver an Officers’ Certificate setting forth
the names of individuals and/or titles of officers authorized at such time to take specified actions pursuant to this Indenture, which Officers’ Certificate may be signed by any person authorized to sign an Officers’ Certificate, including
any Person specified as so authorized in any such certificate previously delivered and not superseded. 
 (m) The permissive rights of the
Trustee enumerated herein shall not be construed as duties. 

  
 -77- 

 Section 7.03 Individual Rights of Trustee. 

The Trustee in its individual or any other capacity may become the owner or pledgee of Notes and may otherwise deal with the Company or any
Affiliate of the Company with the same rights it would have if it were not Trustee. However, in the event that the Trustee acquires any conflicting interest as defined by Trust Indenture Act Section 310(b) it must eliminate such conflict within
90 days, apply to the SEC for permission to continue as trustee or resign. Any Agent may do the same with like rights and duties. The Trustee is also subject to Sections 7.10 and 7.11. 

Section 7.04 Trustee’s Disclaimer. 

The Trustee shall not be responsible for and makes no representation as to the validity or adequacy of this Indenture or the Notes or the
Subsidiary Guarantees; it shall not be accountable for the Company’s use of the proceeds from the Notes or any money paid to the Company or upon the Company’s direction under any provision of this Indenture; it shall not be responsible for
the use or application of any money received by any Paying Agent other than the Trustee; and it shall not be responsible for any statement or recital herein or any statement in the Notes, the Offering Memorandum or any other document in connection
with the sale of the Notes or pursuant to this Indenture other than its certificate of authentication. 
 Section 7.05 Notice of
Defaults. 
 If a Default occurs and is continuing and is known to the Trustee, the Trustee shall mail to each Holder notice of the
Default within 90 days after it occurs. Except in the case of a Default in the payment of principal of, premium, if any, or interest on any Note, the Trustee may withhold notice if and so long as a committee of Trust Officers of the Trustee in good
faith determines that withholding notice is in the interests of the Holders. 
 Section 7.06 Reports by Trustee to Holders of the
Notes. 
 Within 60 days after each February 15, beginning with February 15, 2015, and for so long as Notes remain outstanding,
the Trustee shall mail to the Holders of the Notes a brief report dated as of such reporting date that complies with Trust Indenture Act Section 313(a) (but if no event described in Trust Indenture Act Section 313(a) has occurred within
the twelve months preceding the reporting date, no report need be transmitted). The Trustee also shall comply with Trust Indenture Act Section 313(b)(2). The Trustee shall also transmit by mail all reports as required by Trust Indenture Act
Section 313(c). 
 A copy of each report at the time of its mailing to the Holders of Notes shall be mailed to the Company and filed
with the SEC and each stock exchange on which the Notes are listed in accordance with Trust Indenture Act Section 313(d). The Company shall promptly notify the Trustee when the Notes are listed on any stock exchange. 

Section 7.07 Compensation and Indemnity. 

The Company and the Subsidiary Guarantors, jointly and severally, shall pay to the financial institution acting as Trustee from time to time
such reasonable compensation for its acceptance of this Indenture and services hereunder as the parties shall agree in writing from time to time. Such compensation shall not be limited by any law on compensation of a trustee of an express trust. The
Company shall reimburse the financial institution acting as Trustee promptly upon request for all reasonable out of pocket disbursements, advances and expenses incurred or made by it in addition to the compensation for its services. Such expenses
shall include the reasonable compensation, disbursements and expenses of the Trustee’s agents and counsel. 
 The Company and the
Subsidiary Guarantors, jointly and severally, shall indemnify the financial institution acting as Trustee for, and hold it harmless against, any and all loss, damage, claims, liability or expense (including the reasonable fees and expenses of its
agents and counsel) incurred by it in connection with the acceptance or administration of this trust and the performance of its duties hereunder (including the costs and expenses of enforcing this Indenture against the Company or any of the
Subsidiary Guarantors (including this Section 7.07) or defending itself against any claim whether asserted by any Holder, the Company or any Subsidiary Guarantor, or 

  
 -78- 

 
liability in connection with the acceptance, exercise or performance of any of its powers or duties hereunder). The Trustee shall notify the Company promptly of any claim for which it may seek
indemnity. Failure by the Trustee to so notify the Company shall not relieve the Company of its obligations hereunder. The Company shall defend the claim and the Trustee may have separate counsel and the Company shall pay the reasonable fees and
expenses of such counsel. Notwithstanding the foregoing, neither the Company nor any Subsidiary Guarantor shall be required to reimburse any expense or indemnify against any loss, damage, claim, liability or expense incurred by the Trustee through
the Trustee’s own willful misconduct, negligence or bad faith. Neither the Company nor any Subsidiary Guarantor shall be required to indemnify the Trustee with respect to any settlement made without the consent of the Company, which consent
will not be unreasonably withheld. 
 The obligations of the Company under this Section 7.07 shall survive the satisfaction and
discharge of this Indenture or the earlier resignation or removal of the Trustee. 
 To secure the payment obligations of the Company and
the Subsidiary Guarantors in this Section 7.07, the financial institution acting as Trustee shall have a Lien prior to the Notes on all money or property held or collected by the Trustee, except that held in trust to pay principal and interest
on particular Notes. Such Lien shall survive the satisfaction and discharge of this Indenture. 
 When the Trustee incurs expenses or
renders services after an Event of Default specified in Section 6.01(a)(7) or Section 6.01(a)(8) occurs, the expenses and the compensation for the services (including the fees and expenses of its agents and counsel) are intended to
constitute expenses of administration under any Bankruptcy Law. 
 The Trustee shall comply with the provisions of Trust Indenture Act
Section 313(b)(2) to the extent applicable. 
 “Trustee” for the purposes of this Section 7.07 shall include any
predecessor Trustee and the Trustee in each of its capacities hereunder and each agent, custodian and other person employed to act hereunder; provided, however, that the negligence, willful misconduct or bad faith of any Trustee hereunder shall not
affect the rights of any other Trustee hereunder. 
 Section 7.08 Replacement of Trustee. 

A resignation or removal of the Trustee and appointment of a successor Trustee shall become effective only upon the successor Trustee’s
acceptance of appointment as provided in this Section 7.08. The Trustee may resign in writing at any time and be discharged from the trust hereby created by so notifying the Company. The Holders of a majority in principal amount of the then
outstanding Notes may remove the Trustee by so notifying the Trustee and the Company in writing. The Company may remove the Trustee if: 

(a) the Trustee fails to comply with Section 7.10; 

(b) the Trustee is adjudged bankrupt or an insolvent or an order for relief is entered with respect to the Trustee under any
Bankruptcy Law; 
 (c) a custodian or public officer takes charge of the Trustee or its property; or 

(d) the Trustee becomes incapable of acting. 

If the Trustee resigns or is removed or if a vacancy exists in the office of Trustee for any reason, the Company shall promptly appoint a
successor Trustee. Within one year after the successor Trustee takes office, the Holders of a majority in principal amount of the then outstanding Notes may appoint a successor Trustee to replace the successor Trustee appointed by the Company. 

If a successor Trustee does not take office within 60 days after the retiring Trustee resigns or is removed, the retiring Trustee (at the
Company’s expense), the Company or the Holders of at least 10% in principal amount of 

  
 -79- 

 
the then outstanding Notes may petition any court of competent jurisdiction for the appointment of a successor Trustee. 

If the Trustee, after written request by any Holder who has been a Holder for at least six months, fails to comply with Section 7.10,
such Holder may petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor Trustee. 
 A
successor Trustee shall deliver a written acceptance of its appointment to the retiring Trustee and to the Company. Thereupon, the resignation or removal of the retiring Trustee shall become effective, and the successor Trustee shall have all the
rights, powers and duties of the Trustee under this Indenture. The successor Trustee shall mail a notice of its succession to Holders. The retiring Trustee shall promptly transfer all property held by it as Trustee to the successor Trustee;
provided all sums owing to the Trustee hereunder have been paid and subject to the Lien provided for in Section 7.07. Notwithstanding replacement of the Trustee pursuant to this Section 7.08, the Company’s obligations under
Section 7.07 shall continue for the benefit of the retiring Trustee. 
 Section 7.09 Successor Trustee by Merger, Etc. 

If the Trustee consolidates with or merges or converts into, or transfers all or substantially all of its corporate trust business to, another
corporation, the successor corporation without any further act shall be the successor Trustee. 
 Section 7.10 Eligibility;
Disqualification. 
 There shall at all times be a Trustee hereunder that is a corporation organized and doing business under the laws of
the United States of America or of any state thereof that is authorized under such laws to exercise corporate trustee power, that is subject to supervision or examination by federal or state authorities and that has a combined capital and surplus of
at least $50,000,000 as set forth in its most recent published annual report of condition. 
 This Indenture shall always have a Trustee who
satisfies the requirements of Trust Indenture Act Sections 310(a)(1), (2) and (5). The Trustee is subject to Trust Indenture Act Section 310(b). There shall be excluded from the operation of Trust Indenture Act Section 310(b)(i)
the Notes under this Indenture or any indenture or indentures under which other securities or certificates of interest or participation in other securities of the Company or any of the Subsidiary Guarantors are outstanding if the requirements for
such exclusion set forth in Trust Indenture Act Section 310(b)(i) are met. 
 Section 7.11 Preferential Collection of Claims
Against the Company. 
 The Trustee is subject to Trust Indenture Act Section 311(a), excluding any creditor relationship listed in
Trust Indenture Act Section 311(b). A Trustee who has resigned or been removed shall be subject to Trust Indenture Act Section 311(a) to the extent indicated therein. 

ARTICLE 8 
 LEGAL DEFEASANCE AND
COVENANT DEFEASANCE 
 Section 8.01 Option to Effect Legal Defeasance or Covenant Defeasance. 

The Company may, at its option and at any time, elect to have either Section 8.02 or 8.03 applied to all outstanding Notes upon compliance
with the conditions set forth below in this Article 8. 
 Section 8.02 Legal Defeasance and Discharge. 

Upon the Company’s exercise under Section 8.01 of the option applicable to this Section 8.02, the Company and the Subsidiary
Guarantors shall, subject to the satisfaction of the conditions set forth in Section 8.04, be deemed to have been discharged from their obligations with respect to all outstanding Notes and Subsidiary

  
 -80- 

 
Guarantees on the date the conditions set forth below are satisfied (“Legal Defeasance”). For this purpose, Legal Defeasance means that the Company shall be deemed to have paid
and discharged the entire Indebtedness represented by the outstanding Notes, which shall thereafter be deemed to be “outstanding” only for the purposes of Section 8.05 and the other Sections of this Indenture referred to in
(a) and (b) below, and to have satisfied all of its other obligations under such Notes, the Subsidiary Guarantees and this Indenture including that of the Subsidiary Guarantors (and the Trustee, on demand of and at the expense of the
Company, shall execute proper instruments acknowledging the same), except for the following provisions which shall survive until otherwise terminated or discharged hereunder: 

(a) the rights of Holders of outstanding Notes to receive payments in respect of the principal of, or interest or premium, if
any, and Additional Interest, if any, on such Notes when such payments are due from the trust referred to in Section 8.04; 

(b) the Company’s obligations with respect to the Notes concerning issuing temporary Notes, registration of Notes,
mutilated, destroyed, lost or stolen Notes and the maintenance of an office or agency for payment and money for security payments held in trust; 

(c) the rights, powers, trusts, duties and immunities of the Trustee hereunder, and the Company’s obligations in
connection therewith; and 
 (d) this Section 8.02. 

If the Company exercises the Legal Defeasance option, the Subsidiary Guarantees in effect at such time shall terminate. 

Subject to compliance with this Article 8, the Company may exercise its option under this Section 8.02 notwithstanding the prior exercise
of its option under Section 8.03. If the Company exercises its Legal Defeasance option, payment of the Notes may not be accelerated because of an Event of Default with respect to the Notes. 

Section 8.03 Covenant Defeasance. 

Upon the Company’s exercise under Section 8.01 of the option applicable to this Section 8.03, the Company and the Subsidiary
Guarantors shall, subject to the satisfaction of the conditions set forth in Section 8.04, be released from their obligations under the covenants contained in Sections 4.03, 4.04, 4.05, 4.07, 4.08, 4.09, 4.10, 4.11, 4.12, 4.14, 4.15 and clauses
(3), (4) and (5) of Section 5.01(a) with respect to the outstanding Notes on and after the date the conditions set forth in Section 8.04 are satisfied (“Covenant Defeasance”), and the Notes shall thereafter be
deemed not “outstanding” for the purposes of any direction, waiver, consent or declaration or act of Holders (and the consequences of any thereof) in connection with such covenants, but shall continue to be deemed “outstanding”
for all other purposes hereunder. For this purpose, Covenant Defeasance means that, with respect to the outstanding Notes, the Company and the Subsidiary Guarantors may omit to comply with and shall have no liability in respect of any term,
condition or limitation set forth in any such covenant, whether directly or indirectly, by reason of any reference elsewhere herein to any such covenant or by reason of any reference in any such covenant to any other provision herein or in any other
document and such omission to comply shall not constitute a Default or an Event of Default under Section 6.01, but, except as specified above, the remainder of this Indenture and such Notes shall be unaffected thereby. In addition, upon the
Company’s exercise under Section 8.01 of the option applicable to this Section 8.03, subject to the satisfaction of the conditions set forth in Section 8.04, Sections 6.01(a)(4), 6.01(a)(6), 6.01(a)(7) (with respect only to
Significant Subsidiaries or any group of Restricted Subsidiaries that taken together would constitute a Significant Subsidiary) or 6.01(a)(8) (with respect only to Significant Subsidiaries or any group of Restricted Subsidiaries that taken together
would constitute a Significant Subsidiary) or because of the failure to comply with clauses (3), (4) or (5) of Section 5.01(a) or Section 5.01(b) shall not constitute Events of Default. 

  
 -81- 

 Section 8.04 Conditions to Legal or Covenant Defeasance. 

The following shall be the conditions to the application of either Section 8.02 or 8.03 to the outstanding Notes: 

In order to exercise either Legal Defeasance or Covenant Defeasance with respect to the Notes: 

(1) the Company must irrevocably deposit with the Trustee, in trust, for the benefit of the Holders of the Notes, cash in U.S.
dollars, non-callable U.S. Government Obligations, or a combination of cash in U.S. dollars and non-callable U.S. Government Obligations, in amounts as shall be sufficient, in the opinion of a nationally recognized investment bank, appraisal firm or
firm of independent public accountants expressed in a written certificate delivered to the Trustee, to pay the principal of, or interest and premium and Additional Interest, if any, on the outstanding Notes on the Stated Maturity or on the
applicable redemption date, as the case may be, and the Company must specify whether the Notes are being defeased to maturity or to a particular redemption date; 

(2) in the case of Legal Defeasance, the Company has delivered to the Trustee an Opinion of Counsel reasonably acceptable to
the Trustee confirming that (a) the Company has received from, or there has been published by, the Internal Revenue Service a ruling or (b) since the date of this Indenture, there has been a change in the applicable federal income tax law,
in either case to the effect that, and based thereon such Opinion of Counsel shall confirm that, the Holders of the respective outstanding Notes shall not recognize income, gain or loss for federal income tax purposes as a result of such Legal
Defeasance and shall be subject to federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such Legal Defeasance had not occurred; 

(3) in the case of Covenant Defeasance, the Company has delivered to the Trustee an Opinion of Counsel reasonably acceptable to
the Trustee confirming that the Holders of the respective outstanding Notes shall not recognize income, gain or loss for federal income tax purposes as a result of such Covenant Defeasance and shall be subject to federal income tax on the same
amounts, in the same manner and at the same times as would have been the case if such Covenant Defeasance had not occurred; 

(4) such Legal Defeasance or Covenant Defeasance shall not result in a breach or violation of, or constitute a default under
any material agreement or instrument (excluding this Indenture) to which the Company or any of its Restricted Subsidiaries is a party or by which the Company or any of its Restricted Subsidiaries is bound; 

(5) no Default or Event of Default has occurred and is continuing on the date of such deposit (other than a Default or Event of
Default resulting from the borrowing of funds to be applied to such deposit and the grant of any Lien securing such borrowings); 

(6) the Company must deliver to the Trustee an Officers’ Certificate stating that the deposit was not made by the Company
with the intent of defeating, hindering, delaying or defrauding creditors of the Company or others; and 
 (7) the Company
must deliver to the Trustee an Officers’ Certificate and an Opinion of Counsel (which Opinion of Counsel may be subject to customary assumptions and exclusions), each stating that all conditions precedent relating to the Legal Defeasance or the
Covenant Defeasance have been complied with. 
 Section 8.05 Deposited Money and U.S. Government Obligations to Be Held in Trust;
Other Miscellaneous Provisions. 
 Subject to Section 8.06, all money and U.S. Government Obligations (including the proceeds
thereof) deposited with the Trustee (or other qualifying trustee, collectively for purposes of this Section 8.05, the “Trustee”) pursuant to Section 8.04 in respect of the outstanding Notes shall be held in trust and
applied by the Trustee, in 

  
 -82- 

 
accordance with the provisions of such Notes and this Indenture, to the payment, either directly or through any Paying Agent (including the Company or a Subsidiary Guarantor acting as Paying
Agent) as the Trustee may determine, to the Holders of such Notes of all sums due and to become due thereon in respect of principal, premium and Additional Interest, if any, and interest, but such money need not be segregated from other funds except
to the extent required by law. 
 The Company shall pay and indemnify the Trustee against any tax, fee or other charge imposed on or
assessed against the cash or U.S. Government Obligations deposited pursuant to Section 8.04 or the principal and interest received in respect thereof other than any such tax, fee or other charge which by law is for the account of the Holders of
the outstanding Notes. 
 Anything in this Article 8 to the contrary notwithstanding, the Trustee shall deliver or pay to the Company from
time to time upon the request of the Company any money or U.S. Government Obligations held by it as provided in Section 8.04 which, in the opinion of a nationally recognized investment bank, appraisal firm or firm of independent public
accountants expressed in a written certification thereof delivered to the Trustee (which may be the opinion delivered under Section 8.04(1)), are in excess of the amount thereof that would then be required to be deposited to effect an
equivalent Legal Defeasance or Covenant Defeasance. 
 Section 8.06 Repayment to the Company. 

Any money deposited with the Trustee or any Paying Agent, or then held by the Company, in trust for the payment of the principal of, premium
and Additional Interest, if any, or interest on any Note and remaining unclaimed for two years after such principal, and premium and Additional Interest, if any, or interest has become due and payable shall, subject to applicable abandoned property
law, be paid to the Company on its request or (if then held by the Company) shall be discharged from such trust; and the Holder of such Note shall thereafter look only to the Company for payment thereof, and all liability of the Trustee or such
Paying Agent with respect to such trust money, and all liability of the Company as trustee thereof, shall thereupon cease. 

Section 8.07 Reinstatement. 

If the Trustee or Paying Agent is unable to apply any United States dollars or U.S. Government Obligations in accordance with Section 8.02
or 8.03, as the case may be, by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, then the Company’s obligations under this Indenture and the Notes shall be
revived and reinstated as though no deposit had occurred pursuant to Section 8.02 or 8.03 until such time as the Trustee or Paying Agent is permitted to apply all such money in accordance with Section 8.02 or 8.03, as the case may be;
provided that, if the Company makes any payment of principal of, premium and Additional Interest, if any, or interest on any Note following the reinstatement of its obligations, the Company shall be subrogated to the rights of the Holders of
such Notes to receive such payment from the money held by the Trustee or Paying Agent. 
 ARTICLE 9 

AMENDMENT, SUPPLEMENT AND WAIVER 

Section 9.01 Without Consent of Holders of Notes. 

Notwithstanding Section 9.02, the Company, any Subsidiary Guarantor (with respect to its Subsidiary Guarantee or this Indenture;
provided that any supplemental indenture pursuant to Section 4.15 need only be signed by the Company, the guaranteeing Subsidiary Guarantor and the Trustee) and the Trustee may amend or supplement this Indenture, any Subsidiary Guarantee
or the Notes without the consent of any Holder to: 
 (1) cure any ambiguity, omission, defect, mistake or inconsistency;

  
 -83- 

 (2) provide for the assumption by a successor entity (or co-issuer) of the
obligations of the Company or any Subsidiary Guarantor under this Indenture (whether through merger, consolidation, sale of all or substantially all of assets, properties or otherwise); 

(3) provide for uncertificated Notes in addition to or in place of certificated Notes (provided that the uncertificated
Notes are issued in registered form for purposes of Section 163(f) of the Code, or in a manner such that the uncertificated Notes are described in Section 163(f)(2)(B) of the Code); 

(4) add Subsidiary Guarantees with respect to the Notes or release a Subsidiary Guarantor from its obligations under its
Subsidiary Guarantee or this Indenture in accordance with the applicable provisions of this Indenture; 
 (5) secure the
Notes; 
 (6) add to the covenants of the Company for the benefit of the Holders or surrender any right or power conferred
upon the Company; 
 (7) make any change that does not materially adversely affect the rights of any Holder under this
Indenture; 
 (8) comply with any requirement of the SEC in connection with the qualification of this Indenture under the
Trust Indenture Act; 
 (9) provide for the appointment of a successor trustee; provided that the successor trustee is
otherwise qualified and eligible to act as such under the terms of this Indenture; 
 (10) provide for the issuance of
Additional Notes under this Indenture; 
 (11) comply with the provisions described under Section 4.15 or Article 10;

 (12) provide for the issuance of exchange securities which shall have terms substantially identical in all respects to the
Notes (except that the transfer restrictions contained in the Notes shall be modified or eliminated as appropriate and except as otherwise provided in Section 2.01(a) with respect to Additional Notes) and which shall be treated, together with
any outstanding Notes, as a single class of securities; or 
 (13) conform the text of this Indenture, the Notes or the
Subsidiary Guarantees to any provision of the “Description of notes” section of the Offering Memorandum to the extent that such provision in such “Description of notes” section was intended to be a verbatim recitation of a
provision of this Indenture, the Notes or the Subsidiary Guarantees (as certified in an Officers’ Certificate delivered to the Trustee). 

After an amendment or supplement under this Indenture becomes effective, the Company is required to send to the Holders a notice briefly
describing such amendment or supplement. However, the failure to give such notice to all the Holders, or any defect in the notice, shall not impair or affect the validity of the amendment or supplement. 

Upon the request of the Company accompanied by a resolution of its Board of Directors authorizing the execution of any such amended or
supplemental indenture, and upon receipt by the Trustee of the documents described in Section 12.04, the Trustee shall join with the Company and the Subsidiary Guarantors in the execution of any amended or supplemental indenture authorized or
permitted by the terms of this Indenture and to make any further appropriate agreements and stipulations that may be therein contained, but the Trustee shall not be obligated to enter into such amended or supplemental indenture that affects its own
rights, duties or immunities under this Indenture or otherwise. 

  
 -84- 

 Section 9.02 With Consent of Holders of Notes. 

Except as provided below in this Section 9.02, the Company, the Subsidiary Guarantors (as applicable) and the Trustee may amend or
supplement this Indenture, any Subsidiary Guarantee and the Notes with the consent of the Holders of a majority in aggregate principal amount of the then outstanding Notes (including Additional Notes, if any) voting as a single class (including,
without limitation, consents obtained in connection with a purchase of, or tender offer or exchange offer for, Notes), and, subject to Sections 6.04 and 6.07, any past Default or Event of Default (other than a Default or Event of Default in the
payment of the principal of, premium, if any, and Additional Interest, if any, or interest on the Notes, except a payment default resulting from an acceleration that has been rescinded) or compliance with any provision of this Indenture, the
Subsidiary Guarantees or the Notes may be waived with the consent of the Holders of a majority in principal aggregate amount of the then outstanding Notes (including Additional Notes, if any) voting as a single class (including consents obtained in
connection with the purchase of, or tender offer or exchange offer for, Notes). Section 2.10 and Section 2.11 shall determine which Notes are considered to be “outstanding” for the purposes of this Section 9.02. 

Upon the request of the Company accompanied by a resolution of its Board of Directors authorizing the execution of any such amended or
supplemental indenture, and upon the filing with the Trustee of evidence satisfactory to the Trustee of the consent of the Holders of Notes as aforesaid, and upon receipt by the Trustee of the documents described in Section 12.04, the Trustee
shall join with the Company in the execution of such amended or supplemental indenture unless such amended or supplemental indenture directly affects the Trustee’s own rights, duties or immunities under this Indenture or otherwise, in which
case the Trustee may in its discretion, but shall not be obligated to, enter into such amended or supplemental indenture. 
 It shall not be
necessary for the consent of the Holders of Notes under this Section 9.02 to approve the particular form of any proposed amendment or waiver, but it shall be sufficient if such consent approves the substance thereof. A consent to any amendment,
supplement or waiver under this Indenture by any Holder of Notes given in connection with a tender of such Holder’s Notes shall not be rendered invalid by such tender. 

After an amendment or supplement under this Section 9.02 becomes effective, the Company shall mail to the Holders a notice briefly
describing such amendment or supplement; provided that the failure to give such notice to all the Holders, or any defect in the notice will not impair or affect the validity of the amendment or supplement. 

Without the consent of each adversely affected Holder of Notes, an amendment or waiver under this Section 9.02 may not (with respect to
any Notes held by a non-consenting Holder): 
 (1) reduce the amount of Notes whose Holders must consent to an amendment;

 (2) reduce the stated rate of interest or extend the stated interest payment date of the Notes; 

(3) reduce the principal of or extend the Stated Maturity of any Note; 

(4) waive a Default or Event of Default in the payment of principal of, or interest or premium, if any, or Additional Interest,
if any, on the Notes (except a rescission of acceleration of the Notes by the Holders of at least a majority in aggregate principal amount of the then outstanding Notes with respect to a nonpayment default and a waiver of the payment default that
resulted from such acceleration); 
 (5) reduce the premium payable upon the redemption or repurchase of any Note or change
the time at which any Note may be redeemed or repurchased as described above under Section 3.07, Section 4.10 or Section 4.14 whether through an amendment or waiver of provisions in the covenants, definitions or otherwise (except
amendments to the definition of “Change of Control” or “Asset Sale”); 
 (6) [reserved]; 

(7) make any Note payable in money other than that stated in the Note; 

  
 -85- 

 (8) otherwise impair the right of any Holder to receive payment of principal of,
premium, if any, and interest on such Holder’s Notes on or after the due dates therefor or to institute suit for the enforcement of any payment on or with respect to such Holder’s Notes; 

(9) make any change in the amendment provisions that require each Holder’s consent or in the waiver provisions; or 

(10) modify the Subsidiary Guarantees in any manner materially adverse to the Holders of the Notes. 

Section 9.03 Compliance with Trust Indenture Act. 

Every amendment or supplement to this Indenture or the Notes shall be set forth in an amended or supplemental indenture that complies with the
Trust Indenture Act as then in effect. 
 Section 9.04 Revocation and Effect of Consents. 

Until an amendment, supplement or waiver becomes effective, a consent to it by a Holder of a Note is a continuing consent by the Holder of a
Note and every subsequent Holder of a Note or portion of a Note that evidences the same debt as the consenting Holder’s Note, even if notation of the consent is not made on any Note. However, any such Holder of a Note or subsequent Holder of a
Note may revoke the consent as to its Note if the Trustee receives written notice of revocation before the date the waiver, supplement or amendment becomes effective. An amendment, supplement or waiver becomes effective in accordance with its terms
and thereafter binds every Holder. 
 Section 9.05 Notation on or Exchange of Notes. 

The Trustee may place an appropriate notation about an amendment, supplement or waiver on any Note thereafter authenticated. The Company in
exchange for all Notes may issue and the Trustee shall, upon receipt of an Authentication Order, authenticate new Notes that reflect the amendment, supplement or waiver. 

Failure to make the appropriate notation or issue a new Note shall not affect the validity and effect of such amendment, supplement or waiver.

 Section 9.06 Trustee to Sign Amendments, Etc. 

The Trustee shall sign any amendment, supplement or waiver authorized pursuant to this Article 9 if the amendment or supplement does not
adversely affect the rights, duties, liabilities or immunities of the Trustee. The Company may not sign an amendment, supplement or waiver until its Board of Directors approves it. In executing any amendment, supplement or waiver, the Trustee shall
be entitled to receive and (subject to Section 7.01) shall be fully protected in relying upon, in addition to the documents required by Section 12.04, an Officers’ Certificate and an Opinion of Counsel stating that the execution of
such amended or supplemental indenture is authorized or permitted by this Indenture and that such amendment, supplement or waiver is the legal, valid and binding obligation of the Company and any Subsidiary Guarantors party thereto, enforceable
against them in accordance with its terms, subject to customary exceptions, and complies with the provisions hereof (including Section 9.03). 

ARTICLE 10 
 SUBSIDIARY GUARANTEES

 Section 10.01 Subsidiary Guarantee. 

Subject to this Article 10, each of the Subsidiary Guarantors shall, jointly and severally, unconditionally guarantee, on a senior unsecured
basis, to each Holder of a Note authenticated and delivered by the Trustee and to the Trustee and its successors and assigns, irrespective of the validity and enforceability of this Indenture, the Notes

  
 -86- 

 
or the obligations of the Company hereunder or thereunder, that: (a) the principal of, premium, if any, or interest on or Additional Interest, if any, on the Notes shall be promptly paid in
full when due, whether at maturity, by acceleration, redemption or otherwise, and interest on the overdue principal of and interest on the Notes, if any, if lawful, and all other Obligations of the Company to the Holders or the Trustee hereunder or
thereunder shall be promptly paid in full or performed, all in accordance with the terms hereof and thereof; and (b) in case of any extension of time of payment or renewal of any Notes or any of such other obligations, that the same shall be
promptly paid in full when due or performed in accordance with the terms of the extension or renewal, whether at Stated Maturity, by acceleration or otherwise. Failing payment when due of any amount so guaranteed or any performance so guaranteed for
whatever reason, the Subsidiary Guarantors shall be jointly and severally obligated to pay the same immediately. Each Subsidiary Guarantor agrees that this is a guarantee of payment and not a guarantee of collection. 

The Subsidiary Guarantors hereby agree that their obligations hereunder shall be unconditional, irrespective of the validity, regularity or
enforceability of the Notes or this Indenture, the absence of any action to enforce the same, any waiver or consent by any Holder of the Notes with respect to any provisions or thereof, the recovery of any judgment against the Company, any action to
enforce the same or any other circumstance which might otherwise constitute a legal or equitable discharge or defense of a guarantor. Each Subsidiary Guarantor hereby waives diligence, presentment, demand of payment, filing of claims with a court in
the event of insolvency or bankruptcy of the Company, any right to require a proceeding first against the Company, protest, notice and all demands whatsoever and covenants that this Subsidiary Guarantee shall not be discharged except by complete
performance of the obligations contained in the Notes and this Indenture, except as provided in Section 10.06. 
 If any Holder or the
Trustee is required by any court or otherwise to return to the Company, the Subsidiary Guarantors or any custodian, trustee, liquidator or other similar official acting in relation to the Company or the Subsidiary Guarantors, any amount paid either
to the Trustee or such Holder, this Subsidiary Guarantee, to the extent theretofore discharged, shall be reinstated in full force and effect. 

Each Subsidiary Guarantor agrees that it shall not be entitled to any right of subrogation in relation to the Holders in respect of any
obligations guaranteed hereby until payment in full of all obligations guaranteed hereby. Each Subsidiary Guarantor further agrees that, as between the Subsidiary Guarantors, on the one hand, and the Holders and the Trustee, on the other hand,
(x) the maturity of the obligations guaranteed hereby may be accelerated as provided in Article 6 for the purposes of this Subsidiary Guarantee, notwithstanding any stay, injunction or other prohibition preventing such acceleration in respect
of the obligations guaranteed hereby, and (y) in the event of any declaration of acceleration of such obligations as provided in Article 6, such obligations (whether or not due and payable) shall forthwith become due and payable by the
Subsidiary Guarantors for the purpose of this Subsidiary Guarantee. The Subsidiary Guarantors shall have the right to seek contribution from any non-paying Subsidiary Guarantor so long as the exercise of such right does not impair the rights of the
Holders under the Subsidiary Guarantees. 
 Each Subsidiary Guarantee shall remain in full force and effect and continue to be effective
should any petition be filed by or against the Company for liquidation, reorganization, should the Company become insolvent or make an assignment for the benefit of creditors or should a receiver or trustee be appointed for all or any significant
part of the Company’s assets, and shall, to the fullest extent permitted by law, continue to be effective or be reinstated, as the case may be, if at any time payment and performance of the Notes are, pursuant to applicable law, rescinded or
reduced in amount, or must otherwise be restored or returned by any obligee on the Notes or Subsidiary Guarantees, whether as a “voidable preference,” “fraudulent transfer” or otherwise, all as though such payment or performance
had not been made. In the event that any payment or any part thereof, is rescinded, reduced, restored or returned, the Notes shall, to the fullest extent permitted by law, be reinstated and deemed reduced only by such amount paid and not so
rescinded, reduced, restored or returned. 
 In case any provision of any Subsidiary Guarantee shall be invalid, illegal or unenforceable,
the validity, legality, and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 
 Each payment
to be made by a Subsidiary Guarantor in respect of its Subsidiary Guarantee shall be made without set-off, counterclaim, reduction or diminution of any kind or nature. 

  
 -87- 

 Section 10.02 Limitation on Subsidiary Guarantor Liability. 

Each Subsidiary Guarantor, and by its acceptance of Notes, each Holder, hereby confirms that it is the intention of all such parties that the
Subsidiary Guarantee of such Subsidiary Guarantor not constitute a fraudulent transfer or conveyance for purposes of Bankruptcy Law, the Uniform Fraudulent Conveyance Act, the Uniform Fraudulent Transfer Act or any similar federal or state law to
the extent applicable to any Subsidiary Guarantee. 
 To effectuate the foregoing intention, the Trustee, the Holders and the Subsidiary
Guarantors hereby irrevocably agree that the obligations of each Subsidiary Guarantor under its Subsidiary Guarantee will be limited to the maximum amount as will, after giving effect to such maximum amount and all other contingent and fixed
liabilities of such Subsidiary Guarantor (including, without limitation, any Guarantees under the Senior Credit Facility) that are relevant under such laws and after giving effect to any collections from, rights to receive contribution from or
payments made by or on behalf of any other Subsidiary Guarantor in respect of the obligations of such other Subsidiary Guarantor under this Article 10, result in the obligations of such Subsidiary Guarantor under its Subsidiary Guarantee not
constituting a fraudulent conveyance or fraudulent transfer under applicable law. Any Subsidiary Guarantor that makes a payment under its Subsidiary Guarantee will be entitled upon payment in full of all Guaranteed Obligations under this Indenture
to a contribution from each other Subsidiary Guarantor in an amount equal to such other Subsidiary Guarantor’s pro rata portion of such payment based upon the respective net assets of all the Subsidiary Guarantors at the time of such payment
determined in accordance with GAAP. 
 Section 10.03 Execution and Delivery. 

To evidence its Subsidiary Guarantee set forth in Section 10.01, each Subsidiary Guarantor hereby agrees that this Indenture or a
supplemental indenture shall be executed on behalf of such Subsidiary Guarantor by an Officer of such Subsidiary Guarantor. 
 Each
Subsidiary Guarantor hereby agrees that its Subsidiary Guarantee set forth in Section 10.01 shall remain in full force and effect notwithstanding the absence of the endorsement of any notation of such Subsidiary Guarantee on the Notes. 

If an Officer whose signature is on this Indenture or a supplemental indenture no longer holds that office at the time the Trustee
authenticates the Note, the Subsidiary Guarantee shall be valid nevertheless. 
 The delivery of any Note by the Trustee, after the
authentication thereof hereunder, shall constitute due delivery of the Subsidiary Guarantee set forth in this Indenture on behalf of the Subsidiary Guarantors. 

To the extent required by Section 4.15, the Company shall cause any newly created or acquired Restricted Subsidiary to comply with the
provisions of Section 4.15 and this Article 10, to the extent applicable. 
 Section 10.04 Subrogation. 

Each Subsidiary Guarantor shall be subrogated to all rights of Holders of Notes against the Company in respect of any amounts paid by
any Subsidiary Guarantor pursuant to the provisions of Section 10.01; provided that, if an Event of Default has occurred and is continuing, no Subsidiary Guarantor shall be entitled to enforce or receive any payments arising out of, or
based upon, such right of subrogation until all amounts then due and payable by the Company under this Indenture or the Notes shall have been paid in full. 

Section 10.05 Benefits Acknowledged. 

Each Subsidiary Guarantor acknowledges that it will receive direct and indirect benefits from the financing arrangements contemplated by this
Indenture and that the guarantee and waivers made by it pursuant to its Subsidiary Guarantee are knowingly made in contemplation of such benefits. 

  
 -88- 

 Section 10.06 Release of Subsidiary Guarantees. 

A Subsidiary Guarantee by a Subsidiary Guarantor shall be automatically and unconditionally released and discharged, and no further action by
such Subsidiary Guarantor, the Company or the Trustee is required for the release of such Subsidiary Guarantor’s Subsidiary Guarantee, upon: 

(a) the occurrence of (i) any sale, exchange, transfer or other disposition (by merger, consolidation, liquidation,
dissolution or otherwise) of the Capital Stock of such Subsidiary Guarantor after which the applicable Subsidiary Guarantor is no longer a Restricted Subsidiary or of all of the assets and property of such Subsidiary Guarantor (other than by lease),
which sale, exchange, transfer or other disposition is made in compliance with the applicable provisions of this Indenture, including Section 4.10 (it being understood that only such portion of the Net Available Cash as is required to be
applied on or before the date of such release in accordance with the terms of this Indenture needs to be applied in accordance therewith at such time) and Section 5.01; 

(b) the release or discharge of such Subsidiary Guarantor from its Guarantee of Indebtedness of the Company and the Subsidiary
Guarantors under the Senior Credit Facilities (including by reason of the termination of the Senior Credit Facilities); provided that if such Subsidiary Guarantor has Incurred any Indebtedness or issued any Preferred Stock or Disqualified
Stock in reliance on its status as a Subsidiary Guarantor under Section 4.09, such Subsidiary Guarantor’s obligations under such Indebtedness, Disqualified Stock or Preferred Stock, as the case may be, so Incurred are satisfied in full or
discharged or are otherwise permitted to be Incurred by a Non-Guarantor Restricted Subsidiary under Section 4.09; 
 (c) the
designation of any Restricted Subsidiary that is a Subsidiary Guarantor as an Unrestricted Subsidiary in accordance with the provisions described in Section 4.07 and the definition of Unrestricted Subsidiary; or 

(d) the Company exercising its Legal Defeasance or Covenant Defeasance option as described under Article 8 or the
Company’s obligations under this Indenture being discharged in accordance with the terms of this Indenture. 
 If the Subsidiary
Guarantee of any Subsidiary Guarantor is deemed to be released or is automatically released, the Company shall deliver to the Trustee an Officers’ Certificate stating the identity of the released Subsidiary Guarantor, the basis for release in
reasonable detail, and that such release complies with this Indenture. At the request of the Company, and upon delivery to the Trustee of an Officers’ Certificate and an Opinion of Counsel stating that such release complies with this Indenture,
the Trustee shall execute and deliver an appropriate instrument evidencing such release of a Subsidiary Guarantor from the Subsidiary Guarantee (it being understood that the failure to obtain any such instrument shall not impair any automatic
release pursuant to Section 10.06). 
 ARTICLE 11 

SATISFACTION AND DISCHARGE 

Section 11.01 Satisfaction and Discharge. 

This Indenture shall be discharged and shall cease to be of further effect as to all Notes, when: 

(1) either: 

(a) all Notes that have been authenticated, except lost, stolen or destroyed Notes that have been replaced pursuant to
Section 2.09 or paid and Notes for whose payment money has been deposited in trust and thereafter repaid to the Company, have been delivered to the Trustee for cancellation; or 

  
 -89- 

 (b) all Notes not theretofore delivered to the Trustee for cancellation have
become due and payable by reason of the making of a notice of redemption or otherwise or will become due and payable within one year or may be called for redemption within one year under arrangements satisfactory to the Trustee for the giving of
notice of redemption by the Trustee in the name, and at the expense, of the Company, and the Company or any Subsidiary Guarantor has irrevocably deposited or caused to be deposited with the Trustee, as trust funds in trust solely for the benefit of
the Holders of the Notes, cash in U.S. dollars, U.S. Government Obligations, or a combination thereof, in such amounts as shall be sufficient without consideration of any reinvestment of interest to pay and discharge the entire Indebtedness on the
Notes not theretofore delivered to the Trustee for cancellation for principal, premium, if any, and accrued interest to the date of maturity or redemption; 

(2) the deposit shall not result in a breach or violation of, or constitute a default under, any other material instrument to
which the Company is a party or by which the Company is bound; 
 (3) the Company has paid or caused to be paid all sums
payable by it under this Indenture; and 
 (4) the Company has delivered irrevocable instructions to the Trustee under this
Indenture to apply the deposited money toward the payment of the Notes at maturity or the redemption date, as the case may be, then the Trustee shall acknowledge satisfaction and discharge of this Indenture with respect to the Notes on demand of the
Company (accompanied by an Officers’ Certificate and an Opinion of Counsel stating that all conditions precedent specified herein relating to the satisfaction and discharge of this Indenture have been complied with) and at the cost and expense
of the Company. 
 (5) if U.S. Government Obligations shall have been deposited in connection with such satisfaction and
discharge, then as a further condition to such satisfaction and discharge, the Trustee shall have received a certificate from a nationally recognized investment bank, appraisal firm or firm of independent accountants to the effect set forth in
Section 8.04(1). 
 Notwithstanding the satisfaction and discharge of this Indenture, if money shall have been deposited with the
Trustee pursuant to clause (1)(b) of this Section 11.01, the provisions of Section 11.02 and Section 8.06 shall survive. 

Section 11.02 Application of Trust Money. 

Subject to the provisions of Section 8.06, all money deposited with the Trustee pursuant to Section 11.01 shall be held in trust and
applied by it, in accordance with the provisions of the Notes and this Indenture, to the payment, either directly or through any Paying Agent (including the Company acting as its own Paying Agent) as the Trustee may determine, to the Persons
entitled thereto, of the principal (and premium and Additional Interest, if any) and interest for whose payment such money has been deposited with the Trustee; but such money need not be segregated from other funds except to the extent required by
law. 
 If the Trustee or Paying Agent is unable to apply any money or U.S. Government Obligations in accordance with
Section 11.01 by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, the Company’s and any Subsidiary
Guarantor’s obligations under this Indenture and the Notes shall be revived and reinstated as though no deposit had occurred pursuant to Section 11.01; provided that if the Company has made any payment of principal of, premium, if
any, and Additional Interest, if any, or interest on any Notes because of the reinstatement of its obligations, the Company shall be subrogated to the rights of the Holders of such Notes to receive such payment from the money or U.S. Government
Obligations held by the Trustee or Paying Agent. 

  
 -90- 

 ARTICLE 12 

MISCELLANEOUS 

Section 12.01 Trust Indenture Act Controls. 

If any provision of this Indenture limits, qualifies or conflicts with the duties imposed by Trust Indenture Act Section 318(c), the
imposed duties shall control. 
 Section 12.02 Notices. 

Any notice or communication by the Company, any Subsidiary Guarantor or the Trustee to the others is duly given if in writing and delivered in
person or mailed by first-class mail (registered or certified, return receipt requested), fax or overnight air courier guaranteeing next day delivery, to the others’ addresses: 

If to the Company and/or any Subsidiary Guarantor: 

c/o Kindred Healthcare, Inc. 

680 South Fourth Street 

Louisville, Kentucky 40202-2412 

Fax No.: 502-596-4075 

Attention: General Counsel and Treasurer 

With a copy to (which shall not itself constitute proper notice): 

Cleary Gottlieb Steen & Hamilton LLP 

One Liberty Plaza 
 New York,
New York 10006 
 Fax No.: 212-225-3999 

Attention: Richard Lincer, Esq. 

If to the Trustee: 
 Wells Fargo
Bank, National Association 
 10 South Wacker Drive, 13th Floor 

Chicago, Illinois 60606 
 Fax
No.: 312-726-2158 
 Attention: Corporate Trust Services 

The Company, any Subsidiary Guarantor or the Trustee, by notice to the others, may designate additional or different addresses for subsequent
notices or communications. 
 All notices and communications (other than those sent to Holders) shall be deemed to have been duly given: by
publication, on the first date on which publication is made, at the time delivered by hand, if personally delivered; three Business Days after being deposited in the mail, postage prepaid, if mailed by first-class mail; when receipt acknowledged, if
faxed; and the next Business Day after timely delivery to the courier, if sent by overnight air courier guaranteeing next day delivery. Any notices required to be given to the holders while the Notes are Global Notes will be given to DTC pursuant to
Applicable Procedures. 
 Any notice or communication to a Holder shall be mailed by first-class mail, certified or registered, return
receipt requested, or by overnight air courier guaranteeing next day delivery to its address shown on the register kept by the Registrar or by other electronic means or such other delivery system as the Trustee agrees to accept. Any notice or
communication shall also be so mailed to any Person described in Trust Indenture Act Section 313(c), to the extent required by the Trust Indenture Act. Failure to mail a notice or communication to a Holder or any defect in it shall not affect
its sufficiency with respect to other Holders. 

  
 -91- 

 If a notice or communication is mailed in the manner provided above within the time prescribed,
it is duly given, whether or not the addressee receives it. 
 If the Company mails a notice or communication to Holders, they shall mail a
copy to the Trustee and each Agent at the same time. 
 Section 12.03 Communication by Holders of Notes with Other Holders of
Notes. 
 Holders may communicate pursuant to Trust Indenture Act Section 312(b) with other Holders with respect to their rights
under this Indenture or the Notes. The Company, the Trustee, the Registrar and anyone else shall have the protection of Trust Indenture Act Section 312(c). 

Section 12.04 Certificate and Opinion as to Conditions Precedent. 

(a) Upon any request or application by the Company or any of the Subsidiary Guarantors to the Trustee to take or refrain from taking any action
under this Indenture, the Company or such Subsidiary Guarantor, as the case may be, shall furnish to the Trustee: 
 (i) An
Officers’ Certificate in form and substance reasonably satisfactory to the Trustee (which shall include the statements set forth in Section 12.05) stating that, in the opinion of the signers, all conditions precedent and covenants, if any,
provided for in this Indenture relating to the proposed action have been satisfied; and 
 (ii) An Opinion of Counsel in form
and substance reasonably satisfactory to the Trustee (which shall include the statements set forth in Section 12.05) stating that, in the opinion of such counsel, all such conditions precedent and covenants have been satisfied. 

Section 12.05 Statements Required in Certificate or Opinion. 

Each certificate or opinion with respect to compliance with a condition or covenant provided for in this Indenture (other than a certificate
provided pursuant to Section 4.04 or Trust Indenture Act Section 314(a)(4)) shall comply with the provisions of Trust Indenture Act Section 314(e) and shall include: 

(a) a statement that the Person making such certificate or opinion has read such covenant or condition; 

(b) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such
certificate or opinion are based; 
 (c) a statement that, in the opinion of such Person, he or she has made such examination or
investigation as is necessary to enable him or her to express an informed opinion as to whether or not such covenant or condition has been complied with (and, in the case of an Opinion of Counsel, may be limited to reliance on an Officers’
Certificate or certificates of public officers as to matters of fact); and 
 (d) a statement as to whether or not, in the opinion of such
Person, such condition or covenant has been complied with. 
 Section 12.06 Rules by Trustee and Agents. 

The Trustee may make reasonable rules for action by or at a meeting of Holders. The Registrar or Paying Agent may make reasonable rules and set
reasonable requirements for its functions. 

  
 -92- 

 Section 12.07 No Personal Liability of Directors, Officers, Employees and
Stockholders. 
 No director, officer, employee, incorporator or stockholder of the Company or the Subsidiary Guarantors, as such, shall
have any liability for any obligations of the Company or the Subsidiary Guarantors under the Notes, this Indenture or the Subsidiary Guarantees or for any claim based upon, in respect of, or by reason of, such obligations or their creation. Each
Holder by accepting a Note waives and releases all such liability. The waiver and release are part of the consideration for issuance of the Notes. 

Section 12.08 Governing Law. 

THIS INDENTURE, THE NOTES AND ANY SUBSIDIARY GUARANTEE WILL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.

 Section 12.09 Waiver of Jury Trial. 

EACH OF THE COMPANY, THE SUBSIDIARY GUARANTORS AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW,
ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS INDENTURE, THE NOTES OR ANY SUBSIDIARY GUARANTEE, OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. 

Section 12.10 Force Majeure. 

In no event shall the Trustee be responsible or liable for any failure or delay in the performance of its obligations under this Indenture
arising out of or caused by, directly or indirectly, forces beyond its reasonable control, including without limitation strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or
acts of God, and interruptions, loss or malfunctions of utilities, communications or computer (software or hardware) services. 

Section 12.11 No Adverse Interpretation of Other Agreements. 

This Indenture may not be used to interpret any other indenture, loan or debt agreement of the Company or its Restricted Subsidiaries or of any
other Person. Any such indenture, loan or debt agreement may not be used to interpret this Indenture. 
 Section 12.12
Successors. 
 All agreements of the Company in this Indenture and the Notes shall bind its successors. All agreements of the Trustee
in this Indenture shall bind its successors. All agreements of each Subsidiary Guarantor in this Indenture shall bind its successors, except as otherwise provided in Section 10.06. 

Section 12.13 Severability. 

In case any provision in this Indenture or in the Notes shall be invalid, illegal or unenforceable, the validity, legality and enforceability
of the remaining provisions shall not in any way be affected or impaired thereby. 
 Section 12.14 Counterpart Originals. 

The parties may sign any number of copies of this Indenture. Each signed copy shall be an original, but all of them together represent the same
agreement. The exchange of copies of this Indenture and of signature pages by facsimile or PDF transmission shall constitute effective execution and delivery of this Indenture as to the parties hereto and may be used in lieu of the original
Indenture for all purposes. Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes. 

  
 -93- 

 Section 12.15 Table of Contents, Headings, etc. 

The Table of Contents, Cross-Reference Table and headings of the Articles and Sections of this Indenture have been inserted for convenience of
reference only, are not to be considered a part of this Indenture and shall in no way modify or restrict any of the terms or provisions hereof. 

Section 12.16 Qualification of Indenture. 

The Company and the Subsidiary Guarantors shall qualify this Indenture under the Trust Indenture Act in accordance with the terms and
conditions of the Registration Rights Agreement and shall pay all reasonable costs and expenses (including attorneys’ fees and expenses for the Company, the Subsidiary Guarantors and the Trustee) incurred in connection therewith, including, but
not limited to, costs and expenses of qualification of this Indenture and the Notes and printing this Indenture and the Notes. The Trustee shall be entitled to receive from the Company and the Subsidiary Guarantors any such Officers’
Certificates, Opinions of Counsel or other documentation as it may reasonably request in connection with any such qualification of this Indenture under the Trust Indenture Act. 

Section 12.17 U.S.A. Patriot Act 

The Company and the Subsidiary Guarantors acknowledge that in accordance with Section 326 of the U.S.A. PATRIOT Act, the Trustee, like all
financial institutions and in order to help fight the funding of terrorism and money laundering, is required to obtain, verify, and record information that identifies each person or legal entity that establishes a relationship or opens an account
with the Trustee. The parties to this Indenture agree that they will provide the Trustee with such information as it may request in order for the Trustee to satisfy the requirements of the U.S.A. PATRIOT Act. 

[Signatures on following page] 

  
 -94- 

  

			
	 KINDRED HEALTHCARE, INC.

		
	By:	 	/s/ Donald H. Robinson
	 Name: Donald H. Robinson

	Title: Senior Vice President, Tax and Treasurer

  
 S-1 

			
	 ABERDEEN HOLDINGS, INC.
 ABLE HOME HEALTHCARE,
INC.
 ADVANCED ONCOLOGY SERVICES, INC.
 AVERY MANOR NURSING,
L.L.C.
 BAYBERRY CARE CENTER, L.L.C.
 BRAINTREE NURSING,
L.L.C.
 BWB SUNBELT HOME HEALTH SERVICES, LLC
 CALIFORNIA
NURSING CENTERS, L.L.C.
 CARE CENTER OF ROSSMOOR, L.L.C.

CENTRAL ARIZONA HOME HEALTH CARE, INC.
 COMPASS HOSPICE, INC.

COUNTRY ESTATES NURSING, L.L.C.
 COURTLAND GARDENS HEALTH CENTER,
INC.
 FOCUS CARE HEALTH RESOURCES, INC.
 FORESTVIEW NURSING,
L.L.C.
 GBA HOLDING, INC.
 GBA WEST, LLC

GODDARD NURSING, L.L.C.
 GREENBRAE CARE CENTER, L.L.C.

GREENS NURSING AND ASSISTED LIVING, L.L.C.
 HARBORLIGHTS NURSING,
L.L.C.
 HAVEN HEALTH, LLC
 HELIAN ASC OF NORTHRIDGE, INC.

HELIAN HEALTH GROUP, INC.
 HHS HEALTHCARE CORP.

HIGHGATE NURSING, L.L.C.
 HIGHLANDER NURSING, L.L.C.

HOMECARE HOLDINGS, INC.
 HOME HEALTH OF RURAL TEXAS, INC.

HOME HEALTH SERVICES, INC.
 HOMESTEAD HEALTH AND REHABILITATION
CENTER, L.L.C.
 INTEGRACARE HOLDINGS, INC.
 INTEGRACARE HOME
HEALTH SERVICES, INC.
 INTEGRACARE HOSPICE OF ABILENE, LLC

INTEGRACARE INTERMEDIATE HOLDINGS, INC.
 INTEGRACARE OF ABILENE,
LLC
 INTEGRACARE OF ALBANY, LLC
 INTEGRACARE OF ATHENS-HOME
HEALTH, LLC
 INTEGRACARE OF ATHENS-HOSPICE, LLC
 INTEGRACARE OF
GRANBURY, LLC
 INTEGRACARE OF LITTLEFIELD, LLC
 INTEGRACARE OF
OLNEY HOME HEALTH, LLC
 INTEGRACARE OF TEXAS, LLC
 INTEGRACARE
OF WEST TEXAS-HOME HEALTH, LLC
	  	 INTEGRACARE OF WEST TEXAS-HOSPICE, LLC

INTEGRACARE OF WICHITA FALLS, LLC
 J. B. THOMAS HOSPITAL, INC.

KAH DEVELOPMENT 1, L.L.C.
 KAH DEVELOPMENT 2, L.L.C.

KAH DEVELOPMENT 3, L.L.C
 KAH DEVELOPMENT 4, L.L.C.

KAH DEVELOPMENT 5, L.L.C
 KAH DEVELOPMENT 6, L.L.C.

KAH DEVELOPMENT 7, L.L.C.
 KAH DEVELOPMENT 8, L.L.C

KAH DEVELOPMENT 9, L.L.C
 KAH DEVELOPMENT 10, L.L.C

KAH DEVELOPMENT 11, L.L.C.
 KAH DEVELOPMENT 12, L.L.C.

KAH DEVELOPMENT 13, L.L.C
 KAH DEVELOPMENT 14, L.L.C

KAH DEVELOPMENT 15, L.L.C
 KINDRED BRAINTREE HOSPITAL, L.L.C.

KINDRED DEVELOPMENT 4, L.L.C.
 KINDRED DEVELOPMENT 7, L.L.C.

KINDRED DEVELOPMENT 8, L.L.C.
 KINDRED DEVELOPMENT 9, L.L.C.

KINDRED DEVELOPMENT 10, L.L.C.
 KINDRED DEVELOPMENT 11, L.L.C.

KINDRED DEVELOPMENT 12, L.L.C.
 KINDRED DEVELOPMENT 13, L.L.C.

KINDRED DEVELOPMENT 15, L.L.C.
 KINDRED DEVELOPMENT 17, L.L.C.

KINDRED DEVELOPMENT 27, L.L.C.
 KINDRED DEVELOPMENT 29, L.L.C.

KINDRED DEVELOPMENT HOLDINGS 3, L.L.C.
 KINDRED DEVELOPMENT
HOLDINGS 5, L.L.C.
 KINDRED HEALTHCARE OPERATING, INC.
 KINDRED
HEALTHCARE SERVICES, INC.
 KINDRED HOSPICE SERVICES, L.L.C.

KINDRED HOSPITAL-PITTSBURGH-NORTH SHORE, L.L.C.
 KINDRED HOSPITALS
EAST, L.L.C.
 KINDRED HOSPITAL PALM BEACH, L.L.C.
 KINDRED
HOSPITAL-SPRINGFIELD, L.L.C.
 KINDRED HOSPITAL-TOLEDO, L.L.C.

KINDRED HOSPITALS WEST, L.L.C.
 KINDRED NEVADA, L.L.C.

KINDRED NURSING CENTERS EAST, L.L.C.
 KINDRED NURSING CENTERS
NORTH, L.L.C.

  

			
	By:	 	/s/ Donald H. Robinson
	 Name: Donald H. Robinson

	 Title: Senior Vice President, Tax and Treasurer

  

	
	 

  
 S-2 

			
	 KINDRED NURSING CENTERS SOUTH, L.L.C.
 KINDRED
NURSING CENTERS WEST, L.L.C.
 KINDRED REHAB SERVICES, INC.

KINDRED SYSTEMS, INC.
 KND DEVELOPMENT 50, L.L.C.

KND DEVELOPMENT 51, L.L.C.
 KND DEVELOPMENT 52, L.L.C.

KND DEVELOPMENT 53, L.L.C.
 KND DEVELOPMENT 54, L.L.C.

KND DEVELOPMENT 55, L.L.C.
 KND DEVELOPMENT 56, L.L.C.

KND DEVELOPMENT 57, L.L.C.
 KND DEVELOPMENT 58, L.L.C.

KND DEVELOPMENT 59, L.L.C.
 KND DEVELOPMENT 60, L.L.C.

KND DEVELOPMENT 61, L.L.C.
 KND DEVELOPMENT 62, L.L.C.

KND DEVELOPMENT 63, L.L.C.
 KND HOSPITAL REAL ESTATE HOLDINGS,
L.L.C.
 KND REAL ESTATE 1, L.L.C.
 KND REAL ESTATE 2,
L.L.C.
 KND REAL ESTATE 3, L.L.C.
 KND REAL ESTATE 4,
L.L.C.
 KND REAL ESTATE 5, L.L.C.
 KND REAL ESTATE 6,
L.L.C.
 KND REAL ESTATE 7, L.L.C.
 KND REAL ESTATE 8,
L.L.C.
 KND REAL ESTATE 9, L.L.C.
 KND REAL ESTATE 10,
L.L.C.
 KND REAL ESTATE 11, L.L.C.
 KND REAL ESTATE 12,
L.L.C.
 KND REAL ESTATE 13, L.L.C.
 KND REAL ESTATE 14,
L.L.C.
 KND REAL ESTATE 15, L.L.C.
 KND REAL ESTATE 16,
L.L.C.
 KND REAL ESTATE 17, L.L.C.
 KND REAL ESTATE 18,
L.L.C.
 KND REAL ESTATE 19, L.L.C.
 KND REAL ESTATE 20,
L.L.C.
 KND REAL ESTATE 21, L.L.C.
 KND REAL ESTATE 22,
L.L.C.
 KND REAL ESTATE 23, L.L.C.
 KND REAL ESTATE 24,
L.L.C.
 KND REAL ESTATE 25, L.L.C.
 KND REAL ESTATE 26,
L.L.C.
	  	 KND REAL ESTATE 27, L.L.C.
 KND REAL ESTATE 28,
L.L.C.
 KND REAL ESTATE 29, L.L.C.
 KND REAL ESTATE 30,
L.L.C.
 KND REAL ESTATE 31, L.L.C.
 KND REAL ESTATE 32,
L.L.C.
 KND REAL ESTATE 33, L.L.C.
 KND REAL ESTATE 34,
L.L.C.
 KND REAL ESTATE 35, L.L.C.
 KND REAL ESTATE 36,
L.L.C.
 KND REAL ESTATE 37, L.L.C.
 KND REAL ESTATE 38,
L.L.C.
 KND REAL ESTATE 39, L.L.C.
 KND REAL ESTATE 40,
L.L.C.
 KND REAL ESTATE 41, L.L.C.
 KND REAL ESTATE 42,
L.L.C.
 KND REAL ESTATE 43, L.L.C.
 KND REAL ESTATE 44,
L.L.C.
 KND REAL ESTATE 45, L.L.C.
 KND REAL ESTATE 46,
L.L.C.
 KND REAL ESTATE 47, L.L.C.
 KND REAL ESTATE 48,
L.L.C.
 KND REAL ESTATE 49, L.L.C.
 KND REAL ESTATE 50,
L.L.C.
 KND REAL ESTATE 51, L.L.C.
 KND REAL ESTATE HOLDINGS,
L.L.C.
 KND REHAB REAL ESTATE HOLDINGS, L.L.C.
 KND SNF REAL
ESTATE HOLDINGS, L.L.C.
 LAFAYETTE HEALTH CARE CENTER, INC.

LAUREL LAKE HEALTH AND REHABILITATION, L.L.C.
 MAINE ASSISTED
LIVING, L.L.C.
 MASSACHUSETTS ASSISTED LIVING, L.L.C.
 MEADOWS
NURSING, L.L.C.
 MEDEQUITIES, INC.
 MEDICAL HILL REHAB CENTER,
L.L.C.
 MED-TECH PRIVATE CARE, INC.
 MED-TECH SERVICES OF DADE,
INC.
 MED-TECH SERVICES OF PALM BEACH, INC.
 MED. TECH SERVICES
OF SOUTH FLORIDA, INC.
 MILLS MEDICAL PRACTICES, LLC
 NORTH
WEST TEXAS HOME HEALTH SERVICES, LLC
 NP PLUS, LLC

  

			
	By:	 	/s/ Donald H. Robinson
	 Name: Donald H. Robinson

	Title: Senior Vice President, Tax and Treasurer

  

  
 S-3 

			
	 NRP HOLDINGS COMPANY
 OUTREACH HEALTH SERVICES
OF NORTH TEXAS, LLC
 OUTREACH HEALTH SERVICES OF THE PANHANDLE, LLC

PACIFIC COAST CARE CENTER, L.L.C.
 PACIFIC WEST HOME CARE, LLC

PEOPLEFIRST HOMECARE & HOSPICE OF CALIFORNIA, L.L.C.

PEOPLEFIRST HOMECARE & HOSPICE OF COLORADO, L.L.C.

PEOPLEFIRST HOMECARE & HOSPICE OF INDIANA, L.L.C.
 PEOPLEFIRST
HOMECARE & HOSPICE OF MASSACHUSETTS, L.L.C.
 PEOPLEFIRST HOMECARE & HOSPICE OF OHIO, L.L.C.

PEOPLEFIRST HOMECARE & HOSPICE OF UTAH, L.L.C.
 PEOPLEFIRST
HOMECARE OF COLORADO, L.L.C.
 PEOPLEFIRST VIRGINIA, L.L.C.

PERSONACARE OF CONNECTICUT, INC.
 PERSONACARE OF HUNTSVILLE,
INC.
 PERSONACARE OF OHIO, INC.
 PERSONACARE OF READING,
INC.
 PERSONACARE OF WISCONSIN, INC.
 PF DEVELOPMENT 5,
L.L.C.
 PF DEVELOPMENT 6, L.L.C.
 PF DEVELOPMENT 7, L.L.C.

PF DEVELOPMENT 8, L.L.C.
 PF DEVELOPMENT 9, L.L.C.

PF DEVELOPMENT 10, L.L.C.
 PF DEVELOPMENT 15, L.L.C.

PF DEVELOPMENT 16, L.L.C.
 PF DEVELOPMENT 17, L.L.C.

PF DEVELOPMENT 18, L.L.C.
 PF DEVELOPMENT 19, L.L.C.

PF DEVELOPMENT 20, L.L.C.
 PF DEVELOPMENT 21, L.L.C.

PF DEVELOPMENT 22, L.L.C.
 PF DEVELOPMENT 23, L.L.C.

PF DEVELOPMENT 26, L.L.C.
 PF DEVELOPMENT 27, L.L.C.

PHH ACQUISITION CORP.
 PROFESSIONAL HEALTHCARE AT HOME,
LLC
	  	 PROFESSIONAL HEALTHCARE, LLC
 REHABCARE
DEVELOPMENT 2, L.L.C.
 REHABCARE DEVELOPMENT 3, L.L.C.

REHABCARE DEVELOPMENT 4, L.L.C.
 REHABCARE DEVELOPMENT 5,
L.L.C.
 REHAB INSURANCE CORPORATION
 REHAB STAFFING, L.L.C.

SENIOR HOME CARE, INC.
 SHC HOLDING, INC.

SHC REHAB, INC.
 SIENA CARE CENTER, L.L.C.

SMITH RANCH CARE CENTER, L.L.C.
 SOUTHERN CALIFORNIA SPECIALTY
CARE, INC.
 SOUTHERN NEVADA HOME HEALTH CARE, INC.
 SOUTHERN
UTAH HOME HEALTH, INC.
 SOUTHERN UTAH HOME OXYGEN & MEDICAL EQUIPMENT, INC.

SPECIALTY HEALTHCARE SERVICES, INC.
 SPECIALTY HOSPITAL OF
CLEVELAND, INC.
 SPECIALTY HOSPITAL OF PHILADELPHIA, INC.

SPECIALTY HOSPITAL OF SOUTH CAROLINA, INC.
 SPRINGFIELD PARK VIEW
HOSPITAL, L.L.C.
 SYNERGY, INC.
 SYNERGY HEALTHCARE GROUP,
INC.
 SYNERGY HOME CARE-ACADIANA REGION, INC.
 SYNERGY HOME
CARE-CAPITOL REGION, INC.
 SYNERGY HOME CARE-CENTRAL REGION, INC.

SYNERGY HOME CARE-NORTHEASTERN REGION, INC.
 SYNERGY HOME
CARE-NORTHSHORE REGION, INC
 SYNERGY HOME CARE-NORTHWESTERN REGION, INC.

SYNERGY HOME CARE-SOUTHEASTERN REGION, INC.
 TEXAS HEALTH
MANAGEMENT GROUP, LLC
 THC – CHICAGO, INC.
 THC –
HOUSTON, INC.
 THC – NORTH SHORE, INC.
 THC – ORANGE
COUNTY, INC.
 THC – SEATTLE, INC.
 THEREX, INC.

THE THERAPY GROUP, INC.
 TOWER HILL NURSING, L.L.C.

  

			
	By:	 	/s/ Donald H. Robinson
	 Name: Donald H. Robinson

	 Title: Senior Vice President, Tax and Treasurer

  
 S-4 

			
	TRANSITIONAL HOSPITALS CORPORATION OF	  	REHABCARE GROUP EAST, INC.
	INDIANA, INC.	  	REHABCARE GROUP MANAGEMENT SERVICES,
	TRANSITIONAL HOSPITALS CORPORATION OF	  	INC.
	LOUISIANA, INC.	  	REHABCARE GROUP OF TEXAS, LLC
	TRANSITIONAL HOSPITALS CORPORATION OF	  	REHABCARE GROUP OF CALIFORNIA, LLC
	NEVADA, INC.	  	REHABCARE HOSPITAL HOLDINGS, L.L.C.
	TRANSITIONAL HOSPITALS CORPORATION OF	  	SALT LAKE PHYSICAL THERAPY ASSOCIATES,
	NEW MEXICO, INC.	  	INC
	TRANSITIONAL HOSPITALS CORPORATION OF	  	SCCI HEALTH SERVICES CORPORATION.
	TAMPA, INC.	  	SCCI HOSPITAL – EASTON, INC.
	TRANSITIONAL HOSPITALS CORPORATION OF	  	SCCI HOSPITAL – EL PASO, INC.
	TEXAS, INC.	  	SCCI HOSPITAL – MANSFIELD, INC.
	TRANSITIONAL HOSPITALS CORPORATION OF	  	SCCI HOSPITAL VENTURES, INC.
	WISCONSIN, INC.	  	SCCI HOSPITALS OF AMERICA, INC.
	TRINITY HOSPICE OF TEXAS, LLC	  	SYMPHONY HEALTH SERVICES, LLC
	TUCKER NURSING CENTER, INC.	  	TRIUMPH HEALTHCARE HOLDINGS, INC.
	VERNON HOME HEALTH CARE AGENCY, LLC	  	TRIUMPH HEALTHCARE SECOND HOLDINGS,
	WELLSTREAM HEALTH SERVICES, LLC	  	LLC
	WEST TEXAS, LLC	  	TRIUMPH HEALTHCARE THIRD HOLDINGS,
	YGNACIO VALLEY CARE CENTER, L.L.C.	  	LLC
	FOOTHILL NURSING COMPANY PARTNERSHIP	  	TRIUMPH HOSPITAL NORTHWEST INDIANA,
	HILLHAVEN–MSC PARTNERSHIP	  	INC.
	KINDRED HOSPITALS LIMITED PARTNERSHIP	  	TRIUMPH REHABILITATION HOSPITAL
	KINDRED NURSING CENTERS CENTRAL LIMITED	  	NORTHERN INDIANA, LLC
	PARTNERSHIP	  	TRIUMPH REHABILITATION HOSPITAL OF
	KINDRED NURSING CENTERS LIMITED	  	NORTHEAST HOUSTON, LLC
	PARTNERSHIP	  	TULSA SPECIALTY HOSPITAL L.L.C.
	AMERICAN VITALCARE, LLC	  	VTA MANAGEMENT SERVICES, LLC
	CANNON & ASSOCIATES, LLC	  	VTA STAFFING SERVICES, LLC
	CLEAR LAKE REHABILITATION HOSPITAL, L.L.C.	  	NEW TRIUMPH HEALTHCARE, LLP
	LAFAYETTE SPECIALTY HOSPITAL, L.L.C.	  	REHABCARE GROUP OF AMARILLO, LP
	NEW TRIUMPH HEALTHCARE OF TEXAS, LLC	  	REHABCARE GROUP OF ARLINGTON, LP
	NEW TRIUMPH HEALTHCARE, INC.	  	
	NORTHLAND LTACH, LLC	  	
	 REHABCARE GROUP, INC.
	  	

  

			
	By:	 	/s/ Donald H. Robinson
	Name: Donald H. Robinson
	Title: Senior Vice President, Tax and Treasurer

  
 S-5 

 
			
	WELLS FARGO BANK, NATIONAL ASSOCIATION,
	as Trustee
		
	By:	 	/s/ Gregory S. Clarke
	Name:	 	Gregory S. Clarke
	Title:	 	Vice President

  
 S-6 

 EXHIBIT A 

[FORM OF FACE OF INITIAL NOTE] 

[Global Notes Legend] 
 UNLESS
THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), NEW YORK, NEW YORK, TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY
CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN
AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 

TRANSFERS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO DTC, TO NOMINEES OF DTC OR TO A SUCCESSOR
THEREOF OR SUCH SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE INDENTURE REFERRED TO ON THE REVERSE HEREOF. 

[Restricted Notes Legend] 
 THIS
NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION. NEITHER THIS NOTE NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE OFFERED, SOLD,
ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR UNLESS SUCH TRANSACTION IS EXEMPT FROM, OR NOT SUBJECT TO, SUCH REGISTRATION. THE HOLDER OF THIS NOTE, BY ITS ACCEPTANCE HEREOF, AGREES ON ITS
OWN BEHALF AND ON BEHALF OF ANY INVESTOR ACCOUNT FOR WHICH IT HAS PURCHASED SECURITIES TO OFFER, SELL OR OTHERWISE TRANSFER SUCH SECURITY, PRIOR TO THE DATE (THE “RESALE RESTRICTION TERMINATION DATE”) THAT IS ONE YEAR, IN THE CASE OF RULE
144A NOTES, AND 40 DAYS, IN THE CASE OF REGULATION S NOTES, AFTER THE LATER OF THE ORIGINAL ISSUE DATE HEREOF, THE ORIGINAL ISSUE DATE OF THE ISSUANCE OF ANY ADDITIONAL NOTES AND THE LAST DATE ON WHICH THE ISSUER OR ANY AFFILIATE OF THE ISSUER WAS
THE OWNER OF THIS SECURITY (OR ANY PREDECESSOR OF SUCH SECURITY), ONLY (A) TO THE ISSUER, (B) PURSUANT TO A REGISTRATION STATEMENT THAT HAS BEEN DECLARED EFFECTIVE UNDER THE SECURITIES ACT, (C) FOR SO LONG AS THE SECURITIES ARE
ELIGIBLE FOR RESALE PURSUANT TO RULE 144A UNDER THE SECURITIES ACT (“RULE 144A”), TO A PERSON IT REASONABLY BELIEVES IS A “QUALIFIED INSTITUTIONAL BUYER” AS DEFINED IN RULE 144A THAT PURCHASES FOR ITS OWN ACCOUNT OR FOR THE
ACCOUNT OF A QUALIFIED INSTITUTIONAL BUYER TO WHOM NOTICE IS GIVEN THAT THE TRANSFER IS BEING MADE IN RELIANCE ON RULE 144A, (D) PURSUANT TO OFFERS AND SALES TO NON-U.S. PERSONS THAT OCCUR OUTSIDE THE UNITED STATES WITHIN THE MEANING OF
REGULATION S UNDER THE SECURITIES ACT, (E) TO AN INSTITUTIONAL “ACCREDITED INVESTOR” WITHIN THE MEANING OF RULE 501(a)(1), (2), (3) OR (7) UNDER THE SECURITIES ACT THAT IS AN INSTITUTIONAL ACCREDITED INVESTOR ACQUIRING THE
SECURITY FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF SUCH AN INSTITUTIONAL ACCREDITED INVESTOR, IN EACH CASE IN A MINIMUM PRINCIPAL AMOUNT OF THE SECURITIES OF $250,000, FOR INVESTMENT PURPOSES AND NOT WITH A VIEW TO OR FOR OFFER OR SALE IN CONNECTION
WITH ANY DISTRIBUTION IN VIOLATION OF THE SECURITIES ACT, OR (F) PURSUANT TO ANOTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT, SUBJECT TO THE ISSUER’S AND THE TRUSTEE’S RIGHT PRIOR TO ANY SUCH
OFFER, SALE OR TRANSFER (1) PURSUANT TO CLAUSES (D), (E) OR (F) TO REQUIRE THE DELIVERY OF AN OPINION OF COUNSEL, CERTIFICATION 

  
 A-1 

 
AND/ OR OTHER INFORMATION SATISFACTORY TO EACH OF THEM, AND (2) IN EACH OF THE FOREGOING CASES, TO REQUIRE THAT A CERTIFICATE OF TRANSFER IN THE FORM APPEARING ON THIS NOTE IS COMPLETED AND
DELIVERED BY THE TRANSFEROR TO THE TRUSTEE. THIS LEGEND WILL BE REMOVED UPON THE REQUEST OF THE HOLDER AFTER THE RESALE RESTRICTION TERMINATION DATE. [IN THE CASE OF REGULATION S NOTES: BY ITS ACQUISITION HEREOF, THE HOLDER HEREOF REPRESENTS THAT IT
IS NOT A U.S. PERSON NOR IS IT PURCHASING FOR THE ACCOUNT OF A U.S. PERSON AND IS ACQUIRING THIS SECURITY IN AN OFFSHORE TRANSACTION IN ACCORDANCE WITH REGULATION S UNDER THE SECURITIES ACT.] 

  
 A-2 

 CUSIP: [            ] 

ISIN: [            ]1 

[RULE 144A][REGULATION S][GLOBAL] NOTE 

6.375% Senior Notes due 2022 
 No. 

KINDRED HEALTHCARE, INC. 
 [promises to pay to
CEDE & CO. or registered assigns, the principal sum set forth on the Schedule of Exchanges of Interests in the Global Note attached hereto [of up to             United States
Dollars on April 15, 2022.] [USE ONLY FOR GLOBAL NOTES.] 
 [promises to pay to
[            ] or registered assigns, the principal sum of [            United States Dollars] on
[            ],] [USE ONLY FOR DEFINITIVE NOTES.] 
 Interest Payment Dates: April 15 and
October 15 
 Record Dates: April 1 and October 1 
  

 

	1 	Rule 144A Note CUSIP: 494580 AC7 

	    	Rule 144A Note ISIN: US494580AC74 

	    	Regulation S Note CUSIP: U4946L AA7 

	    	Regulation S Note ISIN: USU4946LAA71 

  
 A-3 

 IN WITNESS HEREOF, the Company has caused this instrument to be duly executed. 

Dated: 
  

			
	KINDRED HEALTHCARE, INC.
		
	By:	 	 
		 	 Name:
 Title:

  
 A-4 

 This is one of the Notes referred to in the within-mentioned Indenture: 

 

			
	WELLS FARGO BANK, NATIONAL ASSOCIATION,
	 as Trustee

		
	 By:
	 	 
		 	 Authorized Signatory

  
 A-5 

 [Back of Note] 

6.375% Senior Notes due 2022 

Capitalized terms used herein shall have the meanings assigned to them in the Indenture referred to below unless otherwise indicated. 

1. INTEREST. Kindred Healthcare, Inc., a Delaware corporation, promises to pay interest on the principal amount of this Note at 6.375% per
annum from [April 9, 2014]2 [         ]3 until maturity and shall pay the Additional Interest, if any,
payable pursuant to the Registration Rights Agreement referred to below or pursuant to Section 6.01(b) of the Indenture. The Company will pay interest and Additional Interest, if any, semi-annually in arrears on April 15 and
October 15 of each year, or if any such day is not a Business Day, on the next succeeding Business Day (each, an “Interest Payment Date”) with the same force and effect and no interest for the intervening period shall accrue.
Interest on the Notes will accrue from the most recent date to which interest has been paid or, if no interest has been paid, from the date of issuance; provided that the first Interest Payment Date shall be October 15, 2014. The Company
will pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue principal and premium, if any, from time to time on demand at the interest rate on the Notes; it shall pay interest (including post-petition
interest in any proceeding under any Bankruptcy Law) on overdue installments of interest and Additional Interest, if any, (without regard to any applicable grace periods) from time to time on demand at the interest rate on the Notes. Interest will
be computed on the basis of a 360-day year comprised of twelve 30-day months. 
 2. METHOD OF PAYMENT. The Company will pay interest
on the Notes and Additional Interest, if any, to the Persons who are Holders at the close of business on April 1 and October 1 (whether or not a Business Day), as the case may be, next preceding the Interest Payment Date, even if such
Notes are canceled after such Record Date and on or before such Interest Payment Date, except as provided in Section 2.14 of the Indenture with respect to defaulted interest. Principal of, premium, if any, and interest on the Notes will be
payable at the office or agency of the Company maintained for such purpose or, at the option of the Company, payment of interest and Additional Interest, if any, may be made by check mailed to the Holders at their respective addresses set forth in
the register of Holders; provided that payment by wire transfer of immediately available funds will be required with respect to principal of and interest, premium and Additional Interest, if any, on, all Global Notes and all other Notes the
Holders of which shall have provided wire transfer instructions to the Company or the Paying Agent. Such payment shall be in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and
private debts. 
 3. PAYING AGENT AND REGISTRAR. Initially, Wells Fargo Bank, National Association, the Trustee under the Indenture,
will act as Paying Agent and Registrar. The Company may change any Paying Agent or Registrar without notice to the Holders. The Company or any of its Restricted Subsidiaries may act in any such capacity. 

4. INDENTURE. The Company issued the Notes under an Indenture, dated as of April 9, 2014 (as amended or supplemented the
“Indenture”), among Kindred Healthcare, Inc., the Subsidiary Guarantors and the Trustee. This Note is one of a duly authorized issue of notes of the Company designated as its 6.375% Senior Notes due 2022. The Company shall be
entitled to issue Additional Notes pursuant to Sections 2.01 and 4.09 of the Indenture. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939, as amended
(the “Trust Indenture Act”). The Notes are subject to all such terms, and Holders are referred to the Indenture and such Act for a statement of such terms. To the extent any 

 

	2 	With respect to the Initial Notes. 

	3 	With respect to Notes other than the Initial Notes. Fill in appropriate date. 

  
 A-6 

 
provision of this Note conflicts with the express provisions of the Indenture, the provisions of the Indenture shall govern and be controlling. 

The Notes are senior unsecured obligations of the Company. The aggregate principal amount of Notes that may be authenticated and delivered
under the Indenture is unlimited. This Note is one of the 6.375% Senior Notes due 2022 referred to in the Indenture. The Notes include (i) $500,000,000 aggregate principal amount of the Company’s 6.375% Senior Notes due 2022 issued under
the Indenture on April 9, 2014 (herein called “Initial Notes”), (ii) if and when issued, additional 6.375% Senior Notes due 2022 of the Company that may be issued from time to time under the Indenture on or after
April 9, 2014 (herein called “Additional Notes”) as provided in Section 2.01(a) of the Indenture and (iii) if and when issued, the Company’s 6.375% Senior Notes due 2022 that may be issued from time to time under
the Indenture in exchange for Initial Notes or Additional Notes in an offer registered under the Securities Act as provided in the Registration Rights Agreement (herein called “Exchange Notes”). The Initial Notes, Additional Notes
and Exchange Notes are treated as a single class of securities under the Indenture. The Indenture imposes certain covenants as specified in Article 4 thereof. The Indenture also imposes requirements with respect to the provision of financial
information and the provision of guarantees of the Notes by certain subsidiaries. 
 To guarantee the due and punctual payment of the
principal, premium, if any, and interest on the Notes and all other amounts payable by the Company under the Indenture, the Notes and the Registration Rights Agreement when and as the same shall be due and payable, whether at maturity, by
acceleration or otherwise, according to the terms of the Notes and the Indenture, the Subsidiary Guarantors have unconditionally guaranteed (and future guarantors, together with the Subsidiary Guarantors, will unconditionally Guarantee), jointly and
severally, such obligations on a senior unsecured basis pursuant to the terms of the Indenture. 
 5. OPTIONAL REDEMPTION. 

(a) Except as described below under clauses 5(b) and 5(c), the Notes will not be redeemable at the Company’s option before April 15,
2017. 
 (b) At any time prior to April 15, 2017, upon not less than 30 nor more than 60 days’ prior notice mailed by first-class
mail to each Holder’s registered address, the Company may redeem all or part of the Notes at a redemption price equal to 100% of the principal amount thereof plus the Applicable Premium as of, plus accrued and unpaid interest, if any, to, the
redemption date (subject to the right of Holders on the relevant Record Date to receive interest due on the relevant Interest Payment Date). 

(c) At any time prior to April 15, 2017, the Company may, at its option, redeem up to 35% of the aggregate original principal
amount of Notes issued by it under the Indenture (calculated after giving effect to any issuance of Additional Notes) with the Net Cash Proceeds of one or more Equity Offerings at a redemption price of 106.375% of the principal amount thereof, plus
accrued and unpaid interest, if any, to the redemption date (subject to the right of Holders on the relevant Record Date to receive interest due on the relevant Interest Payment Date); provided that:  

(1) at least 65% of the aggregate original principal amount of Notes issued under the Indenture (calculated after giving effect
to any issuance of Additional Notes) remains outstanding immediately after each such redemption; and 
 (2) the redemption
occurs within 120 days after the closing of each such Equity Offering. 
 (d) On and after April 15, 2017, the Company may, at its
option, redeem all or, from time to time, a part of the Notes upon not less than 30 nor more than 60 days’ notice, at the following redemption prices (expressed as a percentage of principal amount of the Notes to be redeemed) plus accrued and
unpaid interest and Additional Interest on the Notes, if any, to the applicable redemption date (subject to the right of Holders on the relevant Record Date to receive interest due on the relevant Interest Payment Date), if redeemed during the
twelve-month period beginning on April 15 of the years indicated below: 

  
 A-7 

					
	Year	  	Percentage	 
	 2017
	  	 	104.781	% 
	 2018
	  	 	103.188	% 
	 2019
	  	 	101.594	% 
	 2020 and thereafter
	  	 	100.000	% 

 (e) Any redemption pursuant to this paragraph 5 shall be made pursuant to the provisions of Sections 3.01
through 3.06 of the Indenture. 
 6. [Reserved.] 

7. MANDATORY REDEMPTION. The Company shall not be required to make mandatory redemption or sinking fund payments with respect to the Notes.

 8. NOTICE OF REDEMPTION. Subject to Section 3.09 of the Indenture, the Company shall mail or cause to be mailed by first-class mail,
postage prepaid, notices of redemption at least 30 days but not more than 60 days before the redemption date to each Holder of Notes to be redeemed at such Holder’s registered address or otherwise in accordance with the procedures of DTC,
except that redemption notices may be mailed more than 60 days prior to a redemption date if the notice is issued in connection with Article 8 or Article 11 of the Indenture. Except as set forth in Section 3.07(g) and Section 4.14 of the
Indenture, notices of redemption may not be conditional. Notes and portions of Notes selected shall be in amounts of $2,000 or whole multiples of $1,000 on excess thereof; no Notes of $2,000 or less can be redeemed in part, except that if all of the
Notes of a Holder are to be redeemed or purchased, the entire outstanding amount of Notes held by such Holder, even if not $2,000 or a multiple of $1,000 in excess thereof, shall be redeemed or purchased. Subject to Section 3.05 of the
Indenture, on and after the redemption date, interest ceases to accrue on Notes or portions of Notes called for redemption. Notice of any redemption upon any Equity Offering may be given prior to the completion thereof, and any such redemption or
notice may, at the Company’s discretion, be subject to one or more conditions precedent, including, but not limited to, completion of the related Equity Offering. 

9. OFFERS TO REPURCHASE. 
 (a) If
a Change of Control occurs, unless the Company has exercised its right to redeem all of the Notes as described under Section 3.07 of the Indenture, each Holder shall have the right to require the Company to repurchase all or any part (equal to
$2,000 or larger integral multiples of $1,000) of such Holder’s Notes at a purchase price in cash equal to 101% of the aggregate principal amount of the Notes repurchased plus accrued and unpaid interest, if any, to the date of purchase
(subject to the right of Holders on the relevant Record Date to receive interest due on the relevant Interest Payment Date). 
 (b) On the
367th day after the date of receipt of such Net Available Cash (or such later date upon which an applicable Acceptable Commitment is canceled or terminates or the applicable 180-day period with respect to an applicable Acceptable Commitment expires
without full application of such Net Available Cash), if the aggregate amount of Excess Proceeds exceeds $25.0 million, the Company shall be required to make an offer (an “Asset Sale Offer”) to all Holders of Notes and to the extent
required by the terms of other Pari Passu Indebtedness, to all holders of other Pari Passu Indebtedness outstanding with similar provisions requiring the Company to make an offer to purchase such Pari Passu Indebtedness with the proceeds from any
Asset Sale, to purchase the maximum principal amount of Notes and any such Pari Passu Indebtedness to which the Asset Sale Offer applies that may be purchased out of the Excess Proceeds, at an offer price in cash in an amount equal to 100% of the
principal amount of the Notes and Pari Passu Indebtedness plus accrued and unpaid interest to the date of purchase, in accordance with the procedures set forth in the Indenture or the agreements governing the Pari Passu Indebtedness, as applicable,
in each case in minimum denominations of $2,000 and larger integral multiples of $1,000 in excess thereof. To the extent that the aggregate amount of Notes and Pari Passu Indebtedness so properly tendered and not withdrawn pursuant to an Asset Sale
Offer is less than the Excess Proceeds, the Company may use any remaining Excess Proceeds for any purpose not prohibited by the Indenture. If the aggregate principal amount of Notes surrendered by Holders thereof and other Pari Passu Indebtedness
surrendered by holders or lenders, collectively, exceeds the amount of Excess Proceeds, the Trustee shall select the Notes, and the trustee or agent for the Pari Passu Indebtedness shall select the Pari Passu Indebtedness, to be purchased on a pro
rata basis on the basis of the 

  
 A-8 

 
aggregate principal amount of tendered Notes and Pari Passu Indebtedness. Upon completion of such Asset Sale Offer, the amount of Excess Proceeds shall be reset at zero. Accordingly, to the
extent that the aggregate amount of Notes and other Indebtedness tendered pursuant to an Asset Sale Offer is less than the aggregate amount of unapplied Excess Proceeds, the Company may use any remaining amount for the general corporate purposes of
the Company and its Restricted Subsidiaries. 
 Holders electing to have a Note purchased pursuant to any Asset Sale Offer shall be required
to surrender the Note, with the form entitled “Option of Holder to Elect Purchase” attached to the Note completed, or transfer by book-entry transfer, to the Company, the Depositary, if appointed by the Company, or a Paying Agent at the
address specified in the notice at least three days before the Asset Sale Purchase Date. 
 10. DENOMINATIONS, TRANSFER, EXCHANGE. The Notes
are in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess thereof. The transfer of Notes may be registered and Notes may be exchanged as provided in the Indenture. The Registrar and the Trustee may
require a Holder, among other things, to furnish appropriate endorsements and transfer documents, and Holders shall be required to pay any taxes and fees required by law or permitted by the Indenture. The Company need not exchange or register the
transfer of any Note or portion of a Note selected for redemption, except for the unredeemed portion of any Note being redeemed in part. Also, the Company need not exchange or register the transfer of any Notes for a period of 15 days before a
selection of Notes to be redeemed. 
 11. PERSONS DEEMED OWNERS. A Holder may be treated as its owner for all purposes. 

12. AMENDMENT, SUPPLEMENT AND WAIVER. The Indenture, the Subsidiary Guarantees or the Notes may be amended or supplemented as provided in the
Indenture. 
 13. DEFAULTS AND REMEDIES. 

(a) If an Event of Default (other than an Event of Default arising from certain events of bankruptcy or insolvency) occurs and is continuing,
the Trustee by notice in writing specifying the Event of Default and that it is a “notice” to the Company, or the Holders of at least 25% in aggregate principal amount of the then outstanding Notes by notice to the Company and the Trustee,
may declare the principal of, premium, if any, and accrued and unpaid interest, if any, on all the Notes to be due and payable. Upon such a declaration, such principal, premium and accrued and unpaid interest shall be due and payable immediately.

 (b) In the event of a declaration of acceleration of the Notes because an Event of Default arising from certain defaults under any
mortgage, indenture or instrument under which there may be issued or by which there may be secured or evidenced any Indebtedness for money borrowed by the Company or any of its Restricted Subsidiaries (or the payment of which is guaranteed by the
Company or any of its Restricted Subsidiaries), other than Indebtedness owed to the Company or a Restricted Subsidiary, whether such Indebtedness or Guarantee now exists or is created after the Issue Date, has occurred and is continuing, the
declaration of acceleration of the Notes shall be automatically annulled if the default triggering such Event of Default pursuant to such Event of Default shall be remedied or cured by the Company or a Restricted Subsidiary or waived by the holders
of the relevant Indebtedness within 20 days after the declaration of acceleration with respect thereto and if (1) the annulment of the acceleration of the Notes would not conflict with any judgment or decree of a court of competent jurisdiction
and (2) all existing Events of Default, except nonpayment of principal, premium or interest on the Notes that became due solely because of the acceleration of the Notes, have been cured or waived. 

(c) If an Event of Default arising from certain events of bankruptcy or insolvency occurs and is continuing, the principal of, premium, if any,
and accrued and unpaid interest on all the Notes shall become and be immediately due and payable without any declaration or other act on the part of the Trustee or any Holders. 

(d) The Holders of a majority in aggregate principal amount of the then outstanding Notes may waive all past defaults (except with respect to a
continuing Default or Event of Default with respect to nonpayment of principal, premium or interest on the Notes) and rescind any such acceleration with respect to the Notes and its consequences if (1) rescission would not conflict with any
judgment or decree of a court of competent jurisdiction 

  
 A-9 

 
and (2) all existing Events of Default, other than the nonpayment of the principal of, premium, if any, and interest on the Notes that have become due solely by such declaration of
acceleration, have been cured or waived. 
 (d) If a Default occurs and is continuing and is known to the Trustee, the Trustee shall mail to
each Holder notice of the Default within 90 days after it occurs. Except in the case of a Default in the payment of principal of, premium, if any, or interest on any Note, the Trustee may withhold notice if and so long as a committee of Trust
Officers of the Trustee in good faith determines that withholding notice is in the interests of the Holders. In addition, the Company shall deliver to the Trustee, within 120 days after the end of each fiscal year, a certificate indicating whether
the signers thereof know of any Default that occurred during the previous year. 
 14. AUTHENTICATION. This Note shall not be entitled to any
benefit under the Indenture or be valid or obligatory for any purpose until authenticated by the manual signature of the Trustee. 
 15.
GOVERNING LAW. THE LAWS OF THE STATE OF NEW YORK SHALL GOVERN AND BE USED TO CONSTRUE THE INDENTURE, THE NOTES AND THE GUARANTEES. 
 16. NO
PERSONAL LIABILITY. No director, officer, employee, incorporator or stockholder of the Company or the Subsidiary Guarantors, as such, shall have any liability for any obligations of the Company or the Subsidiary Guarantors under this Note, the
Indenture or the Subsidiary Guarantees or for any claim based upon, in respect of, or by reason of, such obligations or their creation. Each Holder by accepting this Note waives and releases all such liability. The waiver and release are part of the
consideration for issuance of the Notes. 
 17. CUSIP NUMBERS. Pursuant to a recommendation promulgated by the Committee on Uniform Security
Identification Procedures, the Company has caused CUSIP numbers to be printed on the Notes, and the Trustee may use CUSIP numbers in notices of redemption as a convenience to Holders. No representation is made as to the accuracy of such numbers
either as printed on the Notes or as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. 

The Company will furnish to any Holder upon written request and without charge a copy of the Indenture and/or the Registration Rights
Agreement. Requests may be made to the Company at the following address: 
 c/o Kindred Healthcare, Inc. 

680 South Fourth Street 

Louisville, Kentucky 40202-2412 

Fax No.: 502-596-4075 
 Attention:
General Counsel and Treasurer 

  
 A-10 

 ASSIGNMENT FORM 

To assign this Security, fill in the form below: 

I or we assign and transfer this Security to: 
  

 
 (Print or type assignee’s name,
address and zip code) 
  
  

(Insert assignee’s social security or tax I.D. No.) 

and irrevocably appoint             agent to transfer this Security on the books of the Company.
The agent may substitute another to act for him. 
  

			
	Date:                            	  	Your Signature:                            
	  
 Signature
Guarantee:                            
	  	

 (Signature must be guaranteed) 

Sign exactly as your name appears on the other side of this Security. 

The signature(s) should be guaranteed by an eligible guarantor institution (banks, stockbrokers, savings and loan associations and credit unions with
membership in an approved signature guarantee medallion program), pursuant to S.E.C. Rule 17Ad-15. 
 The undersigned hereby certifies that it [is / is
not] an Affiliate of the Company and that, to its knowledge, the proposed transferee [is / is not] an Affiliate of the Company. 
 In
connection with any transfer or exchange of any of the Notes evidenced by this certificate occurring prior to the date that is one year after the later of the date of original issuance of such Notes and the last date, if any, on which such Notes
were owned by the Company or any Affiliate of the Company, the undersigned confirms that such Notes are being: 
 CHECK ONE BOX BELOW: 

 

			
	(1)     ̈	  	acquired for the undersigned’s own account, without transfer; or
		
	(2)     ̈	  	transferred to the Company; or
		
	(3)     ̈	  	transferred pursuant to and in compliance with Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”); or
		
	(4)     ̈	  	transferred pursuant to an effective registration statement under the Securities Act; or
		
	(5)     ̈	  	transferred pursuant to and in compliance with Regulation S under the Securities Act; or
		
	(6)     ̈	  	transferred pursuant to another available exemption from the registration requirements of the Securities Act of 1933, as amended.

 Unless one of the boxes is checked, the Trustee will refuse to register any of the Notes evidenced by this certificate
in the name of any person other than the Holder thereof; provided, however, that if box (5), (6) or (7) is checked, the Company may require, prior to registering any such transfer of the Notes, in its sole discretion, such
legal opinions,  

  
 A-11 

 
certifications and other information as the Company may reasonably request to confirm that such transfer is being made pursuant to an exemption from, or in a transaction not subject to, the
registration requirements of the Securities Act of 1933, as amended, such as the exemption provided by Rule 144 under such Act. 
  

			
		  	Signature                            
	Signature Guarantee:                            	  	
	  
 (Signature must be guaranteed)
	  	Signature                            

 The signature(s) should be guaranteed by an eligible guarantor institution (banks, stockbrokers, savings and loan associations
and credit unions with membership in an approved signature guarantee medallion program), pursuant to S.E.C. Rule 17Ad-15. 
 TO BE COMPLETED BY PURCHASER IF
BOX (1) OR (3) ABOVE IS CHECKED. 
 The undersigned represents and warrants that it is purchasing this Security for its own account or an account
with respect to which it exercises sole investment discretion and that it and any such account is a “qualified institutional buyer” within the meaning of Rule 144A under the Securities Act of 1933, as amended, and is aware that the sale to
it is being made in reliance on Rule 144A and acknowledges that it has received such information regarding the Company as the undersigned has requested pursuant to Rule 144A or has determined not to request such information and that it is aware that
the transferor is relying upon the undersigned’s foregoing representations in order to claim the exemption from registration provided by Rule 144A. 
  

	
	 Dated:

	
	
Signature                       
                                         
                     

  
 A-12 

 OPTION OF HOLDER TO ELECT PURCHASE 

If you want to elect to have this Note purchased by the Company pursuant to Section 4.10 or 4.14 of the Indenture, check the appropriate
box below: 

 ̈  Section 4.10           
           ̈  Section 4.14 
 If
you want to elect to have only part of this Note purchased by the Company pursuant to Section 4.10 or Section 4.14 of the Indenture, state the amount you elect to have purchased: 

$                     

Date:                         
                    
  

			
	Your
Signature:                                       
                     
	                            (Sign exactly as your name appears
	                             on the face of this Note)
	
	Tax Identification
No.:                                        
            

 Signature
Guarantee*:                                       
      
  

	*	Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee). 

  
 A-13 

 SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL NOTE 

The initial outstanding principal amount of this Global Note is $            . The
following exchanges of a part of this Global Note for an interest in another Global Note or for a Definitive Note, or exchanges of a part of another Global or Definitive Note for an interest in this Global Note, have been made: 

 

									
	Date of Exchange	  	 Amount of decrease

in Principal Amount
	  	 Amount of increase

in Principal Amount
 of this Global
Note
	  	 Principal Amount of

this Global Note
 following such

decrease or increase
	  	 Signature of

authorized officer of
 Trustee or
Custodian

		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	

  
 A-14 

 EXHIBIT B 

[FORM OF FACE OF EXCHANGE NOTE] 

[Global Notes Legend] 
 UNLESS
THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), NEW YORK, NEW YORK, TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND
ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN
AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 

TRANSFERS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO DTC, TO NOMINEES OF DTC OR TO A SUCCESSOR
THEREOF OR SUCH SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE INDENTURE REFERRED TO ON THE REVERSE HEREOF. 

  
 B-1 

 CUSIP: [            ] 

ISIN: [            ]4 

[GLOBAL] NOTE 
 6.375% Senior
Notes due 2022 
 No.                      

KINDRED HEALTHCARE, INC 
 [promises to pay to
CEDE & CO. or registered assigns, the principal sum set forth on the Schedule of Exchanges of Interests in the Global Note attached hereto [of up to             United States
Dollars on [            ],] [USE ONLY FOR GLOBAL NOTES.] 
 [promises to pay to
[            ] or registered assigns, the principal sum of [            United States Dollars] on
[            ],] [USE ONLY FOR DEFINITIVE NOTES.] 
 Interest Payment Dates: April 15 and
October 15 
 Record Dates: April 1 and October 1 
  

  
  

	4 	CUSIP: 

 ISIN: 

  
 B-2 

 IN WITNESS HEREOF, the Company has caused this instrument to be duly executed. Dated:
                , 20__. 
  

			
	KINDRED HEALTHCARE, INC.
		
	By:	 	  

		 	 Name:
 Title:

  
 B-3 

 This is one of the Notes referred to in the within-mentioned Indenture: 

 

			
	 WELLS FARGO BANK, NATIONAL ASSOCIATION,

	 as Trustee

		
	By:	 	 
		 	 Authorized Signatory

  
 B-4 

 [Back of Note] 

6.375% Senior Notes due 2022 

Capitalized terms used herein shall have the meanings assigned to them in the Indenture referred to below unless otherwise indicated. 

1. INTEREST. Kindred Healthcare, Inc., a Delaware corporation, promises to pay interest on the principal amount of this Note at
6.375% per annum from [April 9, 2014]5 [                
]6 until maturity. The Company will pay interest semi-annually in arrears on April 15 and October 15 of each year, or if any such day is not a Business Day, on the next succeeding
Business Day (each, an “Interest Payment Date”) with the same force and effect and no interest for the intervening period shall accrue. Interest on the Notes will accrue from the most recent date to which interest has been paid or,
if no interest has been paid, from the date of issuance; provided that the first Interest Payment Date shall be October 15, 2014. The Company will pay interest (including post-petition interest in any proceeding under any Bankruptcy Law)
on overdue principal and premium, if any, from time to time on demand at the interest rate on the Notes; it shall pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue installments of interest (without
regard to any applicable grace periods) from time to time on demand at the interest rate on the Notes. Interest will be computed on the basis of a 360-day year comprised of twelve 30-day months. 

2. METHOD OF PAYMENT. The Company will pay interest on the Notes to the Persons who are Holders at the close of business on
April 1 and October 1 (whether or not a Business Day), as the case may be, next preceding the Interest Payment Date, even if such Notes are canceled after such Record Date and on or before such Interest Payment Date, except as provided in
Section 2.14 of the Indenture with respect to defaulted interest. Principal of, premium, if any, and interest on the Notes will be payable at the office or agency of the Company maintained for such purpose or, at the option of the Company,
payment of interest may be made by check mailed to the Holders at their respective addresses set forth in the register of Holders; provided that payment by wire transfer of immediately available funds will be required with respect to
principal of and interest and premium on, all Global Notes and all other Notes the Holders of which shall have provided wire transfer instructions to the Company or the Paying Agent. Such payment shall be in such coin or currency of the United
States of America as at the time of payment is legal tender for payment of public and private debts. 
 3. PAYING AGENT AND
REGISTRAR. Initially, Wells Fargo Bank, National Association, the Trustee under the Indenture, will act as Paying Agent and Registrar. The Company may change any Paying Agent or Registrar without notice to the Holders. The Company or any of its
Restricted Subsidiaries may act in any such capacity. 
 4. INDENTURE. The Company issued the Notes under an Indenture, dated as of
April 9, 2014 (as amended or supplemented, the “Indenture”), among Kindred Healthcare, Inc., the Subsidiary Guarantors and the Trustee. This Note is one of a duly authorized issue of notes of the Company designated as its
6.375% Senior Notes due 2022. The Company shall be entitled to issue Additional Notes pursuant to Sections 2.01 and 4.09 of the Indenture. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference
to the Trust Indenture Act of 1939, as amended (the “Trust Indenture Act”). The Notes are subject to all such terms, and Holders are referred to the Indenture and such Act for a statement of such terms. To the extent any provision
of this Note conflicts with the express provisions of the Indenture, the provisions of the Indenture shall govern and be controlling. 
  

 

	5 	With respect to the Initial Notes. 

	6 	With respect to Notes other than the Initial Notes. Fill in appropriate date. 

  
 B-5 

 The Notes are senior unsecured obligations of the Company. The aggregate principal amount of
Notes that may be authenticated and delivered under the Indenture is unlimited. This Note is one of the 6.375% Senior Notes due 2022 referred to in the Indenture. The Notes include (i) $500,000,000 aggregate principal amount of the
Company’s 6.375% Senior Notes due 2022 issued under the Indenture on April 9, 2014 (herein called “Initial Notes”), (ii) if and when issued, additional 6.375% Senior Notes due 2022 of the Company that may be issued
from time to time under the Indenture on or after April 9, 2014 (herein called “Additional Notes”) as provided in Section 2.01(a) of the Indenture and (iii) if and when issued, the Company’s 6.375% Senior Notes
due 2022 that may be issued from time to time under the Indenture in exchange for Initial Notes or Additional Notes in an offer registered under the Securities Act as provided in the Registration Rights Agreement (herein called “Exchange
Notes”). The Initial Notes, Additional Notes and Exchange Notes are treated as a single class of securities under the Indenture. The Indenture imposes certain covenants as specified in Article 4 thereof. The Indenture also imposes
requirements with respect to the provision of financial information and the provision of guarantees of the Notes by certain subsidiaries. 

To guarantee the due and punctual payment of the principal, premium, if any, and interest on the Notes and all other amounts payable by the
Company under the Indenture, the Notes and the Registration Rights Agreement when and as the same shall be due and payable, whether at maturity, by acceleration or otherwise, according to the terms of the Notes and the Indenture, the Subsidiary
Guarantors have unconditionally guaranteed (and future guarantors, together with the Subsidiary Guarantors, will unconditionally Guarantee), jointly and severally, such obligations on a senior unsecured basis pursuant to the terms of the Indenture.

 5. OPTIONAL REDEMPTION. 

(a) Except as described below under clauses 5(b) and 5(c), the Notes will not be redeemable at the Company’s option before April 15,
2017. 
 (b) At any time prior to April 15, 2017, upon not less than 30 nor more than 60 days’ prior notice mailed by first-class
mail to each Holder’s registered address, the Company may redeem all or part of the Notes at a redemption price equal to 100% of the principal amount thereof plus the Applicable Premium as of, plus accrued and unpaid interest, if any, to, the
redemption date (subject to the right of Holders on the relevant Record Date to receive interest due on the relevant Interest Payment Date). 

(c) At any time prior to April 15, 2017, the Company may, at its option, redeem up to 35% of the aggregate principal amount of Notes
issued by it (calculated after giving effect to any issuance of Additional Notes) with the Net Cash Proceeds of one or more Equity Offerings at a redemption price of 106.375% of the principal amount thereof, plus accrued and unpaid interest, if any,
to the redemption date (subject to the right of Holders on the relevant Record Date to receive interest due on the relevant Interest Payment Date); provided that: 

(1) at least 65% of the aggregate original principal amount of Notes issued under the Indenture (calculated after giving effect
to any issuance of Additional Notes) remains outstanding immediately after each such redemption; and 
 (2) the redemption
occurs within 120 days after the closing of each such Equity Offering. 
 (d) On and after April 15, 2017, the Company may, at its
option, redeem all or, from time to time, a part of the Notes upon not less than 30 nor more than 60 days’ notice, at the following redemption prices (expressed as a percentage of principal amount of the Notes to be redeemed) plus accrued and
unpaid interest on the Notes, if any, to the applicable redemption date (subject to the right of Holders on the relevant Record Date to receive interest due on the relevant Interest Payment Date), if redeemed during the twelve-month period beginning
on April 15 of the years indicated below: 
  

				                     	
	Year	  	Percentage	 
	 2017
	  	 	104.781	% 
	 2018
	  	 	103.188	% 
	 2019
	  	 	101.594	% 

  
 B-6 

				                     	
	 2020 and thereafter
	  	 	100.000	% 

 (e) Any redemption pursuant to this paragraph 5 shall be made pursuant to the provisions of Sections 3.01
through 3.06 of the Indenture. 
 6. [Reserved.] 

7. MANDATORY REDEMPTION. The Company shall not be required to make mandatory redemption or sinking fund payments with respect to the Notes.

 8. NOTICE OF REDEMPTION. Subject to Section 3.09 of the Indenture, the Company shall mail or cause to be mailed by first-class mail,
postage prepaid, notices of redemption at least 30 days but not more than 60 days before the redemption date to each Holder of Notes to be redeemed at such Holder’s registered address or otherwise in accordance with the procedures of DTC,
except that redemption notices may be mailed more than 60 days prior to a redemption date if the notice is issued in connection with Article 8 or Article 11 of the Indenture. Except as set forth in Section 3.07(g) and Section 4.14 of the
Indenture, notices of redemption may not be conditional. Notes and portions of Notes selected shall be in amounts of $2,000 or whole multiples of $1,000 on excess thereof; no Notes of $2,000 or less can be redeemed in part, except that if all of the
Notes of a Holder are to be redeemed or purchased, the entire outstanding amount of Notes held by such Holder, even if not $2,000 or a multiple of $1,000 in excess thereof, shall be redeemed or purchased. Subject to Section 3.05 of the
Indenture, on and after the redemption date, interest ceases to accrue on Notes or portions of Notes called for redemption. Notice of any redemption upon any Equity Offering may be given prior to the completion thereof, and any such redemption or
notice may, at the Company’s discretion, be subject to one or more conditions precedent, including, but not limited to, completion of the related Equity Offering. 

9. OFFERS TO REPURCHASE. 
 (a) If
a Change of Control occurs, unless the Company has exercised its right to redeem all of the Notes as described under Section 3.07 of the Indenture, each Holder shall have the right to require the Company to repurchase all or any part (equal to
$2,000 or larger integral multiples of $1,000) of such Holder’s Notes at a purchase price in cash equal to 101% of the aggregate principal amount of the Notes repurchased plus accrued and unpaid interest, if any, to the date of purchase
(subject to the right of Holders on the relevant Record Date to receive interest due on the relevant Interest Payment Date). 
 (b) On the
367th day after the date of receipt of such Net Available Cash (or such later date upon which an applicable Acceptable Commitment is canceled or terminates or the applicable 180-day period with respect to an applicable Acceptable Commitment expires
without full application of such Net Available Cash), if the aggregate amount of Excess Proceeds exceeds $25.0 million, the Company shall be required to make an offer (an “Asset Sale Offer”) to all Holders of Notes and to the extent
required by the terms of other Pari Passu Indebtedness, to all holders of other Pari Passu Indebtedness outstanding with similar provisions requiring the Company to make an offer to purchase such Pari Passu Indebtedness with the proceeds from any
Asset Sale, to purchase the maximum principal amount of Notes and any such Pari Passu Indebtedness to which the Asset Sale Offer applies that may be purchased out of the Excess Proceeds, at an offer price in cash in an amount equal to 100% of the
principal amount of the Notes and Pari Passu Indebtedness plus accrued and unpaid interest to the date of purchase, in accordance with the procedures set forth in the Indenture or the agreements governing the Pari Passu Indebtedness, as applicable,
in each case in minimum denominations of $2,000 and larger integral multiples of $1,000 in excess thereof. To the extent that the aggregate amount of Notes and Pari Passu Indebtedness so properly tendered and not withdrawn pursuant to an Asset Sale
Offer is less than the Excess Proceeds, the Company may use any remaining Excess Proceeds for any purpose not prohibited by the Indenture. If the aggregate principal amount of Notes surrendered by Holders thereof and other Pari Passu Indebtedness
surrendered by holders or lenders, collectively, exceeds the amount of Excess Proceeds, the Trustee shall select the Notes, and the trustee or agent for the Pari Passu Indebtedness shall select the Pari Passu Indebtedness, to be purchased on a pro
rata basis on the basis of the aggregate principal amount of tendered Notes and Pari Passu Indebtedness. Upon completion of such Asset Sale Offer, the amount of Excess Proceeds shall be reset at zero. Accordingly, to the extent that the aggregate
amount of Notes and other Indebtedness tendered pursuant to an Asset Sale Offer is less than the aggregate amount of 

  
 B-7 

 
unapplied Excess Proceeds, the Company may use any remaining amount for the general corporate purposes of the Company and its Restricted Subsidiaries. 

Holders electing to have a Note purchased pursuant to any Asset Sale Offer shall be required to surrender the Note, with the form entitled
“Option of Holder to Elect Purchase” attached to the Note completed, or transfer by book-entry transfer, to the Company, the Depositary, if appointed by the Company, or a Paying Agent at the address specified in the notice at least three
days before the Asset Sale Purchase Date. 
 10. DENOMINATIONS, TRANSFER, EXCHANGE. The Notes are in registered form without coupons in
denominations of $2,000 and integral multiples of $1,000 in excess thereof. The transfer of Notes may be registered and Notes may be exchanged as provided in the Indenture. The Registrar and the Trustee may require a Holder, among other things, to
furnish appropriate endorsements and transfer documents, and Holders shall be required to pay any taxes and fees required by law or permitted by the Indenture. The Company need not exchange or register the transfer of any Note or portion of a Note
selected for redemption, except for the unredeemed portion of any Note being redeemed in part. Also, the Company need not exchange or register the transfer of any Notes for a period of 15 days before a selection of Notes to be redeemed. 

11. PERSONS DEEMED OWNERS. A Holder may be treated as its owner for all purposes. 

12. AMENDMENT, SUPPLEMENT AND WAIVER. The Indenture, the Subsidiary Guarantees or the Notes may be amended or supplemented as provided in the
Indenture. 
 13. DEFAULTS AND REMEDIES. 

(a) If an Event of Default (other than an Event of Default arising from certain events of bankruptcy or insolvency) occurs and is continuing,
the Trustee by notice in writing specifying the Event of Default and that it is a “notice” to the Company, or the Holders of at least 25% in aggregate principal amount of the then outstanding Notes by notice to the Company and the Trustee,
may declare the principal of, premium, if any, and accrued and unpaid interest, if any, on all the Notes to be due and payable. Upon such a declaration, such principal, premium and accrued and unpaid interest shall be due and payable immediately.

 (b) In the event of a declaration of acceleration of the Notes because an Event of Default arising from certain defaults under any
mortgage, indenture or instrument under which there may be issued or by which there may be secured or evidenced any Indebtedness for money borrowed by the Company or any of its Restricted Subsidiaries (or the payment of which is guaranteed by the
Company or any of its Restricted Subsidiaries), other than Indebtedness owed to the Company or a Restricted Subsidiary, whether such Indebtedness or Guarantee now exists or is created after the Issue Date, has occurred and is continuing, the
declaration of acceleration of the Notes shall be automatically annulled if the default triggering such Event of Default pursuant to such Event of Default shall be remedied or cured by the Company or a Restricted Subsidiary or waived by the holders
of the relevant Indebtedness within 20 days after the declaration of acceleration with respect thereto and if (1) the annulment of the acceleration of the Notes would not conflict with any judgment or decree of a court of competent jurisdiction
and (2) all existing Events of Default, except nonpayment of principal, premium or interest on the Notes that became due solely because of the acceleration of the Notes, have been cured or waived. 

(c) If an Event of Default arising from certain events of bankruptcy or insolvency occurs and is continuing, the principal of, premium, if any,
and accrued and unpaid interest on all the Notes shall become and be immediately due and payable without any declaration or other act on the part of the Trustee or any Holders. 

(d) The Holders of a majority in aggregate principal amount of the then outstanding Notes may waive all past defaults (except with respect to a
continuing Default or Event of Default with respect to nonpayment of principal, premium or interest on the Notes) and rescind any such acceleration with respect to the Notes and its consequences if (1) rescission would not conflict with any
judgment or decree of a court of competent jurisdiction and (2) all existing Events of Default, other than the nonpayment of the principal of, premium, if any, and interest on the Notes that have become due solely by such declaration of
acceleration, have been cured or waived. 

  
 B-8 

 (e) If a Default occurs and is continuing and is known to the Trustee, the Trustee shall mail to
each Holder notice of the Default within 90 days after it occurs. Except in the case of a Default in the payment of principal of, premium, if any, or interest on any Note, the Trustee may withhold notice if and so long as a committee of Trust
Officers of the Trustee in good faith determines that withholding notice is in the interests of the Holders. In addition, the Company shall deliver to the Trustee, within 120 days after the end of each fiscal year, a certificate indicating whether
the signers thereof know of any Default that occurred during the previous year. 
 14. AUTHENTICATION. This Note shall not be entitled to any
benefit under the Indenture or be valid or obligatory for any purpose until authenticated by the manual signature of the Trustee. 
 15.
GOVERNING LAW. THE LAWS OF THE STATE OF NEW YORK SHALL GOVERN AND BE USED TO CONSTRUE THE INDENTURE, THE NOTES AND THE GUARANTEES. 
 16. NO
PERSONAL LIABILITY. No director, officer, employee, incorporator or stockholder of the Company or the Subsidiary Guarantors, as such, shall have any liability for any obligations of the Company or the Subsidiary Guarantors under this Note, the
Indenture or the Subsidiary Guarantees or for any claim based upon, in respect of, or by reason of, such obligations or their creation. Each Holder by accepting this Note waives and releases all such liability. The waiver and release are part of the
consideration for issuance of the Notes. 
 17. CUSIP NUMBERS. Pursuant to a recommendation promulgated by the Committee on Uniform Security
Identification Procedures, the Company has caused CUSIP numbers to be printed on the Notes, and the Trustee may use CUSIP numbers in notices of redemption as a convenience to Holders. No representation is made as to the accuracy of such numbers
either as printed on the Notes or as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. 

The Company will furnish to any Holder upon written request and without charge a copy of the Indenture. Requests may be made to the Company at
the following address: 
 c/o Kindred Healthcare, Inc. 

680 South Fourth Street 

Louisville, Kentucky 40202-2412 

Fax No.: 502-596-4075 
 Attention:
General Counsel and Treasurer 

  
 B-9 

 ASSIGNMENT FORM 

To assign this Security, fill in the form below: 

I or we assign and transfer this Security to: 
  

 
 (Print or type assignee’s name,
address and zip code) 
  
  

(Insert assignee’s social security or tax I.D. No.) 

and irrevocably appoint             agent to transfer this Security on the books of the Company.
The agent may substitute another to act for him. 
  

			
	Date:                                     
       	  	Your
Signature:                                       
     
	  
 Signature
Guarantee:                            
	  	

 (Signature must be guaranteed) 

Sign exactly as your name appears on the other side of this Security. 

The signature(s) should be guaranteed by an eligible guarantor institution (banks, stockbrokers, savings and loan associations and credit unions with
membership in an approved signature guarantee medallion program), pursuant to S.E.C. Rule 17Ad-15. 
 The undersigned hereby certifies that it [is / is not]
an Affiliate of the Company and that, to its knowledge, the proposed transferee [is / is not] an Affiliate of the Company. 
 In connection
with any transfer or exchange of any of the Notes evidenced by this certificate occurring prior to the date that is one year after the later of the date of original issuance of such Notes and the last date, if any, on which such Notes were owned by
the Company or any Affiliate of the Company, the undersigned confirms that such Notes are being: 
 CHECK ONE BOX BELOW: 

 

			
	(1)     ̈	  	acquired for the undersigned’s own account, without transfer; or
		
	(2)     ̈	  	transferred to the Company; or
		
	(3)     ̈	  	transferred pursuant to and in compliance with Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”); or
		
	(4)     ̈	  	transferred pursuant to an effective registration statement under the Securities Act; or
		
	(5)     ̈	  	transferred pursuant to and in compliance with Regulation S under the Securities Act; or
		
	(6)     ̈	  	transferred pursuant to another available exemption from the registration requirements of the Securities Act of 1933, as amended.

 Unless one of the boxes is checked, the Trustee will refuse to register any of the Notes evidenced by this certificate
in the name of any person other than the Holder thereof; provided, however, that if box (5), (6) or (7) is checked, the Company may require, prior to registering any such transfer of the Notes, in its sole discretion, such
legal opinions,  

  
 B-10 

 
certifications and other information as the Company may reasonably request to confirm that such transfer is being made pursuant to an exemption from, or in a transaction not subject to, the
registration requirements of the Securities Act of 1933, as amended, such as the exemption provided by Rule 144 under such Act. 
  

			
		  	
Signature                       
                                     

	 Signature
Guarantee:                                       
                 
	  	
	  
 (Signature must be
guaranteed)
	  	Signature                                    
                        

 The signature(s) should be guaranteed by an eligible guarantor institution (banks, stockbrokers, savings and loan associations
and credit unions with membership in an approved signature guarantee medallion program), pursuant to S.E.C. Rule 17Ad-15. 
 TO BE COMPLETED BY PURCHASER IF
BOX (1) OR (3) ABOVE IS CHECKED. 
 The undersigned represents and warrants that it is purchasing this Security for its own account or an account
with respect to which it exercises sole investment discretion and that it and any such account is a “qualified institutional buyer” within the meaning of Rule 144A under the Securities Act of 1933, as amended, and is aware that the sale to
it is being made in reliance on Rule 144A and acknowledges that it has received such information regarding the Company as the undersigned has requested pursuant to Rule 144A or has determined not to request such information and that it is aware that
the transferor is relying upon the undersigned’s foregoing representations in order to claim the exemption from registration provided by Rule 144A. 
  

	
	 Dated:

	
	
Signature                       
                                 

  
 B-11 

 OPTION OF HOLDER TO ELECT PURCHASE 

If you want to elect to have this Note purchased by the Company pursuant to Section 4.10 or 4.14 of the Indenture, check the appropriate
box below: 

 ̈  Section 4.10           
           ̈  Section 4.14 
 If
you want to elect to have only part of this Note purchased by the Company pursuant to Section 4.10 or Section 4.14 of the Indenture, state the amount you elect to have purchased: 

$                     

Date:                         
                    
  

			
	Your
Signature:                                       
                             
	                                (Sign exactly as your
name appears
		 	                                on the face of this
Note)
	
	Tax Identification
No.:                                        
                

 Signature
Guarantee*:                                       
      
  

	*	Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee). 

  
 B-12 

 SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL NOTE* 

The initial outstanding principal amount of this Global Note is $            . The
following exchanges of a part of this Global Note for an interest in another Global Note or for a Definitive Note, or exchanges of a part of another Global or Definitive Note for an interest in this Global Note, have been made: 

 

									
	Date of Exchange	  	Amount of decrease in
Principal Amount	  	Amount of increase in
Principal Amount of this
Global Note	  	Principal Amount of this
Global Note following such
decrease or increase	  	Signature of authorized
officer of Trustee or
Custodian

  

	*	This schedule should be included only if the Note is issued in global form. 

  
 B-13 

 EXHIBIT C 

FORM OF SUPPLEMENTAL INDENTURE 
 TO
BE DELIVERED BY SUBSEQUENT SUBSIDIARY GUARANTORS 
 Supplemental Indenture (this “Supplemental Indenture”), dated as
of             , among             (the “New Subsidiary Guarantor”), a subsidiary of Kindred Healthcare, Inc., a
Delaware corporation (the “Company”), the Company and Wells Fargo Bank, National Association, as trustee (the “Trustee”). 

W I T N E S S E T H: 
 WHEREAS,
each of the Company and the Subsidiary Guarantors (as defined in the Indenture referred to below) has heretofore executed and delivered to the Trustee an indenture (as amended or supplemented the “Indenture”), dated as of
April 9, 2014, providing for the issuance of an unlimited aggregate principal amount of 6.375% Senior Notes due 2022 (the “Notes”); 

WHEREAS, the Indenture provides that under certain circumstances the New Subsidiary Guarantor shall execute and deliver to the Trustee a
supplemental indenture pursuant to which the Subsidiary Guarantor shall unconditionally guarantee all of the Company’s Obligations under the Notes and the Indenture on the terms and conditions set forth herein and under the Indenture (the
“Subsidiary Guarantee”); and 
 WHEREAS, pursuant to Section 9.01 of the Indenture, each of the Trustee and the
Company is authorized to execute and deliver this Supplemental Indenture. 
 NOW THEREFORE, in consideration of the foregoing and for other
good and valuable consideration, the receipt of which is hereby acknowledged, the parties mutually covenant and agree for the benefit of each other and the equal and ratable benefit of the Holders of the Notes as follows: 

(1) Capitalized Terms. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture. 

(2) Agreement to Subsidiary Guarantee. The New Subsidiary Guarantor hereby agrees as follows: 

(a) Along with all Subsidiary Guarantors named in the Indenture, subject to Article 10 of the Indenture, to jointly and
severally unconditionally guarantee, on a senior unsecured basis, to each Holder of a Note authenticated and delivered by the Trustee and to the Trustee and its successors and assigns, irrespective of the validity and enforceability of the
Indenture, the Notes or the obligations of the Company hereunder, that: 
 (i) the principal of, premium, if any, or interest
on or Additional Interest, if any, on the Notes shall be promptly paid in full when due, whether at maturity, by acceleration, redemption or otherwise, and interest on the overdue principal of and interest on the Notes, if any, if lawful, and all
other obligations of the Company to the Holders or the Trustee thereunder shall be promptly paid in full or performed, all in accordance with the terms thereof; and 

(ii) in case of any extension of time of payment or renewal of any Notes or any of such other obligations, that same shall be
promptly paid in full when due or performed in accordance with the terms of the extension or renewal, whether at Stated Maturity, by acceleration or otherwise. Failing payment when due of any amount so guaranteed or any performance so guaranteed for
whatever reason, the New Subsidiary Guarantor and the other Subsidiary Guarantors named in the Indenture shall be jointly and severally obligated to pay the same immediately. This is a guarantee of payment and not a guarantee of collection. 

  
 C-1 

 (b) The obligations hereunder shall be unconditional, irrespective of the
validity, regularity or enforceability of the Notes or the Indenture, the absence of any action to enforce the same, any waiver or consent by any Holder of the Notes with respect to any provisions hereof or thereof, the recovery of any judgment
against the Company, any action to enforce the same or any other circumstance which might otherwise constitute a legal or equitable discharge or defense of a guarantor. 

(c) The following is hereby waived: diligence, presentment, demand of payment, filing of claims with a court in the event of
insolvency or bankruptcy of the Company, any right to require a proceeding first against the Company, protest, notice and all demands whatsoever. 

(d) This Subsidiary Guarantee shall not be discharged except by complete performance of the obligations contained in the Notes,
the Indenture and this Supplemental Indenture, and the New Subsidiary Guarantor accepts all obligations of a Subsidiary Guarantor under the Indenture. 

(e) If any Holder or the Trustee is required by any court or otherwise to return to the Company, the Subsidiary Guarantors
(including the New Subsidiary Guarantor), or any custodian, trustee, liquidator or other similar official acting in relation to either the Company or the Subsidiary Guarantors, any amount paid either to the Trustee or such Holder, this Subsidiary
Guarantee, to the extent theretofore discharged, shall be reinstated in full force and effect. 
 (f) The New Subsidiary
Guarantor shall not be entitled to any right of subrogation in relation to the Holders in respect of any obligations guaranteed hereby until payment in full of all obligations guaranteed hereby. 

(g) As between the New Subsidiary Guarantor, on the one hand, and the Holders and the Trustee, on the other hand, (x) the
maturity of the obligations guaranteed hereby may be accelerated as provided in Article 6 of the Indenture for the purposes of this Subsidiary Guarantee, notwithstanding any stay, injunction or other prohibition preventing such acceleration in
respect of the obligations guaranteed hereby, and (y) in the event of any declaration of acceleration of such obligations as provided in Article 6 of the Indenture, such obligations (whether or not due and payable) shall forthwith become due
and payable by the New Subsidiary Guarantor for the purpose of this Subsidiary Guarantee. 
 (h) If the New Subsidiary
Guarantor makes a payment under its New Subsidiary Guarantee, the Subsidiary Guarantor will be entitled upon payment in full of all Guaranteed Obligations under the Indenture to a contribution from each other Subsidiary Guarantor in an amount equal
to such other Subsidiary Guarantor’s pro rata portion of such payment based on the respective net assets of all the Subsidiary Guarantors at the time of such payment determined in accordance with GAAP. 

(i) Pursuant to Section 10.02 of the Indenture, the obligations of the New Subsidiary Guarantor under this Subsidiary
Guarantee shall be limited to the maximum amount as will, after giving effect to such maximum amount and all other contingent and fixed liabilities of such Subsidiary Guarantor that are relevant under any applicable Bankruptcy Law or fraudulent
conveyance laws, and after giving effect to any collections from, rights to receive contribution from or payments made by or on behalf of any other Subsidiary Guarantor in respect of the obligations of such other Subsidiary Guarantor under Article
10 of the Indenture, result in the obligations of such Subsidiary Guarantor under this Subsidiary Guarantee not constituting a fraudulent conveyance or fraudulent transfer under applicable law. 

(j) This Subsidiary Guarantee shall remain in full force and effect and continue to be effective should any petition be filed
by or against the Company for liquidation, reorganization, should the Company become insolvent or make an assignment for the benefit of creditors or should a receiver or trustee be appointed for all or any significant part of the Company’s
assets, and shall, to the fullest extent permitted by law, continue to be effective or be reinstated, as the case may be, if at any time payment and performance of the Notes are, pursuant to applicable law, rescinded or reduced in amount, or must
otherwise be restored or returned by any obligee on the Notes and Subsidiary Guarantee, whether as a “voidable preference,” “fraudulent transfer” or otherwise, all as though such payment or performance had not been made. In the
event that any payment or any part thereof, is rescinded, reduced, restored 

  
 C-2 

 
or returned, the Note shall, to the fullest extent permitted by law, be reinstated and deemed reduced only by such amount paid and not so rescinded, reduced, restored or returned. 

(k) In case any provision of this Subsidiary Guarantee shall be invalid, illegal or unenforceable, the validity, legality, and
enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 
 (l) Each payment to be
made by the New Subsidiary Guarantor in respect of this Subsidiary Guarantee shall be made without set-off, counterclaim, reduction or diminution of any kind or nature. 

(3) Execution and Delivery. The New Subsidiary Guarantor agrees that the Subsidiary Guarantee shall remain in full force and effect
notwithstanding the absence of the endorsement of any notation of such Subsidiary Guarantee on the Notes. 
 (4) Merger, Consolidation or
Sale of All or Substantially All Assets. 
 (a) Except as otherwise provided in Section 5.01(b) of the Indenture, the New Subsidiary
Guarantor may not consolidate or merge with or into or wind up into (whether or not the Company or the New Subsidiary Guarantor is the surviving corporation), or sell, assign, convey, transfer or otherwise dispose of all or substantially all of its
properties or assets, in one or more related transactions, to any Person (other than to the Company or another Subsidiary Guarantor) unless: 

(x) (i) if such entity remains a Subsidiary Guarantor, the resulting, surviving or transferee Person (the “Successor
Guarantor”) will be a corporation, partnership, trust or limited liability company organized and existing under the laws of the United States of America, any State of the United States, the District of Columbia or any other territory
thereof; 
 (ii) the Successor Guarantor, if other than such Subsidiary Guarantor, expressly assumes all the obligations of
such Subsidiary Guarantor under the Notes and the Indenture pursuant to a supplemental indenture or other documents or instruments in form reasonably satisfactory to the Trustee; 

(iii) immediately after giving effect to such transaction, no Default or Event of Default shall have occurred and be
continuing; and 
 (iv) the Company shall have delivered to the Trustee an Officers’ Certificate and an Opinion of
Counsel, each stating that such consolidation, merger or transfer and such supplemental indenture (if any) comply with the Indenture; or 

(y) the transaction is made in compliance with Section 4.10 of the Indenture (it being understood that only such portion
of the Net Available Cash as is required to be applied on the date of such transaction in accordance with the terms of the Indenture needs to be applied in accordance therewith at such time), or excluded from the definition of “Asset
Sale,” and, if applicable, Section 5.01 of the Indenture 
 (5) Releases. 

Subject to Section 10.06 of the Indenture, the Subsidiary Guarantee of the New Subsidiary Guarantor shall be automatically and
unconditionally released and discharged, and no further action by the New Subsidiary Guarantor, the Company or the Trustee is required for the release of the New Subsidiary Guarantor’s Subsidiary Guarantee: 

(i) upon the occurrence of any sale, exchange, transfer or other disposition (by merger, consolidation, liquidation,
dissolution or otherwise) of the Capital Stock of the New Subsidiary Guarantor (including any sale, exchange, transfer or other disposition after which the New Subsidiary Guarantor is no longer a Restricted Subsidiary) or of all or substantially all
the assets and property of the New Subsidiary 

  
 C-3 

 
Guarantor, which sale, exchange, transfer or other disposition is made in compliance with the applicable provisions of the Indenture; 

(ii) upon the release or discharge of the New Subsidiary Guarantor from its Guarantee of Indebtedness of the Company and the
Subsidiary Guarantors under the Senior Credit Facilities (including by reason of the termination of the Senior Credit Facilities), if such Subsidiary Guarantor would not then otherwise be required to guarantee the Notes pursuant to the Indenture,
except a discharge or release by or as a result of payment under such Guarantee; provided, that if such Subsidiary Guarantor has Incurred any Indebtedness or issued any Preferred Stock or Disqualified Stock in reliance on its status as a
Subsidiary Guarantor under Section 4.09 of the Indenture, such Subsidiary Guarantor’s obligations under such Indebtedness, Disqualified Stock or Preferred Stock, as the case may be, so Incurred are satisfied in full or discharged or are
otherwise permitted to be incurred under Section 4.09 of the Indenture. 
 (iii) upon the designation of any Restricted
Subsidiary that is a Subsidiary Guarantor as an Unrestricted Subsidiary in accordance with the Indenture; or 
 (iv) upon the
Company exercising its Legal Defeasance option or Covenant Defeasance option in accordance with Article 8 of the Indenture or the Company’s obligations under the Indenture being discharged in accordance with the terms of the Indenture. 

(6) No Recourse Against Others. No director, officer, employee, incorporator or stockholder of the Subsidiary Guarantor shall have any
liability for any obligations of the Company or the Subsidiary Guarantors (including the Subsidiary Guarantor) under the Notes, the Subsidiary Guarantees, the Indenture or this Supplemental Indenture or for any claim based on, in respect of, or by
reason of, such obligations or their creation. Each Holder by accepting a Note waives and releases all such liability. The waiver and release are part of the consideration for issuance of the Notes. 

(7) Governing Law. THIS SUPPLEMENTAL INDENTURE WILL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.

 (8) Counterparts. The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original,
but all of them together represent the same agreement. 
 (9) Effect of Headings. The Section headings herein are for convenience only
and shall not affect the construction hereof. 
 (10) The Trustee. The Trustee shall not be responsible in any manner whatsoever for
or in respect of the validity or sufficiency of this Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the New Subsidiary Guarantor. 

(11) Subrogation. The New Subsidiary Guarantor shall be subrogated to all rights of Holders of Notes against the Company in respect of
any amounts paid by the New Subsidiary Guarantor pursuant to the provisions of Section 2 hereof and Section 11.01 of the Indenture; provided that, if an Event of Default has occurred and is continuing, the New Subsidiary Guarantor
shall not be entitled to enforce or receive any payments arising out of, or based upon, such right of subrogation until all amounts then due and payable by the Company under the Indenture or the Notes shall have been paid in full. 

(12) Benefits Acknowledged. The New Subsidiary Guarantor’s Subsidiary Guarantee is subject to the terms and conditions set forth in
the Indenture. The New Subsidiary Guarantor acknowledges that it will receive direct and indirect benefits from the financing arrangements contemplated by the Indenture and this Supplemental Indenture and that the guarantee and waivers made by it
pursuant to this Subsidiary Guarantee are knowingly made in contemplation of such benefits. 

  
 C-4 

 (13) Successors. All agreements of the Subsidiary Guarantor in this Supplemental Indenture
shall bind its successors, except as otherwise provided in this Supplemental Indenture. All agreements of the Trustee in this Supplemental Indenture shall bind its successors. 

(14) Severability. In case any provision in this Supplemental Indenture shall be invalid, illegal or unenforceable, the validity,
legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 

  
 C-5 

 IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly
executed, all as of the date first above written. 
  

					
	
	KINDRED HEALTHCARE, INC.
		
	By:	 	  

		 	Name:	 	
		 	Title:	 	
	
	[GUARANTEEING SUBSIDIARY]
		
	By:	 	  

		 	Name:	 	
		 	Title:	 	
	
	WELLS FARGO BANK, NATIONAL ASSOCIATION
		
	By:	 	  

		 	Name:	 	
		 	Title:	 	

  
 C-6EX-4.2

 Exhibit 4.2 

REGISTRATION RIGHTS AGREEMENT 

This REGISTRATION RIGHTS AGREEMENT, dated April 9, 2014 (this “Agreement”), is entered into by and among KINDRED
HEALTHCARE, INC., a Delaware corporation (the “Company”), the guarantors listed in Schedule 1 hereto (the “Guarantors”) and J.P. Morgan Securities LLC (“J. P. Morgan”), as representative (the
“Representative”) of the initial purchasers (the “Initial Purchasers”) listed in Schedule 1 to the Purchase Agreement (as defined below). 

This Agreement is made pursuant to the Purchase Agreement, dated March 26, 2014 (the “Purchase Agreement”), by and among
the Company, the Guarantors and the Representative, which provides for the sale by the Company to the Initial Purchasers of $500,000,000 aggregate principal amount of the Company’s 6.375% Senior Notes due 2022 (the
“Securities”). As an inducement to the Initial Purchasers to enter into the Purchase Agreement, the Company and the Guarantors have agreed to provide to the Initial Purchasers and their direct and indirect transferees the
registration rights set forth in this Agreement. The execution and delivery of this Agreement is a condition to the closing under the Purchase Agreement. 

In consideration of the foregoing, the parties hereto agree as follows: 

1. Definitions. As used in this Agreement, the following terms shall have the following meanings: 

“Additional Guarantor” shall mean any subsidiary of the Company that executes a Subsidiary Guarantee under the Indenture after
the date of this Agreement. 
 “Business Day” shall mean any day that is not a Saturday, Sunday or other day on which
commercial banks in New York City are authorized or required by law, regulation or executive order to remain closed. 

“Company” shall have the meaning set forth in the preamble and shall also include the Company’s successors. 

“Exchange Act” shall mean the Securities Exchange Act of 1934, as amended from time to time. 

“Exchange Dates” shall have the meaning set forth in Section 2(a)(ii) hereof. 

“Exchange Offer” shall mean the exchange offer by the Company and the Guarantors of Exchange Securities for Registrable
Securities pursuant to Section 2(a) hereof. 
 “Exchange Offer Registration” shall mean a registration under the
Securities Act effected pursuant to Section 2(a) hereof. 
 “Exchange Offer Registration Statement” shall mean an
exchange offer registration statement on Form S-4 (or, if applicable, on another appropriate form) and all amendments and supplements to such registration statement, in each case including the Prospectus contained therein or deemed a part thereof,
all exhibits thereto and any document incorporated by reference therein. 
 “Exchange Securities” shall mean senior notes
issued by the Company and guaranteed by the Guarantors under the Indenture containing terms identical to the Securities (except that the Exchange Securities will not be subject to restrictions on transfer or to any increase in annual interest rate
for failure 

 
to comply with this Agreement) and to be offered to Holders of Securities in exchange for Securities pursuant to the Exchange Offer. 

“FINRA” shall mean the Financial Industry Regulatory Authority, Inc. 

“Free Writing Prospectus” shall mean each free writing prospectus (as defined in Rule 405 under the Securities Act)
prepared by or on behalf of the Company or used or referred to by the Company in connection with the sale of the Securities or the Exchange Securities.  

“Guarantors” shall have the meaning set forth in the preamble and shall also include any Guarantor’s successors
and any Additional Guarantors.  
 “Holders” shall mean the Initial Purchasers, for so long as they own any
Registrable Securities, and each of their successors, assigns and direct and indirect transferees who become owners of Registrable Securities under the Indenture; provided that for purposes of Sections 4 and 5 of this Agreement, the term
“Holders” shall include Participating Broker-Dealers.  
 “Indemnified Person” shall have the meaning set
forth in Section 5(c) hereof. 
 “Indemnifying Person” shall have the meaning set forth in Section 5(c) hereof.

 “Indenture” shall mean the indenture relating to the Securities dated as of April 9, 2014 among the Company,
the Guarantors and Wells Fargo Bank, National Association, as trustee, as the same may be further amended or supplemented from time to time in accordance with the terms thereof. 

“Initial Purchasers” shall have the meaning set forth in the preamble. 

“Inspector” shall have the meaning set forth in Section 3(a)(xiv) hereof. 

“Issue Date” shall mean April 9, 2014. 

“Issuer Information” shall have the meaning set forth in Section 5(a) hereof. 

“J.P. Morgan” shall have the meaning set forth in the preamble. 

“Majority Holders” shall mean the Holders of a majority of the aggregate principal amount of the outstanding
Registrable Securities; provided that whenever the consent or approval of Holders of a specified percentage of Registrable Securities is required hereunder, any Registrable Securities owned directly or indirectly by the Company or any of its
affiliates shall not be counted in determining whether such consent or approval was given by the Holders of such required percentage or amount; and provided, further, that if the Company shall issue any additional Securities under the
Indenture prior to consummation of the Exchange Offer or, if applicable, the effectiveness of any Shelf Registration Statement, such additional Securities and the Registrable Securities to which this Agreement relates shall be treated together as
one class for purposes of determining whether the consent or approval of Holders of a specified percentage of Registrable Securities has been obtained.  

“Notice and Questionnaire” shall mean a notice of registration statement and selling security holder questionnaire
distributed to a Holder by the Company upon receipt of a Shelf Request from such Holder. 
 “Participating
Broker-Dealers” shall have the meaning set forth in Section 4(a) hereof. 

  
 -2- 

 “Participating Holder” shall mean any Holder of Registrable Securities
that has returned a completed and signed Notice and Questionnaire to the Company in accordance with Section 2(b) hereof. 

“Person” shall mean an individual, partnership, limited liability company, corporation, trust or unincorporated
organization, or a government or agency or political subdivision thereof.  
 “Prospectus” shall mean the
prospectus included in, or, pursuant to the rules and regulations of the Securities Act, deemed a part of, a Registration Statement, including any preliminary prospectus, and any such prospectus as amended or supplemented by any prospectus
supplement, including a prospectus supplement with respect to the terms of the offering of any portion of the Registrable Securities covered by a Shelf Registration Statement, and by all other amendments and supplements to such prospectus, and in
each case including any document incorporated by reference therein. 
 “Purchase Agreement” shall have the meaning
set forth in the preamble. 
 “Registrable Securities” shall mean the Securities; provided that the
Securities shall cease to be Registrable Securities (i) when a Registration Statement with respect to such Securities has become effective under the Securities Act and such Securities have been exchanged or disposed of pursuant to such
Registration Statement, (ii) when such Securities cease to be outstanding or (iii) except in the case of Securities that otherwise remain Registrable Securities and that are held by an Initial Purchaser and that are ineligible to be
exchanged in the Exchange Offer, when the Exchange Offer is consummated. 
 “Registration Default” shall mean
the occurrence of any of the following: (i) the Exchange Offer is not completed on or prior to the Target Registration Date, (ii) the Shelf Registration Statement, if required pursuant to Section 2(b)(i) or Section 2(b)(ii)
hereof, has not become effective on or prior to the Target Registration Date, (iii) if the Company receives a Shelf Request pursuant to Section 2(b)(iii), the Shelf Registration Statement required to be filed thereby has not become
effective by the later of (a) the Target Registration Date and (b) 90 days after delivery of such Shelf Request, (iv) the Shelf Registration Statement, if required by this Agreement, has become effective and thereafter ceases to be
effective or the Prospectus contained therein ceases to be usable, in each case whether or not permitted by this Agreement, at any time during the Shelf Effectiveness Period, and such failure to remain effective or usable exists for more than 45
days (whether or not consecutive) in any 12-month period or (v) the Shelf Registration Statement, if required by this Agreement, has become effective and thereafter, on more than two occasions in any 12-month period during the Shelf
Effectiveness Period, the Shelf Registration Statement ceases to be effective or the Prospectus contained therein ceases to be usable, in each case whether or not permitted by this Agreement. 

“Registration Expenses” shall mean any and all expenses incident to performance of or compliance by the Company and the
Guarantors with this Agreement, including without limitation: (i) all SEC, stock exchange or FINRA registration and filing fees, (ii) all fees and expenses incurred in connection with compliance with state securities or blue sky laws
(including reasonable fees and disbursements of counsel for any Underwriters or Holders in connection with blue sky qualification of any Exchange Securities or Registrable Securities), (iii) all expenses of any Persons in preparing or assisting
in preparing, word processing, printing and distributing any Registration Statement, any Prospectus, any Free Writing Prospectus and any amendments or supplements thereto, any underwriting agreements, securities sales agreements or other similar
agreements and any other documents relating to the performance of and compliance with this Agreement, (iv) all rating agency fees, (v) all fees and disbursements relating to the qualification of the Indenture under applicable securities
laws, (vi) the reasonable fees and disbursements of the Trustee and its counsel, (vii) the fees and disbursements of counsel for the Company and the Guarantors and, in the case of a Shelf Registration Statement, the fees and disbursements
of one counsel for the Participating Holders (which counsel shall be selected by the 

  
 -3- 

 
Participating Holders holding a majority of the aggregate principal amount of Registrable Securities held by such Participating Holders and which counsel may also be counsel for the Initial
Purchasers) and (viii) the fees and disbursements of the independent public accountants of the Company and the Guarantors, including the expenses of any special audits or “comfort” letters required by or incident to the performance of
and compliance with this Agreement, but excluding fees and expenses of counsel to the Underwriters (other than fees and expenses set forth in clause (ii) above) or the Holders and underwriting discounts and commissions, brokerage commissions
and transfer taxes, if any, relating to the sale or disposition of Registrable Securities by a Holder. 
 “Registration
Statement” shall mean any registration statement of the Company and the Guarantors that covers any of the Exchange Securities or Registrable Securities pursuant to the provisions of this Agreement and all amendments and supplements to any
such registration statement, including post-effective amendments, in each case including the Prospectus contained therein or deemed a part thereof, all exhibits thereto and any document incorporated by reference therein.  

“SEC” shall mean the United States Securities and Exchange Commission. 

“Securities” shall have the meaning set forth in the preamble. 

“Securities Act” shall mean the Securities Act of 1933, as amended from time to time. 

“Shelf Effectiveness Period” shall have the meaning set forth in Section 2(b) hereof. 

“Shelf Registration” shall mean a registration effected pursuant to Section 2(b) hereof. 

“Shelf Registration Statement” shall mean a “shelf” registration statement of the Company and the Guarantors
that covers all or a portion of the Registrable Securities (but no other securities unless approved by a majority in aggregate principal amount of the Securities held by the Participating Holders) on an appropriate form under Rule 415 under the
Securities Act, or any similar rule that may be adopted by the SEC, and all amendments and supplements to such registration statement, including post-effective amendments, in each case including the Prospectus contained therein or deemed a part
thereof, all exhibits thereto and any document incorporated by reference therein  
 “Shelf Request” shall have the
meaning set forth in Section 2(b) hereof. 
 “Staff” shall mean the staff of the SEC. 

“Subsidiary Guarantees” shall mean the guarantees of the Securities and Exchange Securities by the Guarantors under
the Indenture.  
 “Target Registration Date” shall mean 365 days after the Issue Date. 

“Trust Indenture Act” shall mean the Trust Indenture Act of 1939, as amended from time to time. 

“Trustee” shall mean the trustee with respect to the Securities under the Indenture. 

“Underwriter” shall have the meaning set forth in Section 3(e) hereof. 

“Underwritten Offering” shall mean an offering in which Registrable Securities are sold to an Underwriter for reoffering to
the public. 

  
 -4- 

 2. Registration Under the Securities Act. 

(a) To the extent not prohibited by any applicable law or applicable interpretations of the Staff, the Company and the Guarantors shall use
their commercially reasonable efforts to (i) cause to be filed an Exchange Offer Registration Statement covering an offer to the Holders to exchange all the Registrable Securities for Exchange Securities and (ii) have such Registration
Statement become and remain effective until 120 days after the last Exchange Date for use by one or more Participating Broker-Dealers. The Company and the Guarantors shall commence the Exchange Offer promptly after the Exchange Offer Registration
Statement is declared effective by the SEC and use their commercially reasonable efforts to complete the Exchange Offer not later than 60 days after such effective date. 

The Company and the Guarantors shall commence the Exchange Offer by mailing the related Prospectus, appropriate letters of transmittal and
other accompanying documents to each Holder stating, in addition to such other disclosures as are required by applicable law, substantially the following: 

(i) that the Exchange Offer is being made pursuant to this Agreement and that all Registrable Securities validly tendered and
not properly withdrawn will be accepted for exchange; 
 (ii) the dates of acceptance for exchange (which shall be a period
of at least 20 Business Days from the date such notice is mailed) (the “Exchange Dates”); 
 (iii) that any
Registrable Security not tendered will remain outstanding and continue to accrue interest but will not retain any rights under this Agreement, except as otherwise specified herein; 

(iv) that any Holder electing to have a Registrable Security exchanged pursuant to the Exchange Offer will be required to
(A) surrender such Registrable Security, together with the appropriate letters of transmittal, to the institution and at the address and in the manner specified in the notice, or (B) effect such exchange otherwise in compliance with the
applicable procedures of the depositary for such Registrable Security, in each case prior to the close of business on the last Exchange Date; and 

(v) that any Holder will be entitled to withdraw its election, not later than the close of business on the last Exchange Date,
by (A) sending to the institution and at the address specified in the notice, a telegram, facsimile transmission or letter setting forth the name of such Holder, the principal amount of Registrable Securities delivered for exchange and a
statement that such Holder is withdrawing its election to have such Securities exchanged or (B) effecting such withdrawal in compliance with the applicable procedures of the depositary for the Registrable Securities. 

As a condition to participating in the Exchange Offer, a Holder will be required to represent to the Company and the Guarantors that
(i) any Exchange Securities to be received by it will be acquired in the ordinary course of its business, (ii) at the time of the commencement of the Exchange Offer it has no arrangement or understanding with any Person to participate in
the distribution (within the meaning of the Securities Act) of the Exchange Securities in violation of the provisions of the Securities Act, (iii) it is not an “affiliate” (within the meaning of Rule 405 under the Securities Act) of
the Company or any Guarantor and (iv) if such Holder is a broker-dealer that will receive Exchange Securities for its own account in exchange for Registrable Securities that were acquired as a result of market-making or other trading
activities, then such Holder will deliver a Prospectus (or, to the extent permitted by law, make available a Prospectus to purchasers) in connection with any resale of such Exchange Securities. 

  
 -5- 

 As soon as practicable after the last Exchange Date, the Company and the Guarantors shall: 

(i) accept for exchange Registrable Securities or portions thereof validly tendered and not properly withdrawn pursuant to the
Exchange Offer; and 
 (ii) deliver, or cause to be delivered, to the Trustee for cancellation all Registrable Securities or
portions thereof so accepted for exchange by the Company and issue, and cause the Trustee to promptly authenticate and deliver to each Holder, Exchange Securities equal in principal amount to the principal amount of the Registrable Securities
tendered by such Holder. 
 The Company and the Guarantors shall use their commercially reasonable efforts to complete the Exchange Offer as
provided above and shall comply with the applicable requirements of the Securities Act, the Exchange Act and other applicable laws and regulations in connection with the Exchange Offer. The Exchange Offer shall not be subject to any conditions,
other than that the Exchange Offer does not violate any applicable law or applicable interpretations of the Staff. 
 (b) In the event that
(i) the Company and the Guarantors determine that the Exchange Offer Registration provided for in Section 2(a) hereof is not available or the Exchange Offer may not be completed as soon as practicable after the last Exchange Date because
it would violate any applicable law or applicable interpretations of the Staff, (ii) the Exchange Offer is not for any other reason completed by the Target Registration Date or (iii) upon receipt of a written request (a “Shelf
Request”) from any Initial Purchaser representing that it holds Registrable Securities that are or were ineligible to be exchanged in the Exchange Offer, the Company and the Guarantors shall use their commercially reasonable efforts to
cause to be filed as soon as practicable after such determination, date or Shelf Request, as the case may be, a Shelf Registration Statement providing for the sale of all the Registrable Securities by the Holders thereof and to have such Shelf
Registration Statement become effective; provided that no Holder will be entitled to have any Registrable Securities included in any Shelf Registration Statement, or entitled to use the prospectus forming a part of such Shelf Registration
Statement, until such Holder shall have delivered a completed and signed Notice and Questionnaire and provided such other information regarding such Holder to the Company as is contemplated by Section 3(b) hereof. 

In the event that the Company and the Guarantors are required to file a Shelf Registration Statement pursuant to clause (iii) of the
preceding sentence, the Company and the Guarantors shall use their commercially reasonable efforts to file and have become effective both an Exchange Offer Registration Statement pursuant to Section 2(a) hereof with respect to all Registrable
Securities and a Shelf Registration Statement (which may be a combined Registration Statement with the Exchange Offer Registration Statement) with respect to offers and sales of Registrable Securities held by the Initial Purchasers after completion
of the Exchange Offer. 
 The Company and the Guarantors agree to use their commercially reasonable efforts to keep the Shelf Registration
Statement continuously effective until the earlier to occur of (i) the date when the Securities cease to be Registrable Securities and (ii) one year following the date when such Shelf Registration Statement becomes effective (the
“Shelf Effectiveness Period”). The Company and the Guarantors further agree to supplement or amend the Shelf Registration Statement, the related Prospectus and any Free Writing Prospectus if required by the rules, regulations or
instructions applicable to the registration form used by the Company for such Shelf Registration Statement or by the Securities Act or by any other rules and regulations thereunder or if reasonably requested by a Holder of Registrable Securities
with respect to information relating to such Holder, and to use their commercially reasonable efforts to cause any such amendment to become effective, if required, and such Shelf Registration Statement, Prospectus or Free Writing Prospectus, as the
case may be, to become usable as soon as 

  
 -6- 

 
thereafter practicable. The Company and the Guarantors agree to furnish to the Participating Holders copies of any such supplement or amendment promptly after its being used or filed with the
SEC. 
 (c) The Company and the Guarantors shall pay all Registration Expenses in connection with any registration pursuant to
Section 2(a) or Section 2(b) hereof. Each Holder shall pay all underwriting discounts and commissions, brokerage commissions and transfer taxes, if any, relating to the sale or disposition of such Holder’s Registrable Securities
pursuant to the Shelf Registration Statement. 
 (d) An Exchange Offer Registration Statement pursuant to Section 2(a) hereof will not
be deemed to have become effective unless it has been declared effective by the SEC. A Shelf Registration Statement pursuant to Section 2(b) hereof will not be deemed to have become effective unless it has been declared effective by the SEC or
is automatically effective upon filing with the SEC as provided by Rule 462 under the Securities Act. 
 If a Registration Default occurs,
the interest rate on the Registrable Securities will be increased by (i) 0.25% per annum for the first 90-day period beginning on the day immediately following such Registration Default and (ii) an additional 0.25% per annum with
respect to each subsequent 90-day period, in each case until and including the date such Registration Default ends, up to a maximum increase of 1.00% per annum. A Registration Default ends when the Securities cease to be Registrable Securities
or, if earlier, (1) in the case of a Registration Default under clause (i) of the definition thereof, when the Exchange Offer is completed, (2) in the case of a Registration Default under clause (ii) or clause (iii) of the
definition thereof, when the Shelf Registration Statement becomes effective or (3) in the case of a Registration Default under clause (iv) or clause (v) of the definition thereof, when the Shelf Registration Statement again becomes
effective or the Prospectus again becomes usable. If at any time more than one Registration Default has occurred and is continuing, then, until the next date that there is no Registration Default, the increase in interest rate provided for by this
paragraph shall apply as if there occurred a single Registration Default that begins on the date that the earliest such Registration Default occurred and ends on such next date that there is no Registration Default. 

(e) Without limiting the remedies available to the Initial Purchasers and the Holders, the Company and the Guarantors acknowledge that
any failure by the Company or the Guarantors to comply with their obligations under Section 2(a) and Section 2(b) hereof may result in material irreparable injury to the Initial Purchasers or the Holders for which there is no adequate
remedy at law, that it will not be possible to measure damages for such injuries precisely and that, in the event of any such failure, the Initial Purchasers or any Holder may obtain such relief as may be required to specifically enforce the
Company’s and the Guarantors’ obligations under Section 2(a) and Section 2(b) hereof; provided, however, that the parties hereto agree that the additional interest provided for in this Section 2 is intended to
constitute the sole remedy for monetary damages in connection with any Registration Default. 
 3. Registration Procedures.

 (a) In connection with their obligations pursuant to Section 2(a) and Section 2(b) hereof, the Company and the Guarantors shall
as expeditiously as possible: 
 (i) prepare and file with the SEC a Registration Statement on the appropriate form under the
Securities Act, which form (x) shall be selected by the Company and the Guarantors, (y) shall, in the case of a Shelf Registration, be available for the sale of the Registrable Securities by the Holders thereof and (z) shall comply as
to form in all material respects with the requirements of the applicable form and include all financial statements required by the SEC to be filed therewith; and use their commercially reasonable efforts to cause such Registration

  
 -7- 

 
Statement to become effective and remain effective for the applicable period in accordance with Section 2 hereof; 

(ii) prepare and file with the SEC such amendments and post-effective amendments to each Registration Statement as may be
necessary to keep such Registration Statement effective for the applicable period in accordance with Section 2 hereof and cause each Prospectus to be supplemented by any required prospectus supplement and, as so supplemented, to be filed
pursuant to Rule 424 under the Securities Act; and keep each Prospectus current during the period described in Section 4(3) of and Rule 174 under the Securities Act that is applicable to transactions by brokers or dealers with respect to the
Registrable Securities or Exchange Securities; 
 (iii) to the extent any Free Writing Prospectus is used, file with the SEC
any Free Writing Prospectus that is required to be filed by the Company or the Guarantors with the SEC in accordance with the Securities Act and to retain any Free Writing Prospectus not required to be filed; 

(iv) in the case of a Shelf Registration, furnish to each Participating Holder, to counsel for the Initial Purchasers, to
counsel for such Participating Holders and to each Underwriter of an Underwritten Offering of Registrable Securities, if any, without charge, as many copies of each Prospectus, preliminary prospectus or Free Writing Prospectus, and any amendment or
supplement thereto, as such Participating Holder, counsel or Underwriter may reasonably request in order to facilitate the sale or other disposition of the Registrable Securities thereunder; and, subject to Section 3(c) hereof, the Company and
the Guarantors consent to the use of such Prospectus, preliminary prospectus or such Free Writing Prospectus and any amendment or supplement thereto in accordance with applicable law by each of the Participating Holders and any such Underwriters in
connection with the offering and sale of the Registrable Securities covered by and in the manner described in such Prospectus, preliminary prospectus or such Free Writing Prospectus or any amendment or supplement thereto in accordance with
applicable law; 
 (v) use their commercially reasonable efforts to register or qualify the Registrable Securities under all
applicable state securities or blue sky laws of such jurisdictions as any Participating Holder shall reasonably request in writing by the time the applicable Registration Statement becomes effective; cooperate with such Participating Holders in
connection with any filings required to be made with FINRA; and do any and all other acts and things that may be reasonably necessary or advisable to enable each Participating Holder to complete the disposition in each such jurisdiction of the
Registrable Securities owned by such Participating Holder; provided that neither the Company nor any Guarantor shall be required to (1) qualify as a foreign corporation or other entity or as a dealer in securities in any such
jurisdiction where it would not otherwise be required to so qualify, (2) file any general consent to service of process in any such jurisdiction or (3) subject itself to taxation in any such jurisdiction if it is not so subject; 

(vi) notify counsel for the Initial Purchasers and, in the case of a Shelf Registration, notify each Participating Holder and
counsel for such Participating Holders promptly and, if requested by any such Participating Holder or counsel, confirm such advice in writing (1) when a Registration Statement has become effective, when any post-effective amendment thereto has
been filed and becomes effective, when any Free Writing Prospectus has been filed or any amendment or supplement to the Prospectus or any Free Writing Prospectus has been filed, (2) of any request by the SEC or any state securities authority
for amendments and supplements to a Registration Statement, Prospectus or any Free Writing Prospectus or for additional information 

  
 -8- 

 
after the Registration Statement has become effective, (3) of the issuance by the SEC or any state securities authority of any stop order suspending the effectiveness of a Registration
Statement or the initiation of any proceedings for that purpose, including the receipt by the Company of any notice of objection of the SEC to the use of a Shelf Registration Statement or any post-effective amendment thereto pursuant to Rule
401(g)(2) under the Securities Act, (4) if, between the applicable effective date of a Shelf Registration Statement and the closing of any sale of Registrable Securities covered thereby, the representations and warranties of the Company or any
Guarantor contained in any underwriting agreement, securities sales agreement or other similar agreement, if any, relating to an offering of such Registrable Securities cease to be true and correct in all material respects or if the Company or any
Guarantor receives any notification with respect to the suspension of the qualification of the Registrable Securities for sale in any jurisdiction or the initiation of any proceeding for such purpose, (5) of the happening of any event during
the period a Registration Statement is effective that makes any statement made in such Registration Statement or the related Prospectus or any Free Writing Prospectus untrue in any material respect or that requires the making of any changes in such
Registration Statement or Prospectus or any Free Writing Prospectus in order to make the statements therein not misleading and (6) of any determination by the Company or any Guarantor that a post-effective amendment to a Registration Statement
or any amendment or supplement to the Prospectus or any Free Writing Prospectus would be appropriate; 
 (vii) use their
commercially reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of a Registration Statement or, in the case of a Shelf Registration, the resolution of any objection of the SEC pursuant to Rule 401(g)(2) under the
Securities Act, including by filing an amendment to such Registration Statement on the proper form, at the earliest possible moment and provide immediate notice to each Holder or Participating Holder of the withdrawal of any such order or such
resolution; 
 (viii) in the case of a Shelf Registration, furnish to any Participating Holder upon its request, without
charge, at least one conformed copy of each Registration Statement and any post-effective amendment thereto (without any documents incorporated therein by reference or exhibits thereto, unless requested); 

(ix) in the case of a Shelf Registration, cooperate with the Participating Holders to facilitate the timely preparation and
delivery of certificates representing Registrable Securities to be sold and not bearing any restrictive legends and enable such Registrable Securities to be issued in such denominations and registered in such names (consistent with the provisions of
the Indenture) as such Participating Holders may reasonably request at least one Business Day prior to the closing of any sale of Registrable Securities; 

(x) subject to the Company’s right to, pursuant to Section 3(d), suspend the disposition of Registrable Securities
pursuant to a Registration Statement upon the occurrence of any event contemplated by Section 3(a)(vi)(5) hereof, use their commercially reasonable efforts to prepare and file with the SEC a supplement or post-effective amendment to the
applicable Exchange Offer Registration Statement or Shelf Registration Statement or the related Prospectus or any Free Writing Prospectus or any document incorporated therein by reference or file any other required document so that, as thereafter
delivered (or, to the extent permitted by law, made available) to purchasers of the Registrable Securities, such Prospectus or Free Writing Prospectus, as the case may be, will not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; and the Company and the Guarantors shall notify the Participating Holders (in the case of a Shelf Registration
Statement) and the Initial Purchasers and 

  
 -9- 

 
any Participating Broker-Dealers known to the Company (in the case of an Exchange Offer Registration Statement) to suspend use of the Prospectus or any Free Writing Prospectus as promptly as
practicable after the occurrence of such an event, and such Participating Holders, such Participating Broker-Dealers and the Initial Purchasers, as applicable, hereby agree to suspend use of the Prospectus or any Free Writing Prospectus, as the case
may be, until the Company and the Guarantors have amended or supplemented the Prospectus or the Free Writing Prospectus, as the case may be, to correct such misstatement or omission; 

(xi) a reasonable time prior to the filing of any Registration Statement, any Prospectus, any Free Writing Prospectus, any
amendment to a Registration Statement or amendment or supplement to a Prospectus or a Free Writing Prospectus or of any document that is to be incorporated by reference into a Registration Statement, a Prospectus or a Free Writing Prospectus after
initial filing of a Registration Statement, provide copies of such document to the Initial Purchasers and their counsel (and, in the case of a Shelf Registration Statement, to the Participating Holders and their counsel) and make such of the
representatives of the Company and the Guarantors as shall be reasonably requested by the Initial Purchasers or their counsel (and, in the case of a Shelf Registration Statement, the Participating Holders or their counsel) available for discussion
of such document; and the Company and the Guarantors shall not, at any time after initial filing of a Registration Statement, use or file any Prospectus, any Free Writing Prospectus, any amendment of or supplement to a Registration Statement or a
Prospectus or a Free Writing Prospectus, or any document that is to be incorporated by reference into a Registration Statement, a Prospectus or a Free Writing Prospectus, of which the Initial Purchasers and their counsel (and, in the case of a Shelf
Registration Statement, the Participating Holders and their counsel) shall not have previously been advised and furnished a copy or to which the Initial Purchasers or their counsel (and, in the case of a Shelf Registration Statement, the
Participating Holders or their counsel) shall object; 
 (xii) obtain a CUSIP number for all Exchange Securities or
Registrable Securities, as the case may be, not later than the initial effective date of a Registration Statement; 
 (xiii)
cause the Indenture to be qualified under the Trust Indenture Act in connection with the registration of the Exchange Securities or Registrable Securities, as the case may be; cooperate with the Trustee and the Holders to effect such changes to the
Indenture as may be required for the Indenture to be so qualified in accordance with the terms of the Trust Indenture Act; and execute, and use their commercially reasonable efforts to cause the Trustee to execute, all documents as may be required
to effect such changes and all other forms and documents required to be filed with the SEC to enable the Indenture to be so qualified in a timely manner; 

(xiv) in the case of a Shelf Registration, make available for inspection by a representative of the Participating Holders (an
“Inspector”), any Underwriter participating in any disposition pursuant to such Shelf Registration Statement, any attorneys and accountants designated by a majority in aggregate principal amount of the Securities held by the
Participating Holders and any attorneys and accountants designated by such Underwriter, at reasonable times and in a reasonable manner, all pertinent financial and other records, documents and properties of the Company and its subsidiaries, and
cause the respective officers, directors and employees of the Company and the Guarantors to supply all information reasonably requested by any such Inspector, Underwriter, attorney or accountant in connection with a Shelf Registration Statement;
provided that if any such information is identified by the Company or any Guarantor as being confidential or proprietary, each Person receiving such information shall take such actions as are reasonably necessary to protect the
confidentiality of such information to the extent such action is 

  
 -10- 

 
otherwise not inconsistent with, an impairment of or in derogation of the rights and interests of any Inspector, Holder or Underwriter); 

(xv) in the case of a Shelf Registration, use their commercially reasonable efforts to cause all Registrable Securities to be
listed on any securities exchange or any automated quotation system on which similar securities issued or guaranteed by the Company or any Guarantor are then listed if requested by the Majority Holders, to the extent such Registrable Securities
satisfy applicable listing requirements; 
 (xvi) if reasonably requested by any Participating Holder, promptly include in a
Prospectus supplement or post-effective amendment such information with respect to such Participating Holder as such Participating Holder reasonably requests to be included therein and make all required filings of such Prospectus supplement or such
post-effective amendment as soon as the Company has received notification of the matters to be so included in such filing; 

(xvii) in the case of a Shelf Registration, enter into such customary agreements and take all such other actions in connection
therewith (including those requested by the Holders of a majority in principal amount of the Registrable Securities covered by the Shelf Registration Statement) in order to expedite or facilitate the disposition of such Registrable Securities
including, but not limited to, an Underwritten Offering and in such connection, (1) to the extent possible, make such representations and warranties to the Participating Holders and any Underwriters of such Registrable Securities with respect
to the business of the Company and its subsidiaries and the Registration Statement, Prospectus, any Free Writing Prospectus and documents incorporated by reference or deemed incorporated by reference, if any, in each case, in form, substance and
scope as are customarily made by issuers to underwriters in underwritten offerings and confirm the same if and when requested, (2) obtain opinions of counsel to the Company and the Guarantors (which counsel and opinions, in form, scope and
substance, shall be reasonably satisfactory to the Participating Holders and such Underwriters and their respective counsel) addressed to each Participating Holder and Underwriter of Registrable Securities, covering the matters customarily covered
in opinions requested in underwritten offerings, (3) obtain “comfort” letters from the independent registered public accountants of the Company and the Guarantors (and, if necessary, any other registered public accountant of any
subsidiary of the Company or any Guarantor, or of any business acquired by the Company or any Guarantor for which financial statements and financial data are or are required to be included in the Registration Statement) addressed to each
Participating Holder (to the extent permitted by applicable professional standards) and Underwriter of Registrable Securities, such letters to be in customary form and covering matters of the type customarily covered in “comfort” letters
in connection with underwritten offerings, including but not limited to financial information contained in any preliminary prospectus, Prospectus or Free Writing Prospectus and (4) deliver such documents and certificates as may be reasonably
requested by the Holders of a majority in principal amount of the Registrable Securities being sold or the Underwriters, and which are customarily delivered in underwritten offerings, to evidence the continued validity of the representations and
warranties of the Company and the Guarantors made pursuant to clause (1) above and to evidence compliance with any customary conditions contained in an underwriting agreement; and 

(xviii) so long as any Registrable Securities remain outstanding, cause each Additional Guarantor upon the creation or
acquisition by the Company of such Additional Guarantor, to execute a counterpart to this Agreement in the form attached hereto as Annex A and to deliver such counterpart, together with an opinion of counsel as to the enforceability thereof against
such entity, to the Initial Purchasers no later than five Business Days following the execution thereof. 

  
 -11- 

 (b) In the case of a Shelf Registration Statement, the Company may require each Holder of
Registrable Securities to furnish to the Company a Notice and Questionnaire and such other information regarding such Holder and the proposed disposition by such Holder of such Registrable Securities as the Company and the Guarantors may from time
to time reasonably request in writing. 
 (c) Each Participating Holder agrees that, upon receipt of any notice from the Company and the
Guarantors of the happening of any event of the kind described in Section 3(a)(vi)(3) or Section 3(a)(vi)(5) hereof, such Participating Holder will forthwith discontinue disposition of Registrable Securities pursuant to the Shelf
Registration Statement until such Participating Holder’s receipt of the copies of the supplemented or amended Prospectus and any Free Writing Prospectus contemplated by Section 3(a)(x) hereof and, if so directed by the Company and the
Guarantors, such Participating Holder will deliver to the Company and the Guarantors all copies in its possession, other than permanent file copies then in such Participating Holder’s possession, of the Prospectus and any Free Writing
Prospectus covering such Registrable Securities that is current at the time of receipt of such notice. 
 (d) If the Company and the
Guarantors shall give any notice to suspend the disposition of Registrable Securities pursuant to a Registration Statement, the Company and the Guarantors shall extend the period during which such Registration Statement shall be maintained effective
pursuant to this Agreement by the number of days during the period from and including the date of the giving of such notice to and including the date when the Holders of such Registrable Securities shall have received copies of the supplemented or
amended Prospectus or any Free Writing Prospectus necessary to resume such dispositions. The Company and the Guarantors may give any such notice only twice during any 365-day period and any such suspensions shall not exceed 45 days for each
suspension and there shall not be more than two suspensions in effect during any 365 day period. 
 (e) The Participating Holders who desire
to do so may sell such Registrable Securities in an Underwritten Offering. In any such Underwritten Offering, the investment bank or investment banks and manager or managers (each an “Underwriter”) that will administer the offering
will be selected by the Holders of a majority in principal amount of the Registrable Securities included in such offering. 
 4.
Participation of Broker-Dealers in Exchange Offer. 
 (a) The Staff has taken the position that any broker-dealer that receives
Exchange Securities for its own account in the Exchange Offer in exchange for Securities that were acquired by such broker-dealer as a result of market-making or other trading activities (a “Participating Broker-Dealer”) may be
deemed to be an “underwriter” within the meaning of the Securities Act and must deliver a prospectus meeting the requirements of the Securities Act in connection with any resale of such Exchange Securities. 

The Company and the Guarantors understand that it is the Staff’s position that if the Prospectus contained in the Exchange Offer
Registration Statement includes a plan of distribution containing a statement to the above effect and the means by which Participating Broker-Dealers may resell the Exchange Securities, without naming the Participating Broker-Dealers or specifying
the amount of Exchange Securities owned by them, such Prospectus may be delivered by Participating Broker-Dealers (or, to the extent permitted by law, made available to purchasers) to satisfy their prospectus delivery obligation under the Securities
Act in connection with resales of Exchange Securities for their own accounts, so long as the Prospectus otherwise meets the requirements of the Securities Act. 

(b) In light of the above, and notwithstanding the other provisions of this Agreement, the Company and the Guarantors agree to amend or
supplement the Prospectus contained in the Exchange Offer Registration Statement for a period of up to 120 days after the last Exchange Date (as such period may be extended pursuant to Section 3(d) hereof), in order to expedite or facilitate
the disposition of any 

  
 -12- 

 
Exchange Securities by Participating Broker-Dealers consistent with the positions of the Staff recited in Section 4(a) above. The Company and the Guarantors further agree that Participating
Broker-Dealers shall be authorized to deliver such Prospectus (or, to the extent permitted by law, make available) during such period in connection with the resales contemplated by this Section 4. 

(c) The Initial Purchasers shall have no liability to the Company, any Guarantor or any Holder with respect to any request that they may make
pursuant to Section 4(b) hereof. 
 5. Indemnification and Contribution. 

(a) The Company and each Guarantor, jointly and severally, agree to indemnify and hold harmless each Initial Purchaser and each Holder, their
respective affiliates, directors and officers and each Person, if any, who controls any Initial Purchaser or any Holder within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against any and all
losses, claims, damages and liabilities (including, without limitation, legal fees and other expenses incurred in connection with any suit, action or proceeding or any claim asserted, as such fees and expenses are incurred), joint or several, that
arise out of, or are based upon, (1) any untrue statement or alleged untrue statement of a material fact contained in any Registration Statement or any omission or alleged omission to state therein a material fact required to be stated therein
or necessary in order to make the statements therein not misleading, or (2) any untrue statement or alleged untrue statement of a material fact contained in any Prospectus, any Free Writing Prospectus or any “issuer information”
(“Issuer Information”) filed or required to be filed pursuant to Rule 433(d) under the Securities Act, or any omission or alleged omission to state therein a material fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading, in each case except insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or
omission made in reliance upon and in conformity with any information relating to any Initial Purchaser or information relating to any Holder furnished to the Company in writing (including, without limitation, a Notice and Questionnaire of such
Holder) through J.P. Morgan or any selling Holder, respectively, expressly for use therein. In connection with any Underwritten Offering permitted by Section 3, the Company and the Guarantors, jointly and severally, will also indemnify the
Underwriters, if any, selling brokers, dealers and similar securities industry professionals participating in the distribution, their respective affiliates and each Person who controls such Persons (within the meaning of the Securities Act and the
Exchange Act) to the same extent as provided above with respect to the indemnification of the Holders, if requested in connection with any Registration Statement, any Prospectus, any Free Writing Prospectus or any Issuer Information. 

(b) Each Holder agrees, severally and not jointly, to indemnify and hold harmless the Company, the Guarantors, the Initial Purchasers and the
other selling Holders, the directors of the Company and the Guarantors, each officer of the Company and the Guarantors who signed the Registration Statement and each Person, if any, who controls the Company, the Guarantors, any Initial Purchaser and
any other selling Holder within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act to the same extent as the indemnity set forth in paragraph (a) above, but only with respect to any losses, claims,
damages or liabilities that arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to such Holder furnished to the Company in
writing by such Holder expressly for use in any Registration Statement, any Prospectus and any Free Writing Prospectus. 
 (c) If any suit,
action, proceeding (including any governmental or regulatory investigation), claim or demand shall be brought or asserted against any Person in respect of which indemnification may be sought pursuant to either paragraph (a) or (b) above,
such Person (the “Indemnified Person”) shall promptly notify the Person against whom such indemnification may be sought (the “Indemnifying 

  
 -13- 

 
Person”) in writing; provided that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have under paragraph (a) or (b) above
except to the extent that it has been materially prejudiced (including through the forfeiture of substantive rights or defenses) by such failure; and provided, further, that the failure to notify the Indemnifying Person shall not relieve it from any
liability that it may have to an Indemnified Person otherwise than under paragraph (a) or (b) above. If any such proceeding shall be brought or asserted against an Indemnified Person and it shall have notified the Indemnifying Person
thereof, the Indemnifying Person shall retain counsel reasonably satisfactory to the Indemnified Person, to represent the Indemnified Person and any others entitled to indemnification pursuant to this Section 5 that the Indemnifying Person may
designate in such proceeding and shall pay the fees and expenses of such proceeding and shall pay the fees and expenses of such counsel related to such proceeding, as incurred. In any such proceeding, any Indemnified Person shall have the right to
retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified Person unless (i) the Indemnifying Person and the Indemnified Person shall have mutually agreed to the contrary; (ii) the
Indemnifying Person has failed within a reasonable time to retain counsel reasonably satisfactory to the Indemnified Person; (iii) the Indemnified Person shall have reasonably concluded that there may be legal defenses available to it that are
different from or in addition to those available to the Indemnifying Person; or (iv) the named parties in any such proceeding (including any impleaded parties) include both the Indemnifying Person and the Indemnified Person and representation
of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. It is understood and agreed that the Indemnifying Person shall not, in connection with any proceeding or related proceeding in
the same jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any local counsel) for all Indemnified Persons, and that all such fees and expenses shall be reimbursed as they are incurred. Any such separate
firm (x) for any Initial Purchaser, its affiliates, directors and officers and any control Persons of such Initial Purchaser shall be designated in writing by J. P. Morgan, (y) for any Holder, its directors and officers and any control
Persons of such Holder shall be designated in writing by the Majority Holders and (z) in all other cases shall be designated in writing by the Company. The Indemnifying Person shall not be liable for any settlement of any proceeding effected
without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the Indemnifying Person agrees to indemnify each Indemnified Person from and against any loss or liability by reason of such settlement
or judgment. No Indemnifying Person shall, without the written consent of the Indemnified Person, effect any settlement of any pending or threatened proceeding in respect of which any Indemnified Person is or could have been a party and
indemnification could have been sought hereunder by such Indemnified Person, unless such settlement (A) includes an unconditional release of such Indemnified Person, in form and substance reasonably satisfactory to such Indemnified Person, from
all liability on claims that are the subject matter of such proceeding and (B) does not include any statement as to or any admission of fault, culpability or a failure to act by or on behalf of any Indemnified Person. 

(d) If the indemnification provided for in paragraphs (a) and (b) above is unavailable to an Indemnified Person or insufficient in
respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or payable by such
Indemnified Person as a result of such losses, claims, damages or liabilities (i) in such proportion as is appropriate to reflect the relative benefits received by the Company and the Guarantors from the offering of the Securities and the
Exchange Securities, on the one hand, and by the Holders from receiving Securities or Exchange Securities registered under the Securities Act, on the other hand, or (ii) if the allocation provided by clause (i) is not permitted by
applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) but also the relative fault of the Company and the Guarantors on the one hand and the Holders on the other hand in
connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations. The relative fault of the Company and the Guarantors on the one hand and the Holders on

  
 -14- 

 
the other shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact
relates to information supplied by the Company and the Guarantors or by the Holders and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. 

(e) The Company, the Guarantors and the Holders agree that it would not be just and equitable if contribution pursuant to this Section 5
were determined by pro rata allocation (even if the Holders were treated as one entity for such purpose) or by any other method of allocation that does not take account of the equitable considerations referred to in paragraph (d) above. The
amount paid or payable by an Indemnified Person as a result of the losses, claims, damages and liabilities referred to in paragraph (d) above shall be deemed to include, subject to the limitations set forth above, any legal or other expenses
incurred by such Indemnified Person in connection with any such action or claim for which such Indemnified Party would be entitled to Indemnification hereunder. Notwithstanding the provisions of this Section 5, in no event shall a Holder be
required to contribute any amount in excess of the amount by which the total price at which the Securities or Exchange Securities sold by such Holder exceeds the amount of any damages that such Holder has otherwise been required to pay by reason of
such untrue or alleged untrue statement or omission or alleged omission. No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not
guilty of such fraudulent misrepresentation. The Holders’ obligations to contribute pursuant to this Section 5 are several and not joint. 

(f) The remedies provided for in this Section 5 are not exclusive and shall not limit any rights or remedies that may otherwise be
available to any Indemnified Person at law or in equity. 
 (g) The indemnity and contribution provisions contained in this Section 5
shall remain operative and in full force and effect regardless of (i) any termination of this Agreement, (ii) any investigation made by or on behalf of the Initial Purchasers or any Holder or any Person controlling any Initial Purchaser or
any Holder, or by or on behalf of the Company or the Guarantors or the officers or directors of or any Person controlling the Company or the Guarantors, (iii) acceptance of any of the Exchange Securities and (iv) any sale of Registrable
Securities pursuant to a Shelf Registration Statement. 
 6. General. 

(a) No Inconsistent Agreements. The Company and the Guarantors represent, warrant and agree that (i) the rights granted to
the Holders hereunder do not in any way conflict with and are not inconsistent with the rights granted to the holders of any other outstanding securities issued or guaranteed by the Company or any Guarantor under any other agreement and
(ii) neither the Company nor any Guarantor has entered into, or on or after the date of this Agreement will enter into, any agreement that is inconsistent with the rights granted to the Holders of Registrable Securities in this Agreement or
otherwise conflicts with the provisions hereof.  
 (b) Amendments and Waivers. The provisions of this Agreement,
including the provisions of this sentence, may not be amended, modified or supplemented, and waivers or consents to departures from the provisions hereof may not be given unless the Company and the Guarantors have obtained the written consent of
Holders of at least a majority in aggregate principal amount of the outstanding Registrable Securities affected by such amendment, modification, supplement, waiver or consent; provided that no amendment, modification, supplement, waiver or
consent to any departure from the provisions of Section 5 hereof shall be effective as against any Holder of Registrable Securities unless consented to in writing by such Holder. Any amendments, modifications, supplements, waivers or consents
pursuant to this Section 6(b) shall be by a writing executed by each of the parties hereto.  

  
 -15- 

 (c) Notices. All notices and other communications provided for or permitted
hereunder shall be made in writing by hand-delivery, registered first-class mail, telecopier, or any courier guaranteeing overnight delivery (i) if to a Holder, at the most current address given by such Holder to the Company by means of a
notice given in accordance with the provisions of this Section 6(c), which address initially is, with respect to the Initial Purchasers, the address set forth in the Purchase Agreement; (ii) if to the Company and the Guarantors, initially
at the Company’s address set forth in the Purchase Agreement and thereafter at such other address, notice of which is given in accordance with the provisions of this Section 6(c); and (iii) to such other persons at their respective
addresses as provided in the Purchase Agreement and thereafter at such other address, notice of which is given in accordance with the provisions of this Section 6(c). All such notices and communications shall be deemed to have been duly given:
at the time delivered by hand, if personally delivered; five Business Days after being deposited in the mail, postage prepaid, if mailed; when receipt is acknowledged, if telecopied; and on the next Business Day if timely delivered to an air courier
guaranteeing overnight delivery. Copies of all such notices, demands or other communications shall be concurrently delivered by the Person giving the same to the Trustee, at the address specified in the Indenture.  

(d) Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors, assigns and
transferees of each of the parties, including, without limitation and without the need for an express assignment, subsequent Holders; provided that nothing herein shall be deemed to permit any assignment, transfer or other disposition of
Registrable Securities in violation of the terms of the Purchase Agreement or the Indenture. If any transferee of any Holder shall acquire Registrable Securities in any manner, whether by operation of law or otherwise, such Registrable Securities
shall be held subject to all the terms of this Agreement, and by taking and holding such Registrable Securities such Person shall be conclusively deemed to have agreed to be bound by and to perform all of the terms and provisions of this Agreement
and such Person shall be entitled to receive the benefits hereof. The Initial Purchasers (in their capacity as Initial Purchasers) shall have no liability or obligation to the Company or the Guarantors with respect to any failure by a Holder to
comply with, or any breach by any Holder of, any of the obligations of such Holder under this Agreement.  
 (e) Third Party
Beneficiaries. Each Holder shall be a third party beneficiary to the agreements made hereunder between the Company and the Guarantors, on the one hand, and the Initial Purchasers, on the other hand, and shall have the right to enforce such
agreements directly to the extent it deems such enforcement necessary or advisable to protect its rights or the rights of other Holders hereunder.  

(f) Counterparts. This Agreement may be executed in any number of counterparts and by the parties hereto in separate
counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this Agreement by facsimile, email
or other electronic transmission (i.e., “pdf”) shall be effective as delivery of a manually executed counterpart of this Agreement. 

(g) Headings. The headings in this Agreement are for convenience of reference only, are not a part of this Agreement and shall
not limit or otherwise affect the meaning hereof.  
 (h) Governing Law. This Agreement, and any claim, controversy or
dispute arising under or related to this Agreement, shall be governed by and construed in accordance with the laws of the State of New York. 

(i) Entire Agreement; Severability. This Agreement contains the entire agreement between the parties relating to the subject
matter hereof and supersedes all oral statements and prior writings with 

  
 -16- 

 
respect thereto. If any term, provision, covenant or restriction contained in this Agreement is held by a court of competent jurisdiction to be invalid, void or unenforceable or against
public policy, the remainder of the terms, provisions, covenants and restrictions contained herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated. The Company, the Guarantors and the Initial Purchasers
shall endeavor in good faith negotiations to replace the invalid, void or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the invalid, void or unenforceable provisions.  

  
 -17- 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  

			
	KINDRED HEALTHCARE, INC.
		
	By:	 	 /s/ Joseph Landenwich

	Name:	 	Joseph Landenwich
	Title:	 	Co-General Counsel and Corporate Secretary

  
 S-1 

			
	 ABERDEEN HOLDINGS, INC.
 ABLE HOME HEALTHCARE,
INC.
 ADVANCED ONCOLOGY SERVICES, INC.
 AVERY MANOR NURSING,
L.L.C.
 BAYBERRY CARE CENTER, L.L.C.
 BRAINTREE NURSING,
L.L.C.
 BWB SUNBELT HOME HEALTH SERVICES, LLC
 CALIFORNIA
NURSING CENTERS, L.L.C.
 CARE CENTER OF ROSSMOOR, L.L.C.

CENTRAL ARIZONA HOME HEALTH CARE, INC.
 COMPASS HOSPICE, INC.

COUNTRY ESTATES NURSING, L.L.C.
 COURTLAND GARDENS HEALTH CENTER,
INC.
 FOCUS CARE HEALTH RESOURCES, INC.
 FORESTVIEW NURSING,
L.L.C.
 GBA HOLDING, INC.
 GBA WEST, LLC

GODDARD NURSING, L.L.C.
 GREENBRAE CARE CENTER, L.L.C.

GREENS NURSING AND ASSISTED LIVING, L.L.C.
 HARBORLIGHTS NURSING,
L.L.C.
 HAVEN HEALTH, LLC
 HELIAN ASC OF NORTHRIDGE, INC.

HELIAN HEALTH GROUP, INC.
 HHS HEALTHCARE CORP.

HIGHGATE NURSING, L.L.C.
 HIGHLANDER NURSING, L.L.C.

HOMECARE HOLDINGS, INC.
 HOME HEALTH OF RURAL TEXAS, INC.

HOME HEALTH SERVICES, INC.
 HOMESTEAD HEALTH AND REHABILITATION
CENTER, L.L.C.
 INTEGRACARE HOLDINGS, INC.
 INTEGRACARE HOME
HEALTH SERVICES, INC.
 INTEGRACARE HOSPICE OF ABILENE, LLC

INTEGRACARE INTERMEDIATE HOLDINGS, INC.
 INTEGRACARE OF ABILENE,
LLC
 INTEGRACARE OF ALBANY, LLC
 INTEGRACARE OF ATHENS-HOME
HEALTH, LLC
 INTEGRACARE OF ATHENS-HOSPICE, LLC
 INTEGRACARE OF
GRANBURY, LLC
 INTEGRACARE OF LITTLEFIELD, LLC
 INTEGRACARE OF
OLNEY HOME HEALTH, LLC
 INTEGRACARE OF TEXAS, LLC
 INTEGRACARE
OF WEST TEXAS-HOME HEALTH, LLC
	 	 INTEGRACARE OF WEST TEXAS-HOSPICE, LLC

INTEGRACARE OF WICHITA FALLS, LLC
 J. B. THOMAS HOSPITAL, INC.

KAH DEVELOPMENT 1, L.L.C.
 KAH DEVELOPMENT 2, L.L.C.

KAH DEVELOPMENT 3, L.L.C
 KAH DEVELOPMENT 4, L.L.C.

KAH DEVELOPMENT 5, L.L.C
 KAH DEVELOPMENT 6, L.L.C.

KAH DEVELOPMENT 7, L.L.C.
 KAH DEVELOPMENT 8, L.L.C

KAH DEVELOPMENT 9, L.L.C
 KAH DEVELOPMENT 10, L.L.C

KAH DEVELOPMENT 11, L.L.C.
 KAH DEVELOPMENT 12, L.L.C.

KAH DEVELOPMENT 13, L.L.C
 KAH DEVELOPMENT 14, L.L.C

KAH DEVELOPMENT 15, L.L.C
 KINDRED BRAINTREE HOSPITAL, L.L.C.

KINDRED DEVELOPMENT 4, L.L.C.
 KINDRED DEVELOPMENT 7, L.L.C.

KINDRED DEVELOPMENT 8, L.L.C.
 KINDRED DEVELOPMENT 9, L.L.C.

KINDRED DEVELOPMENT 10, L.L.C.
 KINDRED DEVELOPMENT 11, L.L.C.

KINDRED DEVELOPMENT 12, L.L.C.
 KINDRED DEVELOPMENT 13, L.L.C.

KINDRED DEVELOPMENT 15, L.L.C.
 KINDRED DEVELOPMENT 17, L.L.C.

KINDRED DEVELOPMENT 27, L.L.C.
 KINDRED DEVELOPMENT 29, L.L.C.

KINDRED DEVELOPMENT HOLDINGS 3, L.L.C.
 KINDRED DEVELOPMENT
HOLDINGS 5, L.L.C.
 KINDRED HEALTHCARE OPERATING, INC.
 KINDRED
HEALTHCARE SERVICES, INC.
 KINDRED HOSPICE SERVICES, L.L.C.

KINDRED HOSPITAL-PITTSBURGH-NORTH SHORE, L.L.C.
 KINDRED HOSPITALS
EAST, L.L.C.
 KINDRED HOSPITAL PALM BEACH, L.L.C.
 KINDRED
HOSPITAL-SPRINGFIELD, L.L.C.
 KINDRED HOSPITAL-TOLEDO, L.L.C.

KINDRED HOSPITALS WEST, L.L.C.
 KINDRED NEVADA, L.L.C.

KINDRED NURSING CENTERS EAST, L.L.C.
 KINDRED NURSING CENTERS
NORTH, L.L.C.

  

			
	By:	 	 /s/ Joseph Landenwich

		 	Name: Joseph Landenwich
		 	Title: Co-General Counsel and Corporate Secretary

  
 S-1 

			
	 KINDRED NURSING CENTERS SOUTH, L.L.C.
 KINDRED
NURSING CENTERS WEST, L.L.C.
 KINDRED REHAB SERVICES, INC.

KINDRED SYSTEMS, INC.
 KND DEVELOPMENT 50, L.L.C.

KND DEVELOPMENT 51, L.L.C.
 KND DEVELOPMENT 52, L.L.C.

KND DEVELOPMENT 53, L.L.C.
 KND DEVELOPMENT 54, L.L.C.

KND DEVELOPMENT 55, L.L.C.
 KND DEVELOPMENT 56, L.L.C.

KND DEVELOPMENT 57, L.L.C.
 KND DEVELOPMENT 58, L.L.C.

KND DEVELOPMENT 59, L.L.C.
 KND DEVELOPMENT 60, L.L.C.

KND DEVELOPMENT 61, L.L.C.
 KND DEVELOPMENT 62, L.L.C.

KND DEVELOPMENT 63, L.L.C.
 KND HOSPITAL REAL ESTATE HOLDINGS,
L.L.C.
 KND REAL ESTATE 1, L.L.C.
 KND REAL ESTATE 2,
L.L.C.
 KND REAL ESTATE 3, L.L.C.
 KND REAL ESTATE 4,
L.L.C.
 KND REAL ESTATE 5, L.L.C.
 KND REAL ESTATE 6,
L.L.C.
 KND REAL ESTATE 7, L.L.C.
 KND REAL ESTATE 8,
L.L.C.
 KND REAL ESTATE 9, L.L.C.
 KND REAL ESTATE 10,
L.L.C.
 KND REAL ESTATE 11, L.L.C.
 KND REAL ESTATE 12,
L.L.C.
 KND REAL ESTATE 13, L.L.C.
 KND REAL ESTATE 14,
L.L.C.
 KND REAL ESTATE 15, L.L.C.
 KND REAL ESTATE 16,
L.L.C.
 KND REAL ESTATE 17, L.L.C.
 KND REAL ESTATE 18,
L.L.C.
 KND REAL ESTATE 19, L.L.C.
 KND REAL ESTATE 20,
L.L.C.
 KND REAL ESTATE 21, L.L.C.
 KND REAL ESTATE 22,
L.L.C.
 KND REAL ESTATE 23, L.L.C.
 KND REAL ESTATE 24,
L.L.C.
 KND REAL ESTATE 25, L.L.C.
 KND REAL ESTATE 26,
L.L.C.
	 	 KND REAL ESTATE 27, L.L.C.
 KND REAL ESTATE 28,
L.L.C.
 KND REAL ESTATE 29, L.L.C.
 KND REAL ESTATE 30,
L.L.C.
 KND REAL ESTATE 31, L.L.C.
 KND REAL ESTATE 32,
L.L.C.
 KND REAL ESTATE 33, L.L.C.
 KND REAL ESTATE 34,
L.L.C.
 KND REAL ESTATE 35, L.L.C.
 KND REAL ESTATE 36,
L.L.C.
 KND REAL ESTATE 37, L.L.C.
 KND REAL ESTATE 38,
L.L.C.
 KND REAL ESTATE 39, L.L.C.
 KND REAL ESTATE 40,
L.L.C.
 KND REAL ESTATE 41, L.L.C.
 KND REAL ESTATE 42,
L.L.C.
 KND REAL ESTATE 43, L.L.C.
 KND REAL ESTATE 44,
L.L.C.
 KND REAL ESTATE 45, L.L.C.
 KND REAL ESTATE 46,
L.L.C.
 KND REAL ESTATE 47, L.L.C.
 KND REAL ESTATE 48,
L.L.C.
 KND REAL ESTATE 49, L.L.C.
 KND REAL ESTATE 50,
L.L.C.
 KND REAL ESTATE 51, L.L.C.
 KND REAL ESTATE HOLDINGS,
L.L.C.
 KND REHAB REAL ESTATE HOLDINGS, L.L.C.
 KND SNF REAL
ESTATE HOLDINGS, L.L.C.
 LAFAYETTE HEALTH CARE CENTER, INC.

LAUREL LAKE HEALTH AND REHABILITATION, L.L.C.
 MAINE ASSISTED
LIVING, L.L.C.
 MASSACHUSETTS ASSISTED LIVING, L.L.C.
 MEADOWS
NURSING, L.L.C.
 MEDEQUITIES, INC.
 MEDICAL HILL REHAB CENTER,
L.L.C.
 MED-TECH PRIVATE CARE, INC.
 MED-TECH SERVICES OF DADE,
INC.
 MED-TECH SERVICES OF PALM BEACH, INC.
 MED. TECH SERVICES
OF SOUTH FLORIDA, INC.
 MILLS MEDICAL PRACTICES, LLC
 NORTH
WEST TEXAS HOME HEALTH SERVICES, LLC
 NP PLUS, LLC

  

			
	By:	 	 /s/ Joseph Landenwich

		 	Name: Joseph Landenwich
		 	Title: Co-General Counsel and Corporate Secretary

  
 -2- 

			
	 NRP HOLDINGS COMPANY
 OUTREACH HEALTH SERVICES
OF NORTH TEXAS, LLC
 OUTREACH HEALTH SERVICES OF THE PANHANDLE, LLC

PACIFIC COAST CARE CENTER, L.L.C.
 PACIFIC WEST HOME CARE, LLC

PEOPLEFIRST HOMECARE & HOSPICE OF CALIFORNIA, L.L.C.

PEOPLEFIRST HOMECARE & HOSPICE OF COLORADO, L.L.C.

PEOPLEFIRST HOMECARE & HOSPICE OF INDIANA, L.L.C.
 PEOPLEFIRST
HOMECARE & HOSPICE OF MASSACHUSETTS, L.L.C.
 PEOPLEFIRST HOMECARE & HOSPICE OF OHIO, L.L.C.

PEOPLEFIRST HOMECARE & HOSPICE OF UTAH, L.L.C.
 PEOPLEFIRST
HOMECARE OF COLORADO, L.L.C.
 PEOPLEFIRST VIRGINIA, L.L.C.

PERSONACARE OF CONNECTICUT, INC.
 PERSONACARE OF HUNTSVILLE,
INC.
 PERSONACARE OF OHIO, INC.
 PERSONACARE OF READING,
INC.
 PERSONACARE OF WISCONSIN, INC.
 PF DEVELOPMENT 5,
L.L.C.
 PF DEVELOPMENT 6, L.L.C.
 PF DEVELOPMENT 7, L.L.C.

PF DEVELOPMENT 8, L.L.C.
 PF DEVELOPMENT 9, L.L.C.

PF DEVELOPMENT 10, L.L.C.
 PF DEVELOPMENT 15, L.L.C.

PF DEVELOPMENT 16, L.L.C.
 PF DEVELOPMENT 17, L.L.C.

PF DEVELOPMENT 18, L.L.C.
 PF DEVELOPMENT 19, L.L.C.

PF DEVELOPMENT 20, L.L.C.
 PF DEVELOPMENT 21, L.L.C.

PF DEVELOPMENT 22, L.L.C.
 PF DEVELOPMENT 23, L.L.C.

PF DEVELOPMENT 26, L.L.C.
 PF DEVELOPMENT 27, L.L.C.

PHH ACQUISITION CORP.
 PROFESSIONAL HEALTHCARE AT HOME,
LLC
	 	 PROFESSIONAL HEALTHCARE, LLC
 REHABCARE
DEVELOPMENT 2, L.L.C.
 REHABCARE DEVELOPMENT 3, L.L.C.

REHABCARE DEVELOPMENT 4, L.L.C.
 REHABCARE DEVELOPMENT 5,
L.L.C.
 REHAB INSURANCE CORPORATION
 REHAB STAFFING, L.L.C.

SENIOR HOME CARE, INC.
 SHC HOLDING, INC.

SHC REHAB, INC.
 SIENA CARE CENTER, L.L.C.

SMITH RANCH CARE CENTER, L.L.C.
 SOUTHERN CALIFORNIA SPECIALTY
CARE, INC.
 SOUTHERN NEVADA HOME HEALTH CARE, INC.
 SOUTHERN
UTAH HOME HEALTH, INC.
 SOUTHERN UTAH HOME OXYGEN & MEDICAL EQUIPMENT, INC.

SPECIALTY HEALTHCARE SERVICES, INC.
 SPECIALTY HOSPITAL OF
CLEVELAND, INC.
 SPECIALTY HOSPITAL OF PHILADELPHIA, INC.

SPECIALTY HOSPITAL OF SOUTH CAROLINA, INC.
 SPRINGFIELD PARK VIEW
HOSPITAL, L.L.C.
 SYNERGY, INC.
 SYNERGY HEALTHCARE GROUP,
INC.
 SYNERGY HOME CARE-ACADIANA REGION, INC.
 SYNERGY HOME
CARE-CAPITOL REGION, INC.
 SYNERGY HOME CARE-CENTRAL REGION, INC.

SYNERGY HOME CARE-NORTHEASTERN REGION, INC.
 SYNERGY HOME
CARE-NORTHSHORE REGION, INC
 SYNERGY HOME CARE-NORTHWESTERN REGION, INC.

SYNERGY HOME CARE-SOUTHEASTERN REGION, INC.
 TEXAS HEALTH
MANAGEMENT GROUP, LLC
 THC – CHICAGO, INC.
 THC –
HOUSTON, INC.
 THC – NORTH SHORE, INC.
 THC – ORANGE
COUNTY, INC.
 THC – SEATTLE, INC.
 THEREX, INC.

THE THERAPY GROUP, INC.
 TOWER HILL NURSING, L.L.C.

  

			
	By:	 	 /s/ Joseph Landenwich

		 	Name: Joseph Landenwich
		 	Title: Co-General Counsel and Corporate Secretary

  
 -3- 

			
	 TRANSITIONAL HOSPITALS CORPORATION OF INDIANA, INC.

TRANSITIONAL HOSPITALS CORPORATION OF LOUISIANA, INC.

TRANSITIONAL HOSPITALS CORPORATION OF NEVADA, INC.
 TRANSITIONAL
HOSPITALS CORPORATION OF NEW MEXICO, INC.
 TRANSITIONAL HOSPITALS CORPORATION OF TAMPA, INC.

TRANSITIONAL HOSPITALS CORPORATION OF TEXAS, INC.
 TRANSITIONAL
HOSPITALS CORPORATION OF WISCONSIN, INC.
 TRINITY HOSPICE OF TEXAS, LLC

TUCKER NURSING CENTER, INC.
 VERNON HOME HEALTH CARE AGENCY,
LLC
 WELLSTREAM HEALTH SERVICES, LLC
 WEST TEXAS, LLC

YGNACIO VALLEY CARE CENTER, L.L.C.
 FOOTHILL NURSING COMPANY
PARTNERSHIP
 HILLHAVEN–MSC PARTNERSHIP
 KINDRED HOSPITALS
LIMITED PARTNERSHIP
 KINDRED NURSING CENTERS CENTRAL LIMITED PARTNERSHIP

KINDRED NURSING CENTERS LIMITED PARTNERSHIP
 AMERICAN VITALCARE,
LLC
 CANNON & ASSOCIATES, LLC
 CLEAR LAKE REHABILITATION
HOSPITAL, L.L.C.
 LAFAYETTE SPECIALTY HOSPITAL, L.L.C.
 NEW
TRIUMPH HEALTHCARE OF TEXAS, LLC
 NEW TRIUMPH HEALTHCARE, INC.

NORTHLAND LTACH, LLC
 REHABCARE GROUP, INC.
	 	 REHABCARE GROUP EAST, INC.
 REHABCARE GROUP
MANAGEMENT SERVICES, INC.
 REHABCARE GROUP OF TEXAS, LLC

REHABCARE GROUP OF CALIFORNIA, LLC
 REHABCARE HOSPITAL HOLDINGS,
L.L.C.
 SALT LAKE PHYSICAL THERAPY ASSOCIATES, INC
 SCCI HEALTH
SERVICES CORPORATION.
 SCCI HOSPITAL – EASTON, INC.
 SCCI
HOSPITAL – EL PASO, INC.
 SCCI HOSPITAL – MANSFIELD, INC.

SCCI HOSPITAL VENTURES, INC.
 SCCI HOSPITALS OF AMERICA, INC.

SYMPHONY HEALTH SERVICES, LLC
 TRIUMPH HEALTHCARE HOLDINGS,
INC.
 TRIUMPH HEALTHCARE SECOND HOLDINGS, LLC
 TRIUMPH
HEALTHCARE THIRD HOLDINGS, LLC
 TRIUMPH HOSPITAL NORTHWEST INDIANA, INC.

TRIUMPH REHABILITATION HOSPITAL NORTHERN INDIANA, LLC
 TRIUMPH
REHABILITATION HOSPITAL OF NORTHEAST HOUSTON, LLC
 TULSA SPECIALTY HOSPITAL L.L.C.

VTA MANAGEMENT SERVICES, LLC
 VTA STAFFING SERVICES, LLC

NEW TRIUMPH HEALTHCARE, LLP
 REHABCARE GROUP OF AMARILLO, LP

REHABCARE GROUP OF ARLINGTON, LP

  

			
	By:	 	 /s/ Joseph Landenwich

		 	Name: Joseph Landenwich
		 	Title: Co-General Counsel and Corporate Secretary

  
 -4- 

			
	Confirmed and accepted as of the date first above written:
	
	J.P. MORGAN SECURITIES LLC
	 For itself and on behalf of the

several Initial Purchasers

		
	By:	 	 /s/ Andreas L. Pierroutsakos

		 	Authorized Signatory

  
 S-5 

 Schedule 1 

GUARANTORS 
  

					
	No.	 	Name	  	 State of

Organization

			
	 1.
	 	Aberdeen Holdings, Inc.	  	TX
			
	 2.
	 	Able Home Healthcare, Inc.	  	TX
			
	 3.
	 	Advanced Oncology Services, Inc.	  	FL
			
	 4.
	 	American VitalCare, L.L.C.	  	CA
			
	 5.
	 	Avery Manor Nursing, L.L.C.	  	DE
			
	 6.
	 	Bayberry Care Center, L.L.C.	  	DE
			
	 7.
	 	Braintree Nursing, L.L.C.	  	DE
			
	 8.
	 	BWB Sunbelt Home Health Services, LLC	  	TX
			
	 9.
	 	California Nursing Centers, L.L.C.	  	DE
			
	 10.
	 	Cannon & Associates, L.L.C.	  	DE
			
	 11.
	 	Care Center of Rossmoor, L.L.C.	  	DE
			
	 12.
	 	Central Arizona Home Health Care, Inc.	  	AZ
			
	 13.
	 	Clear Lake Rehabilitation Hospital, L.L.C.	  	DE
			
	 14.
	 	Compass Hospice, Inc.	  	TX
			
	 15.
	 	Country Estates Nursing, L.L.C.	  	DE
			
	 16.
	 	Courtland Gardens Health Center, Inc.	  	CT
			
	 17.
	 	Focus Care Health Resources, Inc.	  	TX
			
	 18.
	 	Foothill Nursing Company Partnership	  	CA
			
	 19.
	 	Forestview Nursing, L.L.C.	  	DE
			
	 20.
	 	GBA Holding, Inc.	  	TX
			
	 21.
	 	GBA West, LLC	  	TX
			
	 22.
	 	Goddard Nursing, L.L.C.	  	DE

  
 1-1 

					
	No.	 	Name	  	 State of

Organization

			
	 23.
	 	Greenbrae Care Center, L.L.C.	  	DE
			
	 24.
	 	Greens Nursing and Assisted Living, L.L.C.	  	DE
			
	 25.
	 	Harborlights Nursing, L.L.C.	  	DE
			
	 26.
	 	Haven Health, LLC	  	DE
			
	 27.
	 	Helian ASC of Northridge, Inc.	  	CA
			
	 28.
	 	Helian Health Group, Inc.	  	DE
			
	 29.
	 	HHS Healthcare Corp.	  	DE
			
	 30.
	 	Highgate Nursing, L.L.C.	  	DE
			
	 31.
	 	Highlander Nursing, L.L.C.	  	DE
			
	 32.
	 	Hillhaven–MSC Partnership	  	CA
			
	 33.
	 	Home Health of Rural Texas, Inc.	  	TX
			
	 34.
	 	Home Health Services, Inc.	  	UT
			
	 35.
	 	Homecare Holdings, Inc.	  	FL
			
	 36.
	 	Homestead Health and Rehabilitation Center, L.L.C. 	  	DE
			
	 37.
	 	IntegraCare Holdings, Inc.	  	DE
			
	 38.
	 	IntegraCare Home Health Services, Inc.	  	TX
			
	 39.
	 	IntegraCare Hospice of Abilene, LLC	  	TX
			
	 40.
	 	IntegraCare Intermediate Holdings, Inc.	  	DE
			
	 41.
	 	IntegraCare of Abilene, LLC	  	TX
			
	 42.
	 	IntegraCare of Albany, LLC	  	TX
			
	 43.
	 	IntegraCare of Athens-Home Health, LLC	  	TX
			
	 44.
	 	IntegraCare of Athens-Hospice, LLC	  	TX
			
	 45.
	 	IntegraCare of Granbury, LLC	  	TX
			
	 46.
	 	IntegraCare of Littlefield, LLC	  	TX

  
 1-2 

					
	No.	 	Name	  	 State of

Organization

			
	 47.
	 	IntegraCare of Olney Home Health, LLC	  	TX
			
	 48.
	 	IntegraCare of Texas, LLC	  	TX
			
	 49.
	 	IntegraCare of West Texas-Home Health, LLC	  	TX
			
	 50.
	 	IntegraCare of West Texas-Hospice, LLC	  	TX
			
	 51.
	 	IntegraCare of Wichita Falls, LLC	  	TX
			
	 52.
	 	J. B. Thomas Hospital, Inc.	  	MA
			
	 53.
	 	KAH Development 1, L.L.C.	  	DE
			
	 54.
	 	KAH Development 10, L.L.C.	  	DE
			
	 55.
	 	KAH Development 11, L.L.C.	  	DE
			
	 56.
	 	KAH Development 12, L.L.C.	  	DE
			
	 57.
	 	KAH Development 13, L.L.C.	  	DE
			
	 58.
	 	KAH Development 14, L.L.C.	  	DE
			
	 59.
	 	KAH Development 15, L.L.C.	  	DE
			
	 60.
	 	KAH Development 2, L.L.C.	  	DE
			
	 61.
	 	KAH Development 3, L.L.C.	  	DE
			
	 62.
	 	KAH Development 4, L.L.C.	  	DE
			
	 63.
	 	KAH Development 5, L.L.C.	  	DE
			
	 64.
	 	KAH Development 6, L.L.C.	  	DE
			
	 65.
	 	KAH Development 7, L.L.C.	  	DE
			
	 66.
	 	KAH Development 8, L.L.C.	  	DE
			
	 67.
	 	KAH Development 9, L.L.C.	  	DE
			
	 68.
	 	Kindred Braintree Hospital, L.L.C.	  	DE
			
	 69.
	 	Kindred Development 10, L.L.C.	  	DE
			
	 70.
	 	Kindred Development 11, L.L.C.	  	DE

  
 1-3 

					
	No.	 	Name	  	 State of

Organization

			
	 71.
	 	Kindred Development 12, L.L.C.	  	DE
			
	 72.
	 	Kindred Development 13, L.L.C.	  	DE
			
	 73.
	 	Kindred Development 15, L.L.C.	  	DE
			
	 74.
	 	Kindred Development 17, L.L.C.	  	DE
			
	 75.
	 	Kindred Development 27, L.L.C.	  	DE
			
	 76.
	 	Kindred Development 29, L.L.C.	  	DE
			
	 77.
	 	Kindred Development 4, L.L.C.	  	DE
			
	 78.
	 	Kindred Development 7, L.L.C.	  	DE
			
	 79.
	 	Kindred Development 8, L.L.C.	  	DE
			
	 80.
	 	Kindred Development 9, L.L.C.	  	DE
			
	 81.
	 	Kindred Development Holdings 3, L.L.C.	  	DE
			
	 82.
	 	Kindred Development Holdings 5, L.L.C.	  	DE
			
	 83.
	 	Kindred Healthcare Operating, Inc.	  	DE
			
	 84.
	 	Kindred Healthcare Services, Inc.	  	DE
			
	 85.
	 	Kindred Hospice Services, L.L.C.	  	DE
			
	 86.
	 	Kindred Hospital-Palm Beach, L.L.C.	  	DE
			
	 87.
	 	Kindred Hospital-Pittsburgh-North Shore, L.L.C.	  	DE
			
	 88.
	 	Kindred Hospitals East, L.L.C.	  	DE
			
	 89.
	 	Kindred Hospitals Limited Partnership	  	DE
			
	 90.
	 	Kindred Hospitals West, L.L.C.	  	DE
			
	 91.
	 	Kindred Hospital-Springfield, L.L.C.	  	DE
			
	 92.
	 	Kindred Hospital-Toledo, L.L.C.	  	DE
			
	 93.
	 	Kindred Nevada, L.L.C.	  	DE
			
	 94.
	 	Kindred Nursing Centers Central Limited Partnership	  	DE

  
 1-4 

					
	No.	 	Name	  	 State of

Organization

			
	 95.
	 	Kindred Nursing Centers East, L.L.C.	  	DE
			
	 96.
	 	Kindred Nursing Centers Limited Partnership	  	DE
			
	 97.
	 	Kindred Nursing Centers North, L.L.C.	  	DE
			
	 98.
	 	Kindred Nursing Centers South, L.L.C.	  	DE
			
	 99.
	 	Kindred Nursing Centers West, L.L.C.	  	DE
			
	 100.
	 	Kindred Rehab Services, Inc.	  	DE
			
	 101.
	 	Kindred Systems, Inc.	  	DE
			
	 102.
	 	KND Development 50, L.L.C.	  	DE
			
	 103.
	 	KND Development 51, L.L.C.	  	DE
			
	 104.
	 	KND Development 52, L.L.C.	  	DE
			
	 105.
	 	KND Development 53, L.L.C.	  	DE
			
	 106.
	 	KND Development 54, L.L.C.	  	DE
			
	 107.
	 	KND Development 55, L.L.C.	  	DE
			
	 108.
	 	KND Development 56, L.L.C.	  	DE
			
	 109.
	 	KND Development 57, L.L.C.	  	DE
			
	 110.
	 	KND Development 58, L.L.C.	  	DE
			
	 111.
	 	KND Development 59, L.L.C.	  	DE
			
	 112.
	 	KND Development 60, L.L.C.	  	DE
			
	 113.
	 	KND Development 61, L.L.C.	  	DE
			
	 114.
	 	KND Development 62, L.L.C.	  	DE
			
	 115.
	 	KND Development 63, L.L.C.	  	DE
			
	 116.
	 	KND Hospital Real Estate Holdings, L.L.C.	  	DE
			
	 117.
	 	KND Real Estate 1, L.L.C.	  	DE
			
	 118.
	 	KND Real Estate 10, L.L.C.	  	DE

  
 1-5 

					
	No.	 	Name	  	 State of

Organization

			
	 119.
	 	KND Real Estate 11, L.L.C.	  	DE
			
	 120.
	 	KND Real Estate 12, L.L.C.	  	DE
			
	 121.
	 	KND Real Estate 13, L.L.C.	  	DE
			
	 122.
	 	KND Real Estate 14, L.L.C.	  	DE
			
	 123.
	 	KND Real Estate 15, L.L.C.	  	DE
			
	 124.
	 	KND Real Estate 16, L.L.C.	  	DE
			
	 125.
	 	KND Real Estate 17, L.L.C.	  	DE
			
	 126.
	 	KND Real Estate 18, L.L.C.	  	DE
			
	 127.
	 	KND Real Estate 19, L.L.C.	  	DE
			
	 128.
	 	KND Real Estate 2, L.L.C.	  	DE
			
	 129.
	 	KND Real Estate 20, L.L.C.	  	DE
			
	 130.
	 	KND Real Estate 21, L.L.C.	  	DE
			
	 131.
	 	KND Real Estate 22, L.L.C.	  	DE
			
	 132.
	 	KND Real Estate 23, L.L.C.	  	DE
			
	 133.
	 	KND Real Estate 24, L.L.C.	  	DE
			
	 134.
	 	KND Real Estate 25, L.L.C.	  	DE
			
	 135.
	 	KND Real Estate 26, L.L.C.	  	DE
			
	 136.
	 	KND Real Estate 27, L.L.C.	  	DE
			
	 137.
	 	KND Real Estate 28, L.L.C.	  	DE
			
	 138.
	 	KND Real Estate 29, L.L.C.	  	DE
			
	 139.
	 	KND Real Estate 3, L.L.C.	  	DE
			
	 140.
	 	KND Real Estate 30, L.L.C.	  	DE
			
	 141.
	 	KND Real Estate 31, L.L.C.	  	DE
			
	 142.
	 	KND Real Estate 32, L.L.C.	  	DE

  
 1-6 

					
	No.	 	Name	  	 State of

Organization

			
	 143.
	 	KND Real Estate 33, L.L.C.	  	DE
			
	 144.
	 	KND Real Estate 34, L.L.C.	  	DE
			
	 145.
	 	KND Real Estate 35, L.L.C.	  	DE
			
	 146.
	 	KND Real Estate 36, L.L.C.	  	DE
			
	 147.
	 	KND Real Estate 37, L.L.C.	  	DE
			
	 148.
	 	KND Real Estate 38, L.L.C.	  	DE
			
	 149.
	 	KND Real Estate 39, L.L.C.	  	DE
			
	 150.
	 	KND Real Estate 4, L.L.C.	  	DE
			
	 151.
	 	KND Real Estate 40, L.L.C.	  	DE
			
	 152.
	 	KND Real Estate 41, L.L.C.	  	DE
			
	 153.
	 	KND Real Estate 42, L.L.C.	  	DE
			
	 154.
	 	KND Real Estate 43, L.L.C.	  	DE
			
	 155.
	 	KND Real Estate 44, L.L.C.	  	DE
			
	 156.
	 	KND Real Estate 45, L.L.C.	  	DE
			
	 157.
	 	KND Real Estate 46, L.L.C.	  	DE
			
	 158.
	 	KND Real Estate 47, L.L.C.	  	DE
			
	 159.
	 	KND Real Estate 48, L.L.C.	  	DE
			
	 160.
	 	KND Real Estate 49, L.L.C.	  	DE
			
	 161.
	 	KND Real Estate 5, L.L.C.	  	DE
			
	 162.
	 	KND Real Estate 50, L.L.C.	  	DE
			
	 163.
	 	KND Real Estate 51, L.L.C.	  	DE
			
	 164.
	 	KND Real Estate 6, L.L.C.	  	DE
			
	 165.
	 	KND Real Estate 7, L.L.C.	  	DE
			
	 166.
	 	KND Real Estate 8, L.L.C.	  	DE

  
 1-7 

					
	No.	 	Name	  	 State of

Organization

			
	 167.
	 	KND Real Estate 9, L.L.C.	  	DE
			
	 168.
	 	KND Real Estate Holdings, L.L.C.	  	DE
			
	 169.
	 	KND Rehab Real Estate Holdings, L.L.C.	  	DE
			
	 170.
	 	KND SNF Real Estate Holdings, L.L.C.	  	DE
			
	 171.
	 	Lafayette Health Care Center, Inc.	  	GA
			
	 172.
	 	Lafayette Specialty Hospital, L.L.C.	  	DE
			
	 173.
	 	Laurel Lake Health and Rehabilitation, L.L.C.	  	DE
			
	 174.
	 	Maine Assisted Living, L.L.C.	  	DE
			
	 175.
	 	Massachusetts Assisted Living, L.L.C.	  	DE
			
	 176.
	 	Meadows Nursing, L.L.C.	  	DE
			
	 177.
	 	Med. Tech. Services of South Florida, Inc.	  	FL
			
	 178.
	 	MedEquities, Inc.	  	CA
			
	 179.
	 	Medical Hill Rehab Center, L.L.C.	  	DE
			
	 180.
	 	Med-Tech Private Care, Inc.	  	FL
			
	 181.
	 	Med-Tech Services of Dade, Inc.	  	FL
			
	 182.
	 	Med-Tech Services of Palm Beach, Inc.	  	FL
			
	 183.
	 	Mills Medical Practices, LLC	  	OH
			
	 184.
	 	New Triumph HealthCare of Texas, L.L.C.	  	TX
			
	 185.
	 	New Triumph HealthCare, Inc.	  	DE
			
	 186.
	 	New Triumph HealthCare, L.L.P.	  	TX
			
	 187.
	 	North West Texas Home Health Services, LLC	  	TX
			
	 188.
	 	Northland LTACH, LLC	  	DE
			
	 189.
	 	NP Plus, LLC	  	DE
			
	 190.
	 	NRP Holdings Company	  	DE

  
 1-8 

					
	No.	 	Name	  	 State of

Organization

			
	 191.
	 	Outreach Health Services of North Texas, LLC	  	TX
			
	 192.
	 	Outreach Health Services of the Panhandle, LLC	  	TX
			
	 193.
	 	Pacific Coast Care Center, L.L.C.	  	DE
			
	 194.
	 	Pacific West Home Care, LLC	  	DE
			
	 195.
	 	Peoplefirst HomeCare & Hospice of California, L.L.C.	  	DE
			
	 196.
	 	Peoplefirst HomeCare & Hospice of Colorado, L.L.C.	  	DE
			
	 197.
	 	Peoplefirst HomeCare & Hospice of Indiana, L.L.C.	  	DE
			
	 198.
	 	Peoplefirst HomeCare & Hospice of Massachusetts, L.L.C.	  	DE
			
	 199.
	 	Peoplefirst HomeCare & Hospice of Ohio, L.L.C.	  	DE
			
	 200.
	 	Peoplefirst HomeCare & Hospice of Utah, L.L.C.	  	DE
			
	 201.
	 	Peoplefirst HomeCare of Colorado, L.L.C.	  	DE
			
	 202.
	 	Peoplefirst Virginia, L.L.C.	  	DE
			
	 203.
	 	PersonaCare of Connecticut, Inc.	  	CT
			
	 204.
	 	PersonaCare of Huntsville, Inc.	  	DE
			
	 205.
	 	PersonaCare of Ohio, Inc.	  	DE
			
	 206.
	 	PersonaCare of Reading, Inc.	  	DE
			
	 207.
	 	PersonaCare of Wisconsin, Inc.	  	DE
			
	 208.
	 	PF Development 10, L.L.C.	  	DE
			
	 209.
	 	PF Development 15, L.L.C.	  	DE
			
	 210.
	 	PF Development 16, L.L.C.	  	DE
			
	 211.
	 	PF Development 17, L.L.C.	  	DE
			
	 212.
	 	PF Development 18, L.L.C.	  	DE
			
	 213.
	 	PF Development 19, L.L.C.	  	DE
			
	 214.
	 	PF Development 20, L.L.C.	  	DE

  
 1-9 

					
	No.	 	Name	  	 State of

Organization

			
	 215.
	 	PF Development 21, L.L.C.	  	DE
			
	 216.
	 	PF Development 22, L.L.C.	  	DE
			
	 217.
	 	PF Development 23, L.L.C.	  	DE
			
	 218.
	 	PF Development 26, L.L.C.	  	DE
			
	 219.
	 	PF Development 27, L.L.C.	  	DE
			
	 220.
	 	PF Development 5, L.L.C.	  	DE
			
	 221.
	 	PF Development 6, L.L.C.	  	DE
			
	 222.
	 	PF Development 7, L.L.C.	  	DE
			
	 223.
	 	PF Development 8, L.L.C.	  	DE
			
	 224.
	 	PF Development 9, L.L.C.	  	DE
			
	 225.
	 	PHH Acquisition Corp.	  	DE
			
	 226.
	 	Professional Healthcare at Home, LLC	  	CA
			
	 227.
	 	Professional Healthcare, LLC	  	DE
			
	 228.
	 	Rehab Insurance Corporation	  	DE
			
	 229.
	 	Rehab Staffing, L.L.C.	  	DE
			
	 230.
	 	RehabCare Development 2, L.L.C.	  	DE
			
	 231.
	 	RehabCare Development 3, L.L.C.	  	DE
			
	 232.
	 	RehabCare Development 4, L.L.C.	  	DE
			
	 233.
	 	RehabCare Development 5, L.L.C.	  	DE
			
	 234.
	 	RehabCare Group East, Inc.	  	DE
			
	 235.
	 	RehabCare Group Management Services, Inc.	  	DE
			
	 236.
	 	RehabCare Group of Amarillo, L.P.	  	TX
			
	 237.
	 	RehabCare Group of Arlington, L.P.	  	TX
			
	 238.
	 	RehabCare Group of California, L.L.C.	  	DE

  
 1-10 

					
	No.	 	Name	  	 State of

Organization

			
	 239.
	 	RehabCare Group of Texas, L.L.C.	  	TX
			
	 240.
	 	RehabCare Group, Inc.	  	DE
			
	 241.
	 	RehabCare Hospital Holdings, L.L.C.	  	DE
			
	 242.
	 	Salt Lake Physical Therapy Associates, Inc.	  	UT
			
	 243.
	 	SCCI Health Services Corporation	  	DE
			
	 244.
	 	SCCI Hospital – Easton, Inc.	  	DE
			
	 245.
	 	SCCI Hospital – El Paso, Inc.	  	DE
			
	 246.
	 	SCCI Hospital – Mansfield, Inc.	  	DE
			
	 247.
	 	SCCI Hospital Ventures, Inc.	  	DE
			
	 248.
	 	SCCI Hospitals of America, Inc.	  	DE
			
	 249.
	 	Senior Home Care, Inc.	  	FL
			
	 250.
	 	SHC Holding, Inc.	  	DE
			
	 251.
	 	SHC Rehab, Inc.	  	FL
			
	 252.
	 	Siena Care Center, L.L.C.	  	DE
			
	 253.
	 	Smith Ranch Care Center, L.L.C.	  	DE
			
	 254.
	 	Southern California Specialty Care, Inc.	  	CA
			
	 255.
	 	Southern Nevada Home Health Care, Inc.	  	NV
			
	 256.
	 	Southern Utah Home Health, Inc.	  	UT
			
	 257.
	 	Southern Utah Home Oxygen & Medical Equipment, Inc.	  	UT
			
	 258.
	 	Specialty Healthcare Services, Inc.	  	DE
			
	 259.
	 	Specialty Hospital of Cleveland, Inc.	  	OH
			
	 260.
	 	Specialty Hospital of Philadelphia, Inc.	  	PA
			
	 261.
	 	Specialty Hospital of South Carolina, Inc.	  	SC
			
	 262.
	 	Springfield Park View Hospital, L.L.C.	  	DE

  
 1-11 

					
	No.	 	Name	  	 State of

Organization

			
	 263.
	 	Symphony Health Services, L.L.C.	  	DE
			
	 264.
	 	Synergy Healthcare Group, Inc.	  	LA
			
	 265.
	 	Synergy Home Care-Acadiana Region, Inc.	  	LA
			
	 266.
	 	Synergy Home Care-Capitol Region, Inc.	  	LA
			
	 267.
	 	Synergy Home Care-Central Region, Inc.	  	LA
			
	 268.
	 	Synergy Home Care-Northeastern Region, Inc.	  	LA
			
	 269.
	 	Synergy Home Care-Northshore Region, Inc.	  	LA
			
	 270.
	 	Synergy Home Care-Northwestern Region, Inc.	  	LA
			
	 271.
	 	Synergy Home Care-Southeastern Region, Inc.	  	LA
			
	 272.
	 	Synergy, Inc.	  	LA
			
	 273.
	 	Texas Health Management Group, LLC	  	TX
			
	 274.
	 	THC – Chicago, Inc.	  	IL
			
	 275.
	 	THC – Houston, Inc.	  	TX
			
	 276.
	 	THC – North Shore, Inc.	  	IL
			
	 277.
	 	THC – Orange County, Inc.	  	CA
			
	 278.
	 	THC – Seattle, Inc.	  	WA
			
	 279.
	 	The Therapy Group, Inc.	  	LA
			
	 280.
	 	TherEX, Inc.	  	DE
			
	 281.
	 	Tower Hill Nursing, L.L.C.	  	DE
			
	 282.
	 	Transitional Hospitals Corporation of Indiana, Inc.	  	IN
			
	 283.
	 	Transitional Hospitals Corporation of Louisiana, Inc.	  	LA
			
	 284.
	 	Transitional Hospitals Corporation of Nevada, Inc.	  	NV
			
	 285.
	 	Transitional Hospitals Corporation of New Mexico, Inc.	  	NM
			
	 286.
	 	Transitional Hospitals Corporation of Tampa, Inc.	  	FL

  
 1-12 

					
	No.	 	Name	  	 State of

Organization

			
	 287.
	 	Transitional Hospitals Corporation of Texas, Inc.	  	TX
			
	 288.
	 	Transitional Hospitals Corporation of Wisconsin, Inc.	  	WI
			
	 289.
	 	Trinity Hospice of Texas, LLC	  	TX
			
	 290.
	 	Triumph HealthCare Holdings, Inc.	  	DE
			
	 291.
	 	Triumph HealthCare Second Holdings, L.L.C.	  	DE
			
	 292.
	 	Triumph HealthCare Third Holdings, L.L.C.	  	DE
			
	 293.
	 	Triumph Hospital Northwest Indiana, Inc.	  	MO
			
	 294.
	 	Triumph Rehabilitation Hospital Northern Indiana, L.L.C.	  	IN
			
	 295.
	 	Triumph Rehabilitation Hospital of Northeast Houston, LLC	  	DE
			
	 296.
	 	Tucker Nursing Center, Inc.	  	GA
			
	 297.
	 	Tulsa Specialty Hospital L.L.C.	  	DE
			
	 298.
	 	Vernon Home Health Care Agency, LLC	  	TX
			
	 299.
	 	VTA Management Services, L.L.C.	  	DE
			
	 300.
	 	VTA Staffing Services, LLC	  	DE
			
	 301.
	 	Wellstream Health Services, LLC	  	TX
			
	 302.
	 	West Texas, LLC	  	TX
			
	 303.
	 	Ygnacio Valley Care Center, L.L.C.	  	DE

  
 1-13 

 Annex A 

Counterpart to Registration Rights Agreement 

The undersigned hereby absolutely, unconditionally and irrevocably agrees as a Guarantor (as defined in the Registration Rights Agreement,
dated as of April 9, 2014, by and among Kindred Healthcare, Inc., a Delaware corporation, the Guarantors and J.P. Morgan Securities LLC, on behalf of itself and the other Initial Purchasers) to be bound by the terms and provisions of such
Registration Rights Agreement. 
 IN WITNESS WHEREOF, the undersigned has executed this counterpart as of ____________. 

 

			
	[NAME]
		
	By:	 	  

		 	Name:
		 	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00229-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00229-of-00352.parquet"}]]